0001753926-23-000594.txt : 20230508 0001753926-23-000594.hdr.sgml : 20230508 20230508162156 ACCESSION NUMBER: 0001753926-23-000594 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 52 CONFORMED PERIOD OF REPORT: 20230331 FILED AS OF DATE: 20230508 DATE AS OF CHANGE: 20230508 FILER: COMPANY DATA: COMPANY CONFORMED NAME: INTER PARFUMS INC CENTRAL INDEX KEY: 0000822663 STANDARD INDUSTRIAL CLASSIFICATION: PERFUMES, COSMETICS & OTHER TOILET PREPARATIONS [2844] IRS NUMBER: 133275609 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 000-16469 FILM NUMBER: 23898087 BUSINESS ADDRESS: STREET 1: 551 FIFTH AVE STREET 2: STE 1500 CITY: NEW YORK STATE: NY ZIP: 10176 BUSINESS PHONE: 2129832640 MAIL ADDRESS: STREET 1: 551 FIFTH AVENUE STREET 2: STE 1500 CITY: NEW YORK STATE: NY ZIP: 10176 FORMER COMPANY: FORMER CONFORMED NAME: JEAN PHILIPPE FRAGRANCES INC DATE OF NAME CHANGE: 19920703 10-Q 1 g083513_10q.htm 10-Q
0000822663 false --12-31 2023 Q1 2023-03-31 NY NASDAQ P7Y P50Y P10Y P4Y P10Y P5Y6M0D P4Y P5Y 90000 P3Y6M21D P1Y9M0D 5580000 0000822663 2023-01-01 2023-03-31 0000822663 2023-05-08 0000822663 2023-03-31 0000822663 2022-12-31 0000822663 2022-01-01 2022-03-31 0000822663 us-gaap:CommonStockMember 2022-12-31 0000822663 us-gaap:CommonStockMember 2021-12-31 0000822663 us-gaap:AdditionalPaidInCapitalMember 2022-12-31 0000822663 us-gaap:AdditionalPaidInCapitalMember 2021-12-31 0000822663 us-gaap:RetainedEarningsMember 2022-12-31 0000822663 us-gaap:RetainedEarningsMember 2021-12-31 0000822663 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-12-31 0000822663 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-12-31 0000822663 us-gaap:TreasuryStockCommonMember 2022-12-31 0000822663 us-gaap:TreasuryStockCommonMember 2021-12-31 0000822663 us-gaap:NoncontrollingInterestMember 2022-12-31 0000822663 us-gaap:NoncontrollingInterestMember 2021-12-31 0000822663 2021-12-31 0000822663 us-gaap:CommonStockMember 2023-01-01 2023-03-31 0000822663 us-gaap:CommonStockMember 2022-01-01 2022-03-31 0000822663 us-gaap:AdditionalPaidInCapitalMember 2023-01-01 2023-03-31 0000822663 us-gaap:AdditionalPaidInCapitalMember 2022-01-01 2022-03-31 0000822663 us-gaap:RetainedEarningsMember 2023-01-01 2023-03-31 0000822663 us-gaap:RetainedEarningsMember 2022-01-01 2022-03-31 0000822663 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-01-01 2023-03-31 0000822663 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-01-01 2022-03-31 0000822663 us-gaap:TreasuryStockCommonMember 2023-01-01 2023-03-31 0000822663 us-gaap:TreasuryStockCommonMember 2022-01-01 2022-03-31 0000822663 us-gaap:NoncontrollingInterestMember 2023-01-01 2023-03-31 0000822663 us-gaap:NoncontrollingInterestMember 2022-01-01 2022-03-31 0000822663 us-gaap:CommonStockMember 2023-03-31 0000822663 us-gaap:CommonStockMember 2022-03-31 0000822663 us-gaap:AdditionalPaidInCapitalMember 2023-03-31 0000822663 us-gaap:AdditionalPaidInCapitalMember 2022-03-31 0000822663 us-gaap:RetainedEarningsMember 2023-03-31 0000822663 us-gaap:RetainedEarningsMember 2022-03-31 0000822663 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-03-31 0000822663 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-03-31 0000822663 us-gaap:TreasuryStockCommonMember 2023-03-31 0000822663 us-gaap:TreasuryStockCommonMember 2022-03-31 0000822663 us-gaap:NoncontrollingInterestMember 2023-03-31 0000822663 us-gaap:NoncontrollingInterestMember 2022-03-31 0000822663 2022-03-31 0000822663 ipar:LacosteMember 2023-01-01 2023-03-31 0000822663 ipar:DonnaKaranAndDKNYMember 2023-01-01 2023-03-31 0000822663 ipar:RochasFashionMember 2023-01-01 2023-03-31 0000822663 2021-04-30 0000822663 us-gaap:LandMember 2023-01-01 2023-03-31 0000822663 us-gaap:BuildingMember 2023-01-01 2023-03-31 0000822663 srt:MinimumMember 2023-03-31 0000822663 srt:MaximumMember 2023-03-31 0000822663 currency:EUR 2023-03-31 0000822663 us-gaap:FairValueMeasurementsRecurringMember 2023-03-31 0000822663 us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel1Member 2023-03-31 0000822663 us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel2Member 2023-03-31 0000822663 us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel3Member 2023-03-31 0000822663 us-gaap:FairValueMeasurementsRecurringMember 2022-12-31 0000822663 us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel1Member 2022-12-31 0000822663 us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel2Member 2022-12-31 0000822663 us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel3Member 2022-12-31 0000822663 currency:EUR 2022-12-31 0000822663 currency:EUR 2021-04-30 0000822663 currency:EUR us-gaap:InterestRateSwapMember 2021-04-30 0000822663 us-gaap:ForeignExchangeContractMember 2023-03-31 0000822663 us-gaap:StockOptionMember srt:MinimumMember 2023-01-01 2023-03-31 0000822663 us-gaap:StockOptionMember srt:MaximumMember 2023-01-01 2023-03-31 0000822663 us-gaap:StockOptionMember 2023-01-01 2023-03-31 0000822663 us-gaap:StockOptionMember 2022-01-01 2022-03-31 0000822663 ipar:InterparfumsSASubsidiaryMember ipar:EmployeesMember 2018-12-31 0000822663 ipar:InterparfumsSASubsidiaryMember ipar:OfficersAndManagersMember 2018-12-31 0000822663 2022-06-01 2022-06-30 0000822663 ipar:InterparfumsSASubsidiaryMember ipar:EmployeesMember 2022-03-31 0000822663 ipar:InterparfumsSASubsidiaryMember ipar:EmployeesMember 2023-01-01 2023-03-31 0000822663 ipar:InterparfumsSASubsidiaryMember ipar:EmployeesMember 2022-12-31 0000822663 ipar:InterparfumsSASubsidiaryMember ipar:EmployeesMember 2022-01-01 2022-12-31 0000822663 country:US 2023-01-01 2023-03-31 0000822663 country:US 2022-01-01 2022-03-31 0000822663 srt:EuropeMember 2023-01-01 2023-03-31 0000822663 srt:EuropeMember 2022-01-01 2022-03-31 0000822663 ipar:EliminationsMember 2023-01-01 2023-03-31 0000822663 ipar:EliminationsMember 2022-01-01 2022-03-31 0000822663 country:US 2023-03-31 0000822663 country:US 2022-12-31 0000822663 srt:EuropeMember 2023-03-31 0000822663 srt:EuropeMember 2022-12-31 0000822663 ipar:EliminationsMember 2023-03-31 0000822663 ipar:EliminationsMember 2022-12-31 iso4217:USD xbrli:shares iso4217:USD xbrli:shares xbrli:pure iso4217:JPY iso4217:EUR iso4217:GBP

 

UNITED STATES 

SECURITIES AND EXCHANGE COMMISSION 

WASHINGTON, D.C. 20549

 

FORM 10-Q

 

(MARK ONE)

 

☒Quarterly Report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 for the quarterly period ended March 31, 2023.

 

OR

 

☐Transition Report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 for the transition period from ___________to ________.

 

Commission File No. 0-16469

 

INTER PARFUMS, INC. 

(Exact name of registrant as specified in its charter)

 

Delaware   13-3275609
(State or other jurisdiction of   (I.R.S. Employer
incorporation or organization)   Identification No.)

 

551 Fifth Avenue, New York, New York     10176
(Address of Principal Executive Offices)          (Zip Code)

 

(212) 983-2640
(Registrants telephone number, including area code)

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class   Trading Symbol(s)   Name of each exchange on which
registered
 Common Stock, $.001 par value per share   IPAR    The Nasdaq Stock Market

 

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days: Yes ☒  No ☐

 

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). 

Yes ☒  No ☐

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company. See definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act).

 

Large accelerated filer ☒ Accelerated filer ☐
Non-accelerated filer ☐ (Do not check if a smaller reporting company) Smaller reporting company ☐
  Emerging Growth company ☐

 

 

 

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐  No ☒

 

Indicate the number of shares outstanding of each of the issuer’s classes of common stock, as of the latest practicable date.

 

At May 8, 2023, there were 32,012,950 shares of common stock, par value $.001 per share, outstanding.

 

 

 

 

INTER PARFUMS, INC. AND SUBSIDIARIES

 

INDEX

 

  Page Number
   
Part I.    Financial Information 1
       
  Item 1. Financial Statements  
       
    Consolidated Balance Sheets as of March 31, 2023 and December 31, 2022 2
       
    Consolidated Statements of Income for the Three Months Ended March 31, 2023 and March 31, 2022 3
       
    Consolidated Statements of Comprehensive Income for the Three Months Ended March 31, 2023 and March 31, 2022 4
       
    Consolidated Statements of Changes in Equity for the Three Months Ended March 31, 2023 and March 31, 2022 5
       
    Consolidated Statements of Cash Flows for the Three Months Ended  March 31, 2023 and March 31, 2022 6
       
    Notes to Consolidated Financial Statements 7
       
  Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations 15
       
  Item 3. Quantitative and Qualitative Disclosures About Market Risk 24
       
  Item 4. Controls and Procedures 25
       
Part II.    Other Information 25
       
  Item 2. Unregistered Sales of Equity Securities and Use of Proceeds 25
       
  Item 6. Exhibits 26
       
Signatures 27

 

 

 

 

INTER PARFUMS, INC. AND SUBSIDIARIES

 

Part I. Financial Information

 

Item 1. Financial Statements

 

In our opinion, the accompanying unaudited consolidated financial statements contain all adjustments (consisting only of normal recurring adjustments) necessary to present fairly our financial position, results of operations and cash flows for the interim periods presented. We have condensed such financial statements in accordance with the rules and regulations of the Securities and Exchange Commission (“SEC”). Therefore, such financial statements do not include all disclosures required by accounting principles generally accepted in the United States of America. In preparing these consolidated financial statements, the Company has evaluated events and transactions for potential recognition or disclosure through the date the consolidated financial statements were issued by filing with the SEC. These financial statements should be read in conjunction with our audited financial statements for the year ended December 31, 2022, included in our annual report filed on Form 10-K.

 

The results of operations for the three months ended March 31, 2023, are not necessarily indicative of the results to be expected for the entire fiscal year.

 

Page 1

 

 

INTER PARFUMS, INC. AND SUBSIDIARIES

 

CONSOLIDATED BALANCE SHEETS 

(In thousands except share and per share data) 

(Unaudited)

 

             
ASSETS
   March 31,  
2023		   December 31,
2022		 
Current assets:          
Cash and cash equivalents  $149,055   $104,713 
Short-term investments   88,702    150,833 
Accounts receivable, net   241,948    197,584 
Inventories   323,700    289,984 
Receivables, other   27,779    28,803 
Other current assets   20,346    15,650 
Income taxes receivable   71    157 
Total current assets   851,601    787,724 
Property, equipment and leasehold improvements, net   169,036    166,722 
Right-of-use assets, net   26,901    27,964 
Trademarks, licenses and other intangible assets, net   294,300    290,853 
Deferred tax assets   12,543    11,159 
Other assets   25,825    24,120 
Total assets  $1,380,206   $1,308,542 
           
LIABILITIES AND EQUITY 
Current liabilities:          
Loans payable - banks  $18,000   $— 
Current portion of long-term debt   29,092    28,547 
Current portion of lease liabilities   5,310    5,296 
Accounts payable – trade   93,053    88,388 
Accrued expenses   190,305    213,621 
Income taxes payable   26,409    8,715 
Total current liabilities   362,169    344,567 
           
Long–term debt, less current portion   145,128    151,494 
           
Lease liabilities, less current portion   23,302    24,335 
           
Equity:          
Inter Parfums, Inc. shareholders’ equity:          
Preferred stock, $.001 par; authorized 1,000,000 shares; none issued   —    — 

Common stock, $.001 par; authorized 100,000,000 shares; outstanding 32,012,950 and 31,967,300 shares at March 31, 2023 and December 31, 2022, respectively 

   32    32 
Additional paid-in capital   95,429    90,186 
Retained earnings   654,440    620,095 
Accumulated other comprehensive loss   (48,440)   (56,056)
Treasury stock, at cost, 9,907,865 and 9,864,805 shares at March 31, 2023 and December 31, 2022, respectively   (43,055)   (37,475)
Total Inter Parfums, Inc. shareholders’ equity   658,406    616,782 
Noncontrolling interest   191,201    171,364 
Total equity   849,607    788,146 
Total liabilities and equity  $1,380,206   $1,308,542 

 

See notes to consolidated financial statements.

 

Page 2

 

 

INTER PARFUMS, INC. AND SUBSIDIARIES 

 

CONSOLIDATED STATEMENTS OF INCOME 

(In thousands except per share data) 

(Unaudited)

 

             
   Three Months Ended
March 31,		 
   2023   2022 
         
Net sales  $311,723   $250,678 
           
Cost of sales   108,766    92,020 
           
Gross margin   202,957    158,658 
           
Selling, general and administrative expenses   112,678    97,441 
           
Income from operations   90,279    61,217 
           
Other expenses (income):          
Interest expense   2,357    883 
Loss (gain) on foreign currency   759    (2,239)
Interest and investment (income) loss   (5,382)   1,466 
Other income    (41)   (116)
           
Nonoperating Income (Expense)     (2,307 )     (6 )
           
Income before income taxes   92,586    61,223 
           
Income taxes   21,678    14,932 
           
Net income   70,908    46,291 
           
Less:  Net income attributable to the noncontrolling interest   16,840    10,992 
           
Net income attributable to Inter Parfums, Inc.  $54,068   $35,299 
           
Earnings per share:          
           
Net income attributable to Inter Parfums, Inc. common shareholders:          
   Basic  $1.69   $1.11 
   Diluted  $1.68   $1.10 
           
Weighted average number of shares outstanding:          
   Basic   32,018    31,840 
   Diluted   32,159    32,010 
           
Dividends declared per share  $0.625   $0.50 

 

See notes to consolidated financial statements.

Page 3

 

 

INTER PARFUMS, INC. AND SUBSIDIARIES 

 

CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME 

(In thousands) 

(Unaudited)

 

             
   Three Months Ended
March 31,		 
   2023   2022 
Comprehensive income:          
           
Net income  $70,908   $46,291 
           
Other comprehensive income:          
           
Net derivative instrument gain (loss), net of tax
   (4,166)   261 
           
Transfer from OCI into earnings
   1,709    992 
           
Translation adjustments, net of tax   13,489    (12,441)
           
Comprehensive income   81,940    35,103 
           
Comprehensive income attributable to the noncontrolling interests:          
           
Net income   16,840    10,992 
           
Other comprehensive income:          
           
Net derivative instrument gain (loss), net of tax
   (206)   72 
           
Translation adjustments, net of tax   3,622    (3,419)
           
Comprehensive income attributable to the noncontrolling interests   20,256    7,645 
           
Comprehensive income attributable to Inter Parfums, Inc.  $61,684   $27,458 

 

See notes to consolidated financial statements.

 

Page 4

 

 

INTER PARFUMS, INC. AND SUBSIDIARIES 

 

CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY 

(In thousands) 

(Unaudited)

 

             
   Three months ended
March 31,		 
   2023   2022 
         
Common stock, beginning and end of period  $32   $32 
         
         
Additional paid-in capital, beginning of period   90,186    87,132 
Shares issued upon exercise of stock options   4,929    708 
Share-based compensation   314    341 
Additional paid-in capital, end of period   95,429    88,181 
           
Retained earnings, beginning of period   620,095    560,663 
Net income   54,068    35,299 
Dividends   (20,023)   (15,921)
Share-based compensation   300    53 
Retained earnings, end of period   654,440    580,094 
           
Accumulated other comprehensive loss, beginning of   period   (56,056)   (38,432)
Foreign currency translation adjustment, net of tax   9,867    (9,022)
Transfer from other comprehensive income into earnings   1,709    992 
Net derivative instrument gain (loss), net of tax   (3960)   189 
Accumulated other comprehensive loss, end of period   (48,440)   (46,273)
    -    - 
Treasury stock, beginning of period   (37,475)   (37,475)
Shares repurchased   (5,580)   — 
  Treasury stock, end of period   (43,055)   (37,475)
           
Noncontrolling interest, beginning of period   171,364    166,412 
Net income   16,840    10,992 
Foreign currency translation adjustment, net of tax   3,622    (3,419)
Net derivative instrument gain (loss), net of tax   (206)   72 
Share-based compensation (adjustment)   54    11 
Transfer of subsidiary shares purchased   —    54 
Dividends   (473)   (440)
Noncontrolling interest, end of period   191,201    173,682 
    \788,146    738,332 
    70,908    46,291 
Total equity  $849,607   $758,241 

 

See notes to consolidated financial statements.

 

Page 5

 

 

INTER PARFUMS, INC. AND SUBSIDIARIES 

 

CONSOLIDATED STATEMENTS OF CASH FLOWS 

(In thousands) 

(Unaudited)

 

             
   Three months ended
March 31,		 
   2023   2022 
Cash flows from operating activities:          
Net income  $70,908   $46,291 
Adjustments to reconcile net income to net cash provided by (used in) operating activities:          
Depreciation and amortization   4,115    3,124 
Provision for doubtful accounts   220    1,048 
Noncash stock compensation   633    654 
Share of income of equity investment   (41)   (116)
Noncash lease expense   1,324    1,881 
Deferred tax provision   (1,188)   135 
Change in fair value of derivatives   1,518    (3,803)
Changes in:          
Accounts receivable   (42,670)   (50,316)
Inventories   (29,688)   (31,195)
Other assets   (5,640)   (2,869)
Operating lease liabilities   (1,293)   (1,671)
Accounts payable and accrued expenses   (23,327)   3,203 
Income taxes, net   17,771    9,690 
           
Net cash used in operating activities   (7,358)   (23,944)
           
Cash flows from investing activities:          
Purchases of short-term investments   (42,835)   (2,243)
Proceeds from sale of short-term investments   107,045    3,982 
Purchases of property, equipment and leasehold improvements   (2,415)   (12,895)
Payment for intangible assets acquired   (151)   (647)
           
Net cash provided by (used in) investing activities   61,644    (11,803)
           
Cash flows from financing activities:          
Proceeds from issuance of long-term debt   17,989    — 
Repayment of long-term debt   (9,397)   (4,379)
Proceeds from exercise of options   4,929    708 
Dividends paid   (20,023)   (15,921)
Dividends paid to noncontrolling interest   (473)   (440)
Purchase of treasury stock   (5,580)   — 
           
Net cash used in financing activities   (12,555)   (20,032)
           
Effect of exchange rate changes on cash   2,611    (2,486)
           
Net increase (decrease) in cash and cash equivalents   44,342    (58,265)
           
Cash and cash equivalents - beginning of period   104,713    168,387 
           
Cash and cash equivalents - end of period  $149,055   $110,122 
           
Supplemental disclosure of cash flow information:          
Cash paid for:          
Interest  $1,563   $797 
Income taxes   4,816    5,193 

 

See notes to consolidated financial statements.

 

Page 6

 

 

INTER PARFUMS, INC. AND SUBSIDIARIES 

 

Notes to Consolidated Financial Statements

 

1.Significant Accounting Policies:

 

The accounting policies we follow are set forth in the notes to our consolidated financial statements included in our Form 10-K, which was filed with the Securities and Exchange Commission for the year ended December 31, 2022.

 

 

2.Impact of COVID-19 Pandemic:

 

Our business has continued to significantly improve throughout 2022 and the first quarter of 2023 after the disastrous effects of the COVID-19 Pandemic starting in early 2020, as retail stores reopened, and consumers increased online purchasing. The introduction of variants of COVID-19 in various parts of the world continues to cause the temporary re-implementation of governmental restrictions to prevent further spread of the virus. In addition, international air travel remains curtailed in several jurisdictions due to both governmental restrictions and consumer health concerns. While COVID-19 had significantly restricted international travel, the travel retail business has picked up. Lastly, we have experienced significant strains on our supply chain causing disruptions affecting the procurement of components, the ability to transport goods, and related cost increases. These disruptions have come at a time when demand for our product lines has never been stronger or more sustained. We have been addressing this issue since the beginning of 2021, by ordering well in advance of need and in larger quantities. Since 2021, we have strived to carry more inventory overall, source the same components from multiple suppliers and when possible, manufacture products closer to where they are sold. We do not expect the supply chain bottlenecks to begin lifting until the second half of 2023. Therefore, despite recent business improvement, the impact of the COVID-19 pandemic might continue to have adverse effects on our results of our operations, financial position and cash flows through at least the first half of 2023.

 

 

3.Recent Agreements:

 

Lacoste

 

In December 2022, we closed a transaction agreement with Lacoste, whereby an exclusive and worldwide license was granted for the production and distribution of Lacoste brand perfumes and cosmetics. Our rights under this license are subject to certain minimum advertising expenditures and royalty payments as are customary in our industry. The license becomes effective in January 2024 and will last for 15 years.

 

Dunhill

 

In April 2022, we announced that the Dunhill fragrance license will expire on September 30, 2023 and will not be renewed. The Company will continue to produce and sell Dunhill fragrances until the license expires and will maintain the right to sell-off remaining Dunhill fragrance inventory for a limited time as is customary in the fragrance industry.

 

Donna Karan and DKNY

 

In September 2021, we entered into a long-term global licensing agreement for the creation, development and distribution of fragrances and fragrance-related products under the Donna Karan and DKNY brands. Our rights under this license are subject to certain minimum advertising expenditures and royalty payments as are customary in our industry. With this agreement, we gained several well-established and valuable fragrance franchises, most notably Donna Karan Cashmere Mist and DKNY Be Delicious, as well as a significant loyal consumer base around the world. In connection with the grant of license, we issued 65,342 shares of Inter Parfums, Inc. common stock valued at $5.0 million to the licensor. The exclusive license became effective July 1, 2022, and we are planning to launch new fragrances under these brands in 2024.

 

Page 7

 

 

INTER PARFUMS, INC. AND SUBSIDIARIES 

 

Notes to Consolidated Financial Statements

 

Rochas Fashion

 

Effective January 1, 2021, we entered into a new license agreement modifying our Rochas fashion business model. The new agreement calls for a reduction in royalties to be received. As a result, in the first quarter of 2021, we took a $2.4 million impairment charge on our Rochas fashion trademark. In the fourth quarter of 2022, we again took a $6.8 million impairment charge on the Rochas fashion trademark after an independent expert concluded that the valuation of the trademark was $11.3 million. The new license also contains an option for the licensee to buy-out the Rochas fashion trademarks in June 2025 at its then fair market value.

 

Land and Building Acquisition - New Headquarters in Paris

 

In April 2021, Interparfums SA, our 72% owned French subsidiary, completed the acquisition of its new headquarters at 10 rue de Solférino in the 7th arrondissement of Paris from the property developer. This is an office complex combining three buildings connected by two inner courtyards, and consists of approximately 40,000 total sq. ft.

 

The purchase price included the complete renovation of the site. As of March 31, 2023, $151 million of the purchase price, including approximately $4.5 million of acquisition costs, is included in property, equipment and leasehold improvements on the accompanying balance sheet. The purchase price has been allocated approximately $62.3 million to land and $88.7 million to the building. The building, which was delivered on February 28, 2022, includes the building structure, development of the property, façade waterproofing, general and technical installations and interior fittings that will be depreciated over a range of 7 to 50 years. The Company has elected to depreciate the building cost based on the useful lives of its components. Approximately $1.8 million of cash held in escrow is also included in property, equipment and leasehold improvements on the accompanying balance sheet as of March 31, 2023.

 

The acquisition was financed by a 10-year €120 million (approximately $130.5 million) bank loan which bears interest at one-month Euribor plus 0.75%. Approximately €80 million of the variable rate debt was swapped for variable interest rate debt with a maximum rate of 2% per annum. The swap effectively exchanges the variable interest rate to a fixed rate of approximately 1.1%.

 

 

4.Recent Accounting Pronouncements:

 

There are no recent accounting pronouncements issued but not yet adopted that would have a material effect on our consolidated financial statements.

 

 

5.Inventories:

 

Inventories consist of the following:

 

(In thousands)  March 31, 
2023		   December 31,
2022		 
Raw materials and component parts  $155,013   $146,772 
Finished goods   168,687    143,212 
           
Inventories  $323,700   $289,984 

 

 

Page 8

 

 

INTER PARFUMS, INC. AND SUBSIDIARIES 

 

Notes to Consolidated Financial Statements

 

6.Fair Value Measurement:

 

The following tables present our financial assets and liabilities that are measured at fair value on a recurring basis and are categorized using the fair value hierarchy. The fair value hierarchy has three levels based on the reliability of the inputs used to determine fair value.

 

                             
          Fair Value Measurements at March 31, 2023  
          Quoted Prices in     Significant Other     Significant  
          Active Markets for     Observable     Unobservable  
          Identical Assets     Inputs     Inputs  
    Total     (Level 1)     (Level 2)     (Level 3)  
Assets:                      
Short-term investments   $ 88,702     $ 681     $ 87,210     $ 811  
Interest rate swaps     6,429               6,429          
Foreign currency forward exchange contracts not accounted for using hedge accounting     1,539       —       1,539       —  
Foreign currency forward exchange contracts accounted for using hedge accounting     339     $ —       339       —  
                                 
Total assets   $ 97,010     $ 681     $ 95,517     $ 811  

 

                               
           Fair Value Measurements at December 31, 2022 
       Quoted Prices in   Significant Other   Significant 
       Active Markets for   Observable   Unobservable 
       Identical Assets   Inputs   Inputs 
   Total   (Level 1)   (Level 2)   (Level 3) 
Assets:                
Short-term investments  $150,833   $19,861   $130,174   $798 
Interest rate swaps   6,758    —    6,758    — 
Foreign currency forward exchange contracts accounted for using hedge accounting   1,189    —    1,189    — 
                     
Total assets  $158,780   $19,861   $138,122   $798 
Liabilities:                    
Foreign currency forward exchange contracts not accounted for using hedge accounting   68    —    68    — 
                     
Total liabilities  $68   $—   $68   $— 

 

The carrying amount of cash and cash equivalents including money market funds, short-term investments, accounts receivable, other receivables, cash held in escrow, accounts payable and accrued expenses approximate fair value due to the short terms to maturity of these instruments.

 

Page 9

 

 

INTER PARFUMS, INC. AND SUBSIDIARIES 

 

Notes to Consolidated Financial Statements

 

The carrying amount of loans payable approximates fair value as the interest rates on the Company’s indebtedness approximate current market rates. The fair value of the Company’s long-term debt was estimated based on the current rates offered to companies for debt with the same remaining maturities and is approximately equal to its carrying value.

 

Foreign currency forward exchange contracts are valued based on quotations from financial institutions and the value of interest rate swaps are the discounted net present value of the swaps using third party quotes from financial institutions.

 

 

7.Derivative Financial Instruments:

 

The Company enters into foreign currency forward exchange contracts to hedge exposure related to receivables denominated in a foreign currency and occasionally to manage risks related to future sales expected to be denominated in a foreign currency. Before entering into a derivative transaction for hedging purposes, it is determined that a high degree of initial effectiveness exists between the change in value of the hedged item and the change in the value of the derivative instrument from movement in exchange rates. High effectiveness means that the change in the cash flows of the derivative instrument will effectively offset the change in the cash flows of the hedged item. The effectiveness of each hedged item is measured throughout the hedged period and is based on the dollar offset methodology and excludes the portion of the fair value of the foreign currency forward exchange contract attributable to the change in spot-forward difference which is reported in current period earnings. Any hedge ineffectiveness is also recognized as a gain or loss on foreign currency in the income statement. For hedge contracts that are no longer deemed highly effective, hedge accounting is discontinued, and gains and losses accumulated in other comprehensive income are reclassified to earnings. If it is probable that the forecasted transaction will no longer occur, then any gains or losses accumulated in other comprehensive income are reclassified to current-period earnings. 

 

In December 2022, to finance the acquisition of the Lacoste trademark, the Company entered into a €50 million ($54.4 million) 4-year term loan with a variable interest rate. This variable rate debt was swapped for variable interest rate debt with a maximum rate of 2% per annum. This swap is a hedged derivative instrument and is therefore recorded at fair value and changes in fair value are reflected in other comprehensive income.

 

In connection with the April 2021 acquisition of the office building complex in Paris, €120 million (approximately $130.5 million) of the purchase price was financed through a 10-year term loan. The Company entered into interest rate swap contracts related to €80 million of the loan, effectively exchanging the variable interest rate to a fixed rate of approximately 1.1%. This derivative instrument is recorded at fair value and changes in fair value are reflected in the accompanying consolidated statements of income.

 

Gains and losses in derivatives designated as hedges are accumulated in other comprehensive income and gains and losses in derivatives not designated as hedges are included in (gain) loss on foreign currency on the accompanying income statements. Such gains and losses were immaterial for both the three months ended March 31, 2023 and 2022.

 

All derivative instruments are reported as either assets or liabilities on the balance sheet measured at fair value. The valuation of interest rate swaps is included in long-term debt on the accompanying balance sheets. The valuation of foreign currency forward exchange contracts at March 31, 2023, resulted in a net asset and is included in other current assets on the accompanying balance sheet.

 

At March 31, 2023, we had foreign currency contracts in the form of forward exchange contracts in the amount of approximately U.S. $37 million which all have maturities of less than one year.

 

Page 10

 

 

INTER PARFUMS, INC. AND SUBSIDIARIES 

 

Notes to Consolidated Financial Statements

 

8.Leases:

 

The Company leases its offices and warehouses, vehicles, and certain office equipment, substantially all of which are classified as operating leases. The Company currently has no material financing leases. The Company determines if an arrangement is a lease at inception. Operating lease assets and obligations are recognized at the lease commencement date based on the present value of lease payments over the lease term.

 

In determining lease asset value, the Company considers fixed or variable payment terms, prepayments, incentives, and options to extend or terminate, depending on the lease. Renewal, termination or purchase options affect the lease term used for determining lease asset value only if the option is reasonably certain to be exercised. The Company generally uses its incremental borrowing rate based on information available at the lease commencement date for the location in which the lease is held in determining the present value of lease payments.

 

As of March 31, 2023, the weighted average remaining lease term was 5.5 years and the weighted average discount rate used to determine the operating lease liability was 2.6%. Rental expense related to operating leases was $1.4 million and $1.8 million for the three months ended March 31, 2023 and 2022, respectively. Operating lease payments included in operating cash flows totaled $1.3 million and $1.7 million for the three months ended March 31, 2023 and 2022, respectively, and there were no noncash additions to operating lease assets for the three months ended March 31, 2023 and 2022.

 

 

9.Share-Based Payments:

 

The Company maintains a stock option program for key employees, executives and directors. The plans, all of which have been approved by shareholder vote, provide for the granting of both nonqualified and incentive options. Options granted under the plans typically have a six-year term and vest over a four to five-year period. The fair value of shares vested during the three months ended March 31, 2023 and 2022 aggregated $0.09 million and $0.10 million, respectively. Compensation cost, net of forfeitures, is recognized on a straight-line basis over the requisite service period for the entire award. Forfeitures are estimated based on historic trends. It is generally our policy to issue new shares upon exercise of stock options.

 

The following table sets forth information with respect to nonvested options for the three months ended March 31, 2023:

 

   Number of Shares   Weighted Average
Grant-Date Fair Value		 
Nonvested options – beginning of period   168,730   $16.31 
Nonvested options granted   —    — 
Nonvested options vested or forfeited   (23,080)  $13.58 
Nonvested options – end of period   145,650   $16.74 

 

Share-based payment expense decreased income before income taxes by $0.63 million and $0.65 million for the three months ended March 31, 2023 and 2022, respectively, and decreased income attributable to Inter Parfums, Inc. by $0.43 million and $0.44 million for the three months ended March 31, 2023 and 2022, respectively.

 

Page 11

 

 

INTER PARFUMS, INC. AND SUBSIDIARIES 

 

Notes to Consolidated Financial Statements

 

The following table summarizes stock option information as of March 31, 2023:

 

   Shares   Weighted Average
Exercise Price		 
         
Outstanding at January 1, 2023   441,580   $67.30 
Options forfeited   (15,480)   70.48 
Options exercised   (88,710)   55.57 
           
Outstanding at March 31, 2023   337,390   $70.24 
           
Options exercisable   191,740   $61.38 
Options available for future grants   574,455      

 

As of March 31, 2023, the weighted average remaining contractual life of options outstanding is 3.56 years (1.75 years for options exercisable); the aggregate intrinsic value of options outstanding and options exercisable is $24.3 million and $15.5 million, respectively; and unrecognized compensation cost related to stock options outstanding aggregated $2.4 million.

 

Cash proceeds, tax benefits and intrinsic value related to stock options exercised during the three months ended March 31, 2023 and 2022 were as follows:

 

(In thousands)  March 31,  
2023		   March 31,  
2022		 
         
Cash proceeds from stock options exercised  $4,929   $708 
Tax benefits   780    75 
Intrinsic value of stock options exercised   5,403    635 

 

There were no options granted during the three months ended March 31, 2023 and March 31, 2022.

 

Expected volatility is estimated based on historic volatility of the Company’s common stock. The expected term of the option is estimated based on historic data. The risk-free rate is based on the U.S. Treasury yield curve in effect at the time of the grant of the option and the dividend yield reflects the assumption that the dividend payout as authorized by the Board of Directors would increase as the earnings of the Company and its stock price continue to increase.

 

In December 2018, Interparfums SA approved a plan to grant an aggregate of 26,600 shares of its stock to employees with no performance condition requirement, and an aggregate of 133,000 shares to officers and managers, subject to certain corporate performance conditions. The corporate performance conditions were met and therefore in June 2022, 211,955 shares, adjusted for stock splits, were distributed. The aggregate cost of the grant of approximately $4.8 million was recognized as compensation cost on a straight-line basis over the requisite three-year service period.

 

In March 2022, Interparfums SA approved an additional plan to grant an aggregate of 88,400 shares to all Interparfums SA employees and corporate officers having more than six months of employment at grant date, subject to certain corporate performance conditions. The shares, subject to adjustment for stock splits, will be distributed in June 2025 and will follow the same guidelines as the December 2018 plan.

 

Page 12

 

 

INTER PARFUMS, INC. AND SUBSIDIARIES 

 

Notes to Consolidated Financial Statements

 

The fair value of the grant had been determined based on the quoted stock price of Interparfums SA shares as reported by the Euronext on the date of grant. The estimated number of shares to be distributed of 85,107 has been determined taking into account employee turnover. The aggregate cost of the grant of approximately $4.1 million will be recognized as compensation cost on a straight-line basis over the requisite three and a quarter year service period.

 

Similar to the December 2018 plan, in order to avoid dilution of the Company’s ownership of Interparfums SA, all shares distributed or to be distributed pursuant to these plans will be pre-existing shares of Interparfums SA, purchased in the open market by Interparfums SA. During the year ended December 31, 2022, the Company acquired 63,281 shares at an aggregate cost of $3.0 million.

 

In the first quarter of 2023, the Company initiated a small share repurchase program, and over the course the course of the first quarter of 2023, the Company repurchased 43,060 shares at a cost of $5.58 million. These shares are classified as treasury shares on the accompanying balance sheet. The Company plans to continue repurchasing shares throughout 2023.

 

All share purchases and issuances have been classified as equity transactions on the accompanying balance sheet.

 

 

10.Net Income Attributable to Inter Parfums, Inc. Common Shareholders:

 

Net income attributable to Inter Parfums, Inc. per common share (“basic EPS”) is computed by dividing net income attributable to Inter Parfums, Inc. by the weighted average number of shares outstanding. Net income attributable to Inter Parfums, Inc. per share assuming dilution (“diluted EPS”), is computed using the weighted average number of shares outstanding, plus the incremental shares outstanding assuming the exercise of dilutive stock options using the treasury stock method.

 

The reconciliation between the numerators and denominators of the basic and diluted EPS computations is as follows:

 

             
   Three months ended 
(In thousands)  March 31, 
   2023   2022 
Numerator:        
Net income attributable to Inter Parfums, Inc.  $54,068   $35,299 
Denominator:          
Weighted average shares   32,018    31,840 
Effect of dilutive securities:          
Stock options   141    170 
Denominator for diluted earnings per share   32,159    32,010 
           
Earnings per share:          
Net income attributable to Inter Parfums, Inc. common shareholders:          
Basic  $1.69   $1.11 
Diluted   1.68    1.10 

 

There were no antidilutive potential common shares outstanding for the three months ended March 31, 2023 and March 31, 2022.

 

Page 13

 

 

INTER PARFUMS, INC. AND SUBSIDIARIES 

 

Notes to Consolidated Financial Statements

 

11.Segment and Geographic Areas:

 

The Company manufactures and distributes one product line, fragrances and fragrance related products. The Company manages its business in two segments, European based operations and United States based operations. The European assets are located, and operations are primarily conducted, in France. Both European operations and United States operations primarily represent the sale of prestige brand name fragrances. Information on our operations by geographical areas is as follows:

 

(In thousands)  Three months ended
March 31,		 
   2023   2022 
Net sales:          
United States  $81,454   $68,502 
Europe   230,269    182,182 
Eliminations   —    (6)
           
   $311,723   $250,678 
           
Net income attributable to Inter Parfums, Inc.:          
United States  $10,343   $6,514 
Europe   43,725    28,785 
           
   $54,068   $35,299 

 

   March 31,   December 31, 
   2023   2022 
Total Assets:          
United States  $288,927   $278,090 
Europe   1,110,902    1,052,004 
Eliminations   (19,623)   (21,522)
   $1,380,206   $1,308,542 

 

 

Page 14

 

 

INTER PARFUMS, INC. AND SUBSIDIARIES 

 

Item 2:MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

 

Forward Looking Information

 

Statements in this report which are not historical in nature are forward-looking statements. Although we believe that our plans, intentions and expectations reflected in such forward-looking statements are reasonable, we can give no assurance that such plans, intentions or expectations will be achieved. In some cases, you can identify forward-looking statements by forward-looking words such as “anticipate,” “believe,” “could,” “estimate,” “expect,” “intend,” “may,” “should,” “will” and “would” or similar words. You should not rely on forward-looking statements because actual events or results may differ materially from those indicated by these forward-looking statements as a result of a number of important factors. These factors include, but are not limited to, the risks and uncertainties discussed under the headings “Forward Looking Statements” and “Risk Factors” in Inter Parfums’ annual report on Form 10-K for the fiscal year ended December 31, 2022, and the reports Inter Parfums files from time to time with the Securities and Exchange Commission. Inter Parfums does not intend to and undertakes no duty to update the information contained in this report.

 

Overview

 

We operate in the fragrance business, and manufacture, market and distribute a wide array of fragrances and fragrance related products. We manage our business in two segments, European based operations and United States based operations. Certain prestige fragrance products are produced and marketed by our European operations through our 72% owned subsidiary in Paris, Interparfums SA, which is also a publicly traded company as 28% of Interparfums SA shares trade on the NYSE Euronext.

 

We produce and distribute through our European operations, fragrance products primarily under license agreements with brand owners, and European based fragrance product sales represented approximately 74% and 73% of net sales for the three months ended March 31, 2023 and 2022, respectively. We have built a portfolio of prestige brands, which include Boucheron, Coach, Jimmy Choo, Karl Lagerfeld, Kate Spade, Lanvin, Moncler, Montblanc, Rochas and Van Cleef & Arpels, whose products are distributed in over 120 countries around the world. In addition, our exclusive and worldwide license for the production and distribution of Lacoste brand perfumes and cosmetics becomes effective in January 2024.

 

Through our United States operations, we also market fragrance and fragrance related products. United States operations represented 26% and 27% of net sales for the three months ended March 31, 2023 and 2022, respectively. These fragrance products are sold primarily pursuant to license or other agreements with the owners of the Abercrombie & Fitch, Anna Sui, Donna Karan, DKNY, Ferragamo, Graff, GUESS, Hollister, MCM, Oscar de la Renta and Ungaro brands.

 

Substantially all of our prestige fragrance brands are licensed from unaffiliated third parties, and our business is dependent upon the continuation and renewal of such licenses. With respect to the Company’s largest brands, we license the Montblanc, Coach, Jimmy Choo and GUESS brand names.

 

Page 15

 

 

INTER PARFUMS, INC. AND SUBSIDIARIES 

 

As a percentage of net sales, product sales for the Company’s largest brands were as follows:

 

  

Three Months Ended  

March 31, 

 
   2023   2022 
         
Montblanc   20%   19%
Jimmy Choo   20%   15%
Coach   15%   15%
GUESS   9%   11%

 

Quarterly sales fluctuations are influenced by the timing of new product launches as well as the third and fourth quarter holiday season. In certain markets where we sell directly to retailers, seasonality is more evident. We primarily sell directly to retailers in France and the United States.

 

We grow our business in two distinct ways. First, we grow by adding new brands to our portfolio, either through new licenses or other arrangements or out-right acquisitions of brands. Second, we grow through the introduction of new products and by supporting new and established products through advertising, merchandising and sampling as well as phasing out underperforming products so we can devote greater resources to those products with greater potential. The economics of developing, producing, launching and supporting products influence our sales and operating performance each year. Our introduction of new products may have some cannibalizing effect on sales of existing products, which we take into account in our business planning.

 

Our business is not capital intensive, and it is important to note that we do not own manufacturing facilities. We act as a general contractor and source our needed components from our suppliers. These components are received at one of our distribution centers and then, based upon production needs, the components are sent to one of several third party fillers, which manufacture the finished product for us and then deliver them to one of our distribution centers.

 

As with any global business, many aspects of our operations are subject to influences outside our control. We believe we have a strong brand portfolio with global reach and potential. As part of our strategy, we plan to continue to make investments behind fast-growing markets and channels to grow market share. 

 

Our reported net sales are impacted by changes in foreign currency exchange rates. A strong U.S. dollar has a negative impact on our net sales. However, earnings are positively affected by a strong dollar, because above 50% of net sales of our European operations are denominated in U.S. dollars, while almost all costs of our European operations are incurred in euro. Conversely, a weak U.S. dollar has a favorable impact on our net sales while gross margins are negatively affected. We address certain financial exposures through a controlled program of risk management that includes the use of derivative financial instruments and primarily enter into foreign currency forward exchange contracts to reduce the effects of fluctuating foreign currency exchange rates.

 

Page 16

 

 

INTER PARFUMS, INC. AND SUBSIDIARIES 

 

Impact of COVID-19 Pandemic

 

Please see our discussion of the Impact of the COVID-19 Pandemic, which is incorporated by reference to note 2 to the Consolidated Financial Statements contained in this Quarterly Report on Form 10-Q for the quarter ended March 31, 2023.

 

Recent Important Events

 

Please see our discussion of Recent Important Events, which is incorporated by reference to note 3 to the Consolidated Financial Statements contained in this Quarterly Report on Form 10-Q for the quarter ended March 31, 2023.

 

Discussion of Critical Accounting Policies

 

Information regarding our critical accounting policies can be found in our 2022 Annual Report on Form 10-K filed with the SEC.

 

Results of Operations

 

Three Months Ended March 31, 2023 as Compared to the Three Months Ended March 31, 2022

 

Net Sales:

 

   Three months ended March 31, 
(in millions)  2023   2022   % Change 
     
European based product sales  $230.3   $182.2    26.4%
United States based product sales   81.4    68.5    18.9%
   $311.7   $250.7    24.4%

 

Net sales for the three months ended March 31, 2023 increased 24% from March 31, 2022. At comparable foreign currency exchange rates, net sales increased 29% from the first quarter of 2022. The average dollar/euro exchange rate for the current first quarter was 1.07 compared to 1.12 in the first quarter of 2022.

 

The current first quarter was exceptionally strong for both European and United States based operations, as net sales increased 26% and 19%, respectively, as compared to the corresponding period of the prior year.

 

For European based operations, our largest brands, Jimmy Choo, Montblanc and Coach sales rose 63%, 28% and 24%, respectively, as compared to the corresponding period of the prior year. Our U.S. operations also had a strong start growing 19% off a high 2022 base when first quarter sales had expanded 77%. This increase was driven by the addition and extension of Donna Karan and DKNY to our portfolio and double-digit growth for Ferragamo and Oscar de la Renta, following successful brand extensions.

 

Page 17

 

 

INTER PARFUMS, INC. AND SUBSIDIARIES 

 

During the first quarter of 2023, we debuted Jimmy Choo Rose Passion and Montblanc Signature Absolue, which contributed to the double digit brand sales gains. Many of our mid-sized brands, including Boucheron, Ferragamo, Karl Lagerfeld, and Oscar de la Renta, also achieved double digit sales gains. Additionally, we introduced brand extensions within established lines for Abercrombie & Fitch, and MCM. After the challenging lockdowns, the progressive reopening of China buoyed the Ferragamo and Anna Sui brands.

 

As expected, the implementation of our enterprise resource planning software weighed on our quarterly results, impacting GUESS disproportionately, which was flat off a high base in 2022, but we have strong orders that we will be fulfilling during the second quarter. However, overall our first quarter started the year on a strong note, and we look forward to executing our plans for the remainder of the year. Our brands are in high demand in a robust environment for the fragrance industry. We have a large number of brand extensions across many of our brands launching throughout the year, plus Montblanc Explorer Platinum, Coach Green and Coach Love, later in the year. In sum, 2023 has all the earmarks of another superb year as the growth catalysts currently far outweigh the headwinds, most notably limited travel retail business and supply chain disruptions.

 

Net Sales to Customers by Region  Three months ended March 31, 
(In millions)  2023   2022 
         
North America  $111.2   $81.5 
Western Europe   77.2    63.6 
Asia   46.0    42.5 
Middle East   25.4    24.1 
Central and South America   26.2    18.3 
Eastern Europe   22.5    18.0 
Other   3.1    2.7 
   $311.7   $250.7 

 

First quarter sales in our largest market, North America, rose 36%, followed by Western Europe and Asia/Pacific where comparable quarter sales in both regions increased 21% and 8%, respectively. Our sales in Central and South America, Eastern Europe and the Middle East were also robust, up 43%, 25% and 5%, respectively. Additionally, our travel retail business is beginning to show signs of renewed life.

 

Gross Profit margin  Three months ended March 31, 
(in millions)  2023   2022 
         
European operations          
Net sales  $230.3   $182.2 
Cost of sales   74.3    60.5 
Gross margin  $156.0   $121.7 
Gross margin as a % of net sales   67.8%   66.8%
           
United States operations          
Net sales  $81,4   $68.5 
Cost of sales   34.5    31.6 
Gross margin  $46.9   $36.9 
Gross margin as a % of net sales   57.6%   53.9%

 

Page 18

 

 

INTER PARFUMS, INC. AND SUBSIDIARIES 

 

For European based operations, gross profit margin as a percentage of net sales was 67.8% and 66.8% in the first quarters of 2023 and 2022, respectively as we have benefited from our pricing actions and favorable exchange rate. We carefully monitor movements in foreign currency exchange rates as more than 50% of our European based operations net sales are denominated in U.S. dollars, while most of our costs are incurred in euro. From a gross margin standpoint, a strong U.S. dollar has a positive effect on our gross margin while a weak U.S. dollar has a negative effect. The average dollar/euro exchange rate was 1.07 in the 2023 first quarter as compared to 1.12 in the first quarter of 2022.

 

For United States operations, gross profit margin was 57.6% and 53.9% in the first quarters of 2023 and 2022, respectively. The significant margin expansion stems from a number of factors. Firstly, for the most part, the price increases we took early 2023 weren’t offset by a higher cost of goods given our inventory coverage and FIFO accounting. Secondly, we are seeing favorable brand and channel mix, as a higher portion of our sales are being sold directly to retailers as opposed to third-party distributors. Lastly, the significant increase in sales in the first quarter of 2023 allowed us to better absorb fixed expenses such as depreciation and point of sale expenses, as compared to the corresponding period of the prior year.

 

As previously mentioned, supply chain disruptions affecting the procurement of components, the ability to transport goods, and related cost increases have and are expected to continue to have a negative impact on sales and gross margin. While we have been addressing these issues and have implemented processes to mitigate the impact, prolonged disruption could have a material negative effect on our sales and gross margin.

 

Generally, we do not bill customers for shipping and handling costs, and such costs, which aggregated $3.9 million and $2.7 million for the three months ended March 31, 2023 and 2022, respectively, are included in selling, general and administrative expenses in the consolidated statements of income. As such, our Company’s gross profit may not be comparable to other companies, which may include these expenses as a component of cost of goods sold.

 

Selling, general and administrative expenses 

Three months ended 

March 31, 

 
(In millions)  2023   2022 
         
European Operations          
Selling, general and administrative expenses  $77.3   $69.0 
Selling, general and administrative expenses as a percent of net sales   33.6%   37.9%
           
United States Operations          
Selling, general and administrative expenses  $35.4   $28.4 
Selling, general and administrative expenses as a percent of net sales   43.5%   41.5%

 

For European operations, selling, general and administrative expenses increased 12.0% in the 2023 first quarter, as compared to the corresponding period of the prior year, and represented 33.6% and 37.9% of net sales in the 2023 and 2022 periods, respectively. For United States operations, selling, general and administrative expenses increased 24.7% in the 2023 first quarter, as compared to the corresponding period of the prior year, and represented 43.5% and 41.5% of net sales in the 2023 and 2022 periods, respectively. As discussed in more detail below, the increased selling, general and administrative expenses as a percent of net sales are primarily the result of increases in promotion and advertising expenditures as well as the annualization impact of the structural investments in our US operations that we made throughout 2022 in order to support the new licenses of $4.0 million.

 

Page 19

 

 

INTER PARFUMS, INC. AND SUBSIDIARIES 

 

Promotion and advertising included in selling, general and administrative expenses aggregated $35.2 million and $34.2 million in the first quarters of 2023 and 2022, respectively, and represented 11.3% and 13.6% of net sales in the 2023 and 2022 periods, respectively. Promotion and advertising are integral parts of our industry, and we continue to invest heavily to support new product launches and to build brand awareness. We believe that our promotion and advertising efforts have had a beneficial effect on online net sales. All of our brands have benefitted from newly launched and enhanced e-commerce sites in existing markets in collaboration with our retail customers on their e-commerce sites. We also continue to develop and implement omnichannel concepts and compelling content to deliver an integrated consumer experience. We anticipate that on a full year basis, promotion and advertising expenditures will aggregate approximately 21% of net sales, which is in line with pre-COVID historical averages.

 

Royalty expense included in selling, general and administrative expenses aggregated $24.1 million for the three months ended March 31, 2023, as compared to $19.4 million for the corresponding periods of the prior year. Royalty expense represented 7.7% of net sales for both the three months ended March 31, 2023 and 2022.

 

Income from Operations

 

As a result of the above analysis regarding net sales, gross profit margins and selling, general and administrative expenses, our operating margins aggregated 29.0% and 24.4% for the three months ended March 31, 2023 and 2022, respectively.

 

Other Income and Expense

 

Traditionally, interest expense was primarily related to the financing of brand and licensing acquisitions. However, in April 2021, we completed the acquisition of the headquarters of Interparfums SA. The acquisition was financed by a 10-year €120 million (approximately $130.5 million) bank loan which bears interest at one-month Euribor plus 0.75%. Also in 2021, approximately €80 million of the variable rate debt was swapped for variable rate debt with a maximum interest rate of 2%. The swap effectively exchanges the variable interest rate to a fixed rate of approximately 1.1%.

 

We enter into foreign currency forward exchange contracts to manage exposure related to receivables from unaffiliated third parties denominated in a foreign currency and occasionally to manage risks related to future sales expected to be denominated in a foreign currency. Gains and losses on foreign currency transactions have not been significant. Above 50% of net sales of our European operations are denominated in U.S. dollars.

 

Interest and investment (income) loss represents interest earned on cash and cash equivalents and short-term investments. As of March 31, 2022, short-term investments include approximately $20.7 million of marketable equity securities of other companies in the luxury goods sector. In the first quarter of 2023, the Company sold these marketable securities which generated a gain of $3.1 million. Interest and investment (income) loss for the three months ended March 31, 2023, includes approximately $3.4 million of losses on such marketable equity securities.

 

Page 20

 

 

INTER PARFUMS, INC. AND SUBSIDIARIES 

 

Income Taxes

 

Our consolidated effective tax rate was 23.4% and 24.4% for the three months ended March 31, 2023 and 2022, respectively.

 

The effective tax rate for European operations was 25% for both the three months ended March 31, 2023 and 2022.

 

Our effective tax rate for U.S. operations was 12.7% for the three months ended March 31, 2023, as compared to 20.7% for the corresponding period of the prior year. Our effective tax rate differs from the 21% statutory rate due to benefits received from the exercise of stock options as well as deductions we are allowed for a portion of our foreign derived intangible income, slightly offset by state and local taxes.

 

Other than as discussed above, we did not experience any significant changes in tax rates, and none were expected in jurisdictions where we operate.

 

Net Income

 

   Three Months Ended
    March 31,		 
   2023   2022 
   (In thousands) 
         
Net income attributable to European operations  $60,565   $39,776 
Net income attributable to United States operations   10,343    6,515 
Net income   70,908    46,291 
Less: Net income attributable to the noncontrolling interest   16,840    10,992 
Net income attributable to Inter Parfums, Inc.  $54,068   $35,299 

 

Net income attributable to European operations was $60.6 million and $39.8 million for the three months ended March 31, 2023 and 2022, respectively, while net income attributable to United States operations was $10.3 million and $6.5 million for the three months ended March 31, 2023 and 2022, respectively. The significant fluctuations in net income for both European operations and United States operations are directly related to the previous discussions pertaining to changes in sales, gross margin, and selling, general and administrative expenses.

 

The noncontrolling interest arises from our 72% owned subsidiary in Paris, Interparfums SA, which is also a publicly traded company as 28% of Interparfums SA shares trade on the NYSE Euronext. Net income attributable to the noncontrolling interest is directly related to the profitability of our European operations and aggregated 27.8% and 27.6% of European operations net income for the three months ended March 31, 2023 and 2022, respectively. Net margins attributable to Inter Parfums, Inc. as of March 31, 2023 and 2022 aggregated 17.3% and 14.1%, respectively.

 

Page 21

 

 

INTER PARFUMS, INC. AND SUBSIDIARIES 

 

Liquidity and Capital Resources

 

Our conservative financial tradition has enabled us to amass significant cash balances. As of March 31, 2023, we had $238 million in cash, cash equivalents and short-term investments, most of which is held in euro by our European operations and is readily convertible into U.S. dollars. We have not had any liquidity issues to date, and do not expect any liquidity issues relating to such cash and cash equivalents and short-term investments. As of March 31, 2023, short-term investments include approximately $0.7 million of marketable equity securities.

 

As of March 31, 2023, working capital aggregated $489 million and we had a working capital ratio of 2.4 to 1. Approximately 80% of the Company’s total assets are held by European operations, and approximately $253 million of trademarks, licenses and other intangible assets are also held by European operations.

 

The Company is party to a number of license and other agreements for the use of trademarks and rights in connection with the manufacture and sale of its products expiring at various dates through 2039. In connection with certain of these license agreements, the Company is subject to minimum annual advertising commitments, minimum annual royalties and other commitments. See Item 8. Financial Statements and Supplementary Data – Note 12 – Commitments in our 2022 annual report on Form 10-K, which is incorporated by reference herein. Future advertising commitments are estimated based on planned future sales for the license terms that were in effect at December 31, 2022, without consideration for potential renewal periods and do not reflect the fact that our distributors share our advertising obligations.

 

The Company hopes to continue to benefit from its strong financial position to potentially acquire one or more brands, either on a proprietary basis or as a licensee. In December 2022, we entered into a long-term global licensing agreement for the creation, development and distribution of fragrances and fragrance-related products under the Lacoste brand. This new license takes effect January 2024.

 

Cash used in operating activities aggregated $7.4 million and $23.9 million for the three months ended March 31, 2023 and 2022, respectively. For the three months ended March 31, 2023, working capital items used $84.8 million in cash from operating activities, as compared to $73.2 million in the 2022 period. Although from a cash flow perspective accounts receivable is up 22% from year end 2022, the balance is reasonable based on first quarter 2023 record sales levels and reflects reasonable collection activity as day’s sales outstanding was 69 days, down slightly from 75 days in the corresponding period of the prior year. From a cash flow perspective, inventory levels as of March 31, 2023, increased 10% from year end 2022. Although inventories include components needed to support new product launches, the overall balance is lower than historic levels due primarily to supply chain disruptions. We have been addressing this issue since the beginning of 2021, by ordering well in advance of need and in larger quantities. Since 2021, we have strived to carry more inventory overall, source the same components from multiple suppliers and when possible, manufacture products closer to where they are sold.

 

Cash flows provided by investing activities in 2023 reflect purchases and sales of short-term investments. These investments include certificates of deposit with maturities greater than three months. Approximately $40 million of such certificates of deposit contain penalties where we would forfeit a portion of the interest earned in the event of early withdrawal.

 

Page 22

 

 

INTER PARFUMS, INC. AND SUBSIDIARIES 

 

Our business is not capital intensive as we do not own any manufacturing facilities. On a full year basis, we typically spend approximately $5.0 million on tools and molds, depending on our new product development calendar. Capital expenditures also include amounts for office fixtures, computer equipment and industrial equipment needed at our distribution centers.

 

Our short-term financing requirements are expected to be met by available cash on hand at March 31, 2023, and short-term credit lines provided by domestic and foreign banks. The principal credit facilities for 2023 consist of a $20.0 million unsecured revolving line of credit provided by a domestic commercial bank and approximately $28 million in credit lines provided by a consortium of international financial institutions. There was $18 million of short-term borrowings outstanding pursuant to these facilities as of March 31, 2023 and no short-term borrowings outstanding as of March 31, 2022.

 

In April 2020, as a result of the uncertainties raised by the COVID-19 pandemic, the Board of Directors authorized a temporary suspension of the quarterly cash dividend. In February 2021, our Board of Directors authorized a reinstatement of an annual dividend of $1.00, payable quarterly and in February 2022, our Board authorized a 100% increase in the annual dividend to $2.00 per share. In February 2023 the Board of Directors further increased the annual dividend to $2.50 per share. The next quarterly cash dividend of $0.625 per share is payable on June 30, 2023, to shareholders of record on June 15, 2023.

 

We believe that funds provided by or used in operations can be supplemented by our present cash position and available credit facilities, so that they will provide us with sufficient resources to meet all present and reasonably foreseeable future operating needs.

 

Inflation rates in the U.S. and foreign countries in which we operate did not have a significant impact on operating results for the three months ended March 31, 2023.

 

Page 23

 

 

INTER PARFUMS, INC. AND SUBSIDIARIES 

 

Item 3:QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

 

General

 

We address certain financial exposures through a controlled program of risk management that primarily consists of the use of derivative financial instruments. We primarily enter into foreign currency forward exchange contracts in order to reduce the effects of fluctuating foreign currency exchange rates. We do not engage in the trading of foreign currency forward exchange contracts or interest rate swaps.

 

Foreign Exchange Risk Management

 

We periodically enter into foreign currency forward exchange contracts to hedge exposure related to receivables denominated in a foreign currency and to manage risks related to future sales expected to be denominated in a currency other than our functional currency. We enter into these exchange contracts for periods consistent with our identified exposures. The purpose of the hedging activities is to minimize the effect of foreign exchange rate movements on the receivables and cash flows of Interparfums SA, whose functional currency is the euro. All foreign currency contracts are denominated in currencies of major industrial countries and are with large financial institutions, which are rated as strong investment grade.

 

All derivative instruments are required to be reflected as either assets or liabilities in the balance sheet measured at fair value. Generally, increases or decreases in fair value of derivative instruments will be recognized as gains or losses in earnings in the period of change. If the derivative is designated and qualifies as a cash flow hedge, then the changes in fair value of the derivative instrument will be recorded in other comprehensive income.

 

Before entering into a derivative transaction for hedging purposes, we determine that the change in the value of the derivative will effectively offset the change in the fair value of the hedged item from a movement in foreign currency rates. Then, we measure the effectiveness of each hedge throughout the hedged period. Any hedge ineffectiveness is recognized in the income statement.

 

At March 31, 2023, we had foreign currency contracts in the form of forward exchange contracts of approximately U.S. $37.0 million with maturities of less than one year. We believe that our risk of loss as the result of nonperformance by any of such financial institutions is remote.

 

Interest Rate Risk Management

 

We mitigate interest rate risk by monitoring interest rates, and then determining whether fixed interest rates should be swapped for floating rate debt, or if floating rate debt should be swapped for fixed rate debt.

 

Page 24

 

 

INTER PARFUMS, INC. AND SUBSIDIARIES 

 

Item 4.CONTROLS AND PROCEDURES

 

Evaluation of Disclosure Controls and Procedures

 

Our Chief Executive Officer and Chief Financial Officer have reviewed and evaluated the effectiveness of our disclosure controls and procedures (as defined in the Securities Exchange Act of 1934 Rule 13a-15(e)) as of the end of the period covered by this quarterly report on Form 10-Q (the “Evaluation Date”). Based on their review and evaluation, our Chief Executive Officer and Chief Financial Officer have concluded that as of the Evaluation Date, our Company’s disclosure controls and procedures were effective.

 

Changes in Internal Control Over Financial Reporting

 

There has been no change in our internal control over financial reporting (as defined in Rule 13a-15(f) of the Securities Exchange Act of 1934) that occurred during the quarterly period covered by this report on Form 10-Q that has materially affected, or is reasonably likely to materially affect, the Company’s internal control over financial reporting.

 

Part II. Other Information

 

Item 2.Unregistered Sales of Equity Securities and Use of Proceeds.

 

Item (c).

 

Inter Parfums, Inc. Purchase of Common Stock1
Period  Total Number of Shares Purchased   Average price paid per share   Total number of shares purchased as part of publicly announced plans or programs   Maximum number (or approximate dollar value) of shares that may yet be purchased under the plans or programs
January 1-31   16,060   $110.63    16,060   150,000 shares
February 1-28   0    n/a    16,060   150,000 shares
March 1-31   27,000   $140.87    43,060   123,000 shares
Total   43,060   $129.59    43,060   123,000 shares

 

Items 1. Legal Proceedings, 1A. Risk Factors, 3. Defaults Upon Senior Securities, 4. Mine Safety Disclosures and 5. Other Information, are omitted as they are either not applicable or have been included in Part I.

 

 

1 All shares were purchased in open market transactions.

 

Page 25

 

 

INTER PARFUMS, INC. AND SUBSIDIARIES 

 

Item 6. Exhibits.

 

The following documents are filed herewith:

 

Exhibit No. Description Page Number
     
31.1 Certifications required by Rule 13a-14(a) of Chief Executive Officer 28
     
31.2 Certifications required by Rule 13a-14(a) of Chief Financial Officer and Principal Accounting Officer 29
     
32.1 Certification required by Section 906 of the Sarbanes-Oxley Act of Chief Executive Officer 30
     
32.2 Certification required by Section 906 of the Sarbanes-Oxley Act of Chief Financial Officer and Principal Accounting Officer 31
     
101 Interactive data files  

 

Page 26

 

 

INTER PARFUMS, INC. AND SUBSIDIARIES 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized on the 8th day of May 2023.

 

    INTER PARFUMS, INC.  
       
  By: /s/ Michel Atwood  
    Chief Financial Officer  

  

Page 27

 

 EX-31.1 2 g083513_ex31-1.htm EXHIBIT 31.1

 

INTER PARFUMS, INC. AND SUBSIDIARIES 

 

Exhibit 31.1

 

CERTIFICATIONS

 

I, Jean Madar, certify that:

 

1. I have reviewed this quarterly report on Form 10-Q of Inter Parfums, Inc.;

 

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

3. Based on my knowledge, the financial statements, and other financial information included in this quarterly report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

 

4. The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

 

a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

 

b) Designed such internal control over financial reporting, or caused such control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

 

c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures as of the end of the period covered by this report based upon such evaluation; and

 

d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth quarter in case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

 

5. The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of registrant’s board of directors (or persons performing the equivalent functions):

 

a) all significant deficiencies and material weaknesses in the design or operation of internal controls over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

 

b) any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

 

Date: May 8, 2023

 

/s/ Jean Madar  

Jean Madar,  

Chief Executive Officer

 

Page 28

 

 EX-31.2 3 g083513_ex31-2.htm EXHIBIT 31.2

 

INTER PARFUMS, INC. AND SUBSIDIARIES 

 

Exhibit 31.2

 

I, Michel Atwood, certify that:

 

1. I have reviewed this quarterly report on Form 10-Q of Inter Parfums, Inc.;

 

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

3. Based on my knowledge, the financial statements, and other financial information included in this quarterly report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

 

4. The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

 

a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

 

b) Designed such internal control over financial reporting, or caused such control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

 

c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures as of the end of the period covered by this report based upon such evaluation; and

 

d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth quarter in case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

 

5. The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of registrant’s board of directors (or persons performing the equivalent functions):

 

a) all significant deficiencies and material weaknesses in the design or operation of internal controls over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

 

b) any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

 

Date: May 8, 2023

 

/s/ Michel Atwood  

Michel Atwood
Chief Financial Officer and 

Principal Accounting Officer

 

Page 29

 

 EX-32.1 4 g083513_ex32-1.htm EXHIBIT 32.1

 

INTER PARFUMS, INC. AND SUBSIDIARIES 

 

Exhibit 32.1

 

CERTIFICATION

 

The undersigned hereby certifies, in accordance with 18 U.S.C. 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, in his capacity as an officer of Inter Parfums, Inc., that the Quarterly Report of Inter Parfums, Inc. on Form 10-Q for the period ended March 31, 2023, fully complies with the requirements of Section 13(a) of the Securities Exchange Act of 1934 and that the information contained in such report fairly presents, in all material respects, the financial condition and results of operation of Inter Parfums, Inc.

 

Date: May 8, 2023 By: /s/ Jean Madar  
    Jean Madar,  
    Chief Executive Officer  

  

A signed original of this written statement required by Section 906 has been provided to Inter Parfums, Inc. and will be retained by Inter Parfums, Inc. and furnished to the Securities and Exchange Commission or its staff upon request.

 

Page 30

 EX-32.2 5 g083513_ex32-2.htm EXHIBIT 32.2

 

INTER PARFUMS, INC. AND SUBSIDIARIES 

 

Exhibit 32.2

 

CERTIFICATION

 

The undersigned hereby certifies, in accordance with 18 U.S.C. 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, in his capacity as an officer of Inter Parfums, Inc., that the Quarterly Report of Inter Parfums, Inc. on Form 10-Q for the period ended March 31, 2023, fully complies with the requirements of Section 13(a) of the Securities Exchange Act of 1934 and that the information contained in such report fairly presents, in all material respects, the financial condition and results of operation of Inter Parfums, Inc.

 

Date: May 8, 2023 By: /s/ Michel Atwood  
    Michel Atwood  
    Chief Financial Officer and  
    Principal Accounting Officer  

  

A signed original of this written statement required by Section 906 has been provided to Inter Parfums, Inc. and will be retained by Inter Parfums, Inc. and furnished to the Securities and Exchange Commission or its staff upon request.

 

Page 31

 EX-101.SCH 6 ipar-20230331.xsd XBRL SCHEMA FILE 00000001 - Document - Cover link:presentationLink link:calculationLink link:definitionLink 00000002 - Statement - CONSOLIDATED BALANCE SHEETS (Unaudited) link:presentationLink link:calculationLink link:definitionLink 00000003 - Statement - CONSOLIDATED BALANCE SHEETS (Unaudited) (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 00000004 - Statement - CONSOLIDATED STATEMENTS OF INCOME (Unaudited) link:presentationLink link:calculationLink link:definitionLink 00000005 - Statement - CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (Unaudited) link:presentationLink link:calculationLink link:definitionLink 00000006 - Statement - CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY (Unaudited) link:presentationLink link:calculationLink link:definitionLink 00000007 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) link:presentationLink link:calculationLink link:definitionLink 00000008 - Disclosure - Significant Accounting Policies: link:presentationLink link:calculationLink link:definitionLink 00000009 - Disclosure - Impact of COVID-19 Pandemic: link:presentationLink link:calculationLink link:definitionLink 00000010 - Disclosure - Recent Agreements: link:presentationLink link:calculationLink link:definitionLink 00000011 - Disclosure - Recent Accounting Pronouncements: link:presentationLink link:calculationLink link:definitionLink 00000012 - Disclosure - Inventories: link:presentationLink link:calculationLink link:definitionLink 00000013 - Disclosure - Fair Value Measurement: link:presentationLink link:calculationLink link:definitionLink 00000014 - Disclosure - Derivative Financial Instruments: link:presentationLink link:calculationLink link:definitionLink 00000015 - Disclosure - Leases: link:presentationLink link:calculationLink link:definitionLink 00000016 - Disclosure - Share-Based Payments: link:presentationLink link:calculationLink link:definitionLink 00000017 - Disclosure - Net Income Attributable to Inter Parfums, Inc. Common Shareholders: link:presentationLink link:calculationLink link:definitionLink 00000018 - Disclosure - Segment and Geographic Areas: link:presentationLink link:calculationLink link:definitionLink 00000019 - Disclosure - Inventories: (Tables) link:presentationLink link:calculationLink link:definitionLink 00000020 - Disclosure - Fair Value Measurement: (Tables) link:presentationLink link:calculationLink link:definitionLink 00000021 - Disclosure - Share-Based Payments: (Tables) link:presentationLink link:calculationLink link:definitionLink 00000022 - Disclosure - Net Income Attributable to Inter Parfums, Inc. Common Shareholders: (Tables) link:presentationLink link:calculationLink link:definitionLink 00000023 - Disclosure - Segment and Geographic Areas: (Tables) link:presentationLink link:calculationLink link:definitionLink 00000024 - Disclosure - Recent Agreements: (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000025 - Disclosure - Inventories consist of the following: (Details) link:presentationLink link:calculationLink link:definitionLink 00000026 - Disclosure - The following tables present our financial assets and liabilities that are measured at fair value on a recurring basis and are categorized using the fair value hierarchy. The fair value hierarchy has three levels based on the reliability of the inputs use (Details) link:presentationLink link:calculationLink link:definitionLink 00000027 - Disclosure - Derivative Financial Instruments: (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000028 - Disclosure - Leases: (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000029 - Disclosure - The following table sets forth information with respect to nonvested options for the three months ended March 31, 2023: (Details) link:presentationLink link:calculationLink link:definitionLink 00000030 - Disclosure - The following table summarizes stock option information as of March 31, 2023: (Details) link:presentationLink link:calculationLink link:definitionLink 00000031 - Disclosure - Cash proceeds, tax benefits and intrinsic value related to stock options exercised during the three months ended March 31, 2023 and 2022 were as follows: (Details) link:presentationLink link:calculationLink link:definitionLink 00000032 - Disclosure - Share-Based Payments: (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000033 - Disclosure - The reconciliation between the numerators and denominators of the basic and diluted EPS computations is as follows: (Details) link:presentationLink link:calculationLink link:definitionLink 00000034 - Disclosure - Net Income Attributable to Inter Parfums, Inc. Common Shareholders: (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000035 - Disclosure - Information on the Company’s operations by segments is as follows: (Details) link:presentationLink link:calculationLink link:definitionLink EX-101.CAL 7 ipar-20230331_cal.xml XBRL CALCULATION FILE EX-101.DEF 8 ipar-20230331_def.xml XBRL DEFINITION FILE EX-101.LAB 9 ipar-20230331_lab.xml XBRL LABEL FILE Equity Components [Axis] Common Stock [Member] Additional Paid-in Capital [Member] Retained Earnings [Member] AOCI Attributable to Parent [Member] Treasury Stock, Common [Member] Noncontrolling Interest [Member] Legal Entity [Axis] Lacoste [Member] Donna Karan and DKNY [Member] Business Acquisition [Axis] Rochas Fashion [Member] Long-Lived Tangible Asset [Axis] Land [Member] Building [Member] Statistical Measurement [Axis] Minimum [Member] Maximum [Member] Currency [Axis] Euro Member Countries, Euro Measurement Frequency [Axis] Fair Value, Recurring [Member] Fair Value Hierarchy and NAV [Axis] Fair Value, Inputs, Level 1 [Member] Fair Value, Inputs, Level 2 [Member] Fair Value, Inputs, Level 3 [Member] Derivative Instrument [Axis] Interest Rate Swap [Member] Foreign Exchange Contract [Member] Equity Option [Member] Consolidated Entities [Axis] Interparfums SA Subsidiary [Member] Title of Individual [Axis] Employees [Member] Officers and Managers [Member] Geographical [Axis] UNITED STATES Europe [Member] Eliminations [Member] Cover [Abstract] Document Type Amendment Flag Amendment Description Document Registration Statement Document Annual Report Document Quarterly Report Document Transition Report Document Shell Company Report Document Shell Company Event Date Document Period Start Date Document Period End Date Document Fiscal Period Focus Document Fiscal Year Focus Current Fiscal Year End Date Entity File Number Entity Registrant Name Entity Central Index Key Entity Primary SIC Number Entity Tax Identification Number Entity Incorporation, State or Country Code Entity Address, Address Line One Entity Address, Address Line Two Entity Address, Address Line Three Entity Address, City or Town Entity Address, State or Province Entity Address, Country Entity Address, Postal Zip Code Country Region City Area Code Local Phone Number Extension Written Communications Soliciting Material Pre-commencement Tender Offer Pre-commencement Issuer Tender Offer Title of 12(b) Security No Trading Symbol Flag Trading Symbol Security Exchange Name Title of 12(g) Security Security Reporting Obligation Annual Information Form Audited Annual Financial Statements Entity Well-known Seasoned Issuer Entity Voluntary Filers Entity Current Reporting Status Entity Interactive Data Current Entity Filer Category Entity Small Business Entity Emerging Growth Company Elected Not To Use the Extended Transition Period Document Accounting Standard Other Reporting Standard Item Number Entity Shell Company Entity Public Float Entity Bankruptcy Proceedings, Reporting Current Entity Common Stock, Shares Outstanding Documents Incorporated by Reference [Text Block] Statement of Financial Position [Abstract] ASSETS Current assets: Cash and cash equivalents Short-term investments Accounts receivable, net Inventories Receivables, other Other current assets Income taxes receivable Total current assets Property, equipment and leasehold improvements, net Right-of-use assets, net Trademarks, licenses and other intangible assets, net Deferred tax assets Other assets Total assets LIABILITIES AND EQUITY Current liabilities: Loans payable - banks Current portion of long-term debt Current portion of lease liabilities Accounts payable – trade Accrued expenses Income taxes payable Total current liabilities Long–term debt, less current portion Lease liabilities, less current portion Equity: Inter Parfums, Inc. shareholders’ equity: Preferred stock, $.001 par; authorized 1,000,000 shares; none issued Common stock, $.001 par; authorized 100,000,000 shares; outstanding 32,012,950 and 31,967,300 shares at March 31, 2023 and December 31, 2022, respectively  Additional paid-in capital Retained earnings Accumulated other comprehensive loss Treasury stock, at cost, 9,907,865 and 9,864,805 shares at March 31, 2023 and December 31, 2022, respectively Total Inter Parfums, Inc. shareholders’ equity Noncontrolling interest Total equity Total liabilities and equity Preferred stock, par or stated value per share Preferred stock, shares authorized Preferred stock, shares issued Common stock, par or stated value per share Common stock, shares authorized Common stock, shares, outstanding Treasury stock, shares Income Statement [Abstract] Net sales Cost of sales Gross margin Selling, general and administrative expenses Income from operations Other expenses (income): Interest expense Loss (gain) on foreign currency Interest and investment (income) loss Other income Nonoperating Income (Expense) Income before income taxes Income taxes Net income Less:  Net income attributable to the noncontrolling interest Net income attributable to Inter Parfums, Inc. Earnings per share: Net income attributable to Inter Parfums, Inc. common shareholders:    Basic    Diluted Weighted average number of shares outstanding:    Basic    Diluted Dividends declared per share Comprehensive income: Net income Other comprehensive income: Net derivative instrument gain (loss), net of tax Transfer from OCI into earnings Translation adjustments, net of tax Comprehensive income Comprehensive income attributable to the noncontrolling interests: Net income Net derivative instrument gain (loss), net of tax Translation adjustments, net of tax Comprehensive income attributable to the noncontrolling interests Comprehensive income attributable to Inter Parfums, Inc. Statement [Table] Statement [Line Items] Beginning Balance Shares issued upon exercise of stock options Dividends Foreign currency translation adjustment, net of tax Share-based compensation Transfer from other comprehensive income into earnings Net derivative instrument gain (loss), net of tax Shares repurchased Transfer of subsidiary shares purchased Ending Balance Statement of Cash Flows [Abstract] Cash flows from operating activities: Adjustments to reconcile net income to net cash provided by (used in) operating activities: Depreciation and amortization Provision for doubtful accounts Noncash stock compensation Share of income of equity investment Noncash lease expense Deferred tax provision Change in fair value of derivatives Changes in: Accounts receivable Inventories Other assets Operating lease liabilities Accounts payable and accrued expenses Income taxes, net Net cash used in operating activities Cash flows from investing activities: Purchases of short-term investments Proceeds from sale of short-term investments Purchases of property, equipment and leasehold improvements Payment for intangible assets acquired Net cash provided by (used in) investing activities Cash flows from financing activities: Proceeds from issuance of long-term debt Repayment of long-term debt Proceeds from exercise of options Dividends paid Dividends paid to noncontrolling interest Purchase of treasury stock Net cash used in financing activities Effect of exchange rate changes on cash Net increase (decrease) in cash and cash equivalents Cash and cash equivalents - beginning of period Cash and cash equivalents - end of period Supplemental disclosure of cash flow information: Cash paid for: Interest Income taxes Accounting Policies [Abstract] Significant Accounting Policies: Unusual or Infrequent Items, or Both [Abstract] Impact of COVID-19 Pandemic: Business Combination and Asset Acquisition [Abstract] Recent Agreements: Accounting Changes and Error Corrections [Abstract] Recent Accounting Pronouncements: Inventory Disclosure [Abstract] Inventories: Fair Value Disclosures [Abstract] Fair Value Measurement: Derivative Instruments and Hedging Activities Disclosure [Abstract] Derivative Financial Instruments: Leases [Abstract] Leases: Equity [Abstract] Share-Based Payments: Earnings Per Share [Abstract] Net Income Attributable to Inter Parfums, Inc. Common Shareholders: Segment Reporting [Abstract] Segment and Geographic Areas: Inventories consist of the following: The following tables present our financial assets and liabilities that are measured at fair value on a recurring basis and are categorized using the fair value hierarchy. The fair value hierarchy has three levels based on the reliability of the inputs used to determine fair value. The following table sets forth information with respect to nonvested options for the three months ended March 31, 2023: The following table summarizes stock option information as of March 31, 2023: Cash proceeds, tax benefits and intrinsic value related to stock options exercised during the three months ended March 31, 2023 and 2022 were as follows: The reconciliation between the numerators and denominators of the basic and diluted EPS computations is as follows: Information on the Company’s operations by segments is as follows: Schedule of Business Acquisitions, by Acquisition [Table] Business Acquisition [Line Items] Description of recent agreement Shares issue Shares value Ownership percentage Purchase price, period cost Acquisition costs, period cost Depreciated over a range Cash held in escrow is included in other assets Long-term debt, term Long-term line of credit Description of debt instrument interest rate terms Debt instrument, face amount Variable interest rate Fixed interest rate Raw materials and component parts Finished goods Fair Value, Recurring and Nonrecurring [Table] Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] Assets: Short-term investments Interest rate swaps Foreign currency forward exchange contracts accounted for using hedge accounting Foreign currency forward exchange contracts not accounted for using hedge accounting Total assets Liabilities: Total liabilities Derivative Instruments, Gain (Loss) [Table] Derivative Instruments, Gain (Loss) [Line Items] Loan amount Derivative swap interest rate Forward exchange contracts Operating lease, weighted average remaining lease term Operating lease, weighted average discount rate, percent Operating leases, rent expense, net Operating Lease, Payments Noncash additions to operating lease assets Nonvested options beginning of period Weighted average grant date fair value, beginning of year Nonvested options granted Weighted average grant date fair value, nonvested options granted Nonvested options vested or forfeited Weighted average grant date fair value, nonvested options vested or forfeited Nonvested options end of period Weighted average grant date fair value, nonvested options end of period Options shares under option - beginning of year Weighted average exercise price shares under option - beginning of year Options forfeited Weighted average exercise price options forfeited Options exercised Weighted average exercise price options exercised Options shares under option - end of year Weighted average exercise price shares under option - end of year Options exercisable Weighted average exercise price options exercisable Options available for future grants Cash proceeds from stock options exercised Tax benefits Intrinsic value of stock options exercised Schedule of Subsidiary or Equity Method Investee [Table] Subsidiary or Equity Method Investee [Line Items] Options vesting period Fair value of shares vested Share-based payment arrangement, expense Decreased income Weighted average remaining contractual life of options outstanding (in years) Weighted average remaining contractual life of options exercisable (in years) Aggregate intrinsic value of options outstanding and options outstanding Aggregate intrinsic value of options outstanding and options exercisable Unrecognized compensation cost Options granted Aggregate shares to offices and managers Adjusted for stock splits Recognized as compensation cost Number of share distributed Shares repurchased Shares repurchase value Numerator: Net income attributable to Inter Parfums, Inc. Denominator: Weighted average shares Stock options Denominator for diluted earnings per share Basic Diluted Antidilutive securities excluded from computation of earnings per share, amount Schedule of Revenues from External Customers and Long-Lived Assets [Table] Revenues from External Customers and Long-Lived Assets [Line Items] Assets Total Assets The element represents donna karan and dkny member. The element represents rochas fashion member. The element represents interparfums sa subsidiary member. The element represents employees member. The element represents officers and managers member. The element represents eliminations member. Transfer of subsidiary shares purchased to treasury shares. The element represents provision for doubtful accounts. The element represents change in fair value of derivatives. The element represents investment income interest and dividend. The element represents stock repurchased during period value. The element represents Lacoste member. Assets, Current Liabilities, Current Treasury Stock, Value Equity, Attributable to Parent Equity, Including Portion Attributable to Noncontrolling Interest Liabilities and Equity Gross Profit Operating Income (Loss) Gain (Loss), Foreign Currency Transaction, before Tax Investment Income Interest and Dividend Other Nonoperating Income (Expense) Nonoperating Income (Expense) Other Comprehensive Income (Loss), Derivatives Qualifying as Hedges, Net of Tax, Portion Attributable to Noncontrolling Interest Reclassification from AOCI, Current Period, Net of Tax, Attributable to Parent Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Gain (Loss) Arising During Period, Net of Tax Comprehensive Income (Loss), Net of Tax, Attributable to Noncontrolling Interest Comprehensive Income (Loss), Net of Tax, Attributable to Parent Dividends, Cash Stock Repurchased During Period, Value Income (Loss) from Equity Method Investments Change in Fair Value of Derivatives Increase (Decrease) in Accounts Receivable Increase (Decrease) in Inventories Increase (Decrease) in Other Operating Assets Net Cash Provided by (Used in) Operating Activities Payments to Acquire Investments Payments to Acquire Property, Plant, and Equipment Payments to Acquire Intangible Assets Net Cash Provided by (Used in) Investing Activities Repayments of Long-Term Debt Payments of Ordinary Dividends, Common Stock Payments of Ordinary Dividends, Noncontrolling Interest Payments for Repurchase of Equity Net Cash Provided by (Used in) Financing Activities Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents Income Taxes Paid Investments, Fair Value Disclosure Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Nonvested, Number of Shares Share-Based Compensation Arrangement by Share-Based Payment Award, Option, Nonvested, Weighted Average Exercise Price Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Nonvested Options Forfeited, Number of Shares Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures in Period Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period EX-101.PRE 10 ipar-20230331_pre.xml XBRL PRESENTATION FILE XML 11 R1.htm IDEA: XBRL DOCUMENT v3.23.1
Cover - shares
 3 Months Ended
Mar. 31, 2023
May 08, 2023
Cover [Abstract]    
Document Type 10-Q  
Amendment Flag false  
Document Quarterly Report true  
Document Transition Report false  
Document Period End Date Mar. 31, 2023  
Document Fiscal Period Focus Q1  
Document Fiscal Year Focus 2023  
Current Fiscal Year End Date --12-31  
Entity File Number 0-16469  
Entity Registrant Name INTER PARFUMS, INC.  
Entity Central Index Key 0000822663  
Entity Tax Identification Number 13-3275609  
Entity Incorporation, State or Country Code DE  
Entity Address, Address Line One 551 Fifth Avenue  
Entity Address, City or Town New York  
Entity Address, State or Province NY  
Entity Address, Postal Zip Code 10176  
City Area Code 212  
Local Phone Number 983-2640  
Title of 12(b) Security Common Stock, $.001 par value per share  
Trading Symbol IPAR  
Security Exchange Name NASDAQ  
Entity Current Reporting Status Yes  
Entity Interactive Data Current Yes  
Entity Filer Category Large Accelerated Filer  
Entity Small Business false  
Entity Emerging Growth Company false  
Entity Shell Company false  
Entity Common Stock, Shares Outstanding   32,012,950
XML 12 R2.htm IDEA: XBRL DOCUMENT v3.23.1
CONSOLIDATED BALANCE SHEETS (Unaudited) - USD ($)
$ in Thousands
Mar. 31, 2023
Dec. 31, 2022
Current assets:    
Cash and cash equivalents $ 149,055 $ 104,713
Short-term investments 88,702 150,833
Accounts receivable, net 241,948 197,584
Inventories 323,700 289,984
Receivables, other 27,779 28,803
Other current assets 20,346 15,650
Income taxes receivable 71 157
Total current assets 851,601 787,724
Property, equipment and leasehold improvements, net 169,036 166,722
Right-of-use assets, net 26,901 27,964
Trademarks, licenses and other intangible assets, net 294,300 290,853
Deferred tax assets 12,543 11,159
Other assets 25,825 24,120
Total assets 1,380,206 1,308,542
Current liabilities:    
Loans payable - banks 18,000
Current portion of long-term debt 29,092 28,547
Current portion of lease liabilities 5,310 5,296
Accounts payable – trade 93,053 88,388
Accrued expenses 190,305 213,621
Income taxes payable 26,409 8,715
Total current liabilities 362,169 344,567
Long–term debt, less current portion 145,128 151,494
Lease liabilities, less current portion 23,302 24,335
Inter Parfums, Inc. shareholders’ equity:    
Preferred stock, $.001 par; authorized 1,000,000 shares; none issued
Common stock, $.001 par; authorized 100,000,000 shares; outstanding 32,012,950 and 31,967,300 shares at March 31, 2023 and December 31, 2022, respectively  32 32
Additional paid-in capital 95,429 90,186
Retained earnings 654,440 620,095
Accumulated other comprehensive loss (48,440) (56,056)
Treasury stock, at cost, 9,907,865 and 9,864,805 shares at March 31, 2023 and December 31, 2022, respectively (43,055) (37,475)
Total Inter Parfums, Inc. shareholders’ equity 658,406 616,782
Noncontrolling interest 191,201 171,364
Total equity 849,607 788,146
Total liabilities and equity $ 1,380,206 $ 1,308,542
XML 13 R3.htm IDEA: XBRL DOCUMENT v3.23.1
CONSOLIDATED BALANCE SHEETS (Unaudited) (Parenthetical) - $ / shares
Mar. 31, 2023
Dec. 31, 2022
Statement of Financial Position [Abstract]    
Preferred stock, par or stated value per share $ 0.001 $ 0.001
Preferred stock, shares authorized 1,000,000 1,000,000
Preferred stock, shares issued 0 0
Common stock, par or stated value per share $ 0.001 $ 0.001
Common stock, shares authorized 100,000,000 100,000,000
Common stock, shares, outstanding 32,012,950 31,967,300
Treasury stock, shares 9,907,865 9,864,805
XML 14 R4.htm IDEA: XBRL DOCUMENT v3.23.1
CONSOLIDATED STATEMENTS OF INCOME (Unaudited) - USD ($)
$ in Thousands
 3 Months Ended
Mar. 31, 2023
Mar. 31, 2022
Income Statement [Abstract]    
Net sales $ 311,723 $ 250,678
Cost of sales 108,766 92,020
Gross margin 202,957 158,658
Selling, general and administrative expenses 112,678 97,441
Income from operations 90,279 61,217
Other expenses (income):    
Interest expense 2,357 883
Loss (gain) on foreign currency 759 (2,239)
Interest and investment (income) loss (5,382) 1,466
Other income (41) (116)
Nonoperating Income (Expense) (2,307) (6)
Income before income taxes 92,586 61,223
Income taxes 21,678 14,932
Net income 70,908 46,291
Less:  Net income attributable to the noncontrolling interest 16,840 10,992
Net income attributable to Inter Parfums, Inc. $ 54,068 $ 35,299
Net income attributable to Inter Parfums, Inc. common shareholders:    
   Basic $ 1.69 $ 1.11
   Diluted $ 1.68 $ 1.10
Weighted average number of shares outstanding:    
   Basic 32,018 31,840
   Diluted 32,159 32,010
Dividends declared per share $ 0.625 $ 0.50
XML 15 R5.htm IDEA: XBRL DOCUMENT v3.23.1
CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (Unaudited) - USD ($)
$ in Thousands
 3 Months Ended
Mar. 31, 2023
Mar. 31, 2022
Comprehensive income:    
Net income $ 70,908 $ 46,291
Other comprehensive income:    
Net derivative instrument gain (loss), net of tax (4,166) 261
Transfer from OCI into earnings 1,709 992
Translation adjustments, net of tax 13,489 (12,441)
Comprehensive income 81,940 35,103
Comprehensive income attributable to the noncontrolling interests:    
Net income 16,840 10,992
Net derivative instrument gain (loss), net of tax (206) 72
Translation adjustments, net of tax 3,622 (3,419)
Comprehensive income attributable to the noncontrolling interests 20,256 7,645
Comprehensive income attributable to Inter Parfums, Inc. $ 61,684 $ 27,458
XML 16 R6.htm IDEA: XBRL DOCUMENT v3.23.1
CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY (Unaudited) - USD ($)
$ in Thousands
Common Stock [Member]
Additional Paid-in Capital [Member]
Retained Earnings [Member]
AOCI Attributable to Parent [Member]
Treasury Stock, Common [Member]
Noncontrolling Interest [Member]
Total
Beginning Balance at Dec. 31, 2021 $ 32 $ 87,132 $ 560,663 $ (38,432) $ (37,475) $ 166,412 $ 738,332
Net income   35,299   10,992 46,291
Shares issued upon exercise of stock options   708          
Dividends     (15,921)     (440)  
Foreign currency translation adjustment, net of tax       (9,022)   (3,419)  
Share-based compensation   341 53     11  
Transfer from other comprehensive income into earnings       992      
Net derivative instrument gain (loss), net of tax       189   72 (261)
Shares repurchased            
Transfer of subsidiary shares purchased           54  
Ending Balance at Mar. 31, 2022 32 88,181 580,094 (46,273) (37,475) 173,682 758,241
Beginning Balance at Dec. 31, 2022 32 90,186 620,095 (56,056) (37,475) 171,364 788,146
Net income   54,068   16,840 70,908
Shares issued upon exercise of stock options   4,929          
Dividends     (20,023)     (473)  
Foreign currency translation adjustment, net of tax       9,867   3,622  
Share-based compensation   314 300     54  
Transfer from other comprehensive income into earnings       1,709      
Net derivative instrument gain (loss), net of tax       (3,960)   (206) 4,166
Shares repurchased         (5,580)    
Transfer of subsidiary shares purchased            
Ending Balance at Mar. 31, 2023 $ 32 $ 95,429 $ 654,440 $ (48,440) $ (43,055) $ 191,201 $ 849,607
XML 17 R7.htm IDEA: XBRL DOCUMENT v3.23.1
CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) - USD ($)
$ in Thousands
 3 Months Ended
Mar. 31, 2023
Mar. 31, 2022
Cash flows from operating activities:    
Net income $ 70,908 $ 46,291
Adjustments to reconcile net income to net cash provided by (used in) operating activities:    
Depreciation and amortization 4,115 3,124
Provision for doubtful accounts 220 1,048
Noncash stock compensation 633 654
Share of income of equity investment (41) (116)
Noncash lease expense 1,324 1,881
Deferred tax provision (1,188) 135
Change in fair value of derivatives 1,518 (3,803)
Changes in:    
Accounts receivable (42,670) (50,316)
Inventories (29,688) (31,195)
Other assets (5,640) (2,869)
Operating lease liabilities (1,293) (1,671)
Accounts payable and accrued expenses (23,327) 3,203
Income taxes, net 17,771 9,690
Net cash used in operating activities (7,358) (23,944)
Cash flows from investing activities:    
Purchases of short-term investments (42,835) (2,243)
Proceeds from sale of short-term investments 107,045 3,982
Purchases of property, equipment and leasehold improvements (2,415) (12,895)
Payment for intangible assets acquired (151) (647)
Net cash provided by (used in) investing activities 61,644 (11,803)
Cash flows from financing activities:    
Proceeds from issuance of long-term debt 17,989
Repayment of long-term debt (9,397) (4,379)
Proceeds from exercise of options 4,929 708
Dividends paid (20,023) (15,921)
Dividends paid to noncontrolling interest (473) (440)
Purchase of treasury stock (5,580)
Net cash used in financing activities (12,555) (20,032)
Effect of exchange rate changes on cash 2,611 (2,486)
Net increase (decrease) in cash and cash equivalents 44,342 (58,265)
Cash and cash equivalents - beginning of period 104,713 168,387
Cash and cash equivalents - end of period 149,055 110,122
Cash paid for:    
Interest 1,563 797
Income taxes $ 4,816 $ 5,193
XML 18 R8.htm IDEA: XBRL DOCUMENT v3.23.1
Significant Accounting Policies:
 3 Months Ended
Mar. 31, 2023
Accounting Policies [Abstract]  
Significant Accounting Policies:

 

1.Significant Accounting Policies:

 

The accounting policies we follow are set forth in the notes to our consolidated financial statements included in our Form 10-K, which was filed with the Securities and Exchange Commission for the year ended December 31, 2022.
XML 19 R9.htm IDEA: XBRL DOCUMENT v3.23.1
Impact of COVID-19 Pandemic:
 3 Months Ended
Mar. 31, 2023
Unusual or Infrequent Items, or Both [Abstract]  
Impact of COVID-19 Pandemic:

 

2.Impact of COVID-19 Pandemic:

 

Our business has continued to significantly improve throughout 2022 and the first quarter of 2023 after the disastrous effects of the COVID-19 Pandemic starting in early 2020, as retail stores reopened, and consumers increased online purchasing. The introduction of variants of COVID-19 in various parts of the world continues to cause the temporary re-implementation of governmental restrictions to prevent further spread of the virus. In addition, international air travel remains curtailed in several jurisdictions due to both governmental restrictions and consumer health concerns. While COVID-19 had significantly restricted international travel, the travel retail business has picked up. Lastly, we have experienced significant strains on our supply chain causing disruptions affecting the procurement of components, the ability to transport goods, and related cost increases. These disruptions have come at a time when demand for our product lines has never been stronger or more sustained. We have been addressing this issue since the beginning of 2021, by ordering well in advance of need and in larger quantities. Since 2021, we have strived to carry more inventory overall, source the same components from multiple suppliers and when possible, manufacture products closer to where they are sold. We do not expect the supply chain bottlenecks to begin lifting until the second half of 2023. Therefore, despite recent business improvement, the impact of the COVID-19 pandemic might continue to have adverse effects on our results of our operations, financial position and cash flows through at least the first half of 2023.
XML 20 R10.htm IDEA: XBRL DOCUMENT v3.23.1
Recent Agreements:
 3 Months Ended
Mar. 31, 2023
Business Combination and Asset Acquisition [Abstract]  
Recent Agreements:

 

3.Recent Agreements:

 

Lacoste

 

In December 2022, we closed a transaction agreement with Lacoste, whereby an exclusive and worldwide license was granted for the production and distribution of Lacoste brand perfumes and cosmetics. Our rights under this license are subject to certain minimum advertising expenditures and royalty payments as are customary in our industry. The license becomes effective in January 2024 and will last for 15 years.

 

Dunhill

 

In April 2022, we announced that the Dunhill fragrance license will expire on September 30, 2023 and will not be renewed. The Company will continue to produce and sell Dunhill fragrances until the license expires and will maintain the right to sell-off remaining Dunhill fragrance inventory for a limited time as is customary in the fragrance industry.

 

Donna Karan and DKNY

 

In September 2021, we entered into a long-term global licensing agreement for the creation, development and distribution of fragrances and fragrance-related products under the Donna Karan and DKNY brands. Our rights under this license are subject to certain minimum advertising expenditures and royalty payments as are customary in our industry. With this agreement, we gained several well-established and valuable fragrance franchises, most notably Donna Karan Cashmere Mist and DKNY Be Delicious, as well as a significant loyal consumer base around the world. In connection with the grant of license, we issued 65,342 shares of Inter Parfums, Inc. common stock valued at $5.0 million to the licensor. The exclusive license became effective July 1, 2022, and we are planning to launch new fragrances under these brands in 2024.

 

Rochas Fashion

 

Effective January 1, 2021, we entered into a new license agreement modifying our Rochas fashion business model. The new agreement calls for a reduction in royalties to be received. As a result, in the first quarter of 2021, we took a $2.4 million impairment charge on our Rochas fashion trademark. In the fourth quarter of 2022, we again took a $6.8 million impairment charge on the Rochas fashion trademark after an independent expert concluded that the valuation of the trademark was $11.3 million. The new license also contains an option for the licensee to buy-out the Rochas fashion trademarks in June 2025 at its then fair market value.

 

Land and Building Acquisition - New Headquarters in Paris

 

In April 2021, Interparfums SA, our 72% owned French subsidiary, completed the acquisition of its new headquarters at 10 rue de Solférino in the 7th arrondissement of Paris from the property developer. This is an office complex combining three buildings connected by two inner courtyards, and consists of approximately 40,000 total sq. ft.

 

The purchase price included the complete renovation of the site. As of March 31, 2023, $151 million of the purchase price, including approximately $4.5 million of acquisition costs, is included in property, equipment and leasehold improvements on the accompanying balance sheet. The purchase price has been allocated approximately $62.3 million to land and $88.7 million to the building. The building, which was delivered on February 28, 2022, includes the building structure, development of the property, façade waterproofing, general and technical installations and interior fittings that will be depreciated over a range of 7 to 50 years. The Company has elected to depreciate the building cost based on the useful lives of its components. Approximately $1.8 million of cash held in escrow is also included in property, equipment and leasehold improvements on the accompanying balance sheet as of March 31, 2023.

 

The acquisition was financed by a 10-year €120 million (approximately $130.5 million) bank loan which bears interest at one-month Euribor plus 0.75%. Approximately €80 million of the variable rate debt was swapped for variable interest rate debt with a maximum rate of 2% per annum. The swap effectively exchanges the variable interest rate to a fixed rate of approximately 1.1%.
XML 21 R11.htm IDEA: XBRL DOCUMENT v3.23.1
Recent Accounting Pronouncements:
 3 Months Ended
Mar. 31, 2023
Accounting Changes and Error Corrections [Abstract]  
Recent Accounting Pronouncements:

 

4.Recent Accounting Pronouncements:

 

There are no recent accounting pronouncements issued but not yet adopted that would have a material effect on our consolidated financial statements.
XML 22 R12.htm IDEA: XBRL DOCUMENT v3.23.1
Inventories:
 3 Months Ended
Mar. 31, 2023
Inventory Disclosure [Abstract]  
Inventories:

 

5.Inventories:

 

Inventories consist of the following:

 

(In thousands)  March 31, 
2023		   December 31,
2022		 
Raw materials and component parts  $155,013   $146,772 
Finished goods   168,687    143,212 
           
Inventories  $323,700   $289,984 

 
XML 23 R13.htm IDEA: XBRL DOCUMENT v3.23.1
Fair Value Measurement:
 3 Months Ended
Mar. 31, 2023
Fair Value Disclosures [Abstract]  
Fair Value Measurement:

 

6.Fair Value Measurement:

 

The following tables present our financial assets and liabilities that are measured at fair value on a recurring basis and are categorized using the fair value hierarchy. The fair value hierarchy has three levels based on the reliability of the inputs used to determine fair value.

 

                             
          Fair Value Measurements at March 31, 2023  
          Quoted Prices in     Significant Other     Significant  
          Active Markets for     Observable     Unobservable  
          Identical Assets     Inputs     Inputs  
    Total     (Level 1)     (Level 2)     (Level 3)  
Assets:                      
Short-term investments   $ 88,702     $ 681     $ 87,210     $ 811  
Interest rate swaps     6,429               6,429          
Foreign currency forward exchange contracts not accounted for using hedge accounting     1,539       —       1,539       —  
Foreign currency forward exchange contracts accounted for using hedge accounting     339     $ —       339       —  
                                 
Total assets   $ 97,010     $ 681     $ 95,517     $ 811  

 

                               
           Fair Value Measurements at December 31, 2022 
       Quoted Prices in   Significant Other   Significant 
       Active Markets for   Observable   Unobservable 
       Identical Assets   Inputs   Inputs 
   Total   (Level 1)   (Level 2)   (Level 3) 
Assets:                
Short-term investments  $150,833   $19,861   $130,174   $798 
Interest rate swaps   6,758    —    6,758    — 
Foreign currency forward exchange contracts accounted for using hedge accounting   1,189    —    1,189    — 
                     
Total assets  $158,780   $19,861   $138,122   $798 
Liabilities:                    
Foreign currency forward exchange contracts not accounted for using hedge accounting   68    —    68    — 
                     
Total liabilities  $68   $—   $68   $— 

 

The carrying amount of cash and cash equivalents including money market funds, short-term investments, accounts receivable, other receivables, cash held in escrow, accounts payable and accrued expenses approximate fair value due to the short terms to maturity of these instruments.

 

The carrying amount of loans payable approximates fair value as the interest rates on the Company’s indebtedness approximate current market rates. The fair value of the Company’s long-term debt was estimated based on the current rates offered to companies for debt with the same remaining maturities and is approximately equal to its carrying value.

 

Foreign currency forward exchange contracts are valued based on quotations from financial institutions and the value of interest rate swaps are the discounted net present value of the swaps using third party quotes from financial institutions.
XML 24 R14.htm IDEA: XBRL DOCUMENT v3.23.1
Derivative Financial Instruments:
 3 Months Ended
Mar. 31, 2023
Derivative Instruments and Hedging Activities Disclosure [Abstract]  
Derivative Financial Instruments:

 

7.Derivative Financial Instruments:

 

The Company enters into foreign currency forward exchange contracts to hedge exposure related to receivables denominated in a foreign currency and occasionally to manage risks related to future sales expected to be denominated in a foreign currency. Before entering into a derivative transaction for hedging purposes, it is determined that a high degree of initial effectiveness exists between the change in value of the hedged item and the change in the value of the derivative instrument from movement in exchange rates. High effectiveness means that the change in the cash flows of the derivative instrument will effectively offset the change in the cash flows of the hedged item. The effectiveness of each hedged item is measured throughout the hedged period and is based on the dollar offset methodology and excludes the portion of the fair value of the foreign currency forward exchange contract attributable to the change in spot-forward difference which is reported in current period earnings. Any hedge ineffectiveness is also recognized as a gain or loss on foreign currency in the income statement. For hedge contracts that are no longer deemed highly effective, hedge accounting is discontinued, and gains and losses accumulated in other comprehensive income are reclassified to earnings. If it is probable that the forecasted transaction will no longer occur, then any gains or losses accumulated in other comprehensive income are reclassified to current-period earnings. 

 

In December 2022, to finance the acquisition of the Lacoste trademark, the Company entered into a €50 million ($54.4 million) 4-year term loan with a variable interest rate. This variable rate debt was swapped for variable interest rate debt with a maximum rate of 2% per annum. This swap is a hedged derivative instrument and is therefore recorded at fair value and changes in fair value are reflected in other comprehensive income.

 

In connection with the April 2021 acquisition of the office building complex in Paris, €120 million (approximately $130.5 million) of the purchase price was financed through a 10-year term loan. The Company entered into interest rate swap contracts related to €80 million of the loan, effectively exchanging the variable interest rate to a fixed rate of approximately 1.1%. This derivative instrument is recorded at fair value and changes in fair value are reflected in the accompanying consolidated statements of income.

 

Gains and losses in derivatives designated as hedges are accumulated in other comprehensive income and gains and losses in derivatives not designated as hedges are included in (gain) loss on foreign currency on the accompanying income statements. Such gains and losses were immaterial for both the three months ended March 31, 2023 and 2022.

 

All derivative instruments are reported as either assets or liabilities on the balance sheet measured at fair value. The valuation of interest rate swaps is included in long-term debt on the accompanying balance sheets. The valuation of foreign currency forward exchange contracts at March 31, 2023, resulted in a net asset and is included in other current assets on the accompanying balance sheet.

 

At March 31, 2023, we had foreign currency contracts in the form of forward exchange contracts in the amount of approximately U.S. $37 million which all have maturities of less than one year.
XML 25 R15.htm IDEA: XBRL DOCUMENT v3.23.1
Leases:
 3 Months Ended
Mar. 31, 2023
Leases [Abstract]  
Leases:

 

8.Leases:

 

The Company leases its offices and warehouses, vehicles, and certain office equipment, substantially all of which are classified as operating leases. The Company currently has no material financing leases. The Company determines if an arrangement is a lease at inception. Operating lease assets and obligations are recognized at the lease commencement date based on the present value of lease payments over the lease term.

 

In determining lease asset value, the Company considers fixed or variable payment terms, prepayments, incentives, and options to extend or terminate, depending on the lease. Renewal, termination or purchase options affect the lease term used for determining lease asset value only if the option is reasonably certain to be exercised. The Company generally uses its incremental borrowing rate based on information available at the lease commencement date for the location in which the lease is held in determining the present value of lease payments.

 

As of March 31, 2023, the weighted average remaining lease term was 5.5 years and the weighted average discount rate used to determine the operating lease liability was 2.6%. Rental expense related to operating leases was $1.4 million and $1.8 million for the three months ended March 31, 2023 and 2022, respectively. Operating lease payments included in operating cash flows totaled $1.3 million and $1.7 million for the three months ended March 31, 2023 and 2022, respectively, and there were no noncash additions to operating lease assets for the three months ended March 31, 2023 and 2022.
XML 26 R16.htm IDEA: XBRL DOCUMENT v3.23.1
Share-Based Payments:
 3 Months Ended
Mar. 31, 2023
Equity:  
Share-Based Payments:

 

9.Share-Based Payments:

 

The Company maintains a stock option program for key employees, executives and directors. The plans, all of which have been approved by shareholder vote, provide for the granting of both nonqualified and incentive options. Options granted under the plans typically have a six-year term and vest over a four to five-year period. The fair value of shares vested during the three months ended March 31, 2023 and 2022 aggregated $0.09 million and $0.10 million, respectively. Compensation cost, net of forfeitures, is recognized on a straight-line basis over the requisite service period for the entire award. Forfeitures are estimated based on historic trends. It is generally our policy to issue new shares upon exercise of stock options.

 

The following table sets forth information with respect to nonvested options for the three months ended March 31, 2023:

 

   Number of Shares   Weighted Average
Grant-Date Fair Value		 
Nonvested options – beginning of period   168,730   $16.31 
Nonvested options granted   —    — 
Nonvested options vested or forfeited   (23,080)  $13.58 
Nonvested options – end of period   145,650   $16.74 

 

Share-based payment expense decreased income before income taxes by $0.63 million and $0.65 million for the three months ended March 31, 2023 and 2022, respectively, and decreased income attributable to Inter Parfums, Inc. by $0.43 million and $0.44 million for the three months ended March 31, 2023 and 2022, respectively.

 

The following table summarizes stock option information as of March 31, 2023:

 

   Shares   Weighted Average
Exercise Price		 
         
Outstanding at January 1, 2023   441,580   $67.30 
Options forfeited   (15,480)   70.48 
Options exercised   (88,710)   55.57 
           
Outstanding at March 31, 2023   337,390   $70.24 
           
Options exercisable   191,740   $61.38 
Options available for future grants   574,455      

 

As of March 31, 2023, the weighted average remaining contractual life of options outstanding is 3.56 years (1.75 years for options exercisable); the aggregate intrinsic value of options outstanding and options exercisable is $24.3 million and $15.5 million, respectively; and unrecognized compensation cost related to stock options outstanding aggregated $2.4 million.

 

Cash proceeds, tax benefits and intrinsic value related to stock options exercised during the three months ended March 31, 2023 and 2022 were as follows:

 

(In thousands)  March 31,  
2023		   March 31,  
2022		 
         
Cash proceeds from stock options exercised  $4,929   $708 
Tax benefits   780    75 
Intrinsic value of stock options exercised   5,403    635 

 

There were no options granted during the three months ended March 31, 2023 and March 31, 2022.

 

Expected volatility is estimated based on historic volatility of the Company’s common stock. The expected term of the option is estimated based on historic data. The risk-free rate is based on the U.S. Treasury yield curve in effect at the time of the grant of the option and the dividend yield reflects the assumption that the dividend payout as authorized by the Board of Directors would increase as the earnings of the Company and its stock price continue to increase.

 

In December 2018, Interparfums SA approved a plan to grant an aggregate of 26,600 shares of its stock to employees with no performance condition requirement, and an aggregate of 133,000 shares to officers and managers, subject to certain corporate performance conditions. The corporate performance conditions were met and therefore in June 2022, 211,955 shares, adjusted for stock splits, were distributed. The aggregate cost of the grant of approximately $4.8 million was recognized as compensation cost on a straight-line basis over the requisite three-year service period.

 

In March 2022, Interparfums SA approved an additional plan to grant an aggregate of 88,400 shares to all Interparfums SA employees and corporate officers having more than six months of employment at grant date, subject to certain corporate performance conditions. The shares, subject to adjustment for stock splits, will be distributed in June 2025 and will follow the same guidelines as the December 2018 plan.

 

The fair value of the grant had been determined based on the quoted stock price of Interparfums SA shares as reported by the Euronext on the date of grant. The estimated number of shares to be distributed of 85,107 has been determined taking into account employee turnover. The aggregate cost of the grant of approximately $4.1 million will be recognized as compensation cost on a straight-line basis over the requisite three and a quarter year service period.

 

Similar to the December 2018 plan, in order to avoid dilution of the Company’s ownership of Interparfums SA, all shares distributed or to be distributed pursuant to these plans will be pre-existing shares of Interparfums SA, purchased in the open market by Interparfums SA. During the year ended December 31, 2022, the Company acquired 63,281 shares at an aggregate cost of $3.0 million.

 

In the first quarter of 2023, the Company initiated a small share repurchase program, and over the course the course of the first quarter of 2023, the Company repurchased 43,060 shares at a cost of $5.58 million. These shares are classified as treasury shares on the accompanying balance sheet. The Company plans to continue repurchasing shares throughout 2023.

 

All share purchases and issuances have been classified as equity transactions on the accompanying balance sheet.
XML 27 R17.htm IDEA: XBRL DOCUMENT v3.23.1
Net Income Attributable to Inter Parfums, Inc. Common Shareholders:
 3 Months Ended
Mar. 31, 2023
Earnings per share:  
Net Income Attributable to Inter Parfums, Inc. Common Shareholders:

 

10.Net Income Attributable to Inter Parfums, Inc. Common Shareholders:

 

Net income attributable to Inter Parfums, Inc. per common share (“basic EPS”) is computed by dividing net income attributable to Inter Parfums, Inc. by the weighted average number of shares outstanding. Net income attributable to Inter Parfums, Inc. per share assuming dilution (“diluted EPS”), is computed using the weighted average number of shares outstanding, plus the incremental shares outstanding assuming the exercise of dilutive stock options using the treasury stock method.

 

The reconciliation between the numerators and denominators of the basic and diluted EPS computations is as follows:

 

             
   Three months ended 
(In thousands)  March 31, 
   2023   2022 
Numerator:        
Net income attributable to Inter Parfums, Inc.  $54,068   $35,299 
Denominator:          
Weighted average shares   32,018    31,840 
Effect of dilutive securities:          
Stock options   141    170 
Denominator for diluted earnings per share   32,159    32,010 
           
Earnings per share:          
Net income attributable to Inter Parfums, Inc. common shareholders:          
Basic  $1.69   $1.11 
Diluted   1.68    1.10 

 

There were no antidilutive potential common shares outstanding for the three months ended March 31, 2023 and March 31, 2022.
XML 28 R18.htm IDEA: XBRL DOCUMENT v3.23.1
Segment and Geographic Areas:
 3 Months Ended
Mar. 31, 2023
Segment Reporting [Abstract]  
Segment and Geographic Areas:

 

11.Segment and Geographic Areas:

 

The Company manufactures and distributes one product line, fragrances and fragrance related products. The Company manages its business in two segments, European based operations and United States based operations. The European assets are located, and operations are primarily conducted, in France. Both European operations and United States operations primarily represent the sale of prestige brand name fragrances. Information on our operations by geographical areas is as follows:

 

(In thousands)  Three months ended
March 31,		 
   2023   2022 
Net sales:          
United States  $81,454   $68,502 
Europe   230,269    182,182 
Eliminations   —    (6)
           
   $311,723   $250,678 
           
Net income attributable to Inter Parfums, Inc.:          
United States  $10,343   $6,514 
Europe   43,725    28,785 
           
   $54,068   $35,299 

 

   March 31,   December 31, 
   2023   2022 
Total Assets:          
United States  $288,927   $278,090 
Europe   1,110,902    1,052,004 
Eliminations   (19,623)   (21,522)
   $1,380,206   $1,308,542 

 
XML 29 R19.htm IDEA: XBRL DOCUMENT v3.23.1
Inventories: (Tables)
 3 Months Ended
Mar. 31, 2023
Inventory Disclosure [Abstract]  
Inventories consist of the following:

Inventories consist of the following:

 

(In thousands)  March 31, 
2023		   December 31,
2022		 
Raw materials and component parts  $155,013   $146,772 
Finished goods   168,687    143,212 
           
Inventories  $323,700   $289,984 
XML 30 R20.htm IDEA: XBRL DOCUMENT v3.23.1
Fair Value Measurement: (Tables)
 3 Months Ended
Mar. 31, 2023
Fair Value Disclosures [Abstract]  
The following tables present our financial assets and liabilities that are measured at fair value on a recurring basis and are categorized using the fair value hierarchy. The fair value hierarchy has three levels based on the reliability of the inputs used to determine fair value.

The following tables present our financial assets and liabilities that are measured at fair value on a recurring basis and are categorized using the fair value hierarchy. The fair value hierarchy has three levels based on the reliability of the inputs used to determine fair value.

 

                             
          Fair Value Measurements at March 31, 2023  
          Quoted Prices in     Significant Other     Significant  
          Active Markets for     Observable     Unobservable  
          Identical Assets     Inputs     Inputs  
    Total     (Level 1)     (Level 2)     (Level 3)  
Assets:                      
Short-term investments   $ 88,702     $ 681     $ 87,210     $ 811  
Interest rate swaps     6,429               6,429          
Foreign currency forward exchange contracts not accounted for using hedge accounting     1,539       —       1,539       —  
Foreign currency forward exchange contracts accounted for using hedge accounting     339     $ —       339       —  
                                 
Total assets   $ 97,010     $ 681     $ 95,517     $ 811  

 

                               
           Fair Value Measurements at December 31, 2022 
       Quoted Prices in   Significant Other   Significant 
       Active Markets for   Observable   Unobservable 
       Identical Assets   Inputs   Inputs 
   Total   (Level 1)   (Level 2)   (Level 3) 
Assets:                
Short-term investments  $150,833   $19,861   $130,174   $798 
Interest rate swaps   6,758    —    6,758    — 
Foreign currency forward exchange contracts accounted for using hedge accounting   1,189    —    1,189    — 
                     
Total assets  $158,780   $19,861   $138,122   $798 
Liabilities:                    
Foreign currency forward exchange contracts not accounted for using hedge accounting   68    —    68    — 
                     
Total liabilities  $68   $—   $68   $— 
XML 31 R21.htm IDEA: XBRL DOCUMENT v3.23.1
Share-Based Payments: (Tables)
 3 Months Ended
Mar. 31, 2023
Equity:  
The following table sets forth information with respect to nonvested options for the three months ended March 31, 2023:

The following table sets forth information with respect to nonvested options for the three months ended March 31, 2023:

 

   Number of Shares   Weighted Average
Grant-Date Fair Value		 
Nonvested options – beginning of period   168,730   $16.31 
Nonvested options granted   —    — 
Nonvested options vested or forfeited   (23,080)  $13.58 
Nonvested options – end of period   145,650   $16.74 
The following table summarizes stock option information as of March 31, 2023:

The following table summarizes stock option information as of March 31, 2023:

 

   Shares   Weighted Average
Exercise Price		 
         
Outstanding at January 1, 2023   441,580   $67.30 
Options forfeited   (15,480)   70.48 
Options exercised   (88,710)   55.57 
           
Outstanding at March 31, 2023   337,390   $70.24 
           
Options exercisable   191,740   $61.38 
Options available for future grants   574,455      
Cash proceeds, tax benefits and intrinsic value related to stock options exercised during the three months ended March 31, 2023 and 2022 were as follows:

Cash proceeds, tax benefits and intrinsic value related to stock options exercised during the three months ended March 31, 2023 and 2022 were as follows:

 

(In thousands)  March 31,  
2023		   March 31,  
2022		 
         
Cash proceeds from stock options exercised  $4,929   $708 
Tax benefits   780    75 
Intrinsic value of stock options exercised   5,403    635 
XML 32 R22.htm IDEA: XBRL DOCUMENT v3.23.1
Net Income Attributable to Inter Parfums, Inc. Common Shareholders: (Tables)
 3 Months Ended
Mar. 31, 2023
Earnings per share:  
The reconciliation between the numerators and denominators of the basic and diluted EPS computations is as follows:

The reconciliation between the numerators and denominators of the basic and diluted EPS computations is as follows:

 

             
   Three months ended 
(In thousands)  March 31, 
   2023   2022 
Numerator:        
Net income attributable to Inter Parfums, Inc.  $54,068   $35,299 
Denominator:          
Weighted average shares   32,018    31,840 
Effect of dilutive securities:          
Stock options   141    170 
Denominator for diluted earnings per share   32,159    32,010 
           
Earnings per share:          
Net income attributable to Inter Parfums, Inc. common shareholders:          
Basic  $1.69   $1.11 
Diluted   1.68    1.10 
XML 33 R23.htm IDEA: XBRL DOCUMENT v3.23.1
Segment and Geographic Areas: (Tables)
 3 Months Ended
Mar. 31, 2023
Segment Reporting [Abstract]  
Information on the Company’s operations by segments is as follows:

 

(In thousands)  Three months ended
March 31,		 
   2023   2022 
Net sales:          
United States  $81,454   $68,502 
Europe   230,269    182,182 
Eliminations   —    (6)
           
   $311,723   $250,678 
           
Net income attributable to Inter Parfums, Inc.:          
United States  $10,343   $6,514 
Europe   43,725    28,785 
           
   $54,068   $35,299 

 

   March 31,   December 31, 
   2023   2022 
Total Assets:          
United States  $288,927   $278,090 
Europe   1,110,902    1,052,004 
Eliminations   (19,623)   (21,522)
   $1,380,206   $1,308,542 
XML 34 R24.htm IDEA: XBRL DOCUMENT v3.23.1
Recent Agreements: (Details Narrative)
€ in Millions
 3 Months Ended
Mar. 31, 2023
USD ($)
shares
Mar. 31, 2023
EUR (€)
Dec. 31, 2022
Apr. 30, 2021
Business Acquisition [Line Items]        
Ownership percentage       72.00%
Purchase price, period cost $ 151,000,000      
Acquisition costs, period cost 4,500,000      
Cash held in escrow is included in other assets $ 1,800,000      
Long-term debt, term 10 years 10 years 4 years 10 years
Long-term line of credit $ 130,500,000 € 120    
Description of debt instrument interest rate terms one-month Euribor plus 0.75%      
Variable interest rate 2.00% 2.00%    
Fixed interest rate 1.10% 1.10%    
Euro Member Countries, Euro        
Business Acquisition [Line Items]        
Debt instrument, face amount | €   € 80    
Minimum [Member]        
Business Acquisition [Line Items]        
Depreciated over a range 7 years 7 years    
Maximum [Member]        
Business Acquisition [Line Items]        
Depreciated over a range 50 years 50 years    
Land [Member]        
Business Acquisition [Line Items]        
Purchase price, period cost $ 62,300,000      
Building [Member]        
Business Acquisition [Line Items]        
Purchase price, period cost $ 88,700,000      
Rochas Fashion [Member]        
Business Acquisition [Line Items]        
Description of recent agreement we entered into a new license agreement modifying our Rochas fashion business model. The new agreement calls for a reduction in royalties to be received. As a result, in the first quarter of 2021, we took a $2.4 million impairment charge on our Rochas fashion trademark. In the fourth quarter of 2022, we again took a $6.8 million impairment charge on the Rochas fashion trademark after an independent expert concluded that the valuation of the trademark was $11.3 million. The new license also contains an option for the licensee to buy-out the Rochas fashion trademarks in June 2025 at its then fair market value.      
Lacoste [Member]        
Business Acquisition [Line Items]        
Description of recent agreement The license becomes effective in January 2024 and will last for 15 years.      
Donna Karan and DKNY [Member]        
Business Acquisition [Line Items]        
Shares issue | shares 65,342      
Shares value $ 5,000,000      
XML 35 R25.htm IDEA: XBRL DOCUMENT v3.23.1
Inventories consist of the following: (Details) - USD ($)
$ in Thousands
Mar. 31, 2023
Dec. 31, 2022
Inventory Disclosure [Abstract]    
Raw materials and component parts $ 155,013 $ 146,772
Finished goods 168,687 143,212
Inventories $ 323,700 $ 289,984
XML 36 R26.htm IDEA: XBRL DOCUMENT v3.23.1
The following tables present our financial assets and liabilities that are measured at fair value on a recurring basis and are categorized using the fair value hierarchy. The fair value hierarchy has three levels based on the reliability of the inputs use (Details) - Fair Value, Recurring [Member] - USD ($)
$ in Thousands
Mar. 31, 2023
Dec. 31, 2022
Assets:    
Short-term investments $ 88,702 $ 150,833
Interest rate swaps 6,429 6,758
Foreign currency forward exchange contracts accounted for using hedge accounting 1,539 1,189
Foreign currency forward exchange contracts not accounted for using hedge accounting 339 68
Total assets 97,010 158,780
Liabilities:    
Total liabilities   68
Fair Value, Inputs, Level 1 [Member]    
Assets:    
Short-term investments 681 19,861
Interest rate swaps  
Foreign currency forward exchange contracts accounted for using hedge accounting
Foreign currency forward exchange contracts not accounted for using hedge accounting
Total assets 681 19,861
Liabilities:    
Total liabilities  
Fair Value, Inputs, Level 2 [Member]    
Assets:    
Short-term investments 87,210 130,174
Interest rate swaps 6,429 6,758
Foreign currency forward exchange contracts accounted for using hedge accounting 1,539 1,189
Foreign currency forward exchange contracts not accounted for using hedge accounting 339 68
Total assets 95,517 138,122
Liabilities:    
Total liabilities   68
Fair Value, Inputs, Level 3 [Member]    
Assets:    
Short-term investments 811 798
Interest rate swaps  
Foreign currency forward exchange contracts accounted for using hedge accounting
Foreign currency forward exchange contracts not accounted for using hedge accounting
Total assets $ 811 798
Liabilities:    
Total liabilities  
XML 37 R27.htm IDEA: XBRL DOCUMENT v3.23.1
Derivative Financial Instruments: (Details Narrative)
€ in Millions, $ in Millions
Mar. 31, 2023
USD ($)
Dec. 31, 2022
USD ($)
Dec. 31, 2022
EUR (€)
Apr. 30, 2021
USD ($)
Apr. 30, 2021
EUR (€)
Derivative Instruments, Gain (Loss) [Line Items]          
Loan amount | $   $ 54.4   $ 130.5  
Long-term debt, term 10 years 4 years 4 years 10 years 10 years
Derivative swap interest rate 1.10% 2.00% 2.00%    
Foreign Exchange Contract [Member]          
Derivative Instruments, Gain (Loss) [Line Items]          
Forward exchange contracts | $ $ 37.0        
Euro Member Countries, Euro          
Derivative Instruments, Gain (Loss) [Line Items]          
Loan amount | €     € 50   € 120
Euro Member Countries, Euro | Interest Rate Swap [Member]          
Derivative Instruments, Gain (Loss) [Line Items]          
Loan amount | €         € 80
XML 38 R28.htm IDEA: XBRL DOCUMENT v3.23.1
Leases: (Details Narrative) - USD ($)
 3 Months Ended
Mar. 31, 2023
Mar. 31, 2022
Leases [Abstract]    
Operating lease, weighted average remaining lease term 5 years 6 months  
Operating lease, weighted average discount rate, percent 2.60%  
Operating leases, rent expense, net $ 1,400,000 $ 1,800,000
Operating Lease, Payments 1,300,000 1,700,000
Noncash additions to operating lease assets $ 0 $ 0
XML 39 R29.htm IDEA: XBRL DOCUMENT v3.23.1
The following table sets forth information with respect to nonvested options for the three months ended March 31, 2023: (Details)
 3 Months Ended
Mar. 31, 2023
$ / shares
shares
Equity:  
Nonvested options beginning of period | shares 168,730
Weighted average grant date fair value, beginning of year | $ / shares $ 16.31
Nonvested options granted | shares
Weighted average grant date fair value, nonvested options granted | $ / shares
Nonvested options vested or forfeited | shares (23,080)
Weighted average grant date fair value, nonvested options vested or forfeited | $ / shares $ 13.58
Nonvested options end of period | shares 145,650
Weighted average grant date fair value, nonvested options end of period | $ / shares $ 16.74
XML 40 R30.htm IDEA: XBRL DOCUMENT v3.23.1
The following table summarizes stock option information as of March 31, 2023: (Details)
 3 Months Ended
Mar. 31, 2023
$ / shares
shares
Equity:  
Options shares under option - beginning of year 441,580
Weighted average exercise price shares under option - beginning of year | $ / shares $ 67.30
Options forfeited (15,480)
Weighted average exercise price options forfeited | $ / shares $ 70.48
Options exercised (88,710)
Weighted average exercise price options exercised | $ / shares $ 55.57
Options shares under option - end of year 337,390
Weighted average exercise price shares under option - end of year | $ / shares $ 70.24
Options exercisable 191,740
Weighted average exercise price options exercisable | $ / shares $ 61.38
Options available for future grants 574,455
XML 41 R31.htm IDEA: XBRL DOCUMENT v3.23.1
Cash proceeds, tax benefits and intrinsic value related to stock options exercised during the three months ended March 31, 2023 and 2022 were as follows: (Details) - USD ($)
$ in Thousands
 3 Months Ended
Mar. 31, 2023
Mar. 31, 2022
Equity:    
Cash proceeds from stock options exercised $ 4,929 $ 708
Tax benefits 780 75
Intrinsic value of stock options exercised $ 5,403 $ 635
XML 42 R32.htm IDEA: XBRL DOCUMENT v3.23.1
Share-Based Payments: (Details Narrative) - USD ($)
 1 Months Ended 3 Months Ended 12 Months Ended
Jun. 30, 2022
Mar. 31, 2023
Mar. 31, 2022
Dec. 31, 2022
Dec. 31, 2018
Subsidiary or Equity Method Investee [Line Items]          
Share-based payment arrangement, expense   $ 630,000 $ 650,000    
Decreased income   430,000 440,000    
Weighted average remaining contractual life of options outstanding (in years)   3 years 6 months 21 days      
Weighted average remaining contractual life of options exercisable (in years)   1 year 9 months      
Aggregate intrinsic value of options outstanding and options outstanding   $ 24,300,000      
Aggregate intrinsic value of options outstanding and options exercisable   15,500,000      
Unrecognized compensation cost   $ 2,400,000      
Options granted   0 0    
Adjusted for stock splits 211,955        
Recognized as compensation cost $ 4,800,000        
Treasury Stock, Common [Member]          
Subsidiary or Equity Method Investee [Line Items]          
Shares repurchased   43,060      
Shares repurchase value   $ 5,580,000      
Interparfums SA Subsidiary [Member] | Employees [Member]          
Subsidiary or Equity Method Investee [Line Items]          
Aggregate shares to offices and managers     88,400 63,281 26,600
Recognized as compensation cost   $ 4,100,000   $ 3,000,000  
Number of share distributed   85,107      
Interparfums SA Subsidiary [Member] | Officers and Managers [Member]          
Subsidiary or Equity Method Investee [Line Items]          
Aggregate shares to offices and managers         133,000
Equity Option [Member]          
Subsidiary or Equity Method Investee [Line Items]          
Fair value of shares vested   $ 90,000 $ 100,000    
Equity Option [Member] | Minimum [Member]          
Subsidiary or Equity Method Investee [Line Items]          
Options vesting period   4 years      
Equity Option [Member] | Maximum [Member]          
Subsidiary or Equity Method Investee [Line Items]          
Options vesting period   5 years      
XML 43 R33.htm IDEA: XBRL DOCUMENT v3.23.1
The reconciliation between the numerators and denominators of the basic and diluted EPS computations is as follows: (Details) - USD ($)
$ / shares in Units, $ in Thousands
 3 Months Ended
Mar. 31, 2023
Mar. 31, 2022
Numerator:    
Net income attributable to Inter Parfums, Inc. $ 54,068 $ 35,299
Denominator:    
Weighted average shares 32,018 31,840
Stock options 141 170
Denominator for diluted earnings per share 32,159 32,010
Net income attributable to Inter Parfums, Inc. common shareholders:    
Basic $ 1.69 $ 1.11
Diluted $ 1.68 $ 1.10
XML 44 R34.htm IDEA: XBRL DOCUMENT v3.23.1
Net Income Attributable to Inter Parfums, Inc. Common Shareholders: (Details Narrative) - shares
 3 Months Ended
Mar. 31, 2023
Mar. 31, 2022
Earnings per share:    
Antidilutive securities excluded from computation of earnings per share, amount 0 0
XML 45 R35.htm IDEA: XBRL DOCUMENT v3.23.1
Information on the Company’s operations by segments is as follows: (Details) - USD ($)
$ in Thousands
 3 Months Ended
Mar. 31, 2023
Mar. 31, 2022
Dec. 31, 2022
Revenues from External Customers and Long-Lived Assets [Line Items]      
Net sales $ 311,723 $ 250,678  
Net income attributable to Inter Parfums, Inc. 54,068 35,299  
Assets 1,380,206   $ 1,308,542
Total Assets (1,380,206)   (1,308,542)
UNITED STATES      
Revenues from External Customers and Long-Lived Assets [Line Items]      
Net sales 81,454 68,502  
Net income attributable to Inter Parfums, Inc. 10,343 6,514  
Assets 288,927   278,090
Total Assets (288,927)   (278,090)
Europe [Member]      
Revenues from External Customers and Long-Lived Assets [Line Items]      
Net sales 230,269 182,182  
Net income attributable to Inter Parfums, Inc. 43,725 28,785  
Assets 1,110,902   1,052,004
Total Assets (1,110,902)   (1,052,004)
Eliminations [Member]      
Revenues from External Customers and Long-Lived Assets [Line Items]      
Net sales $ (6)  
Assets 19,623   21,522
Total Assets $ (19,623)   $ (21,522)
XML 46 g083513_10q_htm.xml IDEA: XBRL DOCUMENT 0000822663 2023-01-01 2023-03-31 0000822663 2023-05-08 0000822663 2023-03-31 0000822663 2022-12-31 0000822663 2022-01-01 2022-03-31 0000822663 us-gaap:CommonStockMember 2022-12-31 0000822663 us-gaap:CommonStockMember 2021-12-31 0000822663 us-gaap:AdditionalPaidInCapitalMember 2022-12-31 0000822663 us-gaap:AdditionalPaidInCapitalMember 2021-12-31 0000822663 us-gaap:RetainedEarningsMember 2022-12-31 0000822663 us-gaap:RetainedEarningsMember 2021-12-31 0000822663 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-12-31 0000822663 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-12-31 0000822663 us-gaap:TreasuryStockCommonMember 2022-12-31 0000822663 us-gaap:TreasuryStockCommonMember 2021-12-31 0000822663 us-gaap:NoncontrollingInterestMember 2022-12-31 0000822663 us-gaap:NoncontrollingInterestMember 2021-12-31 0000822663 2021-12-31 0000822663 us-gaap:CommonStockMember 2023-01-01 2023-03-31 0000822663 us-gaap:CommonStockMember 2022-01-01 2022-03-31 0000822663 us-gaap:AdditionalPaidInCapitalMember 2023-01-01 2023-03-31 0000822663 us-gaap:AdditionalPaidInCapitalMember 2022-01-01 2022-03-31 0000822663 us-gaap:RetainedEarningsMember 2023-01-01 2023-03-31 0000822663 us-gaap:RetainedEarningsMember 2022-01-01 2022-03-31 0000822663 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-01-01 2023-03-31 0000822663 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-01-01 2022-03-31 0000822663 us-gaap:TreasuryStockCommonMember 2023-01-01 2023-03-31 0000822663 us-gaap:TreasuryStockCommonMember 2022-01-01 2022-03-31 0000822663 us-gaap:NoncontrollingInterestMember 2023-01-01 2023-03-31 0000822663 us-gaap:NoncontrollingInterestMember 2022-01-01 2022-03-31 0000822663 us-gaap:CommonStockMember 2023-03-31 0000822663 us-gaap:CommonStockMember 2022-03-31 0000822663 us-gaap:AdditionalPaidInCapitalMember 2023-03-31 0000822663 us-gaap:AdditionalPaidInCapitalMember 2022-03-31 0000822663 us-gaap:RetainedEarningsMember 2023-03-31 0000822663 us-gaap:RetainedEarningsMember 2022-03-31 0000822663 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-03-31 0000822663 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-03-31 0000822663 us-gaap:TreasuryStockCommonMember 2023-03-31 0000822663 us-gaap:TreasuryStockCommonMember 2022-03-31 0000822663 us-gaap:NoncontrollingInterestMember 2023-03-31 0000822663 us-gaap:NoncontrollingInterestMember 2022-03-31 0000822663 2022-03-31 0000822663 ipar:LacosteMember 2023-01-01 2023-03-31 0000822663 ipar:DonnaKaranAndDKNYMember 2023-01-01 2023-03-31 0000822663 ipar:RochasFashionMember 2023-01-01 2023-03-31 0000822663 2021-04-30 0000822663 us-gaap:LandMember 2023-01-01 2023-03-31 0000822663 us-gaap:BuildingMember 2023-01-01 2023-03-31 0000822663 srt:MinimumMember 2023-03-31 0000822663 srt:MaximumMember 2023-03-31 0000822663 currency:EUR 2023-03-31 0000822663 us-gaap:FairValueMeasurementsRecurringMember 2023-03-31 0000822663 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2023-03-31 0000822663 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2023-03-31 0000822663 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2023-03-31 0000822663 us-gaap:FairValueMeasurementsRecurringMember 2022-12-31 0000822663 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2022-12-31 0000822663 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2022-12-31 0000822663 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2022-12-31 0000822663 currency:EUR 2022-12-31 0000822663 currency:EUR 2021-04-30 0000822663 currency:EUR us-gaap:InterestRateSwapMember 2021-04-30 0000822663 us-gaap:ForeignExchangeContractMember 2023-03-31 0000822663 srt:MinimumMember us-gaap:StockOptionMember 2023-01-01 2023-03-31 0000822663 srt:MaximumMember us-gaap:StockOptionMember 2023-01-01 2023-03-31 0000822663 us-gaap:StockOptionMember 2023-01-01 2023-03-31 0000822663 us-gaap:StockOptionMember 2022-01-01 2022-03-31 0000822663 ipar:InterparfumsSASubsidiaryMember ipar:EmployeesMember 2018-12-31 0000822663 ipar:InterparfumsSASubsidiaryMember ipar:OfficersAndManagersMember 2018-12-31 0000822663 2022-06-01 2022-06-30 0000822663 ipar:InterparfumsSASubsidiaryMember ipar:EmployeesMember 2022-03-31 0000822663 ipar:InterparfumsSASubsidiaryMember ipar:EmployeesMember 2023-01-01 2023-03-31 0000822663 ipar:InterparfumsSASubsidiaryMember ipar:EmployeesMember 2022-12-31 0000822663 ipar:InterparfumsSASubsidiaryMember ipar:EmployeesMember 2022-01-01 2022-12-31 0000822663 country:US 2023-01-01 2023-03-31 0000822663 country:US 2022-01-01 2022-03-31 0000822663 srt:EuropeMember 2023-01-01 2023-03-31 0000822663 srt:EuropeMember 2022-01-01 2022-03-31 0000822663 ipar:EliminationsMember 2023-01-01 2023-03-31 0000822663 ipar:EliminationsMember 2022-01-01 2022-03-31 0000822663 country:US 2023-03-31 0000822663 country:US 2022-12-31 0000822663 srt:EuropeMember 2023-03-31 0000822663 srt:EuropeMember 2022-12-31 0000822663 ipar:EliminationsMember 2023-03-31 0000822663 ipar:EliminationsMember 2022-12-31 iso4217:USD shares iso4217:USD shares pure iso4217:JPY iso4217:EUR iso4217:GBP 0000822663 false --12-31 2023 Q1 2023-03-31 NY NASDAQ P7Y P50Y P10Y P4Y P10Y P5Y6M0D P4Y P5Y 90000 P3Y6M21D P1Y9M0D 5580000 10-Q true false 0-16469 INTER PARFUMS, INC. DE 13-3275609 551 Fifth Avenue New York 10176 212 983-2640 Common Stock, $.001 par value per share IPAR Yes Yes Large Accelerated Filer false false false 32012950 149055000 104713000 88702000 150833000 241948000 197584000 323700000 289984000 27779000 28803000 20346000 15650000 71000 157000 851601000 787724000 169036000 166722000 26901000 27964000 294300000 290853000 12543000 11159000 25825000 24120000 1380206000 1308542000 18000000 29092000 28547000 5310000 5296000 93053000 88388000 190305000 213621000 26409000 8715000 362169000 344567000 145128000 151494000 23302000 24335000 0.001 0.001 1000000 1000000 0 0 0.001 0.001 100000000 100000000 32012950 31967300 32000 32000 95429000 90186000 654440000 620095000 -48440000 -56056000 9907865 9864805 43055000 37475000 658406000 616782000 191201000 171364000 849607000 788146000 1380206000 1308542000 311723000 250678000 108766000 92020000 202957000 158658000 112678000 97441000 90279000 61217000 2357000 883000 -759000 2239000 5382000 -1466000 41000 116000 2307000 6000 92586000 61223000 21678000 14932000 70908000 46291000 16840000 10992000 54068000 35299000 1.69 1.11 1.68 1.10 32018 31840 32159 32010 0.625 0.50 70908000 46291000 4166000 -261000 -1709000 -992000 13489000 -12441000 81940000 35103000 16840000 10992000 -206000 72000 -3622000 3419000 20256000 7645000 61684000 27458000 32000 32000 32000 32000 90186000 87132000 4929000 708000 314000 341000 95429000 88181000 620095000 560663000 54068000 35299000 20023000 15921000 300000 53000 654440000 580094000 -56056000 -38432000 9867000 -9022000 1709000 992000 -3960000 189000 -48440000 -46273000 -37475000 -37475000 5580000 -43055000 -37475000 171364000 166412000 16840000 10992000 3622000 -3419000 -206000 72000 54000 11000 54000 473000 440000 191201000 173682000 788146000 738332000 70908000 46291000 849607000 758241000 70908000 46291000 4115000 3124000 220000 1048000 633000 654000 41000 116000 1324000 1881000 -1188000 135000 -1518000 3803000 42670000 50316000 29688000 31195000 5640000 2869000 -1293000 -1671000 -23327000 3203000 17771000 9690000 -7358000 -23944000 42835000 2243000 107045000 3982000 2415000 12895000 151000 647000 61644000 -11803000 17989000 9397000 4379000 4929000 708000 20023000 15921000 473000 440000 5580000 -12555000 -20032000 2611000 -2486000 44342000 -58265000 104713000 168387000 149055000 110122000 1563000 797000 4816000 5193000 <p id="xdx_80E_eus-gaap--SignificantAccountingPoliciesTextBlock_ztt0BglMfXc5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top"> <td style="width: 0"/><td style="width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>1.</b></span></td><td style="padding-right: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span style="text-decoration: underline"><span id="xdx_820_zSJyDUompjad">Significant Accounting Policies:</span></span></b></span></td></tr></table> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The accounting policies we follow are set forth in the notes to our consolidated financial statements included in our Form 10-K, which was filed with the Securities and Exchange Commission for the year ended December 31, 2022.</span></p> <p id="xdx_80B_eus-gaap--UnusualOrInfrequentItemsDisclosureTextBlock_zxdKqOWHhgq7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top"> <td style="width: 0"/><td style="width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2.</b></span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span style="text-decoration: underline"><span id="xdx_825_ziBN6c11KwY5">Impact of COVID-19 Pandemic:</span></span> </b></span></td></tr></table> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our business has continued to significantly improve throughout 2022 and the first quarter of 2023 after the disastrous effects of the COVID-19 Pandemic starting in early 2020, as retail stores reopened, and consumers increased online purchasing. The introduction of variants of COVID-19 in various parts of the world continues to cause the temporary re-implementation of governmental restrictions to prevent further spread of the virus. In addition, international air travel remains curtailed in several jurisdictions due to both governmental restrictions and consumer health concerns. While COVID-19 had significantly restricted international travel, the travel retail business has picked up. Lastly, we have experienced significant strains on our supply chain causing disruptions affecting the procurement of components, the ability to transport goods, and related cost increases. These disruptions have come at a time when demand for our product lines has never been stronger or more sustained. We have been addressing this issue since the beginning of 2021, by ordering well in advance of need and in larger quantities. Since 2021, we have strived to carry more inventory overall, source the same components from multiple suppliers and when possible, manufacture products closer to where they are sold. We do not expect the supply chain bottlenecks to begin lifting until the second half of 2023. Therefore, despite recent business improvement, the impact of the COVID-19 pandemic might continue to have adverse effects on our results of our operations, financial position and cash flows through at least the first half of 2023.</span></p> <p id="xdx_80D_eus-gaap--BusinessCombinationDisclosureTextBlock_z5nab6LrHpPl" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top; text-align: justify"> <td style="width: 0"/><td style="width: 0.5in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>3.</b></span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span style="text-decoration: underline"><span id="xdx_824_zIoDepXerwcj">Recent Agreements:</span></span></b></span></td> </tr></table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Lacoste</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In December 2022, we closed a transaction agreement with Lacoste, whereby an exclusive and worldwide license was granted for the production and distribution of Lacoste brand perfumes and cosmetics. Our rights under this license are subject to certain minimum advertising expenditures and royalty payments as are customary in our industry. <span id="xdx_90A_eus-gaap--BusinessAcquisitionDescriptionOfAcquiredEntity_c20230101__20230331__dei--LegalEntityAxis__custom--LacosteMember_zTm0r2Q5H7bh" title="BusinessAcquisitionDescriptionOfAcquiredEntity">The license becomes effective in January 2024 and will last for 15 years.</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Dunhill</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In April 2022, we announced that the Dunhill fragrance license will expire on September 30, 2023 and will not be renewed. The Company will continue to produce and sell Dunhill fragrances until the license expires and will maintain the right to sell-off remaining Dunhill fragrance inventory for a limited time as is customary in the fragrance industry.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Donna Karan and DKNY </i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In September 2021, we entered into a long-term global licensing agreement for the creation, development and distribution of fragrances and fragrance-related products under the Donna Karan and DKNY brands. Our rights under this license are subject to certain minimum advertising expenditures and royalty payments as are customary in our industry. With this agreement, we gained several well-established and valuable fragrance franchises, most notably Donna Karan <i>Cashmere Mist</i> and DKNY <i>Be Delicious</i>, as well as a significant loyal consumer base around the world. In connection with the grant of license, we issued <span id="xdx_902_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_uShares_c20230101__20230331__dei--LegalEntityAxis__custom--DonnaKaranAndDKNYMember_ziHIv6FRIhTh" title="Shares issue">65,342</span> shares of Inter Parfums, Inc. common stock valued at $<span id="xdx_90D_eus-gaap--StockIssuedDuringPeriodValueNewIssues_pn6n6_c20230101__20230331__dei--LegalEntityAxis__custom--DonnaKaranAndDKNYMember_zD7kbrk9Iha9" title="Shares value">5</span>.0 million to the licensor. The exclusive license became effective July 1, 2022, and we are planning to launch new fragrances under these brands in 2024.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"/></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Rochas Fashion</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Effective January 1, 2021, <span id="xdx_903_eus-gaap--BusinessAcquisitionDescriptionOfAcquiredEntity_c20230101__20230331__us-gaap--BusinessAcquisitionAxis__custom--RochasFashionMember_zS0y6ZUu6Qzh" title="Description of recent agreement">we entered into a new license agreement modifying our Rochas fashion business model. The new agreement calls for a reduction in royalties to be received. As a result, in the first quarter of 2021, we took a $2.4 million impairment charge on our Rochas fashion trademark. In the fourth quarter of 2022, we again took a $6.8 million impairment charge on the Rochas fashion trademark after an independent expert concluded that the valuation of the trademark was $11.3 million. The new license also contains an option for the licensee to buy-out the Rochas fashion trademarks in June 2025 at its then fair market value.</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Land and Building Acquisition - New Headquarters in Paris</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In April 2021, Interparfums SA, our <span id="xdx_90D_eus-gaap--MinorityInterestOwnershipPercentageByParent_iI_pid_dp_uPure_c20210430_zSJF1THC5xS3" title="Ownership percentage">72</span>% owned French subsidiary, completed the acquisition of its new headquarters at 10 rue de Solférino in the 7th arrondissement of Paris from the property developer. This is an office complex combining three buildings connected by two inner courtyards, and consists of approximately 40,000 total sq. ft.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The purchase price included the complete renovation of the site. As of March 31, 2023, $<span id="xdx_909_eus-gaap--PaymentsToAcquireProductiveAssets_pn6n6_c20230101__20230331_zB2vs60PM0ee" title="Purchase price, period cost">151</span> million of the purchase price, including approximately $<span id="xdx_901_eus-gaap--AcquisitionCosts_dm_c20230101__20230331_zts0BLqkyMvk" title="Acquisition costs, period cost">4.5 million</span> of acquisition costs, is included in property, equipment and leasehold improvements on the accompanying balance sheet. The purchase price has been allocated approximately $<span id="xdx_907_eus-gaap--PaymentsToAcquireProductiveAssets_dm_c20230101__20230331__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--LandMember_zUza2G49adRh">62.3 million</span> to land and $<span id="xdx_900_eus-gaap--PaymentsToAcquireProductiveAssets_dm_c20230101__20230331__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--BuildingMember_z7wxwsC0covg">88.7 million</span> to the building. The building, which was delivered on February 28, 2022, includes the building structure, development of the property, façade waterproofing, general and technical installations and interior fittings that will be depreciated over a range of <span id="xdx_90A_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dxL_c20230331__srt--RangeAxis__srt--MinimumMember_zn6ylZh8l0Ag" title="Depreciated over a range::XDX::P7Y"><span style="-sec-ix-hidden: xdx2ixbrl0541">7</span></span> to <span id="xdx_90A_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dxL_c20230331__srt--RangeAxis__srt--MaximumMember_zy0X0ehjRmxj" title="Depreciated over a range::XDX::P50Y"><span style="-sec-ix-hidden: xdx2ixbrl0543">50</span></span> years. The Company has elected to depreciate the building cost based on the useful lives of its components. Approximately $<span id="xdx_903_eus-gaap--EscrowDeposit_iI_dm_c20230331_zSrPBCWZWsti" title="Cash held in escrow is included in other assets">1.8 million</span> of cash held in escrow is also included in property, equipment and leasehold improvements on the accompanying balance sheet as of March 31, 2023.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The acquisition was financed by a <span id="xdx_908_eus-gaap--LongTermDebtTerm_iI_dtxL_c20230331_zPH8OgfMss36" title="Long-term debt, term::XDX::P10Y"><span style="-sec-ix-hidden: xdx2ixbrl0547">10</span></span>-year €<span id="xdx_906_eus-gaap--LineOfCredit_iI_pn6n6_uUSDEUR_c20230331_zZjT8VsTMwGl" title="Long-term line of credit">120</span> million (approximately $<span id="xdx_90E_eus-gaap--LineOfCredit_iI_pn5n6_c20230331_zoCoLWg4Ybz9" title="Long-term line of credit">130.5</span> million) bank loan which bears interest at <span id="xdx_902_eus-gaap--DebtInstrumentInterestRateTerms_c20230101__20230331_z9Ux2155UG7d" title="Description of debt instrument interest rate terms">one-month Euribor plus 0.75%</span>. Approximately €<span id="xdx_905_eus-gaap--DebtInstrumentFaceAmount_iI_pn6n6_uUSDEUR_c20230331__srt--CurrencyAxis__currency--EUR_z20hpRIOtmu6" title="Debt instrument, face amount">80</span> million of the variable rate debt was swapped for variable interest rate debt with a maximum rate of <span id="xdx_902_eus-gaap--DerivativeVariableInterestRate_iI_pid_dp_uPure_c20230331_zxr9w8pZpLO8" title="Variable interest rate">2</span>% per annum. The swap effectively exchanges the variable interest rate to a fixed rate of approximately <span id="xdx_907_eus-gaap--DerivativeFixedInterestRate_iI_pid_dp_uPure_c20230331_zK0huhykkt4b" title="Fixed interest rate">1.1</span>%.</span></p> The license becomes effective in January 2024 and will last for 15 years. 65342 5000000 we entered into a new license agreement modifying our Rochas fashion business model. The new agreement calls for a reduction in royalties to be received. As a result, in the first quarter of 2021, we took a $2.4 million impairment charge on our Rochas fashion trademark. In the fourth quarter of 2022, we again took a $6.8 million impairment charge on the Rochas fashion trademark after an independent expert concluded that the valuation of the trademark was $11.3 million. The new license also contains an option for the licensee to buy-out the Rochas fashion trademarks in June 2025 at its then fair market value. 0.72 151000000 4500000 62300000 88700000 1800000 120000000 130500000 one-month Euribor plus 0.75% 80000000 0.02 0.011 <p id="xdx_80D_eus-gaap--NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock_zCUrCkAW9Vmd" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top"> <td style="width: 0"/><td style="width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>4.</b></span></td><td style="padding-right: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span style="text-decoration: underline"><span id="xdx_829_zwafkp5Zm2gd">Recent Accounting Pronouncements:</span></span></b></span></td></tr></table> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">There are no recent accounting pronouncements issued but not yet adopted that would have a material effect on our consolidated financial statements.</span></p> <p id="xdx_80E_eus-gaap--InventoryDisclosureTextBlock_zfbuEhCJxP3b" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top; text-align: justify"> <td style="width: 0"/><td style="width: 0.5in; text-align: left"><span style="font: small-caps 10pt Times New Roman, Times, Serif"><b>5.</b></span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span style="text-decoration: underline"><span id="xdx_820_zazylJyyfgwe">Inventories:</span></span></b></span></td> </tr></table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_89C_eus-gaap--ScheduleOfInventoryCurrentTableTextBlock_zhenGQPsopcd" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B1_zRtwCQA9qXIa">Inventories consist of the following:</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 90%; margin-left: 0.5in"> <tr style="vertical-align: bottom"> <td style="text-align: left; vertical-align: top">(In thousands)</td><td style="padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_490_20230331_zFvJkGtZkZa" style="border-bottom: Black 1pt solid; text-align: center">March 31,  <br/>2023</td><td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_494_20221231_zYvPCtYBlft5" style="border-bottom: Black 1pt solid; text-align: center">December 31, <br/> 2022</td><td style="padding-bottom: 1pt"> </td></tr> <tr id="xdx_40F_eus-gaap--InventoryRawMaterials_iI_pn3n3" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 70%; text-align: left">Raw materials and component parts</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">155,013</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">146,772</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_403_eus-gaap--InventoryFinishedGoods_iI_pn3n3" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt">Finished goods</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">168,687</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">143,212</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_40B_eus-gaap--InventoryNet_iI_pn3n3_zgKGl8YiFVWf" style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1.5pt"><b style="display: none; visibility: hidden">Inventories</b></td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">323,700</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">289,984</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> </table> <p id="xdx_8A1_zHVMBGAXxWR8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_89C_eus-gaap--ScheduleOfInventoryCurrentTableTextBlock_zhenGQPsopcd" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B1_zRtwCQA9qXIa">Inventories consist of the following:</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 90%; margin-left: 0.5in"> <tr style="vertical-align: bottom"> <td style="text-align: left; vertical-align: top">(In thousands)</td><td style="padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_490_20230331_zFvJkGtZkZa" style="border-bottom: Black 1pt solid; text-align: center">March 31,  <br/>2023</td><td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_494_20221231_zYvPCtYBlft5" style="border-bottom: Black 1pt solid; text-align: center">December 31, <br/> 2022</td><td style="padding-bottom: 1pt"> </td></tr> <tr id="xdx_40F_eus-gaap--InventoryRawMaterials_iI_pn3n3" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 70%; text-align: left">Raw materials and component parts</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">155,013</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">146,772</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_403_eus-gaap--InventoryFinishedGoods_iI_pn3n3" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt">Finished goods</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">168,687</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">143,212</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_40B_eus-gaap--InventoryNet_iI_pn3n3_zgKGl8YiFVWf" style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1.5pt"><b style="display: none; visibility: hidden">Inventories</b></td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">323,700</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">289,984</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> </table> 155013000 146772000 168687000 143212000 323700000 289984000 <p id="xdx_805_eus-gaap--FairValueDisclosuresTextBlock_zPYSGJxgVJn4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top"> <td style="width: 0"/><td style="width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>6.</b></span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span style="text-decoration: underline"><span id="xdx_829_z6W9MPaBD2H1">Fair Value Measurement:</span></span></b></span></td></tr></table> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_894_eus-gaap--ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_zxtmfv2c2Qui" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B8_z4viMiCF2jK4">The following tables present our financial assets and liabilities that are measured at fair value on a recurring basis and are categorized using the fair value hierarchy. The fair value hierarchy has three levels based on the reliability of the inputs used to determine fair value.</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"/></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 90%; border-collapse: collapse; margin-left: 0.5in"> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1pt; padding-left: 9pt; text-indent: -9pt"> </td> <td style="padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_49F_20230331__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_zPK7EGvYTxB9" style="padding-bottom: 1pt"> </td> <td style="padding-bottom: 1pt"> </td> <td style="padding-bottom: 1pt"> </td> <td style="border-bottom: black 1pt solid; text-align: center"> </td> <td id="xdx_49A_20230331__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_z2qhAJAZ5575" style="border-bottom: black 1pt solid; text-align: center"> </td> <td style="border-bottom: black 1pt solid; text-align: center"> </td> <td style="border-bottom: black 1pt solid; text-align: center"> </td> <td style="border-bottom: black 1pt solid; text-align: center"> </td> <td id="xdx_495_20230331__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zerLq6bEMr5b" style="border-bottom: black 1pt solid; text-align: center"> </td> <td style="border-bottom: black 1pt solid; text-align: center"> </td> <td style="border-bottom: black 1pt solid; text-align: center"> </td> <td colspan="2" id="xdx_49E_20230331__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zaqvjLOnCSzi" style="border-bottom: black 1pt solid; text-align: center"> </td> <td style="padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1pt; padding-left: 9pt; text-indent: -9pt"> </td> <td style="padding-bottom: 1pt"> </td> <td colspan="2" style="padding-bottom: 1pt"> </td> <td style="padding-bottom: 1pt"> </td> <td style="padding-bottom: 1pt"> </td> <td colspan="10" style="border-bottom: black 1pt solid; text-align: center"><b>Fair Value Measurements at March 31, 2023</b></td> <td style="padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 9pt; text-indent: -9pt"> </td> <td> </td> <td colspan="2"> </td> <td> </td> <td> </td> <td colspan="2" style="text-align: right"><b>Quoted Prices in</b></td> <td> </td> <td> </td> <td colspan="2" style="white-space: nowrap; text-align: right"><b>Significant Other</b></td> <td> </td> <td> </td> <td colspan="2" style="text-align: right"><b>Significant</b></td> <td> </td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 9pt; text-indent: -9pt"> </td> <td> </td> <td colspan="2"> </td> <td> </td> <td> </td> <td colspan="2" style="white-space: nowrap; text-align: right"><b>Active Markets for</b></td> <td> </td> <td> </td> <td colspan="2" style="text-align: right"><b>Observable</b></td> <td> </td> <td> </td> <td colspan="2" style="text-align: right"><b>Unobservable</b></td> <td> </td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 9pt; text-indent: -9pt"> </td> <td> </td> <td colspan="2"> </td> <td> </td> <td> </td> <td colspan="2" style="text-align: right"><b>Identical Assets</b></td> <td> </td> <td> </td> <td colspan="2" style="text-align: right"><b>Inputs</b></td> <td> </td> <td> </td> <td colspan="2" style="text-align: right"><b>Inputs</b></td> <td> </td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 9pt; text-indent: -9pt"> </td> <td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: right"><b>Total</b></td> <td style="padding-bottom: 1pt"> </td> <td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: right"><b>(Level 1)</b></td> <td style="padding-bottom: 1pt"> </td> <td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: right"><b>(Level 2)</b></td> <td style="padding-bottom: 1pt"> </td> <td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: right"><b>(Level 3)</b></td> <td style="padding-bottom: 1pt"> </td></tr> <tr id="xdx_406_eus-gaap--AssetsFairValueDisclosureAbstract_iB_zpICwaPOtEre" style="vertical-align: bottom; background-color: #CCEEFF"> <td colspan="2">Assets:</td> <td> </td> <td colspan="2"> </td> <td> </td> <td> </td> <td colspan="2"> </td> <td> </td> <td> </td> <td colspan="2"> </td> <td> </td> <td> </td> <td colspan="2"> </td> </tr> <tr id="xdx_407_eus-gaap--InvestmentsFairValueDisclosure_i01I_zyv5b4TT0y9g" style="vertical-align: bottom; background-color: white"> <td style="width: 30%; padding-left: 0.25in; text-indent: -9pt">Short-term investments</td> <td style="width: 1%"> </td> <td style="width: 1%">$</td> <td style="width: 10%; text-align: right">88,702</td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 1%">$</td> <td style="width: 12%; text-align: right">681</td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 1%">$</td> <td style="width: 12%; text-align: right">87,210</td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 1%">$</td> <td style="width: 10%; text-align: right">811</td> <td style="width: 1%"> </td> </tr> <tr id="xdx_404_eus-gaap--DerivativeAssets_iI_zJtzq1GzVMN8" style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-left: 0.25in; text-indent: -9pt">Interest rate swaps</td> <td> </td> <td> </td> <td style="text-align: right">6,429</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">6,429</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> </tr> <tr id="xdx_40D_eus-gaap--ForeignCurrencyFairValueHedgeAssetAtFairValue_i01I_zIzbVZQlad2h" style="vertical-align: bottom; background-color: white"> <td style="padding-left: 0.25in; text-indent: -9pt">Foreign currency forward exchange contracts not accounted for using hedge accounting</td> <td> </td> <td> </td> <td style="text-align: right">1,539</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0596">—</span></td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">1,539</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0598">—</span></td> <td> </td> </tr> <tr id="xdx_408_eus-gaap--ForeignCurrencyFairValueHedgeLiabilityAtFairValue_i01I_zeVlzgTQQ3Ld" style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-bottom: 1pt; padding-left: 0.25in; text-indent: -9pt">Foreign currency forward exchange contracts accounted for using hedge accounting</td> <td style="padding-bottom: 1pt"> </td> <td style="border-bottom: black 1pt solid"> </td> <td style="border-bottom: black 1pt solid; text-align: right">339</td> <td style="padding-bottom: 1pt"> </td> <td style="padding-bottom: 1pt"> </td> <td style="border-bottom: black 1pt solid">$</td> <td style="border-bottom: black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0601">—</span></td> <td style="padding-bottom: 1pt"> </td> <td style="padding-bottom: 1pt"> </td> <td style="border-bottom: black 1pt solid"> </td> <td style="border-bottom: black 1pt solid; text-align: right">339</td> <td style="padding-bottom: 1pt"> </td> <td style="padding-bottom: 1pt"> </td> <td style="border-bottom: black 1pt solid"> </td> <td style="border-bottom: black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0603">—</span></td> <td style="padding-bottom: 1pt"> </td> </tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-left: 9pt; text-indent: -9pt"> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> </tr> <tr id="xdx_408_eus-gaap--AssetsFairValueDisclosure_iI_z3otBGFKbiD9" style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-bottom: 1.5pt; padding-left: 9pt; text-indent: -9pt"><b style="display: none; visibility: hidden">Total assets</b></td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: black 2.25pt double">$</td> <td style="border-bottom: black 2.25pt double; text-align: right">97,010</td> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: black 2.25pt double">$</td> <td style="border-bottom: black 2.25pt double; text-align: right">681</td> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: black 2.25pt double">$</td> <td style="border-bottom: black 2.25pt double; text-align: right">95,517</td> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: black 2.25pt double">$</td> <td style="border-bottom: black 2.25pt double; text-align: right">811</td> <td style="padding-bottom: 1.5pt"> </td> </tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 90%; border-collapse: collapse; margin-left: 0.5in"> <tr style="vertical-align: bottom"> <td style="text-align: right; padding-bottom: 1pt; padding-left: 0.125in; text-indent: -0.125in"> </td><td style="text-align: right; padding-bottom: 1pt"> </td> <td style="text-align: center"> </td> <td id="xdx_492_20221231__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_zoPvYgpN1g42" style="text-align: center"> </td> <td style="text-align: center"> </td> <td style="text-align: center"> </td> <td style="border-bottom: Black 1pt solid; text-align: center"> </td> <td id="xdx_496_20221231__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zX309rNQA2lj" style="border-bottom: Black 1pt solid; text-align: center"> </td> <td style="border-bottom: Black 1pt solid; text-align: center"> </td> <td style="border-bottom: Black 1pt solid; text-align: center"> </td> <td style="border-bottom: Black 1pt solid; text-align: center"> </td> <td id="xdx_49A_20221231__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_z5VQMpPJNC6h" style="border-bottom: Black 1pt solid; text-align: center"> </td> <td style="border-bottom: Black 1pt solid; text-align: center"> </td> <td style="border-bottom: Black 1pt solid; text-align: center"> </td> <td style="border-bottom: Black 1pt solid; text-align: center"> </td> <td id="xdx_49C_20221231__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_z1p8ce72ijR2" style="border-bottom: Black 1pt solid; text-align: center"> </td><td style="font-weight: bold; text-align: right; padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: right; padding-bottom: 1pt; padding-left: 0.125in; text-indent: -0.125in"> </td><td style="text-align: right; padding-bottom: 1pt"> </td> <td style="text-align: center"> </td> <td style="text-align: center"> </td> <td style="text-align: center"> </td> <td style="text-align: center"> </td> <td colspan="10" style="border-bottom: Black 1pt solid; text-align: center"><b>Fair Value Measurements at December 31, 2022</b></td><td style="font-weight: bold; text-align: right; padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: right; padding-left: 0.125in; text-indent: -0.125in"> </td><td style="text-align: right"> </td> <td colspan="2" style="text-align: right"> </td><td style="text-align: right"> </td><td style="font-weight: bold; text-align: right"> </td> <td colspan="2" style="font-weight: bold; text-align: right">Quoted Prices in</td><td style="font-weight: bold; text-align: right"> </td><td style="font-weight: bold; text-align: right"> </td> <td colspan="2" style="white-space: nowrap; font-weight: bold; text-align: right">Significant Other</td><td style="font-weight: bold; text-align: right"> </td><td style="font-weight: bold; text-align: right"> </td> <td colspan="2" style="font-weight: bold; text-align: right">Significant</td><td style="font-weight: bold; text-align: right"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: right; padding-left: 0.125in; text-indent: -0.125in"> </td><td style="text-align: right"> </td> <td colspan="2" style="text-align: right"> </td><td style="text-align: right"> </td><td style="font-weight: bold; text-align: right"> </td> <td colspan="2" style="white-space: nowrap; white-space: nowrap; font-weight: bold; text-align: right">Active Markets for</td><td style="font-weight: bold; text-align: right"> </td><td style="font-weight: bold; text-align: right"> </td> <td colspan="2" style="font-weight: bold; text-align: right">Observable</td><td style="font-weight: bold; text-align: right"> </td><td style="font-weight: bold; text-align: right"> </td> <td colspan="2" style="font-weight: bold; text-align: right">Unobservable</td><td style="font-weight: bold; text-align: right"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: right; padding-left: 0.125in; text-indent: -0.125in"> </td><td style="text-align: right"> </td> <td colspan="2" style="text-align: right"> </td><td style="text-align: right"> </td><td style="font-weight: bold; text-align: right"> </td> <td colspan="2" style="font-weight: bold; text-align: right">Identical Assets</td><td style="font-weight: bold; text-align: right"> </td><td style="font-weight: bold; text-align: right"> </td> <td colspan="2" style="font-weight: bold; text-align: right">Inputs</td><td style="font-weight: bold; text-align: right"> </td><td style="font-weight: bold; text-align: right"> </td> <td colspan="2" style="font-weight: bold; text-align: right">Inputs</td><td style="font-weight: bold; text-align: right"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: right; padding-bottom: 1pt; padding-left: 0.125in; text-indent: -0.125in"> </td><td style="font-weight: bold; text-align: right; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right">Total</td><td style="font-weight: bold; text-align: right; padding-bottom: 1pt"> </td><td style="font-weight: bold; text-align: right; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right">(Level 1)</td><td style="font-weight: bold; text-align: right; padding-bottom: 1pt"> </td><td style="font-weight: bold; text-align: right; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right">(Level 2)</td><td style="font-weight: bold; text-align: right; padding-bottom: 1pt"> </td><td style="font-weight: bold; text-align: right; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right">(Level 3)</td><td style="font-weight: bold; text-align: right; padding-bottom: 1pt"> </td></tr> <tr id="xdx_406_eus-gaap--AssetsFairValueDisclosureAbstract_iB_zSMVgveDURQ8" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 0.125in; text-indent: -0.125in">Assets:</td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td></tr> <tr id="xdx_407_eus-gaap--InvestmentsFairValueDisclosure_i01I_z9PYQ6ZUX4i3" style="vertical-align: bottom; background-color: White"> <td style="width: 30%; text-align: left; padding-left: 0.25in; text-indent: -0.125in">Short-term investments</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right">150,833</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">19,861</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">130,174</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right">798</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_404_eus-gaap--DerivativeAssets_iI_zKVhkZTsUiSi" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-left: 0.25in; text-indent: -0.125in">Interest rate swaps</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">6,758</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0621">—</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">6,758</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0623">—</span></td><td style="text-align: left"> </td></tr> <tr id="xdx_40D_eus-gaap--ForeignCurrencyFairValueHedgeAssetAtFairValue_i01I_zGy0cs7pCcj2" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-left: 0.25in; text-indent: -0.125in; padding-bottom: 1pt">Foreign currency forward exchange contracts accounted for using hedge accounting</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">1,189</td><td style="text-align: left; padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0626">—</span></td><td style="text-align: left; padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">1,189</td><td style="text-align: left; padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0628">—</span></td><td style="text-align: left; padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 0.125in; text-indent: -0.125in"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_408_eus-gaap--AssetsFairValueDisclosure_iI_z71ZdNHr7WQk" style="vertical-align: bottom; background-color: White"> <td style="padding-left: 0.125in; text-indent: -0.125in; padding-bottom: 1.5pt"><b style="display: none; visibility: hidden">Total assets</b></td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">158,780</td><td style="text-align: left; padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">19,861</td><td style="text-align: left; padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">138,122</td><td style="text-align: left; padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">798</td><td style="text-align: left; padding-bottom: 1.5pt"> </td></tr> <tr id="xdx_402_eus-gaap--LiabilitiesAbstract_iB_zea3h3QhA3w5" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 0.125in; text-indent: -0.125in">Liabilities:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_408_eus-gaap--ForeignCurrencyFairValueHedgeLiabilityAtFairValue_i01I_zzgOIHPq44C5" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-left: 0.25in; text-indent: -0.125in; padding-bottom: 1pt">Foreign currency forward exchange contracts not accounted for using hedge accounting</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">68</td><td style="text-align: left; padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0641">—</span></td><td style="text-align: left; padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">68</td><td style="text-align: left; padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0643">—</span></td><td style="text-align: left; padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 0.125in; text-indent: -0.125in"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_402_eus-gaap--LiabilitiesFairValueDisclosure_iI_zXHNx9NSBKne" style="vertical-align: bottom; background-color: White"> <td style="padding-left: 0.125in; text-indent: -0.125in; padding-bottom: 1.5pt"><b style="display: none; visibility: hidden">Total liabilities</b></td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">68</td><td style="text-align: left; padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0646">—</span></td><td style="text-align: left; padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">68</td><td style="text-align: left; padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0648">—</span></td><td style="text-align: left; padding-bottom: 1.5pt"> </td></tr> </table> <p id="xdx_8AB_z7My4Es67oQ7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The carrying amount of cash and cash equivalents including money market funds, short-term investments, accounts receivable, other receivables, cash held in escrow, accounts payable and accrued expenses approximate fair value due to the short terms to maturity of these instruments.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"/></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The carrying amount of loans payable approximates fair value as the interest rates on the Company’s indebtedness approximate current market rates. The fair value of the Company’s long-term debt was estimated based on the current rates offered to companies for debt with the same remaining maturities and is approximately equal to its carrying value.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Foreign currency forward exchange contracts are valued based on quotations from financial institutions and the value of interest rate swaps are the discounted net present value of the swaps using third party quotes from financial institutions.</span></p> <p id="xdx_894_eus-gaap--ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_zxtmfv2c2Qui" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B8_z4viMiCF2jK4">The following tables present our financial assets and liabilities that are measured at fair value on a recurring basis and are categorized using the fair value hierarchy. The fair value hierarchy has three levels based on the reliability of the inputs used to determine fair value.</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"/></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 90%; border-collapse: collapse; margin-left: 0.5in"> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1pt; padding-left: 9pt; text-indent: -9pt"> </td> <td style="padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_49F_20230331__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_zPK7EGvYTxB9" style="padding-bottom: 1pt"> </td> <td style="padding-bottom: 1pt"> </td> <td style="padding-bottom: 1pt"> </td> <td style="border-bottom: black 1pt solid; text-align: center"> </td> <td id="xdx_49A_20230331__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_z2qhAJAZ5575" style="border-bottom: black 1pt solid; text-align: center"> </td> <td style="border-bottom: black 1pt solid; text-align: center"> </td> <td style="border-bottom: black 1pt solid; text-align: center"> </td> <td style="border-bottom: black 1pt solid; text-align: center"> </td> <td id="xdx_495_20230331__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zerLq6bEMr5b" style="border-bottom: black 1pt solid; text-align: center"> </td> <td style="border-bottom: black 1pt solid; text-align: center"> </td> <td style="border-bottom: black 1pt solid; text-align: center"> </td> <td colspan="2" id="xdx_49E_20230331__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zaqvjLOnCSzi" style="border-bottom: black 1pt solid; text-align: center"> </td> <td style="padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1pt; padding-left: 9pt; text-indent: -9pt"> </td> <td style="padding-bottom: 1pt"> </td> <td colspan="2" style="padding-bottom: 1pt"> </td> <td style="padding-bottom: 1pt"> </td> <td style="padding-bottom: 1pt"> </td> <td colspan="10" style="border-bottom: black 1pt solid; text-align: center"><b>Fair Value Measurements at March 31, 2023</b></td> <td style="padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 9pt; text-indent: -9pt"> </td> <td> </td> <td colspan="2"> </td> <td> </td> <td> </td> <td colspan="2" style="text-align: right"><b>Quoted Prices in</b></td> <td> </td> <td> </td> <td colspan="2" style="white-space: nowrap; text-align: right"><b>Significant Other</b></td> <td> </td> <td> </td> <td colspan="2" style="text-align: right"><b>Significant</b></td> <td> </td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 9pt; text-indent: -9pt"> </td> <td> </td> <td colspan="2"> </td> <td> </td> <td> </td> <td colspan="2" style="white-space: nowrap; text-align: right"><b>Active Markets for</b></td> <td> </td> <td> </td> <td colspan="2" style="text-align: right"><b>Observable</b></td> <td> </td> <td> </td> <td colspan="2" style="text-align: right"><b>Unobservable</b></td> <td> </td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 9pt; text-indent: -9pt"> </td> <td> </td> <td colspan="2"> </td> <td> </td> <td> </td> <td colspan="2" style="text-align: right"><b>Identical Assets</b></td> <td> </td> <td> </td> <td colspan="2" style="text-align: right"><b>Inputs</b></td> <td> </td> <td> </td> <td colspan="2" style="text-align: right"><b>Inputs</b></td> <td> </td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 9pt; text-indent: -9pt"> </td> <td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: right"><b>Total</b></td> <td style="padding-bottom: 1pt"> </td> <td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: right"><b>(Level 1)</b></td> <td style="padding-bottom: 1pt"> </td> <td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: right"><b>(Level 2)</b></td> <td style="padding-bottom: 1pt"> </td> <td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: right"><b>(Level 3)</b></td> <td style="padding-bottom: 1pt"> </td></tr> <tr id="xdx_406_eus-gaap--AssetsFairValueDisclosureAbstract_iB_zpICwaPOtEre" style="vertical-align: bottom; background-color: #CCEEFF"> <td colspan="2">Assets:</td> <td> </td> <td colspan="2"> </td> <td> </td> <td> </td> <td colspan="2"> </td> <td> </td> <td> </td> <td colspan="2"> </td> <td> </td> <td> </td> <td colspan="2"> </td> </tr> <tr id="xdx_407_eus-gaap--InvestmentsFairValueDisclosure_i01I_zyv5b4TT0y9g" style="vertical-align: bottom; background-color: white"> <td style="width: 30%; padding-left: 0.25in; text-indent: -9pt">Short-term investments</td> <td style="width: 1%"> </td> <td style="width: 1%">$</td> <td style="width: 10%; text-align: right">88,702</td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 1%">$</td> <td style="width: 12%; text-align: right">681</td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 1%">$</td> <td style="width: 12%; text-align: right">87,210</td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 1%">$</td> <td style="width: 10%; text-align: right">811</td> <td style="width: 1%"> </td> </tr> <tr id="xdx_404_eus-gaap--DerivativeAssets_iI_zJtzq1GzVMN8" style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-left: 0.25in; text-indent: -9pt">Interest rate swaps</td> <td> </td> <td> </td> <td style="text-align: right">6,429</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">6,429</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> </tr> <tr id="xdx_40D_eus-gaap--ForeignCurrencyFairValueHedgeAssetAtFairValue_i01I_zIzbVZQlad2h" style="vertical-align: bottom; background-color: white"> <td style="padding-left: 0.25in; text-indent: -9pt">Foreign currency forward exchange contracts not accounted for using hedge accounting</td> <td> </td> <td> </td> <td style="text-align: right">1,539</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0596">—</span></td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">1,539</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0598">—</span></td> <td> </td> </tr> <tr id="xdx_408_eus-gaap--ForeignCurrencyFairValueHedgeLiabilityAtFairValue_i01I_zeVlzgTQQ3Ld" style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-bottom: 1pt; padding-left: 0.25in; text-indent: -9pt">Foreign currency forward exchange contracts accounted for using hedge accounting</td> <td style="padding-bottom: 1pt"> </td> <td style="border-bottom: black 1pt solid"> </td> <td style="border-bottom: black 1pt solid; text-align: right">339</td> <td style="padding-bottom: 1pt"> </td> <td style="padding-bottom: 1pt"> </td> <td style="border-bottom: black 1pt solid">$</td> <td style="border-bottom: black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0601">—</span></td> <td style="padding-bottom: 1pt"> </td> <td style="padding-bottom: 1pt"> </td> <td style="border-bottom: black 1pt solid"> </td> <td style="border-bottom: black 1pt solid; text-align: right">339</td> <td style="padding-bottom: 1pt"> </td> <td style="padding-bottom: 1pt"> </td> <td style="border-bottom: black 1pt solid"> </td> <td style="border-bottom: black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0603">—</span></td> <td style="padding-bottom: 1pt"> </td> </tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-left: 9pt; text-indent: -9pt"> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> </tr> <tr id="xdx_408_eus-gaap--AssetsFairValueDisclosure_iI_z3otBGFKbiD9" style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-bottom: 1.5pt; padding-left: 9pt; text-indent: -9pt"><b style="display: none; visibility: hidden">Total assets</b></td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: black 2.25pt double">$</td> <td style="border-bottom: black 2.25pt double; text-align: right">97,010</td> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: black 2.25pt double">$</td> <td style="border-bottom: black 2.25pt double; text-align: right">681</td> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: black 2.25pt double">$</td> <td style="border-bottom: black 2.25pt double; text-align: right">95,517</td> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: black 2.25pt double">$</td> <td style="border-bottom: black 2.25pt double; text-align: right">811</td> <td style="padding-bottom: 1.5pt"> </td> </tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 90%; border-collapse: collapse; margin-left: 0.5in"> <tr style="vertical-align: bottom"> <td style="text-align: right; padding-bottom: 1pt; padding-left: 0.125in; text-indent: -0.125in"> </td><td style="text-align: right; padding-bottom: 1pt"> </td> <td style="text-align: center"> </td> <td id="xdx_492_20221231__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_zoPvYgpN1g42" style="text-align: center"> </td> <td style="text-align: center"> </td> <td style="text-align: center"> </td> <td style="border-bottom: Black 1pt solid; text-align: center"> </td> <td id="xdx_496_20221231__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zX309rNQA2lj" style="border-bottom: Black 1pt solid; text-align: center"> </td> <td style="border-bottom: Black 1pt solid; text-align: center"> </td> <td style="border-bottom: Black 1pt solid; text-align: center"> </td> <td style="border-bottom: Black 1pt solid; text-align: center"> </td> <td id="xdx_49A_20221231__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_z5VQMpPJNC6h" style="border-bottom: Black 1pt solid; text-align: center"> </td> <td style="border-bottom: Black 1pt solid; text-align: center"> </td> <td style="border-bottom: Black 1pt solid; text-align: center"> </td> <td style="border-bottom: Black 1pt solid; text-align: center"> </td> <td id="xdx_49C_20221231__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_z1p8ce72ijR2" style="border-bottom: Black 1pt solid; text-align: center"> </td><td style="font-weight: bold; text-align: right; padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: right; padding-bottom: 1pt; padding-left: 0.125in; text-indent: -0.125in"> </td><td style="text-align: right; padding-bottom: 1pt"> </td> <td style="text-align: center"> </td> <td style="text-align: center"> </td> <td style="text-align: center"> </td> <td style="text-align: center"> </td> <td colspan="10" style="border-bottom: Black 1pt solid; text-align: center"><b>Fair Value Measurements at December 31, 2022</b></td><td style="font-weight: bold; text-align: right; padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: right; padding-left: 0.125in; text-indent: -0.125in"> </td><td style="text-align: right"> </td> <td colspan="2" style="text-align: right"> </td><td style="text-align: right"> </td><td style="font-weight: bold; text-align: right"> </td> <td colspan="2" style="font-weight: bold; text-align: right">Quoted Prices in</td><td style="font-weight: bold; text-align: right"> </td><td style="font-weight: bold; text-align: right"> </td> <td colspan="2" style="white-space: nowrap; font-weight: bold; text-align: right">Significant Other</td><td style="font-weight: bold; text-align: right"> </td><td style="font-weight: bold; text-align: right"> </td> <td colspan="2" style="font-weight: bold; text-align: right">Significant</td><td style="font-weight: bold; text-align: right"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: right; padding-left: 0.125in; text-indent: -0.125in"> </td><td style="text-align: right"> </td> <td colspan="2" style="text-align: right"> </td><td style="text-align: right"> </td><td style="font-weight: bold; text-align: right"> </td> <td colspan="2" style="white-space: nowrap; white-space: nowrap; font-weight: bold; text-align: right">Active Markets for</td><td style="font-weight: bold; text-align: right"> </td><td style="font-weight: bold; text-align: right"> </td> <td colspan="2" style="font-weight: bold; text-align: right">Observable</td><td style="font-weight: bold; text-align: right"> </td><td style="font-weight: bold; text-align: right"> </td> <td colspan="2" style="font-weight: bold; text-align: right">Unobservable</td><td style="font-weight: bold; text-align: right"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: right; padding-left: 0.125in; text-indent: -0.125in"> </td><td style="text-align: right"> </td> <td colspan="2" style="text-align: right"> </td><td style="text-align: right"> </td><td style="font-weight: bold; text-align: right"> </td> <td colspan="2" style="font-weight: bold; text-align: right">Identical Assets</td><td style="font-weight: bold; text-align: right"> </td><td style="font-weight: bold; text-align: right"> </td> <td colspan="2" style="font-weight: bold; text-align: right">Inputs</td><td style="font-weight: bold; text-align: right"> </td><td style="font-weight: bold; text-align: right"> </td> <td colspan="2" style="font-weight: bold; text-align: right">Inputs</td><td style="font-weight: bold; text-align: right"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: right; padding-bottom: 1pt; padding-left: 0.125in; text-indent: -0.125in"> </td><td style="font-weight: bold; text-align: right; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right">Total</td><td style="font-weight: bold; text-align: right; padding-bottom: 1pt"> </td><td style="font-weight: bold; text-align: right; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right">(Level 1)</td><td style="font-weight: bold; text-align: right; padding-bottom: 1pt"> </td><td style="font-weight: bold; text-align: right; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right">(Level 2)</td><td style="font-weight: bold; text-align: right; padding-bottom: 1pt"> </td><td style="font-weight: bold; text-align: right; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right">(Level 3)</td><td style="font-weight: bold; text-align: right; padding-bottom: 1pt"> </td></tr> <tr id="xdx_406_eus-gaap--AssetsFairValueDisclosureAbstract_iB_zSMVgveDURQ8" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 0.125in; text-indent: -0.125in">Assets:</td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td></tr> <tr id="xdx_407_eus-gaap--InvestmentsFairValueDisclosure_i01I_z9PYQ6ZUX4i3" style="vertical-align: bottom; background-color: White"> <td style="width: 30%; text-align: left; padding-left: 0.25in; text-indent: -0.125in">Short-term investments</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right">150,833</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">19,861</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">130,174</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right">798</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_404_eus-gaap--DerivativeAssets_iI_zKVhkZTsUiSi" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-left: 0.25in; text-indent: -0.125in">Interest rate swaps</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">6,758</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0621">—</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">6,758</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0623">—</span></td><td style="text-align: left"> </td></tr> <tr id="xdx_40D_eus-gaap--ForeignCurrencyFairValueHedgeAssetAtFairValue_i01I_zGy0cs7pCcj2" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-left: 0.25in; text-indent: -0.125in; padding-bottom: 1pt">Foreign currency forward exchange contracts accounted for using hedge accounting</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">1,189</td><td style="text-align: left; padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0626">—</span></td><td style="text-align: left; padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">1,189</td><td style="text-align: left; padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0628">—</span></td><td style="text-align: left; padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 0.125in; text-indent: -0.125in"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_408_eus-gaap--AssetsFairValueDisclosure_iI_z71ZdNHr7WQk" style="vertical-align: bottom; background-color: White"> <td style="padding-left: 0.125in; text-indent: -0.125in; padding-bottom: 1.5pt"><b style="display: none; visibility: hidden">Total assets</b></td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">158,780</td><td style="text-align: left; padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">19,861</td><td style="text-align: left; padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">138,122</td><td style="text-align: left; padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">798</td><td style="text-align: left; padding-bottom: 1.5pt"> </td></tr> <tr id="xdx_402_eus-gaap--LiabilitiesAbstract_iB_zea3h3QhA3w5" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 0.125in; text-indent: -0.125in">Liabilities:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_408_eus-gaap--ForeignCurrencyFairValueHedgeLiabilityAtFairValue_i01I_zzgOIHPq44C5" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-left: 0.25in; text-indent: -0.125in; padding-bottom: 1pt">Foreign currency forward exchange contracts not accounted for using hedge accounting</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">68</td><td style="text-align: left; padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0641">—</span></td><td style="text-align: left; padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">68</td><td style="text-align: left; padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0643">—</span></td><td style="text-align: left; padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 0.125in; text-indent: -0.125in"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_402_eus-gaap--LiabilitiesFairValueDisclosure_iI_zXHNx9NSBKne" style="vertical-align: bottom; background-color: White"> <td style="padding-left: 0.125in; text-indent: -0.125in; padding-bottom: 1.5pt"><b style="display: none; visibility: hidden">Total liabilities</b></td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">68</td><td style="text-align: left; padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0646">—</span></td><td style="text-align: left; padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">68</td><td style="text-align: left; padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0648">—</span></td><td style="text-align: left; padding-bottom: 1.5pt"> </td></tr> </table> 88702000 681000 87210000 811000 6429000 6429000 1539000 1539000 339000 339000 97010000 681000 95517000 811000 150833000 19861000 130174000 798000 6758000 6758000 1189000 1189000 158780000 19861000 138122000 798000 68000 68000 68000 68000 <p id="xdx_80F_eus-gaap--DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock_zItb2NxJFsl9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top"> <td style="width: 0"/><td style="width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>7.</b></span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span style="text-decoration: underline"><span id="xdx_821_zmWV34u56vN2">Derivative Financial Instruments:</span></span></b></span></td></tr></table> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company enters into foreign currency forward exchange contracts to hedge exposure related to receivables denominated in a foreign currency and occasionally to manage risks related to future sales expected to be denominated in a foreign currency. Before entering into a derivative transaction for hedging purposes, it is determined that a high degree of initial effectiveness exists between the change in value of the hedged item and the change in the value of the derivative instrument from movement in exchange rates. High effectiveness means that the change in the cash flows of the derivative instrument will effectively offset the change in the cash flows of the hedged item. The effectiveness of each hedged item is measured throughout the hedged period and is based on the dollar offset methodology and excludes the portion of the fair value of the foreign currency forward exchange contract attributable to the change in spot-forward difference which is reported in current period earnings. Any hedge ineffectiveness is also recognized as a gain or loss on foreign currency in the income statement. For hedge contracts that are no longer deemed highly effective, hedge accounting is discontinued, and gains and losses accumulated in other comprehensive income are reclassified to earnings. If it is probable that the forecasted transaction will no longer occur, then any gains or losses accumulated in other comprehensive income are reclassified to current-period earnings. </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"/></p> <p style="font: 10pt Times New Roman,serif; margin: 0pt 0 0pt 0.5in; text-align: justify">In December 2022, to finance the acquisition of the Lacoste trademark, the Company entered into a €<span id="xdx_90A_eus-gaap--DerivativeNotionalAmount_iI_pn6n6_uUSDEUR_c20221231__srt--CurrencyAxis__currency--EUR_zXfdwubX7f5h" title="Loan amount">50</span> million ($<span id="xdx_90B_eus-gaap--DerivativeNotionalAmount_iI_pn5n6_c20221231_zHe9FmVa5Dnk" title="Loan amount">54.4</span> million) <span id="xdx_90C_eus-gaap--LongTermDebtTerm_iI_dxL_c20221231_z3oAti17HOm3" title="Long-term debt, term::XDX::P4Y"><span style="-sec-ix-hidden: xdx2ixbrl0661">4</span></span>-year term loan with a variable interest rate. This variable rate debt was swapped for variable interest rate debt with a maximum rate of <span id="xdx_90E_eus-gaap--DerivativeSwaptionInterestRate_iI_pid_dp_uPure_c20221231_zzPBfZCiwrAl" title="Derivative swap interest rate">2</span>% per annum. This swap is a hedged derivative instrument and is therefore recorded at fair value and changes in fair value are reflected in other comprehensive income.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In connection with the April 2021 acquisition of the office building complex in Paris, €<span id="xdx_906_eus-gaap--DerivativeNotionalAmount_iI_pn6n6_uUSDEUR_c20210430__srt--CurrencyAxis__currency--EUR_zPOCIVo4vum" title="Loan amount">120</span> million (approximately $<span id="xdx_907_eus-gaap--DerivativeNotionalAmount_iI_pn5n6_c20210430_zYsNC93cqsbh" title="Loan amount">130.5</span> million) of the purchase price was financed through a <span id="xdx_902_eus-gaap--LongTermDebtTerm_iI_dxL_c20210430_zzSykjNPKVJk" title="Long-term debt, term::XDX::P10Y"><span style="-sec-ix-hidden: xdx2ixbrl0669">10</span></span>-year term loan. The Company entered into interest rate swap contracts related to €<span id="xdx_907_eus-gaap--DerivativeNotionalAmount_iI_pn6n6_uUSDEUR_c20210430__srt--CurrencyAxis__currency--EUR__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--InterestRateSwapMember_zc8fD659KWeh" title="Loan amount">80</span> million of the loan, effectively exchanging the variable interest rate to a fixed rate of approximately <span id="xdx_906_eus-gaap--DerivativeSwaptionInterestRate_iI_pid_dp_uPure_c20230331_zNoonuHtZqU5" title="Derivative swap interest rate">1.1</span>%. This derivative instrument is recorded at fair value and changes in fair value are reflected in the accompanying consolidated statements of income.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Gains and losses in derivatives designated as hedges are accumulated in other comprehensive income and gains and losses in derivatives not designated as hedges are included in (gain) loss on foreign currency on the accompanying income statements. Such gains and losses were immaterial for both the three months ended March 31, 2023 and 2022.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">All derivative instruments are reported as either assets or liabilities on the balance sheet measured at fair value. The valuation of interest rate swaps is included in long-term debt on the accompanying balance sheets. The valuation of foreign currency forward exchange contracts at March 31, 2023, resulted in a net asset and is included in other current assets on the accompanying balance sheet.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">At March 31, 2023, we had foreign currency contracts in the form of forward exchange contracts in the amount of approximately U.S. $<span id="xdx_904_eus-gaap--ForeignCurrencyContractsLiabilityFairValueDisclosure_iI_pn5n6_c20230331__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--ForeignExchangeContractMember_zcWnxcWwCNG" title="Forward exchange contracts">37</span> million which all have maturities of less than one year.</span></p> 50000000 54400000 0.02 120000000 130500000 80000000 0.011 37000000 <p id="xdx_806_eus-gaap--LesseeOperatingLeasesTextBlock_z4Ibxpvba492" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify"> <td style="width: 0in"/><td style="width: 0.5in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>8.</b></span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span style="text-decoration: underline"><span id="xdx_826_zHiS9vqsJES6">Leases:</span></span></b></span></td> </tr></table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company leases its offices and warehouses, vehicles, and certain office equipment, substantially all of which are classified as operating leases. The Company currently has no material financing leases. The Company determines if an arrangement is a lease at inception. Operating lease assets and obligations are recognized at the lease commencement date based on the present value of lease payments over the lease term.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In determining lease asset value, the Company considers fixed or variable payment terms, prepayments, incentives, and options to extend or terminate, depending on the lease. Renewal, termination or purchase options affect the lease term used for determining lease asset value only if the option is reasonably certain to be exercised. The Company generally uses its incremental borrowing rate based on information available at the lease commencement date for the location in which the lease is held in determining the present value of lease payments.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As of March 31, 2023, the weighted average remaining lease term was <span id="xdx_90C_eus-gaap--OperatingLeaseWeightedAverageRemainingLeaseTerm1_iI_dxL_c20230331_z7X7wFmHBsF3" title="Operating lease, weighted average remaining lease term::XDX::P5Y6M0D"><span style="-sec-ix-hidden: xdx2ixbrl0679">5.5</span></span> years and the weighted average discount rate used to determine the operating lease liability was <span id="xdx_90E_eus-gaap--OperatingLeaseWeightedAverageDiscountRatePercent_iI_pid_dp_uPure_c20230331_zfuXityi2B94" title="Operating lease, weighted average discount rate, percent">2.6</span>%. Rental expense related to operating leases was $<span id="xdx_905_eus-gaap--OperatingLeasesRentExpenseNet_dm_c20230101__20230331_z3tfJS0ujNj7" title="Operating leases, rent expense, net">1.4 million</span> and $<span id="xdx_90E_eus-gaap--OperatingLeasesRentExpenseNet_dm_c20220101__20220331_zHmY32LTXRYi">1.8 million</span> for the three months ended March 31, 2023 and 2022, respectively. Operating lease payments included in operating cash flows totaled $<span id="xdx_901_eus-gaap--OperatingLeasePayments_dm_c20230101__20230331_zPFurBqejNtf">1.3 million</span> and $<span id="xdx_908_eus-gaap--OperatingLeasePayments_dm_c20220101__20220331_z9gN6T7WAsyi">1.7 million</span> for the three months ended March 31, 2023 and 2022, respectively, and there were <span id="xdx_908_eus-gaap--OperatingLeaseCost_do_c20230101__20230331_zLAiukWYDZQ7" title="Noncash additions to operating lease assets"><span id="xdx_903_eus-gaap--OperatingLeaseCost_do_c20220101__20220331_zfgghU5yQAD1" title="Noncash additions to operating lease assets">no</span></span> noncash additions to operating lease assets for the three months ended March 31, 2023 and 2022.</span></p> 0.026 1400000 1800000 1300000 1700000 0 0 <p id="xdx_80A_eus-gaap--StockholdersEquityNoteDisclosureTextBlock_ztnLkOEFfpD1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify"> <td style="width: 0in"/><td style="width: 0.5in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>9.</b></span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span style="text-decoration: underline"><span id="xdx_82D_zbcmn2JC3l1g">Share-Based Payments:</span></span></b></span></td> </tr></table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company maintains a stock option program for key employees, executives and directors. The plans, all of which have been approved by shareholder vote, provide for the granting of both nonqualified and incentive options. Options granted under the plans typically have a six-year term and vest over a <span id="xdx_900_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_dtxL_c20230101__20230331__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember__srt--RangeAxis__srt--MinimumMember_zCoP3czhbCAe" title="Options vesting period::XDX::P4Y"><span style="-sec-ix-hidden: xdx2ixbrl0694">four</span></span> to <span id="xdx_90F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_dtxL_c20230101__20230331__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember__srt--RangeAxis__srt--MaximumMember_zjnRVqAtiCeh" title="Options vesting period::XDX::P5Y"><span style="-sec-ix-hidden: xdx2ixbrl0696">five</span></span>-year period. The fair value of shares vested during the three months ended March 31, 2023 and 2022 aggregated $<span id="xdx_90D_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1_dxL_c20230101__20230331__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zvdYP4VaPIVd" title="Fair value of shares vested::XDX::90000"><span style="-sec-ix-hidden: xdx2ixbrl0698">0.09</span></span> million and $<span id="xdx_90F_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1_pn5n6_c20220101__20220331__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zk0de66pRLhg">0.10</span> million, respectively. Compensation cost, net of forfeitures, is recognized on a straight-line basis over the requisite service period for the entire award. Forfeitures are estimated based on historic trends. It is generally our policy to issue new shares upon exercise of stock options.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_89C_eus-gaap--ScheduleOfNonvestedShareActivityTableTextBlock_zvPL7tymGD6k" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span><span id="xdx_8BC_zNSguLQ3WLp6">The following table sets forth information with respect to nonvested options for the three months ended March 31, 2023:</span></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 90%; margin-left: 0.5in"> <tr style="vertical-align: bottom"> <td style="text-align: justify"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: center">Number of Shares</td><td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: center">Weighted Average <br/> Grant-Date Fair Value</td><td style="padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%; text-align: left; padding-left: 0.05in">Nonvested options – beginning of period</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_98C_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_iS_pid_uShares_c20230101__20230331_zcywzyrx5d3k" style="width: 15%; text-align: right" title="Nonvested options beginning of period">168,730</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_981_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue_iS_pid_c20230101__20230331_zXbb1e0LF7i4" style="width: 15%; text-align: right" title="Weighted average grant date fair value, beginning of year">16.31</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-left: 0.05in">Nonvested options granted</td><td> </td> <td style="text-align: left"> </td><td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_pid_uShares_c20230101__20230331_zedCmhCElalg" style="text-align: right" title="Nonvested options granted"><span style="-sec-ix-hidden: xdx2ixbrl0707">—</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_pid_c20230101__20230331_zz9WCAacEBV6" style="text-align: right" title="Weighted average grant date fair value, nonvested options granted"><span style="-sec-ix-hidden: xdx2ixbrl0709">—</span></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1pt; padding-left: 0.05in">Nonvested options vested or forfeited</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_981_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares_iN_pid_di_uShares_c20230101__20230331_z47bXXUgPMhh" style="border-bottom: Black 1pt solid; text-align: right" title="Nonvested options vested or forfeited">(23,080</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt"> </td> <td style="text-align: left">$</td><td id="xdx_982_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue_pid_c20230101__20230331_zkHAFkZNj6Of" style="text-align: right" title="Weighted average grant date fair value, nonvested options vested or forfeited">13.58</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1.5pt; padding-left: 0.05in">Nonvested options – end of period</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_98B_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_iE_pid_uShares_c20230101__20230331_zgHkFM5SNgdc" style="border-bottom: Black 2.5pt double; text-align: right" title="Nonvested options end of period">145,650</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="text-align: left">$</td><td id="xdx_98E_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue_iE_pid_c20230101__20230331_zwbwMHgMJhXi" style="text-align: right" title="Weighted average grant date fair value, nonvested options end of period">16.74</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> </table> <p id="xdx_8A0_zC7ZinqUBxyh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Share-based payment expense decreased income before income taxes by $<span id="xdx_901_eus-gaap--AllocatedShareBasedCompensationExpense_dm_c20230101__20230331_zfze9gbpyegf" title="Share-based payment arrangement, expense">0.63 million</span> and $<span id="xdx_904_eus-gaap--AllocatedShareBasedCompensationExpense_dm_c20220101__20220331_zKkG2aYQEVyb" title="Share-based payment arrangement, expense">0.65 million</span> for the three months ended March 31, 2023 and 2022, respectively, and decreased income attributable to Inter Parfums, Inc. by $<span id="xdx_90E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOtherShareIncreaseDecrease_dm_c20230101__20230331_zMtMIR3fafG8" title="Decreased income">0.43 million</span> and $<span id="xdx_903_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOtherShareIncreaseDecrease_dm_c20220101__20220331_zeJNKmfcfkh4" title="Decreased income">0.44 million</span> for the three months ended March 31, 2023 and 2022, respectively.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_895_eus-gaap--ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_zxvJSFJIq7Ef" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B8_z0Q6mwQDZCi7">The following table summarizes stock option information as of March 31, 2023:</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 90%; margin-left: 0.5in"> <tr style="vertical-align: bottom"> <td style="text-align: justify"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Shares</td><td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Weighted Average <br/> Exercise Price</td><td style="padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td> </td> <td colspan="2" style="text-align: justify"> </td><td> </td><td> </td> <td colspan="2" style="text-align: justify"> </td><td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 66%">Outstanding at January 1, 2023</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_pid_uShares_c20230101__20230331_zKZvF6WAXted" style="width: 14%; text-align: right" title="Options shares under option - beginning of year">441,580</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_pid_c20230101__20230331_zvOaoYmAhSZ3" style="width: 14%; text-align: right" title="Weighted average exercise price shares under option - beginning of year">67.30</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Options forfeited</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_iN_pid_di_uShares_c20230101__20230331_zrSNifsu8Zcj" style="text-align: right" title="Options forfeited">(15,480</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_pid_c20230101__20230331_zJAh5tkU3mde" style="text-align: right" title="Weighted average exercise price options forfeited">70.48</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1pt">Options exercised</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_98C_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_iN_pid_di_uShares_c20230101__20230331_zMnprTnT0742" style="border-bottom: Black 1pt solid; text-align: right" title="Options exercised">(88,710</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_pid_c20230101__20230331_zpBMnQyou908" style="border-bottom: Black 1pt solid; text-align: right" title="Weighted average exercise price options exercised">55.57</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1.5pt">Outstanding at March 31, 2023</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iE_pid_uShares_c20230101__20230331_z9rVQVT7bbha" style="border-bottom: Black 2.5pt double; text-align: right" title="Options shares under option - end of year">337,390</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iE_pid_c20230101__20230331_zx9CvwtlSKm2" style="border-bottom: Black 2.5pt double; text-align: right" title="Weighted average exercise price shares under option - end of year">70.24</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Options exercisable</td><td> </td> <td style="text-align: left"> </td><td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_iI_pid_uShares_c20230331_zZPhW9dOm252" style="text-align: right" title="Options exercisable">191,740</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_iI_pid_c20230331_zRsl9dvIMel" style="text-align: right" title="Weighted average exercise price options exercisable">61.38</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Options available for future grants</td><td> </td> <td style="text-align: left"> </td><td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_iI_pid_uShares_c20230331_z0UVbJSm6skc" style="text-align: right" title="Options available for future grants">574,455</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> </table> <p id="xdx_8A3_zjEG6gk6VVmg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As of March 31, 2023, the weighted average remaining contractual life of options outstanding is <span id="xdx_90F_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dxL_c20230101__20230331_zMrSlS7FJXRf" title="Weighted average remaining contractual life of options outstanding (in years)::XDX::P3Y6M21D"><span style="-sec-ix-hidden: xdx2ixbrl0756">3.56</span></span> years (<span id="xdx_909_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_dxL_c20230101__20230331_zuG5mRHBWjM1" title="Weighted average remaining contractual life of options exercisable (in years)::XDX::P1Y9M0D"><span style="-sec-ix-hidden: xdx2ixbrl0758">1.75</span></span> years for options exercisable); the aggregate intrinsic value of options outstanding and options exercisable is $<span id="xdx_904_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_iI_pn5n6_c20230331_z0Aj31v7t8Vh" title="Aggregate intrinsic value of options outstanding and options outstanding">24.3</span> million and $<span id="xdx_90E_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_iI_pn5n6_c20230331_ztnHiRqxgkXb" title="Aggregate intrinsic value of options outstanding and options exercisable">15.5</span> million, respectively; and unrecognized compensation cost related to stock options outstanding aggregated $<span id="xdx_907_eus-gaap--EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_iI_pn5n6_c20230331_zKNIzBMiruHl" title="Unrecognized compensation cost">2.4</span> million.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_890_eus-gaap--CashProceedsReceivedAndTaxBenefitFromShareBasedPaymentAwardsTableTextBlock_zXffkRlq82b3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B5_zAyG4VwMcaal">Cash proceeds, tax benefits and intrinsic value related to stock options exercised during the three months ended March 31, 2023 and 2022 were as follows:</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 90%; margin-left: 0.5in"> <tr style="vertical-align: bottom"> <td style="text-align: left; padding-left: 0.125in; text-indent: -0.125in; vertical-align: top">(In thousands)</td><td style="padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_497_20230101__20230331_z5yiKEY7Vrql" style="border-bottom: Black 1pt solid; text-align: center">March 31,   <br/>2023</td><td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_497_20220101__20220331_zc2d2jCQc29i" style="border-bottom: Black 1pt solid; text-align: center">March 31,   <br/>2022</td><td style="padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 0.125in; text-indent: -0.125in"> </td><td> </td> <td colspan="2" style="text-align: justify"> </td><td> </td><td> </td> <td colspan="2" style="text-align: justify"> </td><td> </td></tr> <tr id="xdx_407_eus-gaap--ProceedsFromStockOptionsExercised_pn3n3_ztljOHsSAESl" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 70%; text-align: left; padding-left: 0.125in; text-indent: -0.125in">Cash proceeds from stock options exercised</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">4,929</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">708</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_404_eus-gaap--DeferredTaxExpenseFromStockOptionsExercised_pn3n3_zaZkK7YQkhza" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-left: 0.125in; text-indent: -0.125in">Tax benefits</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">780</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">75</td><td style="text-align: left"> </td></tr> <tr id="xdx_407_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_pn3n3_zDx5YswnCp0k" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-left: 0.125in; text-indent: -0.125in">Intrinsic value of stock options exercised</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">5,403</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">635</td><td style="text-align: left"> </td></tr> </table> <p id="xdx_8A6_zMTbIZdusdJ1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">There were <span id="xdx_901_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_pid_do_uShares_c20230101__20230331_z0DWWX9UBSE9" title="Options granted"><span id="xdx_907_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_pid_do_uShares_c20230101__20230331_z3tkxf4RPp87" title="Options granted"><span id="xdx_90C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_pid_do_uShares_c20220101__20220331_z2rHDiRHVn9k" title="Options granted">no</span></span></span> options granted during the three months ended March 31, 2023 and March 31, 2022.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Expected volatility is estimated based on historic volatility of the Company’s common stock. The expected term of the option is estimated based on historic data. The risk-free rate is based on the U.S. Treasury yield curve in effect at the time of the grant of the option and the dividend yield reflects the assumption that the dividend payout as authorized by the Board of Directors would increase as the earnings of the Company and its stock price continue to increase.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In December 2018, Interparfums SA approved a plan to grant an aggregate of <span id="xdx_905_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_iI_pid_uShares_c20181231__srt--ConsolidatedEntitiesAxis__custom--InterparfumsSASubsidiaryMember__srt--TitleOfIndividualAxis__custom--EmployeesMember_zzCNJe0OL333" title="Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized">26,600</span> shares of its stock to employees with no performance condition requirement, and an aggregate of <span id="xdx_90F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_iI_pid_uShares_c20181231__srt--ConsolidatedEntitiesAxis__custom--InterparfumsSASubsidiaryMember__srt--TitleOfIndividualAxis__custom--OfficersAndManagersMember_zqcwA1Vbxhe6" title="Aggregate shares to offices and managers">133,000</span> shares to officers and managers, subject to certain corporate performance conditions. The corporate performance conditions were met and therefore in June 2022, <span id="xdx_902_eus-gaap--StockIssuedDuringPeriodSharesStockSplits_pid_uShares_c20220601__20220630_zAaZRPqxSMee" title="Adjusted for stock splits">211,955</span> shares, adjusted for stock splits, were distributed. The aggregate cost of the grant of approximately $<span id="xdx_900_eus-gaap--EmployeeStockOwnershipPlanESOPCompensationExpense_pn5n6_c20220601__20220630_zKIekprhR3L7" title="Recognized as compensation cost">4.8</span> million was recognized as compensation cost on a straight-line basis over the requisite three-year service period.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In March 2022, Interparfums SA approved an additional plan to grant an aggregate of <span id="xdx_909_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_iI_pid_uShares_c20220331__srt--ConsolidatedEntitiesAxis__custom--InterparfumsSASubsidiaryMember__srt--TitleOfIndividualAxis__custom--EmployeesMember_zv5WQtLefph7">88,400</span> shares to all Interparfums SA employees and corporate officers having more than six months of employment at grant date, subject to certain corporate performance conditions. The shares, subject to adjustment for stock splits, will be distributed in June 2025 and will follow the same guidelines as the December 2018 plan.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The fair value of the grant had been determined based on the quoted stock price of Interparfums SA shares as reported by the Euronext on the date of grant. The estimated number of shares to be distributed of <span id="xdx_900_eus-gaap--DistributionMadeToLimitedPartnerUnitDistribution_pid_uShares_c20230101__20230331__srt--ConsolidatedEntitiesAxis__custom--InterparfumsSASubsidiaryMember__srt--TitleOfIndividualAxis__custom--EmployeesMember_zDchWGUPP4Fa" title="Number of share distributed">85,107 </span>has been determined taking into account employee turnover. The aggregate cost of the grant of approximately $<span id="xdx_90D_eus-gaap--EmployeeStockOwnershipPlanESOPCompensationExpense_dm_c20230101__20230331__srt--ConsolidatedEntitiesAxis__custom--InterparfumsSASubsidiaryMember__srt--TitleOfIndividualAxis__custom--EmployeesMember_zaWQu4yHSaa6" title="Recognized as compensation cost">4.1 million</span> will be recognized as compensation cost on a straight-line basis over the requisite three and a quarter year service period.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Similar to the December 2018 plan, in order to avoid dilution of the Company’s ownership of Interparfums SA, all shares distributed or to be distributed pursuant to these plans will be pre-existing shares of Interparfums SA, purchased in the open market by Interparfums SA. During the year ended December 31, 2022, the Company acquired <span id="xdx_903_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_iI_pid_uShares_c20221231__srt--ConsolidatedEntitiesAxis__custom--InterparfumsSASubsidiaryMember__srt--TitleOfIndividualAxis__custom--EmployeesMember_zk9ysjRsTeI2">63,281</span> shares at an aggregate cost of $<span id="xdx_902_eus-gaap--EmployeeStockOwnershipPlanESOPCompensationExpense_pn6n6_c20220101__20221231__srt--ConsolidatedEntitiesAxis__custom--InterparfumsSASubsidiaryMember__srt--TitleOfIndividualAxis__custom--EmployeesMember_z7wAh6B7Nu6i" title="Recognized as compensation cost">3</span>.0 million.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In the first quarter of 2023, the Company initiated a small share repurchase program, and over the course the course of the first quarter of 2023, the Company repurchased <span id="xdx_905_eus-gaap--StockRepurchasedDuringPeriodShares_pid_uShares_c20230101__20230331__us-gaap--StatementEquityComponentsAxis__us-gaap--TreasuryStockCommonMember_zfgty4RuKqt2" title="Shares repurchased">43,060</span> shares at a cost of $<span id="xdx_90D_ecustom--StockRepurchasedDuringPeriodValue1_dxL_c20230101__20230331__us-gaap--StatementEquityComponentsAxis__us-gaap--TreasuryStockCommonMember_zT2JgbhxOrD6" title="Shares repurchase value::XDX::5580000"><span style="-sec-ix-hidden: xdx2ixbrl0806">5.58 million</span></span>. These shares are classified as treasury shares on the accompanying balance sheet. The Company plans to continue repurchasing shares throughout 2023.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">All share purchases and issuances have been classified as equity transactions on the accompanying balance sheet.</span></p> 100000 <p id="xdx_89C_eus-gaap--ScheduleOfNonvestedShareActivityTableTextBlock_zvPL7tymGD6k" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span><span id="xdx_8BC_zNSguLQ3WLp6">The following table sets forth information with respect to nonvested options for the three months ended March 31, 2023:</span></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 90%; margin-left: 0.5in"> <tr style="vertical-align: bottom"> <td style="text-align: justify"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: center">Number of Shares</td><td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: center">Weighted Average <br/> Grant-Date Fair Value</td><td style="padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%; text-align: left; padding-left: 0.05in">Nonvested options – beginning of period</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_98C_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_iS_pid_uShares_c20230101__20230331_zcywzyrx5d3k" style="width: 15%; text-align: right" title="Nonvested options beginning of period">168,730</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_981_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue_iS_pid_c20230101__20230331_zXbb1e0LF7i4" style="width: 15%; text-align: right" title="Weighted average grant date fair value, beginning of year">16.31</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-left: 0.05in">Nonvested options granted</td><td> </td> <td style="text-align: left"> </td><td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_pid_uShares_c20230101__20230331_zedCmhCElalg" style="text-align: right" title="Nonvested options granted"><span style="-sec-ix-hidden: xdx2ixbrl0707">—</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_pid_c20230101__20230331_zz9WCAacEBV6" style="text-align: right" title="Weighted average grant date fair value, nonvested options granted"><span style="-sec-ix-hidden: xdx2ixbrl0709">—</span></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1pt; padding-left: 0.05in">Nonvested options vested or forfeited</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_981_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares_iN_pid_di_uShares_c20230101__20230331_z47bXXUgPMhh" style="border-bottom: Black 1pt solid; text-align: right" title="Nonvested options vested or forfeited">(23,080</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt"> </td> <td style="text-align: left">$</td><td id="xdx_982_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue_pid_c20230101__20230331_zkHAFkZNj6Of" style="text-align: right" title="Weighted average grant date fair value, nonvested options vested or forfeited">13.58</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1.5pt; padding-left: 0.05in">Nonvested options – end of period</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_98B_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_iE_pid_uShares_c20230101__20230331_zgHkFM5SNgdc" style="border-bottom: Black 2.5pt double; text-align: right" title="Nonvested options end of period">145,650</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="text-align: left">$</td><td id="xdx_98E_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue_iE_pid_c20230101__20230331_zwbwMHgMJhXi" style="text-align: right" title="Weighted average grant date fair value, nonvested options end of period">16.74</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> </table> 168730 16.31 23080 13.58 145650 16.74 630000 650000 430000 440000 <p id="xdx_895_eus-gaap--ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_zxvJSFJIq7Ef" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B8_z0Q6mwQDZCi7">The following table summarizes stock option information as of March 31, 2023:</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 90%; margin-left: 0.5in"> <tr style="vertical-align: bottom"> <td style="text-align: justify"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Shares</td><td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Weighted Average <br/> Exercise Price</td><td style="padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td> </td> <td colspan="2" style="text-align: justify"> </td><td> </td><td> </td> <td colspan="2" style="text-align: justify"> </td><td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 66%">Outstanding at January 1, 2023</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_pid_uShares_c20230101__20230331_zKZvF6WAXted" style="width: 14%; text-align: right" title="Options shares under option - beginning of year">441,580</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_pid_c20230101__20230331_zvOaoYmAhSZ3" style="width: 14%; text-align: right" title="Weighted average exercise price shares under option - beginning of year">67.30</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Options forfeited</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_iN_pid_di_uShares_c20230101__20230331_zrSNifsu8Zcj" style="text-align: right" title="Options forfeited">(15,480</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_pid_c20230101__20230331_zJAh5tkU3mde" style="text-align: right" title="Weighted average exercise price options forfeited">70.48</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1pt">Options exercised</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_98C_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_iN_pid_di_uShares_c20230101__20230331_zMnprTnT0742" style="border-bottom: Black 1pt solid; text-align: right" title="Options exercised">(88,710</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_pid_c20230101__20230331_zpBMnQyou908" style="border-bottom: Black 1pt solid; text-align: right" title="Weighted average exercise price options exercised">55.57</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1.5pt">Outstanding at March 31, 2023</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iE_pid_uShares_c20230101__20230331_z9rVQVT7bbha" style="border-bottom: Black 2.5pt double; text-align: right" title="Options shares under option - end of year">337,390</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iE_pid_c20230101__20230331_zx9CvwtlSKm2" style="border-bottom: Black 2.5pt double; text-align: right" title="Weighted average exercise price shares under option - end of year">70.24</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Options exercisable</td><td> </td> <td style="text-align: left"> </td><td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_iI_pid_uShares_c20230331_zZPhW9dOm252" style="text-align: right" title="Options exercisable">191,740</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_iI_pid_c20230331_zRsl9dvIMel" style="text-align: right" title="Weighted average exercise price options exercisable">61.38</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Options available for future grants</td><td> </td> <td style="text-align: left"> </td><td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_iI_pid_uShares_c20230331_z0UVbJSm6skc" style="text-align: right" title="Options available for future grants">574,455</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> </table> 441580 67.30 15480 70.48 88710 55.57 337390 70.24 191740 61.38 574455 24300000 15500000 2400000 <p id="xdx_890_eus-gaap--CashProceedsReceivedAndTaxBenefitFromShareBasedPaymentAwardsTableTextBlock_zXffkRlq82b3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B5_zAyG4VwMcaal">Cash proceeds, tax benefits and intrinsic value related to stock options exercised during the three months ended March 31, 2023 and 2022 were as follows:</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 90%; margin-left: 0.5in"> <tr style="vertical-align: bottom"> <td style="text-align: left; padding-left: 0.125in; text-indent: -0.125in; vertical-align: top">(In thousands)</td><td style="padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_497_20230101__20230331_z5yiKEY7Vrql" style="border-bottom: Black 1pt solid; text-align: center">March 31,   <br/>2023</td><td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_497_20220101__20220331_zc2d2jCQc29i" style="border-bottom: Black 1pt solid; text-align: center">March 31,   <br/>2022</td><td style="padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 0.125in; text-indent: -0.125in"> </td><td> </td> <td colspan="2" style="text-align: justify"> </td><td> </td><td> </td> <td colspan="2" style="text-align: justify"> </td><td> </td></tr> <tr id="xdx_407_eus-gaap--ProceedsFromStockOptionsExercised_pn3n3_ztljOHsSAESl" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 70%; text-align: left; padding-left: 0.125in; text-indent: -0.125in">Cash proceeds from stock options exercised</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">4,929</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">708</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_404_eus-gaap--DeferredTaxExpenseFromStockOptionsExercised_pn3n3_zaZkK7YQkhza" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-left: 0.125in; text-indent: -0.125in">Tax benefits</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">780</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">75</td><td style="text-align: left"> </td></tr> <tr id="xdx_407_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_pn3n3_zDx5YswnCp0k" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-left: 0.125in; text-indent: -0.125in">Intrinsic value of stock options exercised</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">5,403</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">635</td><td style="text-align: left"> </td></tr> </table> 4929000 708000 780000 75000 5403000 635000 0 0 0 26600 133000 211955 4800000 88400 85107 4100000 63281 3000000 43060 <p id="xdx_803_eus-gaap--EarningsPerShareTextBlock_z3DPZmI8KfW1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top"> <td style="width: 0"/><td style="width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>10.</b></span></td><td style="text-align: justify; padding-right: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span style="text-decoration: underline"><span id="xdx_826_zCs4aGsYdXO3">Net Income Attributable to Inter Parfums, Inc. Common Shareholders:</span></span></b></span></td></tr></table> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Net income attributable to Inter Parfums, Inc. per common share (“basic EPS”) is computed by dividing net income attributable to Inter Parfums, Inc. by the weighted average number of shares outstanding. Net income attributable to Inter Parfums, Inc. per share assuming dilution (“diluted EPS”), is computed using the weighted average number of shares outstanding, plus the incremental shares outstanding assuming the exercise of dilutive stock options using the treasury stock method.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_897_eus-gaap--ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_zpHUmssy9Mx5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B0_z7oZ0DTPgBC5">The reconciliation between the numerators and denominators of the basic and diluted EPS computations is as follows:</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"/></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 90%; margin-left: 0.5in"> <tr style="vertical-align: bottom"> <td style="padding-left: 0.125in; text-indent: -0.125in"> </td><td> </td> <td style="text-align: center"> </td> <td id="xdx_49A_20230101__20230331_zeDV1OZmla01" style="text-align: center"> </td> <td style="text-align: center"> </td> <td style="text-align: center"> </td> <td colspan="2" id="xdx_493_20220101__20220331_zRKiddKtZyTa" style="text-align: center"> </td><td> </td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 0.125in; text-indent: -0.125in"> </td><td> </td> <td colspan="6" style="text-align: center">Three months ended</td><td> </td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 0.125in; text-indent: -0.125in">(In thousands)</td><td> </td> <td colspan="6" style="text-align: center">March 31,</td><td> </td></tr> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1pt; padding-left: 0.125in; text-indent: -0.125in"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">2023</td><td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">2022</td><td style="padding-bottom: 1pt"> </td></tr> <tr id="xdx_40F_eus-gaap--WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract_iB_zGqfmLHSfCt7" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 0.125in; text-indent: -0.125in">Numerator:</td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="width: 70%; text-align: left; padding-bottom: 1.5pt; padding-left: 0.25in; text-indent: -0.125in">Net income attributable to Inter Parfums, Inc.</td><td style="width: 1%; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left">$</td><td id="xdx_984_eus-gaap--NetIncomeLoss_c20230101__20230331_zE2tAZ1qWGo1" style="border-bottom: Black 2.5pt double; width: 12%; text-align: right" title="Net income attributable to Inter Parfums, Inc.">54,068</td><td style="width: 1%; text-align: left; padding-bottom: 1.5pt"> </td><td style="width: 1%; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left">$</td><td id="xdx_980_eus-gaap--NetIncomeLoss_c20220101__20220331_zypquJHHF9ji" style="border-bottom: Black 2.5pt double; width: 12%; text-align: right" title="Net income attributable to Inter Parfums, Inc.">35,299</td><td style="width: 1%; text-align: left; padding-bottom: 1.5pt"> </td></tr> <tr id="xdx_400_eus-gaap--WeightedAverageNumberOfSharesOutstandingAbstract_iB_zfVNCdiSehxd" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 0.125in; text-indent: -0.125in">Denominator:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_40C_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_i01_pid_uShares_madpes_zmkIV8yBbLgc" style="vertical-align: bottom; background-color: White"> <td style="padding-left: 0.25in; text-indent: -0.125in">Weighted average shares</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">32,018</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">31,840</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-left: 0.25in; text-indent: -0.125in">Effect of dilutive securities:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_406_eus-gaap--WeightedAverageNumberDilutedSharesOutstandingAdjustment_i01_pid_uShares_madpes_zEqxrriz0pNc" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt; padding-left: 0.375in; text-indent: -0.125in">Stock options</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">141</td><td style="text-align: left; padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">170</td><td style="text-align: left; padding-bottom: 1pt"> </td></tr> <tr id="xdx_40D_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_i01_pid_uShares_mtdpes_zlRaioyDgbgg" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt; padding-left: 0.5in; text-indent: -0.125in">Denominator for diluted earnings per share</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right">32,159</td><td style="text-align: left; padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right">32,010</td><td style="text-align: left; padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 0.125in; text-indent: -0.125in"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 0.125in; text-indent: -0.125in">Earnings per share:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_406_eus-gaap--EarningsPerShareBasicAbstract_iB_zvQSAxxnWbzh" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-left: 0.25in; text-indent: -0.125in">Net income attributable to Inter Parfums, Inc. common shareholders:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_407_eus-gaap--EarningsPerShareBasic_i01_pid_uUSDPShares_zuYlnrFTsWo" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 0.5in; text-indent: -0.125in">Basic</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">1.69</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">1.11</td><td style="text-align: left"> </td></tr> <tr id="xdx_402_eus-gaap--EarningsPerShareDiluted_i01_pid_uUSDPShares_zNLfxyZwZh29" style="vertical-align: bottom; background-color: White"> <td style="padding-left: 0.5in; text-indent: -0.125in">Diluted</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1.68</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1.10</td><td style="text-align: left"> </td></tr> </table> <p id="xdx_8A4_zEADtwzjszx7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">There were <span id="xdx_901_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_do_c20230101__20230331_zpB4ZAI9aq9" title="Antidilutive securities excluded from computation of earnings per share, amount"><span id="xdx_905_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_pid_do_c20220101__20220331_zhkauAKM4zs6">no</span></span> antidilutive potential common shares outstanding for the three months ended March 31, 2023 and March 31, 2022.</span></p> <p id="xdx_897_eus-gaap--ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_zpHUmssy9Mx5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B0_z7oZ0DTPgBC5">The reconciliation between the numerators and denominators of the basic and diluted EPS computations is as follows:</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"/></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 90%; margin-left: 0.5in"> <tr style="vertical-align: bottom"> <td style="padding-left: 0.125in; text-indent: -0.125in"> </td><td> </td> <td style="text-align: center"> </td> <td id="xdx_49A_20230101__20230331_zeDV1OZmla01" style="text-align: center"> </td> <td style="text-align: center"> </td> <td style="text-align: center"> </td> <td colspan="2" id="xdx_493_20220101__20220331_zRKiddKtZyTa" style="text-align: center"> </td><td> </td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 0.125in; text-indent: -0.125in"> </td><td> </td> <td colspan="6" style="text-align: center">Three months ended</td><td> </td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 0.125in; text-indent: -0.125in">(In thousands)</td><td> </td> <td colspan="6" style="text-align: center">March 31,</td><td> </td></tr> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1pt; padding-left: 0.125in; text-indent: -0.125in"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">2023</td><td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">2022</td><td style="padding-bottom: 1pt"> </td></tr> <tr id="xdx_40F_eus-gaap--WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract_iB_zGqfmLHSfCt7" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 0.125in; text-indent: -0.125in">Numerator:</td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="width: 70%; text-align: left; padding-bottom: 1.5pt; padding-left: 0.25in; text-indent: -0.125in">Net income attributable to Inter Parfums, Inc.</td><td style="width: 1%; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left">$</td><td id="xdx_984_eus-gaap--NetIncomeLoss_c20230101__20230331_zE2tAZ1qWGo1" style="border-bottom: Black 2.5pt double; width: 12%; text-align: right" title="Net income attributable to Inter Parfums, Inc.">54,068</td><td style="width: 1%; text-align: left; padding-bottom: 1.5pt"> </td><td style="width: 1%; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left">$</td><td id="xdx_980_eus-gaap--NetIncomeLoss_c20220101__20220331_zypquJHHF9ji" style="border-bottom: Black 2.5pt double; width: 12%; text-align: right" title="Net income attributable to Inter Parfums, Inc.">35,299</td><td style="width: 1%; text-align: left; padding-bottom: 1.5pt"> </td></tr> <tr id="xdx_400_eus-gaap--WeightedAverageNumberOfSharesOutstandingAbstract_iB_zfVNCdiSehxd" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 0.125in; text-indent: -0.125in">Denominator:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_40C_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_i01_pid_uShares_madpes_zmkIV8yBbLgc" style="vertical-align: bottom; background-color: White"> <td style="padding-left: 0.25in; text-indent: -0.125in">Weighted average shares</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">32,018</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">31,840</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-left: 0.25in; text-indent: -0.125in">Effect of dilutive securities:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_406_eus-gaap--WeightedAverageNumberDilutedSharesOutstandingAdjustment_i01_pid_uShares_madpes_zEqxrriz0pNc" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt; padding-left: 0.375in; text-indent: -0.125in">Stock options</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">141</td><td style="text-align: left; padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">170</td><td style="text-align: left; padding-bottom: 1pt"> </td></tr> <tr id="xdx_40D_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_i01_pid_uShares_mtdpes_zlRaioyDgbgg" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt; padding-left: 0.5in; text-indent: -0.125in">Denominator for diluted earnings per share</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right">32,159</td><td style="text-align: left; padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right">32,010</td><td style="text-align: left; padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 0.125in; text-indent: -0.125in"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 0.125in; text-indent: -0.125in">Earnings per share:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_406_eus-gaap--EarningsPerShareBasicAbstract_iB_zvQSAxxnWbzh" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-left: 0.25in; text-indent: -0.125in">Net income attributable to Inter Parfums, Inc. common shareholders:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_407_eus-gaap--EarningsPerShareBasic_i01_pid_uUSDPShares_zuYlnrFTsWo" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 0.5in; text-indent: -0.125in">Basic</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">1.69</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">1.11</td><td style="text-align: left"> </td></tr> <tr id="xdx_402_eus-gaap--EarningsPerShareDiluted_i01_pid_uUSDPShares_zNLfxyZwZh29" style="vertical-align: bottom; background-color: White"> <td style="padding-left: 0.5in; text-indent: -0.125in">Diluted</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1.68</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1.10</td><td style="text-align: left"> </td></tr> </table> 54068000 35299000 32018 31840 141 170 32159 32010 1.69 1.11 1.68 1.10 0 0 <p id="xdx_806_eus-gaap--SegmentReportingDisclosureTextBlock_zfx6fyFceJW4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify"> <td style="width: 0in"/><td style="width: 0.5in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>11.</b></span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span style="text-decoration: underline"><span id="xdx_82C_zGjSzXqJzMx8">Segment and Geographic Areas:</span></span></b></span></td> </tr></table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span>The Company manufactures and distributes one product line, fragrances and fragrance related products. The Company manages its business in two segments, European based operations and United States based operations. The European assets are located, and operations are primarily conducted, in France. Both European operations and United States operations primarily represent the sale of prestige brand name fragrances. Information on our operations by geographical areas is as follows:</span></span></p> <p id="xdx_89A_eus-gaap--ScheduleOfSegmentReportingInformationBySegmentTextBlock_zzMYCh0w8w8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8B7_zktQHaJFG56a" style="display: none; visibility: hidden">Information on the Company’s operations by segments is as follows:</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 90%; margin-left: 0.5in"> <tr style="vertical-align: bottom"> <td style="text-align: justify">(In thousands)</td><td> </td> <td colspan="6" style="text-align: center">Three months ended<br/> March 31,</td><td> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: justify"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">2023</td><td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">2022</td><td style="padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify">Net sales:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="width: 70%; text-align: justify; padding-left: 0.125in">United States</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_980_eus-gaap--RevenueFromContractWithCustomerIncludingAssessedTax_pn3n3_c20230101__20230331__srt--StatementGeographicalAxis__country--US_z3CyCXWXP9vh" style="width: 12%; text-align: right" title="Net sales">81,454</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_98C_eus-gaap--RevenueFromContractWithCustomerIncludingAssessedTax_pn3n3_c20220101__20220331__srt--StatementGeographicalAxis__country--US_z4ZZU2riTLWb" style="width: 12%; text-align: right" title="Net sales">68,502</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify; padding-left: 0.125in">Europe</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98D_eus-gaap--RevenueFromContractWithCustomerIncludingAssessedTax_pn3n3_c20230101__20230331__srt--StatementGeographicalAxis__srt--EuropeMember_z0afGMvnnkil" style="text-align: right" title="Net sales">230,269</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_983_eus-gaap--RevenueFromContractWithCustomerIncludingAssessedTax_pn3n3_c20220101__20220331__srt--StatementGeographicalAxis__srt--EuropeMember_z9gtqvjzef5d" style="text-align: right" title="Net sales">182,182</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify; padding-bottom: 1pt; padding-left: 0.125in">Eliminations</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_986_eus-gaap--RevenueFromContractWithCustomerIncludingAssessedTax_pn3n3_c20230101__20230331__srt--StatementGeographicalAxis__custom--EliminationsMember_zJrl2wq6vTI3" style="border-bottom: Black 1pt solid; text-align: right" title="Net sales"><span style="-sec-ix-hidden: xdx2ixbrl0855">—</span></td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_982_eus-gaap--RevenueFromContractWithCustomerIncludingAssessedTax_pn3n3_c20220101__20220331__srt--StatementGeographicalAxis__custom--EliminationsMember_zZmN9yfUkXd5" style="border-bottom: Black 1pt solid; text-align: right" title="Net sales">(6</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify; padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98D_eus-gaap--RevenueFromContractWithCustomerIncludingAssessedTax_pn3n3_c20230101__20230331_zB41oBwoHQ24" style="border-bottom: Black 2.5pt double; text-align: right" title="Net sales">311,723</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_982_eus-gaap--RevenueFromContractWithCustomerIncludingAssessedTax_pn3n3_c20220101__20220331_zIpyMfQhVm0d" style="border-bottom: Black 2.5pt double; text-align: right" title="Net sales">250,678</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Net income attributable to Inter Parfums, Inc.:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify; padding-left: 0.125in">United States</td><td> </td> <td style="text-align: left">$</td><td id="xdx_989_eus-gaap--NetIncomeLoss_pn3n3_c20230101__20230331__srt--StatementGeographicalAxis__country--US_z3yhGc8EQhy6" style="text-align: right" title="Net income attributable to Inter Parfums, Inc.">10,343</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_988_eus-gaap--NetIncomeLoss_pn3n3_c20220101__20220331__srt--StatementGeographicalAxis__country--US_zgepCTE54AOc" style="text-align: right" title="Net income attributable to Inter Parfums, Inc.">6,514</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify; padding-bottom: 1pt; padding-left: 0.125in">Europe</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_98F_eus-gaap--NetIncomeLoss_pn3n3_c20230101__20230331__srt--StatementGeographicalAxis__srt--EuropeMember_zkLoA6spTxIe" style="border-bottom: Black 1pt solid; text-align: right" title="Net income attributable to Inter Parfums, Inc.">43,725</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_98A_eus-gaap--NetIncomeLoss_pn3n3_c20220101__20220331__srt--StatementGeographicalAxis__srt--EuropeMember_zpZiUBuPr0ya" style="border-bottom: Black 1pt solid; text-align: right" title="Net income attributable to Inter Parfums, Inc.">28,785</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify; padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98A_eus-gaap--NetIncomeLoss_pn3n3_c20230101__20230331_zpftsGPhzRrc" style="border-bottom: Black 2.5pt double; text-align: right" title="Net income attributable to Inter Parfums, Inc.">54,068</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_989_eus-gaap--NetIncomeLoss_pn3n3_c20220101__20220331_zZc9JXulQV12" style="border-bottom: Black 2.5pt double; text-align: right" title="Net income attributable to Inter Parfums, Inc.">35,299</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> </table> <p style="margin: 0"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 90%; margin-left: 0.5in"> <tr style="vertical-align: bottom"> <td> </td><td> </td> <td colspan="2" style="text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">March 31,</span></td><td style="text-align: left"> </td><td> </td> <td colspan="2" style="text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">December 31,</span></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: justify; padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">2023</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">2022</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify; width: 70%">Total Assets:</td><td style="width: 1%"> </td> <td style="text-align: left; width: 1%"> </td><td style="text-align: right; width: 12%"> </td><td style="text-align: left; width: 1%"> </td><td style="width: 1%"> </td> <td style="text-align: left; width: 1%"> </td><td style="text-align: right; width: 12%"> </td><td style="text-align: left; width: 1%"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify; padding-left: 0.125in">United States</td><td> </td> <td style="text-align: left">$</td><td id="xdx_985_eus-gaap--Assets_iI_pn3n3_c20230331__srt--StatementGeographicalAxis__country--US_zZN5hG2IaJTh" style="text-align: right" title="Total Assets">288,927</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_98D_eus-gaap--Assets_iI_pn3n3_c20221231__srt--StatementGeographicalAxis__country--US_zP0rLq4zx198" style="text-align: right" title="Total Assets">278,090</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify; padding-left: 0.125in">Europe</td><td> </td> <td style="text-align: left"> </td><td id="xdx_988_eus-gaap--Assets_iI_pn3n3_c20230331__srt--StatementGeographicalAxis__srt--EuropeMember_zKgAtnj9lMI8" style="text-align: right" title="Total Assets">1,110,902</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98B_eus-gaap--Assets_iI_pn3n3_c20221231__srt--StatementGeographicalAxis__srt--EuropeMember_zs8uJwSs97Mg" style="text-align: right" title="Total Assets">1,052,004</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify; padding-bottom: 1pt; padding-left: 0.125in">Eliminations</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_980_eus-gaap--Assets_iNI_pn3n3_di_c20230331__srt--StatementGeographicalAxis__custom--EliminationsMember_zYCnmxKjEWT5" style="border-bottom: Black 1pt solid; text-align: right" title="Total Assets">(19,623</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_982_eus-gaap--Assets_iNI_pn3n3_di_c20221231__srt--StatementGeographicalAxis__custom--EliminationsMember_zGYQJSmxgGX1" style="border-bottom: Black 1pt solid; text-align: right" title="Total Assets">(21,522</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify; padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_986_eus-gaap--Assets_iI_pn3n3_c20230331_zRzz4aqC2mgj" style="border-bottom: Black 2.5pt double; text-align: right" title="Assets">1,380,206</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_988_eus-gaap--Assets_iI_pn3n3_c20221231_zcnLhvL0b436" style="border-bottom: Black 2.5pt double; text-align: right" title="Assets">1,308,542</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> </table> <p id="xdx_8AD_zdUvEPQj6vk5" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"> </p> <p id="xdx_89A_eus-gaap--ScheduleOfSegmentReportingInformationBySegmentTextBlock_zzMYCh0w8w8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8B7_zktQHaJFG56a" style="display: none; visibility: hidden">Information on the Company’s operations by segments is as follows:</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 90%; margin-left: 0.5in"> <tr style="vertical-align: bottom"> <td style="text-align: justify">(In thousands)</td><td> </td> <td colspan="6" style="text-align: center">Three months ended<br/> March 31,</td><td> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: justify"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">2023</td><td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">2022</td><td style="padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify">Net sales:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="width: 70%; text-align: justify; padding-left: 0.125in">United States</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_980_eus-gaap--RevenueFromContractWithCustomerIncludingAssessedTax_pn3n3_c20230101__20230331__srt--StatementGeographicalAxis__country--US_z3CyCXWXP9vh" style="width: 12%; text-align: right" title="Net sales">81,454</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_98C_eus-gaap--RevenueFromContractWithCustomerIncludingAssessedTax_pn3n3_c20220101__20220331__srt--StatementGeographicalAxis__country--US_z4ZZU2riTLWb" style="width: 12%; text-align: right" title="Net sales">68,502</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify; padding-left: 0.125in">Europe</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98D_eus-gaap--RevenueFromContractWithCustomerIncludingAssessedTax_pn3n3_c20230101__20230331__srt--StatementGeographicalAxis__srt--EuropeMember_z0afGMvnnkil" style="text-align: right" title="Net sales">230,269</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_983_eus-gaap--RevenueFromContractWithCustomerIncludingAssessedTax_pn3n3_c20220101__20220331__srt--StatementGeographicalAxis__srt--EuropeMember_z9gtqvjzef5d" style="text-align: right" title="Net sales">182,182</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify; padding-bottom: 1pt; padding-left: 0.125in">Eliminations</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_986_eus-gaap--RevenueFromContractWithCustomerIncludingAssessedTax_pn3n3_c20230101__20230331__srt--StatementGeographicalAxis__custom--EliminationsMember_zJrl2wq6vTI3" style="border-bottom: Black 1pt solid; text-align: right" title="Net sales"><span style="-sec-ix-hidden: xdx2ixbrl0855">—</span></td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_982_eus-gaap--RevenueFromContractWithCustomerIncludingAssessedTax_pn3n3_c20220101__20220331__srt--StatementGeographicalAxis__custom--EliminationsMember_zZmN9yfUkXd5" style="border-bottom: Black 1pt solid; text-align: right" title="Net sales">(6</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify; padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98D_eus-gaap--RevenueFromContractWithCustomerIncludingAssessedTax_pn3n3_c20230101__20230331_zB41oBwoHQ24" style="border-bottom: Black 2.5pt double; text-align: right" title="Net sales">311,723</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_982_eus-gaap--RevenueFromContractWithCustomerIncludingAssessedTax_pn3n3_c20220101__20220331_zIpyMfQhVm0d" style="border-bottom: Black 2.5pt double; text-align: right" title="Net sales">250,678</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Net income attributable to Inter Parfums, Inc.:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify; padding-left: 0.125in">United States</td><td> </td> <td style="text-align: left">$</td><td id="xdx_989_eus-gaap--NetIncomeLoss_pn3n3_c20230101__20230331__srt--StatementGeographicalAxis__country--US_z3yhGc8EQhy6" style="text-align: right" title="Net income attributable to Inter Parfums, Inc.">10,343</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_988_eus-gaap--NetIncomeLoss_pn3n3_c20220101__20220331__srt--StatementGeographicalAxis__country--US_zgepCTE54AOc" style="text-align: right" title="Net income attributable to Inter Parfums, Inc.">6,514</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify; padding-bottom: 1pt; padding-left: 0.125in">Europe</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_98F_eus-gaap--NetIncomeLoss_pn3n3_c20230101__20230331__srt--StatementGeographicalAxis__srt--EuropeMember_zkLoA6spTxIe" style="border-bottom: Black 1pt solid; text-align: right" title="Net income attributable to Inter Parfums, Inc.">43,725</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_98A_eus-gaap--NetIncomeLoss_pn3n3_c20220101__20220331__srt--StatementGeographicalAxis__srt--EuropeMember_zpZiUBuPr0ya" style="border-bottom: Black 1pt solid; text-align: right" title="Net income attributable to Inter Parfums, Inc.">28,785</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify; padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98A_eus-gaap--NetIncomeLoss_pn3n3_c20230101__20230331_zpftsGPhzRrc" style="border-bottom: Black 2.5pt double; text-align: right" title="Net income attributable to Inter Parfums, Inc.">54,068</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_989_eus-gaap--NetIncomeLoss_pn3n3_c20220101__20220331_zZc9JXulQV12" style="border-bottom: Black 2.5pt double; text-align: right" title="Net income attributable to Inter Parfums, Inc.">35,299</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> </table> <p style="margin: 0"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 90%; margin-left: 0.5in"> <tr style="vertical-align: bottom"> <td> </td><td> </td> <td colspan="2" style="text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">March 31,</span></td><td style="text-align: left"> </td><td> </td> <td colspan="2" style="text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">December 31,</span></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: justify; padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">2023</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">2022</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify; width: 70%">Total Assets:</td><td style="width: 1%"> </td> <td style="text-align: left; width: 1%"> </td><td style="text-align: right; width: 12%"> </td><td style="text-align: left; width: 1%"> </td><td style="width: 1%"> </td> <td style="text-align: left; width: 1%"> </td><td style="text-align: right; width: 12%"> </td><td style="text-align: left; width: 1%"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify; padding-left: 0.125in">United States</td><td> </td> <td style="text-align: left">$</td><td id="xdx_985_eus-gaap--Assets_iI_pn3n3_c20230331__srt--StatementGeographicalAxis__country--US_zZN5hG2IaJTh" style="text-align: right" title="Total Assets">288,927</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_98D_eus-gaap--Assets_iI_pn3n3_c20221231__srt--StatementGeographicalAxis__country--US_zP0rLq4zx198" style="text-align: right" title="Total Assets">278,090</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify; padding-left: 0.125in">Europe</td><td> </td> <td style="text-align: left"> </td><td id="xdx_988_eus-gaap--Assets_iI_pn3n3_c20230331__srt--StatementGeographicalAxis__srt--EuropeMember_zKgAtnj9lMI8" style="text-align: right" title="Total Assets">1,110,902</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98B_eus-gaap--Assets_iI_pn3n3_c20221231__srt--StatementGeographicalAxis__srt--EuropeMember_zs8uJwSs97Mg" style="text-align: right" title="Total Assets">1,052,004</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify; padding-bottom: 1pt; padding-left: 0.125in">Eliminations</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_980_eus-gaap--Assets_iNI_pn3n3_di_c20230331__srt--StatementGeographicalAxis__custom--EliminationsMember_zYCnmxKjEWT5" style="border-bottom: Black 1pt solid; text-align: right" title="Total Assets">(19,623</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_982_eus-gaap--Assets_iNI_pn3n3_di_c20221231__srt--StatementGeographicalAxis__custom--EliminationsMember_zGYQJSmxgGX1" style="border-bottom: Black 1pt solid; text-align: right" title="Total Assets">(21,522</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify; padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_986_eus-gaap--Assets_iI_pn3n3_c20230331_zRzz4aqC2mgj" style="border-bottom: Black 2.5pt double; text-align: right" title="Assets">1,380,206</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_988_eus-gaap--Assets_iI_pn3n3_c20221231_zcnLhvL0b436" style="border-bottom: Black 2.5pt double; text-align: right" title="Assets">1,308,542</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> </table> 81454000 68502000 230269000 182182000 -6000 311723000 250678000 10343000 6514000 43725000 28785000 54068000 35299000 288927000 278090000 1110902000 1052004000 19623000 21522000 1380206000 1308542000 EXCEL 47 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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ǐ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end XML 48 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 49 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 50 FilingSummary.xml IDEA: XBRL DOCUMENT 3.23.1 html 87 218 1 false 27 0 false 7 false false R1.htm 00000001 - Document - Cover Sheet http://interparfumsinc.com/role/Cover Cover Cover 1 false false R2.htm 00000002 - Statement - CONSOLIDATED BALANCE SHEETS (Unaudited) Sheet http://interparfumsinc.com/role/ConsolidatedBalanceSheets CONSOLIDATED BALANCE SHEETS (Unaudited) Statements 2 false false R3.htm 00000003 - Statement - CONSOLIDATED BALANCE SHEETS (Unaudited) (Parenthetical) Sheet http://interparfumsinc.com/role/ConsolidatedBalanceSheetsParenthetical CONSOLIDATED BALANCE SHEETS (Unaudited) (Parenthetical) Statements 3 false false R4.htm 00000004 - Statement - CONSOLIDATED STATEMENTS OF INCOME (Unaudited) Sheet http://interparfumsinc.com/role/ConsolidatedStatementsOfIncome CONSOLIDATED STATEMENTS OF INCOME (Unaudited) Statements 4 false false R5.htm 00000005 - Statement - CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (Unaudited) Sheet http://interparfumsinc.com/role/ConsolidatedStatementsOfComprehensiveIncome CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (Unaudited) Statements 5 false false R6.htm 00000006 - Statement - CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY (Unaudited) Sheet http://interparfumsinc.com/role/ConsolidatedStatementsOfChangesInEquity CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY (Unaudited) Statements 6 false false R7.htm 00000007 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) Sheet http://interparfumsinc.com/role/ConsolidatedStatementsOfCashFlows CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) Statements 7 false false R8.htm 00000008 - Disclosure - Significant Accounting Policies: Sheet http://interparfumsinc.com/role/SignificantAccountingPolicies Significant Accounting Policies: Notes 8 false false R9.htm 00000009 - Disclosure - Impact of COVID-19 Pandemic: Sheet http://interparfumsinc.com/role/ImpactOfCovid-19Pandemic Impact of COVID-19 Pandemic: Notes 9 false false R10.htm 00000010 - Disclosure - Recent Agreements: Sheet http://interparfumsinc.com/role/RecentAgreements Recent Agreements: Notes 10 false false R11.htm 00000011 - Disclosure - Recent Accounting Pronouncements: Sheet http://interparfumsinc.com/role/RecentAccountingPronouncements Recent Accounting Pronouncements: Notes 11 false false R12.htm 00000012 - Disclosure - Inventories: Sheet http://interparfumsinc.com/role/Inventories Inventories: Notes 12 false false R13.htm 00000013 - Disclosure - Fair Value Measurement: Sheet http://interparfumsinc.com/role/FairValueMeasurement Fair Value Measurement: Notes 13 false false R14.htm 00000014 - Disclosure - Derivative Financial Instruments: Sheet http://interparfumsinc.com/role/DerivativeFinancialInstruments Derivative Financial Instruments: Notes 14 false false R15.htm 00000015 - Disclosure - Leases: Sheet http://interparfumsinc.com/role/Leases Leases: Notes 15 false false R16.htm 00000016 - Disclosure - Share-Based Payments: Sheet http://interparfumsinc.com/role/Share-basedPayments Share-Based Payments: Notes 16 false false R17.htm 00000017 - Disclosure - Net Income Attributable to Inter Parfums, Inc. Common Shareholders: Sheet http://interparfumsinc.com/role/NetIncomeAttributableToInterParfumsInc.CommonShareholders Net Income Attributable to Inter Parfums, Inc. Common Shareholders: Notes 17 false false R18.htm 00000018 - Disclosure - Segment and Geographic Areas: Sheet http://interparfumsinc.com/role/SegmentAndGeographicAreas Segment and Geographic Areas: Notes 18 false false R19.htm 00000019 - Disclosure - Inventories: (Tables) Sheet http://interparfumsinc.com/role/InventoriesTables Inventories: (Tables) Tables http://interparfumsinc.com/role/Inventories 19 false false R20.htm 00000020 - Disclosure - Fair Value Measurement: (Tables) Sheet http://interparfumsinc.com/role/FairValueMeasurementTables Fair Value Measurement: (Tables) Tables http://interparfumsinc.com/role/FairValueMeasurement 20 false false R21.htm 00000021 - Disclosure - Share-Based Payments: (Tables) Sheet http://interparfumsinc.com/role/Share-basedPaymentsTables Share-Based Payments: (Tables) Tables http://interparfumsinc.com/role/Share-basedPayments 21 false false R22.htm 00000022 - Disclosure - Net Income Attributable to Inter Parfums, Inc. Common Shareholders: (Tables) Sheet http://interparfumsinc.com/role/NetIncomeAttributableToInterParfumsInc.CommonShareholdersTables Net Income Attributable to Inter Parfums, Inc. Common Shareholders: (Tables) Tables http://interparfumsinc.com/role/NetIncomeAttributableToInterParfumsInc.CommonShareholders 22 false false R23.htm 00000023 - Disclosure - Segment and Geographic Areas: (Tables) Sheet http://interparfumsinc.com/role/SegmentAndGeographicAreasTables Segment and Geographic Areas: (Tables) Tables http://interparfumsinc.com/role/SegmentAndGeographicAreas 23 false false R24.htm 00000024 - Disclosure - Recent Agreements: (Details Narrative) Sheet http://interparfumsinc.com/role/RecentAgreementsDetailsNarrative Recent Agreements: (Details Narrative) Details http://interparfumsinc.com/role/RecentAgreements 24 false false R25.htm 00000025 - Disclosure - Inventories consist of the following: (Details) Sheet http://interparfumsinc.com/role/InventoriesConsistOfFollowingDetails Inventories consist of the following: (Details) Details 25 false false R26.htm 00000026 - Disclosure - The following tables present our financial assets and liabilities that are measured at fair value on a recurring basis and are categorized using the fair value hierarchy. The fair value hierarchy has three levels based on the reliability of the inputs use (Details) Sheet http://interparfumsinc.com/role/FollowingTablesPresentOurFinancialAssetsAndLiabilitiesThatAreMeasuredAtFairValueOnRecurringBasisAndAreCategorizedUsingFairValueHierarchy.FairValueHierarchyHasThreeLevelsBasedOnReliabilityOfInputsUseDetails The following tables present our financial assets and liabilities that are measured at fair value on a recurring basis and are categorized using the fair value hierarchy. The fair value hierarchy has three levels based on the reliability of the inputs use (Details) Details 26 false false R27.htm 00000027 - Disclosure - Derivative Financial Instruments: (Details Narrative) Sheet http://interparfumsinc.com/role/DerivativeFinancialInstrumentsDetailsNarrative Derivative Financial Instruments: (Details Narrative) Details http://interparfumsinc.com/role/DerivativeFinancialInstruments 27 false false R28.htm 00000028 - Disclosure - Leases: (Details Narrative) Sheet http://interparfumsinc.com/role/LeasesDetailsNarrative Leases: (Details Narrative) Details http://interparfumsinc.com/role/Leases 28 false false R29.htm 00000029 - Disclosure - The following table sets forth information with respect to nonvested options for the three months ended March 31, 2023: (Details) Sheet http://interparfumsinc.com/role/FollowingTableSetsForthInformationWithRespectToNonvestedOptionsForThreeMonthsEndedMarch312023Details The following table sets forth information with respect to nonvested options for the three months ended March 31, 2023: (Details) Details 29 false false R30.htm 00000030 - Disclosure - The following table summarizes stock option information as of March 31, 2023: (Details) Sheet http://interparfumsinc.com/role/FollowingTableSummarizesStockOptionInformationAsOfMarch312023Details The following table summarizes stock option information as of March 31, 2023: (Details) Details 30 false false R31.htm 00000031 - Disclosure - Cash proceeds, tax benefits and intrinsic value related to stock options exercised during the three months ended March 31, 2023 and 2022 were as follows: (Details) Sheet http://interparfumsinc.com/role/CashProceedsTaxBenefitsAndIntrinsicValueRelatedToStockOptionsExercisedDuringThreeMonthsEndedMarch312023And2022WereAsFollowsDetails Cash proceeds, tax benefits and intrinsic value related to stock options exercised during the three months ended March 31, 2023 and 2022 were as follows: (Details) Details 31 false false R32.htm 00000032 - Disclosure - Share-Based Payments: (Details Narrative) Sheet http://interparfumsinc.com/role/Share-basedPaymentsDetailsNarrative Share-Based Payments: (Details Narrative) Details http://interparfumsinc.com/role/Share-basedPaymentsTables 32 false false R33.htm 00000033 - Disclosure - The reconciliation between the numerators and denominators of the basic and diluted EPS computations is as follows: (Details) Sheet http://interparfumsinc.com/role/ReconciliationBetweenNumeratorsAndDenominatorsOfBasicAndDilutedEpsComputationsIsAsFollowsDetails The reconciliation between the numerators and denominators of the basic and diluted EPS computations is as follows: (Details) Details 33 false false R34.htm 00000034 - Disclosure - Net Income Attributable to Inter Parfums, Inc. Common Shareholders: (Details Narrative) Sheet http://interparfumsinc.com/role/NetIncomeAttributableToInterParfumsInc.CommonShareholdersDetailsNarrative Net Income Attributable to Inter Parfums, Inc. Common Shareholders: (Details Narrative) Details http://interparfumsinc.com/role/NetIncomeAttributableToInterParfumsInc.CommonShareholdersTables 34 false false R35.htm 00000035 - Disclosure - Information on the Company???s operations by segments is as follows: (Details) Sheet http://interparfumsinc.com/role/InformationOnCompanysOperationsBySegmentsIsAsFollowsDetails Information on the Company???s operations by segments is as follows: (Details) Details 35 false false All Reports Book All Reports [ix-0514-Hidden-Fact-Eligible-For-Transform] WARN: 15 fact(s) appearing in ix:hidden were eligible for transformation: dei:DocumentPeriodEndDate, dei:EntityAddressStateOrProvince, dei:SecurityExchangeName, ipar:StockRepurchasedDuringPeriodValue1, us-gaap:LongTermDebtTerm, us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1, us-gaap:PropertyPlantAndEquipmentUsefulLife, us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1, us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1, us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2, us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1 - g083513_10q.htm 33, 34, 35, 47, 48, 49, 62, 63, 64, 65, 66, 67, 70, 71, 72 g083513_10q.htm g083513_ex31-1.htm g083513_ex31-2.htm g083513_ex32-1.htm g083513_ex32-2.htm ipar-20230331.xsd ipar-20230331_cal.xml ipar-20230331_def.xml ipar-20230331_lab.xml ipar-20230331_pre.xml http://fasb.org/us-gaap/2023 http://xbrl.sec.gov/dei/2023 true true JSON 53 MetaLinks.json IDEA: XBRL DOCUMENT { "instance": { "g083513_10q.htm": { "axisCustom": 0, "axisStandard": 12, "baseTaxonomies": { "http://fasb.org/us-gaap/2023": 452, "http://xbrl.sec.gov/dei/2023": 29 }, "contextCount": 87, "dts": { "calculationLink": { "local": [ "ipar-20230331_cal.xml" ] }, "definitionLink": { "local": [ "ipar-20230331_def.xml" ] }, "inline": { "local": [ "g083513_10q.htm" ] }, "labelLink": { "local": [ "ipar-20230331_lab.xml" ] }, "presentationLink": { "local": [ "ipar-20230331_pre.xml" ] }, "schema": { "local": [ "ipar-20230331.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-roles-2023.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-types-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-roles-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-types-2023.xsd", "https://xbrl.sec.gov/country/2023/country-2023.xsd", "https://xbrl.sec.gov/currency/2023/currency-2023.xsd", "https://xbrl.sec.gov/dei/2023/dei-2023.xsd" ] } }, "elementCount": 347, "entityCount": 1, "hidden": { "http://fasb.org/us-gaap/2023": 36, "http://interparfumsinc.com/20230331": 2, "http://xbrl.sec.gov/dei/2023": 8, "total": 46 }, "keyCustom": 5, "keyStandard": 213, "memberCustom": 7, "memberStandard": 20, "nsprefix": "ipar", "nsuri": "http://interparfumsinc.com/20230331", "report": { "R1": { "firstAnchor": { "ancestors": [ "span", "b", "span", "p", "body", "html" ], "baseRef": "g083513_10q.htm", "contextRef": "From2023-01-01to2023-03-31", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "document", "isDefault": "true", "longName": "00000001 - Document - Cover", "menuCat": "Cover", "order": "1", "role": "http://interparfumsinc.com/role/Cover", "shortName": "Cover", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "b", "span", "p", "body", "html" ], "baseRef": "g083513_10q.htm", "contextRef": "From2023-01-01to2023-03-31", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R10": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "g083513_10q.htm", "contextRef": "From2023-01-01to2023-03-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:BusinessCombinationDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000010 - Disclosure - Recent Agreements:", "menuCat": "Notes", "order": "10", "role": "http://interparfumsinc.com/role/RecentAgreements", "shortName": "Recent Agreements:", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "g083513_10q.htm", "contextRef": "From2023-01-01to2023-03-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:BusinessCombinationDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R11": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "g083513_10q.htm", "contextRef": "From2023-01-01to2023-03-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000011 - Disclosure - Recent Accounting Pronouncements:", "menuCat": "Notes", "order": "11", "role": "http://interparfumsinc.com/role/RecentAccountingPronouncements", "shortName": "Recent Accounting Pronouncements:", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "g083513_10q.htm", "contextRef": "From2023-01-01to2023-03-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R12": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "g083513_10q.htm", "contextRef": "From2023-01-01to2023-03-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:InventoryDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000012 - Disclosure - Inventories:", "menuCat": "Notes", "order": "12", "role": "http://interparfumsinc.com/role/Inventories", "shortName": "Inventories:", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "g083513_10q.htm", "contextRef": "From2023-01-01to2023-03-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:InventoryDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R13": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "g083513_10q.htm", "contextRef": "From2023-01-01to2023-03-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:FairValueDisclosuresTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000013 - Disclosure - Fair Value Measurement:", "menuCat": "Notes", "order": "13", "role": "http://interparfumsinc.com/role/FairValueMeasurement", "shortName": "Fair Value Measurement:", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "g083513_10q.htm", "contextRef": "From2023-01-01to2023-03-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:FairValueDisclosuresTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R14": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "g083513_10q.htm", "contextRef": "From2023-01-01to2023-03-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000014 - Disclosure - Derivative Financial Instruments:", "menuCat": "Notes", "order": "14", "role": "http://interparfumsinc.com/role/DerivativeFinancialInstruments", "shortName": "Derivative Financial Instruments:", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "g083513_10q.htm", "contextRef": "From2023-01-01to2023-03-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R15": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "g083513_10q.htm", "contextRef": "From2023-01-01to2023-03-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:LesseeOperatingLeasesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000015 - Disclosure - Leases:", "menuCat": "Notes", "order": "15", "role": "http://interparfumsinc.com/role/Leases", "shortName": "Leases:", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "g083513_10q.htm", "contextRef": "From2023-01-01to2023-03-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:LesseeOperatingLeasesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R16": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "g083513_10q.htm", "contextRef": "From2023-01-01to2023-03-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000016 - Disclosure - Share-Based Payments:", "menuCat": "Notes", "order": "16", "role": "http://interparfumsinc.com/role/Share-basedPayments", "shortName": "Share-Based Payments:", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "g083513_10q.htm", "contextRef": "From2023-01-01to2023-03-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R17": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "g083513_10q.htm", "contextRef": "From2023-01-01to2023-03-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:EarningsPerShareTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000017 - Disclosure - Net Income Attributable to Inter Parfums, Inc. Common Shareholders:", "menuCat": "Notes", "order": "17", "role": "http://interparfumsinc.com/role/NetIncomeAttributableToInterParfumsInc.CommonShareholders", "shortName": "Net Income Attributable to Inter Parfums, Inc. Common Shareholders:", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "g083513_10q.htm", "contextRef": "From2023-01-01to2023-03-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:EarningsPerShareTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R18": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "g083513_10q.htm", "contextRef": "From2023-01-01to2023-03-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SegmentReportingDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000018 - Disclosure - Segment and Geographic Areas:", "menuCat": "Notes", "order": "18", "role": "http://interparfumsinc.com/role/SegmentAndGeographicAreas", "shortName": "Segment and Geographic Areas:", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "g083513_10q.htm", "contextRef": "From2023-01-01to2023-03-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SegmentReportingDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R19": { "firstAnchor": { "ancestors": [ "us-gaap:InventoryDisclosureTextBlock", "body", "html" ], "baseRef": "g083513_10q.htm", "contextRef": "From2023-01-01to2023-03-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfInventoryCurrentTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000019 - Disclosure - Inventories: (Tables)", "menuCat": "Tables", "order": "19", "role": "http://interparfumsinc.com/role/InventoriesTables", "shortName": "Inventories: (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:InventoryDisclosureTextBlock", "body", "html" ], "baseRef": "g083513_10q.htm", "contextRef": "From2023-01-01to2023-03-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfInventoryCurrentTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R2": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "body", "html" ], "baseRef": "g083513_10q.htm", "contextRef": "AsOf2023-03-31", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:CashEquivalentsAtCarryingValue", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "00000002 - Statement - CONSOLIDATED BALANCE SHEETS (Unaudited)", "menuCat": "Statements", "order": "2", "role": "http://interparfumsinc.com/role/ConsolidatedBalanceSheets", "shortName": "CONSOLIDATED BALANCE SHEETS (Unaudited)", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "body", "html" ], "baseRef": "g083513_10q.htm", "contextRef": "AsOf2023-03-31", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:CashEquivalentsAtCarryingValue", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R20": { "firstAnchor": { "ancestors": [ "us-gaap:FairValueDisclosuresTextBlock", "body", "html" ], "baseRef": "g083513_10q.htm", "contextRef": "From2023-01-01to2023-03-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000020 - Disclosure - Fair Value Measurement: (Tables)", "menuCat": "Tables", "order": "20", "role": "http://interparfumsinc.com/role/FairValueMeasurementTables", "shortName": "Fair Value Measurement: (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:FairValueDisclosuresTextBlock", "body", "html" ], "baseRef": "g083513_10q.htm", "contextRef": "From2023-01-01to2023-03-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R21": { "firstAnchor": { "ancestors": [ "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "body", "html" ], "baseRef": "g083513_10q.htm", "contextRef": "From2023-01-01to2023-03-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfNonvestedShareActivityTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000021 - Disclosure - Share-Based Payments: (Tables)", "menuCat": "Tables", "order": "21", "role": "http://interparfumsinc.com/role/Share-basedPaymentsTables", "shortName": "Share-Based Payments: (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "body", "html" ], "baseRef": "g083513_10q.htm", "contextRef": "From2023-01-01to2023-03-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfNonvestedShareActivityTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R22": { "firstAnchor": { "ancestors": [ "us-gaap:EarningsPerShareTextBlock", "body", "html" ], "baseRef": "g083513_10q.htm", "contextRef": "From2023-01-01to2023-03-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000022 - Disclosure - Net Income Attributable to Inter Parfums, Inc. Common Shareholders: (Tables)", "menuCat": "Tables", "order": "22", "role": "http://interparfumsinc.com/role/NetIncomeAttributableToInterParfumsInc.CommonShareholdersTables", "shortName": "Net Income Attributable to Inter Parfums, Inc. Common Shareholders: (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:EarningsPerShareTextBlock", "body", "html" ], "baseRef": "g083513_10q.htm", "contextRef": "From2023-01-01to2023-03-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R23": { "firstAnchor": { "ancestors": [ "us-gaap:SegmentReportingDisclosureTextBlock", "body", "html" ], "baseRef": "g083513_10q.htm", "contextRef": "From2023-01-01to2023-03-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000023 - Disclosure - Segment and Geographic Areas: (Tables)", "menuCat": "Tables", "order": "23", "role": "http://interparfumsinc.com/role/SegmentAndGeographicAreasTables", "shortName": "Segment and Geographic Areas: (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:SegmentReportingDisclosureTextBlock", "body", "html" ], "baseRef": "g083513_10q.htm", "contextRef": "From2023-01-01to2023-03-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R24": { "firstAnchor": { "ancestors": [ "span", "span", "p", "us-gaap:BusinessCombinationDisclosureTextBlock", "body", "html" ], "baseRef": "g083513_10q.htm", "contextRef": "AsOf2021-04-30", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:MinorityInterestOwnershipPercentageByParent", "reportCount": 1, "unique": true, "unitRef": "Pure", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000024 - Disclosure - Recent Agreements: (Details Narrative)", "menuCat": "Details", "order": "24", "role": "http://interparfumsinc.com/role/RecentAgreementsDetailsNarrative", "shortName": "Recent Agreements: (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "p", "us-gaap:BusinessCombinationDisclosureTextBlock", "body", "html" ], "baseRef": "g083513_10q.htm", "contextRef": "AsOf2021-04-30", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:MinorityInterestOwnershipPercentageByParent", "reportCount": 1, "unique": true, "unitRef": "Pure", "xsiNil": "false" } }, "R25": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfInventoryCurrentTableTextBlock", "us-gaap:InventoryDisclosureTextBlock", "body", "html" ], "baseRef": "g083513_10q.htm", "contextRef": "AsOf2023-03-31", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:InventoryRawMaterials", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000025 - Disclosure - Inventories consist of the following: (Details)", "menuCat": "Details", "order": "25", "role": "http://interparfumsinc.com/role/InventoriesConsistOfFollowingDetails", "shortName": "Inventories consist of the following: (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfInventoryCurrentTableTextBlock", "us-gaap:InventoryDisclosureTextBlock", "body", "html" ], "baseRef": "g083513_10q.htm", "contextRef": "AsOf2023-03-31", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:InventoryRawMaterials", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R26": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock", "us-gaap:FairValueDisclosuresTextBlock", "body", "html" ], "baseRef": "g083513_10q.htm", "contextRef": "AsOf2023-03-31_us-gaap_FairValueMeasurementsRecurringMember", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:InvestmentsFairValueDisclosure", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000026 - Disclosure - The following tables present our financial assets and liabilities that are measured at fair value on a recurring basis and are categorized using the fair value hierarchy. The fair value hierarchy has three levels based on the reliability of the inputs use (Details)", "menuCat": "Details", "order": "26", "role": "http://interparfumsinc.com/role/FollowingTablesPresentOurFinancialAssetsAndLiabilitiesThatAreMeasuredAtFairValueOnRecurringBasisAndAreCategorizedUsingFairValueHierarchy.FairValueHierarchyHasThreeLevelsBasedOnReliabilityOfInputsUseDetails", "shortName": "The following tables present our financial assets and liabilities that are measured at fair value on a recurring basis and are categorized using the fair value hierarchy. The fair value hierarchy has three levels based on the reliability of the inputs use (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock", "us-gaap:FairValueDisclosuresTextBlock", "body", "html" ], "baseRef": "g083513_10q.htm", "contextRef": "AsOf2023-03-31_us-gaap_FairValueMeasurementsRecurringMember", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:InvestmentsFairValueDisclosure", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R27": { "firstAnchor": { "ancestors": [ "span", "p", "us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock", "body", "html" ], "baseRef": "g083513_10q.htm", "contextRef": "AsOf2022-12-31", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:DerivativeNotionalAmount", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000027 - Disclosure - Derivative Financial Instruments: (Details Narrative)", "menuCat": "Details", "order": "27", "role": "http://interparfumsinc.com/role/DerivativeFinancialInstrumentsDetailsNarrative", "shortName": "Derivative Financial Instruments: (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "p", "us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock", "body", "html" ], "baseRef": "g083513_10q.htm", "contextRef": "AsOf2022-12-31", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:DerivativeNotionalAmount", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R28": { "firstAnchor": { "ancestors": [ "span", "span", "p", "us-gaap:LesseeOperatingLeasesTextBlock", "body", "html" ], "baseRef": "g083513_10q.htm", "contextRef": "AsOf2023-03-31", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent", "reportCount": 1, "unique": true, "unitRef": "Pure", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000028 - Disclosure - Leases: (Details Narrative)", "menuCat": "Details", "order": "28", "role": "http://interparfumsinc.com/role/LeasesDetailsNarrative", "shortName": "Leases: (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "p", "us-gaap:LesseeOperatingLeasesTextBlock", "body", "html" ], "baseRef": "g083513_10q.htm", "contextRef": "AsOf2023-03-31", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent", "reportCount": 1, "unique": true, "unitRef": "Pure", "xsiNil": "false" } }, "R29": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfNonvestedShareActivityTableTextBlock", "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "body", "html" ], "baseRef": "g083513_10q.htm", "contextRef": "AsOf2022-12-31", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares", "reportCount": 1, "unique": true, "unitRef": "Shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000029 - Disclosure - The following table sets forth information with respect to nonvested options for the three months ended March 31, 2023: (Details)", "menuCat": "Details", "order": "29", "role": "http://interparfumsinc.com/role/FollowingTableSetsForthInformationWithRespectToNonvestedOptionsForThreeMonthsEndedMarch312023Details", "shortName": "The following table sets forth information with respect to nonvested options for the three months ended March 31, 2023: (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfNonvestedShareActivityTableTextBlock", "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "body", "html" ], "baseRef": "g083513_10q.htm", "contextRef": "AsOf2022-12-31", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares", "reportCount": 1, "unique": true, "unitRef": "Shares", "xsiNil": "false" } }, "R3": { "firstAnchor": { "ancestors": [ "span", "span", "td", "tr", "table", "body", "html" ], "baseRef": "g083513_10q.htm", "contextRef": "AsOf2023-03-31", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:PreferredStockParOrStatedValuePerShare", "reportCount": 1, "unique": true, "unitRef": "USDPShares", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "00000003 - Statement - CONSOLIDATED BALANCE SHEETS (Unaudited) (Parenthetical)", "menuCat": "Statements", "order": "3", "role": "http://interparfumsinc.com/role/ConsolidatedBalanceSheetsParenthetical", "shortName": "CONSOLIDATED BALANCE SHEETS (Unaudited) (Parenthetical)", "subGroupType": "parenthetical", "uniqueAnchor": { "ancestors": [ "span", "span", "td", "tr", "table", "body", "html" ], "baseRef": "g083513_10q.htm", "contextRef": "AsOf2023-03-31", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:PreferredStockParOrStatedValuePerShare", "reportCount": 1, "unique": true, "unitRef": "USDPShares", "xsiNil": "false" } }, "R30": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock", "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "body", "html" ], "baseRef": "g083513_10q.htm", "contextRef": "AsOf2022-12-31", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber", "reportCount": 1, "unique": true, "unitRef": "Shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000030 - Disclosure - The following table summarizes stock option information as of March 31, 2023: (Details)", "menuCat": "Details", "order": "30", "role": "http://interparfumsinc.com/role/FollowingTableSummarizesStockOptionInformationAsOfMarch312023Details", "shortName": "The following table summarizes stock option information as of March 31, 2023: (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock", "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "body", "html" ], "baseRef": "g083513_10q.htm", "contextRef": "AsOf2022-12-31", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber", "reportCount": 1, "unique": true, "unitRef": "Shares", "xsiNil": "false" } }, "R31": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "body", "html" ], "baseRef": "g083513_10q.htm", "contextRef": "From2023-01-01to2023-03-31", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:ProceedsFromStockOptionsExercised", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000031 - Disclosure - Cash proceeds, tax benefits and intrinsic value related to stock options exercised during the three months ended March 31, 2023 and 2022 were as follows: (Details)", "menuCat": "Details", "order": "31", "role": "http://interparfumsinc.com/role/CashProceedsTaxBenefitsAndIntrinsicValueRelatedToStockOptionsExercisedDuringThreeMonthsEndedMarch312023And2022WereAsFollowsDetails", "shortName": "Cash proceeds, tax benefits and intrinsic value related to stock options exercised during the three months ended March 31, 2023 and 2022 were as follows: (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:CashProceedsReceivedAndTaxBenefitFromShareBasedPaymentAwardsTableTextBlock", "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "body", "html" ], "baseRef": "g083513_10q.htm", "contextRef": "From2023-01-01to2023-03-31", "decimals": "-3", "lang": null, "name": "us-gaap:DeferredTaxExpenseFromStockOptionsExercised", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R32": { "firstAnchor": { "ancestors": [ "span", "span", "p", "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "body", "html" ], "baseRef": "g083513_10q.htm", "contextRef": "From2023-01-01to2023-03-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:AllocatedShareBasedCompensationExpense", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000032 - Disclosure - Share-Based Payments: (Details Narrative)", "menuCat": "Details", "order": "32", "role": "http://interparfumsinc.com/role/Share-basedPaymentsDetailsNarrative", "shortName": "Share-Based Payments: (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "p", "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "body", "html" ], "baseRef": "g083513_10q.htm", "contextRef": "From2023-01-01to2023-03-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:AllocatedShareBasedCompensationExpense", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R33": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "body", "html" ], "baseRef": "g083513_10q.htm", "contextRef": "From2023-01-01to2023-03-31", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:NetIncomeLoss", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000033 - Disclosure - The reconciliation between the numerators and denominators of the basic and diluted EPS computations is as follows: (Details)", "menuCat": "Details", "order": "33", "role": "http://interparfumsinc.com/role/ReconciliationBetweenNumeratorsAndDenominatorsOfBasicAndDilutedEpsComputationsIsAsFollowsDetails", "shortName": "The reconciliation between the numerators and denominators of the basic and diluted EPS computations is as follows: (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "us-gaap:EarningsPerShareTextBlock", "body", "html" ], "baseRef": "g083513_10q.htm", "contextRef": "From2023-01-01to2023-03-31", "decimals": "INF", "lang": null, "name": "us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment", "reportCount": 1, "unique": true, "unitRef": "Shares", "xsiNil": "false" } }, "R34": { "firstAnchor": { "ancestors": [ "span", "span", "span", "p", "us-gaap:EarningsPerShareTextBlock", "body", "html" ], "baseRef": "g083513_10q.htm", "contextRef": "From2023-01-01to2023-03-31", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount", "reportCount": 1, "unique": true, "unitRef": "Shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000034 - Disclosure - Net Income Attributable to Inter Parfums, Inc. Common Shareholders: (Details Narrative)", "menuCat": "Details", "order": "34", "role": "http://interparfumsinc.com/role/NetIncomeAttributableToInterParfumsInc.CommonShareholdersDetailsNarrative", "shortName": "Net Income Attributable to Inter Parfums, Inc. Common Shareholders: (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "span", "p", "us-gaap:EarningsPerShareTextBlock", "body", "html" ], "baseRef": "g083513_10q.htm", "contextRef": "From2023-01-01to2023-03-31", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount", "reportCount": 1, "unique": true, "unitRef": "Shares", "xsiNil": "false" } }, "R35": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "body", "html" ], "baseRef": "g083513_10q.htm", "contextRef": "From2023-01-01to2023-03-31", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000035 - Disclosure - Information on the Company\u2019s operations by segments is as follows: (Details)", "menuCat": "Details", "order": "35", "role": "http://interparfumsinc.com/role/InformationOnCompanysOperationsBySegmentsIsAsFollowsDetails", "shortName": "Information on the Company\u2019s operations by segments is as follows: (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock", "us-gaap:SegmentReportingDisclosureTextBlock", "body", "html" ], "baseRef": "g083513_10q.htm", "contextRef": "From2023-01-012023-03-31_country_US", "decimals": "-3", "lang": null, "name": "us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R4": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "body", "html" ], "baseRef": "g083513_10q.htm", "contextRef": "From2023-01-01to2023-03-31", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "00000004 - Statement - CONSOLIDATED STATEMENTS OF INCOME (Unaudited)", "menuCat": "Statements", "order": "4", "role": "http://interparfumsinc.com/role/ConsolidatedStatementsOfIncome", "shortName": "CONSOLIDATED STATEMENTS OF INCOME (Unaudited)", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "body", "html" ], "baseRef": "g083513_10q.htm", "contextRef": "From2023-01-01to2023-03-31", "decimals": "-3", "lang": null, "name": "us-gaap:CostOfGoodsAndServicesSold", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R5": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "body", "html" ], "baseRef": "g083513_10q.htm", "contextRef": "From2023-01-01to2023-03-31", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:ProfitLoss", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "00000005 - Statement - CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (Unaudited)", "menuCat": "Statements", "order": "5", "role": "http://interparfumsinc.com/role/ConsolidatedStatementsOfComprehensiveIncome", "shortName": "CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (Unaudited)", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "body", "html" ], "baseRef": "g083513_10q.htm", "contextRef": "From2023-01-01to2023-03-31", "decimals": "-3", "lang": null, "name": "us-gaap:ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R6": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "body", "html" ], "baseRef": "g083513_10q.htm", "contextRef": "AsOf2021-12-31_us-gaap_CommonStockMember", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "00000006 - Statement - CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY (Unaudited)", "menuCat": "Statements", "order": "6", "role": "http://interparfumsinc.com/role/ConsolidatedStatementsOfChangesInEquity", "shortName": "CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY (Unaudited)", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "body", "html" ], "baseRef": "g083513_10q.htm", "contextRef": "AsOf2021-12-31_us-gaap_CommonStockMember", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R7": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "body", "html" ], "baseRef": "g083513_10q.htm", "contextRef": "From2023-01-01to2023-03-31", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:ProfitLoss", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "00000007 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited)", "menuCat": "Statements", "order": "7", "role": "http://interparfumsinc.com/role/ConsolidatedStatementsOfCashFlows", "shortName": "CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited)", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "body", "html" ], "baseRef": "g083513_10q.htm", "contextRef": "From2023-01-01to2023-03-31", "decimals": "-3", "lang": null, "name": "us-gaap:OtherDepreciationAndAmortization", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R8": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "g083513_10q.htm", "contextRef": "From2023-01-01to2023-03-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SignificantAccountingPoliciesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000008 - Disclosure - Significant Accounting Policies:", "menuCat": "Notes", "order": "8", "role": "http://interparfumsinc.com/role/SignificantAccountingPolicies", "shortName": "Significant Accounting Policies:", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "g083513_10q.htm", "contextRef": "From2023-01-01to2023-03-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SignificantAccountingPoliciesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R9": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "g083513_10q.htm", "contextRef": "From2023-01-01to2023-03-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:UnusualOrInfrequentItemsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000009 - Disclosure - Impact of COVID-19 Pandemic:", "menuCat": "Notes", "order": "9", "role": "http://interparfumsinc.com/role/ImpactOfCovid-19Pandemic", "shortName": "Impact of COVID-19 Pandemic:", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "g083513_10q.htm", "contextRef": "From2023-01-01to2023-03-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:UnusualOrInfrequentItemsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } } }, "segmentCount": 27, "tag": { "country_US": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "UNITED STATES" } } }, "localname": "US", "nsuri": "http://xbrl.sec.gov/country/2023", "presentation": [ "http://interparfumsinc.com/role/InformationOnCompanysOperationsBySegmentsIsAsFollowsDetails" ], "xbrltype": "domainItemType" }, "currency_AllCurrenciesDomain": { "auth_ref": [], "localname": "AllCurrenciesDomain", "nsuri": "http://xbrl.sec.gov/currency/2023", "presentation": [ "http://interparfumsinc.com/role/DerivativeFinancialInstrumentsDetailsNarrative", "http://interparfumsinc.com/role/RecentAgreementsDetailsNarrative" ], "xbrltype": "domainItemType" }, "currency_EUR": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Euro Member Countries, Euro" } } }, "localname": "EUR", "nsuri": "http://xbrl.sec.gov/currency/2023", "presentation": [ "http://interparfumsinc.com/role/DerivativeFinancialInstrumentsDetailsNarrative", "http://interparfumsinc.com/role/RecentAgreementsDetailsNarrative" ], "xbrltype": "domainItemType" }, "dei_AmendmentDescription": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Description of changes contained within amended document.", "label": "Amendment Description" } } }, "localname": "AmendmentDescription", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://interparfumsinc.com/role/Cover" ], "xbrltype": "stringItemType" }, "dei_AmendmentFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.", "label": "Amendment Flag" } } }, "localname": "AmendmentFlag", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://interparfumsinc.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_AnnualInformationForm": { "auth_ref": [ "r575" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form.", "label": "Annual Information Form" } } }, "localname": "AnnualInformationForm", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://interparfumsinc.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_AuditedAnnualFinancialStatements": { "auth_ref": [ "r575" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements.", "label": "Audited Annual Financial Statements" } } }, "localname": "AuditedAnnualFinancialStatements", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://interparfumsinc.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_CityAreaCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Area code of city", "label": "City Area Code" } } }, "localname": "CityAreaCode", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://interparfumsinc.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_CountryRegion": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Region code of country", "label": "Country Region" } } }, "localname": "CountryRegion", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://interparfumsinc.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_CoverAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Cover page.", "label": "Cover [Abstract]" } } }, "localname": "CoverAbstract", "nsuri": "http://xbrl.sec.gov/dei/2023", "xbrltype": "stringItemType" }, "dei_CurrentFiscalYearEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "End date of current fiscal year in the format --MM-DD.", "label": "Current Fiscal Year End Date" } } }, "localname": "CurrentFiscalYearEndDate", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://interparfumsinc.com/role/Cover" ], "xbrltype": "gMonthDayItemType" }, "dei_DocumentAccountingStandard": { "auth_ref": [ "r574" ], "lang": { "en-us": { "role": { "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'.", "label": "Document Accounting Standard" } } }, "localname": "DocumentAccountingStandard", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://interparfumsinc.com/role/Cover" ], "xbrltype": "accountingStandardItemType" }, "dei_DocumentAnnualReport": { "auth_ref": [ "r572", "r574", "r575" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as an annual report.", "label": "Document Annual Report" } } }, "localname": "DocumentAnnualReport", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://interparfumsinc.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentFiscalPeriodFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.", "label": "Document Fiscal Period Focus" } } }, "localname": "DocumentFiscalPeriodFocus", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://interparfumsinc.com/role/Cover" ], "xbrltype": "fiscalPeriodItemType" }, "dei_DocumentFiscalYearFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.", "label": "Document Fiscal Year Focus" } } }, "localname": "DocumentFiscalYearFocus", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://interparfumsinc.com/role/Cover" ], "xbrltype": "gYearItemType" }, "dei_DocumentPeriodEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.", "label": "Document Period End Date" } } }, "localname": "DocumentPeriodEndDate", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://interparfumsinc.com/role/Cover" ], "xbrltype": "dateItemType" }, "dei_DocumentPeriodStartDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format.", "label": "Document Period Start Date" } } }, "localname": "DocumentPeriodStartDate", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://interparfumsinc.com/role/Cover" ], "xbrltype": "dateItemType" }, "dei_DocumentQuarterlyReport": { "auth_ref": [ "r573" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as an quarterly report.", "label": "Document Quarterly Report" } } }, "localname": "DocumentQuarterlyReport", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://interparfumsinc.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentRegistrationStatement": { "auth_ref": [ "r561" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as a registration statement.", "label": "Document Registration Statement" } } }, "localname": "DocumentRegistrationStatement", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://interparfumsinc.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentShellCompanyEventDate": { "auth_ref": [ "r574" ], "lang": { "en-us": { "role": { "documentation": "Date of event requiring a shell company report.", "label": "Document Shell Company Event Date" } } }, "localname": "DocumentShellCompanyEventDate", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://interparfumsinc.com/role/Cover" ], "xbrltype": "dateItemType" }, "dei_DocumentShellCompanyReport": { "auth_ref": [ "r574" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act.", "label": "Document Shell Company Report" } } }, "localname": "DocumentShellCompanyReport", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://interparfumsinc.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentTransitionReport": { "auth_ref": [ "r576" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as a transition report.", "label": "Document Transition Report" } } }, "localname": "DocumentTransitionReport", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://interparfumsinc.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentType": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.", "label": "Document Type" } } }, "localname": "DocumentType", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://interparfumsinc.com/role/Cover" ], "xbrltype": "submissionTypeItemType" }, "dei_DocumentsIncorporatedByReferenceTextBlock": { "auth_ref": [ "r564" ], "lang": { "en-us": { "role": { "documentation": "Documents incorporated by reference.", "label": "Documents Incorporated by Reference [Text Block]" } } }, "localname": "DocumentsIncorporatedByReferenceTextBlock", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://interparfumsinc.com/role/Cover" ], "xbrltype": "textBlockItemType" }, "dei_EntityAddressAddressLine1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 1 such as Attn, Building Name, Street Name", "label": "Entity Address, Address Line One" } } }, "localname": "EntityAddressAddressLine1", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://interparfumsinc.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressAddressLine2": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 2 such as Street or Suite number", "label": "Entity Address, Address Line Two" } } }, "localname": "EntityAddressAddressLine2", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://interparfumsinc.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressAddressLine3": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 3 such as an Office Park", "label": "Entity Address, Address Line Three" } } }, "localname": "EntityAddressAddressLine3", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://interparfumsinc.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCityOrTown": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the City or Town", "label": "Entity Address, City or Town" } } }, "localname": "EntityAddressCityOrTown", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://interparfumsinc.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCountry": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "ISO 3166-1 alpha-2 country code.", "label": "Entity Address, Country" } } }, "localname": "EntityAddressCountry", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://interparfumsinc.com/role/Cover" ], "xbrltype": "countryCodeItemType" }, "dei_EntityAddressPostalZipCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Code for the postal or zip code", "label": "Entity Address, Postal Zip Code" } } }, "localname": "EntityAddressPostalZipCode", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://interparfumsinc.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressStateOrProvince": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the state or province.", "label": "Entity Address, State or Province" } } }, "localname": "EntityAddressStateOrProvince", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://interparfumsinc.com/role/Cover" ], "xbrltype": "stateOrProvinceItemType" }, "dei_EntityBankruptcyProceedingsReportingCurrent": { "auth_ref": [ "r567" ], "lang": { "en-us": { "role": { "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not. Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element.", "label": "Entity Bankruptcy Proceedings, Reporting Current" } } }, "localname": "EntityBankruptcyProceedingsReportingCurrent", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://interparfumsinc.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityCentralIndexKey": { "auth_ref": [ "r563" ], "lang": { "en-us": { "role": { "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.", "label": "Entity Central Index Key" } } }, "localname": "EntityCentralIndexKey", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://interparfumsinc.com/role/Cover" ], "xbrltype": "centralIndexKeyItemType" }, "dei_EntityCommonStockSharesOutstanding": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.", "label": "Entity Common Stock, Shares Outstanding" } } }, "localname": "EntityCommonStockSharesOutstanding", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://interparfumsinc.com/role/Cover" ], "xbrltype": "sharesItemType" }, "dei_EntityCurrentReportingStatus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Current Reporting Status" } } }, "localname": "EntityCurrentReportingStatus", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://interparfumsinc.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_EntityDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "All the names of the entities being reported upon in a document. Any legal structure used to conduct activities or to hold assets. Some examples of such structures are corporations, partnerships, limited liability companies, grantor trusts, and other trusts. This item does not include business and geographical segments which are included in the geographical or business segments domains." } } }, "localname": "EntityDomain", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://interparfumsinc.com/role/RecentAgreementsDetailsNarrative" ], "xbrltype": "domainItemType" }, "dei_EntityEmergingGrowthCompany": { "auth_ref": [ "r563" ], "lang": { "en-us": { "role": { "documentation": "Indicate if registrant meets the emerging growth company criteria.", "label": "Entity Emerging Growth Company" } } }, "localname": "EntityEmergingGrowthCompany", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://interparfumsinc.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityExTransitionPeriod": { "auth_ref": [ "r580" ], "lang": { "en-us": { "role": { "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.", "label": "Elected Not To Use the Extended Transition Period" } } }, "localname": "EntityExTransitionPeriod", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://interparfumsinc.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityFileNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.", "label": "Entity File Number" } } }, "localname": "EntityFileNumber", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://interparfumsinc.com/role/Cover" ], "xbrltype": "fileNumberItemType" }, "dei_EntityFilerCategory": { "auth_ref": [ "r563" ], "lang": { "en-us": { "role": { "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Filer Category" } } }, "localname": "EntityFilerCategory", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://interparfumsinc.com/role/Cover" ], "xbrltype": "filerCategoryItemType" }, "dei_EntityIncorporationStateCountryCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Two-character EDGAR code representing the state or country of incorporation.", "label": "Entity Incorporation, State or Country Code" } } }, "localname": "EntityIncorporationStateCountryCode", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://interparfumsinc.com/role/Cover" ], "xbrltype": "edgarStateCountryItemType" }, "dei_EntityInteractiveDataCurrent": { "auth_ref": [ "r577" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).", "label": "Entity Interactive Data Current" } } }, "localname": "EntityInteractiveDataCurrent", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://interparfumsinc.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_EntityPrimarySicNumber": { "auth_ref": [ "r575" ], "lang": { "en-us": { "role": { "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity.", "label": "Entity Primary SIC Number" } } }, "localname": "EntityPrimarySicNumber", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://interparfumsinc.com/role/Cover" ], "xbrltype": "sicNumberItemType" }, "dei_EntityPublicFloat": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.", "label": "Entity Public Float" } } }, "localname": "EntityPublicFloat", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://interparfumsinc.com/role/Cover" ], "xbrltype": "monetaryItemType" }, "dei_EntityRegistrantName": { "auth_ref": [ "r563" ], "lang": { "en-us": { "role": { "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.", "label": "Entity Registrant Name" } } }, "localname": "EntityRegistrantName", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://interparfumsinc.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityShellCompany": { "auth_ref": [ "r563" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.", "label": "Entity Shell Company" } } }, "localname": "EntityShellCompany", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://interparfumsinc.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntitySmallBusiness": { "auth_ref": [ "r563" ], "lang": { "en-us": { "role": { "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).", "label": "Entity Small Business" } } }, "localname": "EntitySmallBusiness", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://interparfumsinc.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityTaxIdentificationNumber": { "auth_ref": [ "r563" ], "lang": { "en-us": { "role": { "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.", "label": "Entity Tax Identification Number" } } }, "localname": "EntityTaxIdentificationNumber", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://interparfumsinc.com/role/Cover" ], "xbrltype": "employerIdItemType" }, "dei_EntityVoluntaryFilers": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.", "label": "Entity Voluntary Filers" } } }, "localname": "EntityVoluntaryFilers", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://interparfumsinc.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_EntityWellKnownSeasonedIssuer": { "auth_ref": [ "r578" ], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.", "label": "Entity Well-known Seasoned Issuer" } } }, "localname": "EntityWellKnownSeasonedIssuer", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://interparfumsinc.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_Extension": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Extension number for local phone number.", "label": "Extension" } } }, "localname": "Extension", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://interparfumsinc.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_LegalEntityAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The set of legal entities associated with a report.", "label": "Legal Entity [Axis]" } } }, "localname": "LegalEntityAxis", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://interparfumsinc.com/role/RecentAgreementsDetailsNarrative" ], "xbrltype": "stringItemType" }, "dei_LocalPhoneNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Local phone number for entity.", "label": "Local Phone Number" } } }, "localname": "LocalPhoneNumber", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://interparfumsinc.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_NoTradingSymbolFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a security having no trading symbol.", "label": "No Trading Symbol Flag" } } }, "localname": "NoTradingSymbolFlag", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://interparfumsinc.com/role/Cover" ], "xbrltype": "trueItemType" }, "dei_OtherReportingStandardItemNumber": { "auth_ref": [ "r574" ], "lang": { "en-us": { "role": { "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS.", "label": "Other Reporting Standard Item Number" } } }, "localname": "OtherReportingStandardItemNumber", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://interparfumsinc.com/role/Cover" ], "xbrltype": "otherReportingStandardItemNumberItemType" }, "dei_PreCommencementIssuerTenderOffer": { "auth_ref": [ "r568" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.", "label": "Pre-commencement Issuer Tender Offer" } } }, "localname": "PreCommencementIssuerTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://interparfumsinc.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_PreCommencementTenderOffer": { "auth_ref": [ "r569" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.", "label": "Pre-commencement Tender Offer" } } }, "localname": "PreCommencementTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://interparfumsinc.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_Security12bTitle": { "auth_ref": [ "r562" ], "lang": { "en-us": { "role": { "documentation": "Title of a 12(b) registered security.", "label": "Title of 12(b) Security" } } }, "localname": "Security12bTitle", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://interparfumsinc.com/role/Cover" ], "xbrltype": "securityTitleItemType" }, "dei_Security12gTitle": { "auth_ref": [ "r566" ], "lang": { "en-us": { "role": { "documentation": "Title of a 12(g) registered security.", "label": "Title of 12(g) Security" } } }, "localname": "Security12gTitle", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://interparfumsinc.com/role/Cover" ], "xbrltype": "securityTitleItemType" }, "dei_SecurityExchangeName": { "auth_ref": [ "r565" ], "lang": { "en-us": { "role": { "documentation": "Name of the Exchange on which a security is registered.", "label": "Security Exchange Name" } } }, "localname": "SecurityExchangeName", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://interparfumsinc.com/role/Cover" ], "xbrltype": "edgarExchangeCodeItemType" }, "dei_SecurityReportingObligation": { "auth_ref": [ "r570" ], "lang": { "en-us": { "role": { "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act.", "label": "Security Reporting Obligation" } } }, "localname": "SecurityReportingObligation", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://interparfumsinc.com/role/Cover" ], "xbrltype": "securityReportingObligationItemType" }, "dei_SolicitingMaterial": { "auth_ref": [ "r571" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.", "label": "Soliciting Material" } } }, "localname": "SolicitingMaterial", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://interparfumsinc.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_TradingSymbol": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Trading symbol of an instrument as listed on an exchange.", "label": "Trading Symbol" } } }, "localname": "TradingSymbol", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://interparfumsinc.com/role/Cover" ], "xbrltype": "tradingSymbolItemType" }, "dei_WrittenCommunications": { "auth_ref": [ "r579" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.", "label": "Written Communications" } } }, "localname": "WrittenCommunications", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://interparfumsinc.com/role/Cover" ], "xbrltype": "booleanItemType" }, "ipar_ChangeInFairValueOfDerivatives": { "auth_ref": [], "calculation": { "http://interparfumsinc.com/role/ConsolidatedStatementsOfCashFlows": { "order": 8.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The element represents change in fair value of derivatives.", "label": "Change in Fair Value of Derivatives", "negatedLabel": "Change in fair value of derivatives" } } }, "localname": "ChangeInFairValueOfDerivatives", "nsuri": "http://interparfumsinc.com/20230331", "presentation": [ "http://interparfumsinc.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "ipar_DonnaKaranAndDKNYMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The element represents donna karan and dkny member.", "label": "Donna Karan and DKNY [Member]" } } }, "localname": "DonnaKaranAndDKNYMember", "nsuri": "http://interparfumsinc.com/20230331", "presentation": [ "http://interparfumsinc.com/role/RecentAgreementsDetailsNarrative" ], "xbrltype": "domainItemType" }, "ipar_EliminationsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The element represents eliminations member.", "label": "Eliminations [Member]" } } }, "localname": "EliminationsMember", "nsuri": "http://interparfumsinc.com/20230331", "presentation": [ "http://interparfumsinc.com/role/InformationOnCompanysOperationsBySegmentsIsAsFollowsDetails" ], "xbrltype": "domainItemType" }, "ipar_EmployeesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The element represents employees member.", "label": "Employees [Member]" } } }, "localname": "EmployeesMember", "nsuri": "http://interparfumsinc.com/20230331", "presentation": [ "http://interparfumsinc.com/role/Share-basedPaymentsDetailsNarrative" ], "xbrltype": "domainItemType" }, "ipar_InterparfumsSASubsidiaryMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The element represents interparfums sa subsidiary member.", "label": "Interparfums SA Subsidiary [Member]" } } }, "localname": "InterparfumsSASubsidiaryMember", "nsuri": "http://interparfumsinc.com/20230331", "presentation": [ "http://interparfumsinc.com/role/Share-basedPaymentsDetailsNarrative" ], "xbrltype": "domainItemType" }, "ipar_InvestmentIncomeInterestAndDividend1": { "auth_ref": [], "calculation": { "http://interparfumsinc.com/role/ConsolidatedStatementsOfIncome": { "order": 3.0, "parentTag": "us-gaap_NonoperatingIncomeExpense", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The element represents investment income interest and dividend.", "label": "Investment Income Interest and Dividend", "negatedLabel": "Interest and investment (income) loss" } } }, "localname": "InvestmentIncomeInterestAndDividend1", "nsuri": "http://interparfumsinc.com/20230331", "presentation": [ "http://interparfumsinc.com/role/ConsolidatedStatementsOfIncome" ], "xbrltype": "monetaryItemType" }, "ipar_LacosteMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The element represents Lacoste member.", "label": "Lacoste [Member]" } } }, "localname": "LacosteMember", "nsuri": "http://interparfumsinc.com/20230331", "presentation": [ "http://interparfumsinc.com/role/RecentAgreementsDetailsNarrative" ], "xbrltype": "domainItemType" }, "ipar_OfficersAndManagersMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The element represents officers and managers member.", "label": "Officers and Managers [Member]" } } }, "localname": "OfficersAndManagersMember", "nsuri": "http://interparfumsinc.com/20230331", "presentation": [ "http://interparfumsinc.com/role/Share-basedPaymentsDetailsNarrative" ], "xbrltype": "domainItemType" }, "ipar_ProvisionForDoubtfulAccounts1": { "auth_ref": [], "calculation": { "http://interparfumsinc.com/role/ConsolidatedStatementsOfCashFlows": { "order": 3.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The element represents provision for doubtful accounts.", "label": "Provision for doubtful accounts" } } }, "localname": "ProvisionForDoubtfulAccounts1", "nsuri": "http://interparfumsinc.com/20230331", "presentation": [ "http://interparfumsinc.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "ipar_RochasFashionMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The element represents rochas fashion member.", "label": "Rochas Fashion [Member]" } } }, "localname": "RochasFashionMember", "nsuri": "http://interparfumsinc.com/20230331", "presentation": [ "http://interparfumsinc.com/role/RecentAgreementsDetailsNarrative" ], "xbrltype": "domainItemType" }, "ipar_StockRepurchasedDuringPeriodValue1": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The element represents stock repurchased during period value.", "label": "Shares repurchase value" } } }, "localname": "StockRepurchasedDuringPeriodValue1", "nsuri": "http://interparfumsinc.com/20230331", "presentation": [ "http://interparfumsinc.com/role/Share-basedPaymentsDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "ipar_SupplementalDisclosureOfCashFlowInformationAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Supplemental disclosure of cash flow information:" } } }, "localname": "SupplementalDisclosureOfCashFlowInformationAbstract", "nsuri": "http://interparfumsinc.com/20230331", "presentation": [ "http://interparfumsinc.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "ipar_TransferOfSubsidiarySharesPurchasedToTreasuryShares": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Transfer of subsidiary shares purchased to treasury shares.", "label": "Transfer of subsidiary shares purchased" } } }, "localname": "TransferOfSubsidiarySharesPurchasedToTreasuryShares", "nsuri": "http://interparfumsinc.com/20230331", "presentation": [ "http://interparfumsinc.com/role/ConsolidatedStatementsOfChangesInEquity" ], "xbrltype": "monetaryItemType" }, "srt_ConsolidatedEntitiesAxis": { "auth_ref": [ "r171", "r310", "r311", "r314", "r315", "r376", "r520", "r600", "r603", "r604" ], "lang": { "en-us": { "role": { "label": "Consolidated Entities [Axis]" } } }, "localname": "ConsolidatedEntitiesAxis", "nsuri": "http://fasb.org/srt/2023", "presentation": [ "http://interparfumsinc.com/role/Share-basedPaymentsDetailsNarrative" ], "xbrltype": "stringItemType" }, "srt_ConsolidatedEntitiesDomain": { "auth_ref": [ "r171", "r310", "r311", "r314", "r315", "r376", "r520", "r600", "r603", "r604" ], "localname": "ConsolidatedEntitiesDomain", "nsuri": "http://fasb.org/srt/2023", "presentation": [ "http://interparfumsinc.com/role/Share-basedPaymentsDetailsNarrative" ], "xbrltype": "domainItemType" }, "srt_CurrencyAxis": { "auth_ref": [ "r617" ], "lang": { "en-us": { "role": { "label": "Currency [Axis]" } } }, "localname": "CurrencyAxis", "nsuri": "http://fasb.org/srt/2023", "presentation": [ "http://interparfumsinc.com/role/DerivativeFinancialInstrumentsDetailsNarrative", "http://interparfumsinc.com/role/RecentAgreementsDetailsNarrative" ], "xbrltype": "stringItemType" }, "srt_EuropeMember": { "auth_ref": [ "r637", "r638", "r639", "r640" ], "lang": { "en-us": { "role": { "label": "Europe [Member]" } } }, "localname": "EuropeMember", "nsuri": "http://fasb.org/srt/2023", "presentation": [ "http://interparfumsinc.com/role/InformationOnCompanysOperationsBySegmentsIsAsFollowsDetails" ], "xbrltype": "domainItemType" }, "srt_MaximumMember": { "auth_ref": [ "r240", "r241", "r242", "r243", "r278", "r381", "r410", "r436", "r437", "r489", "r491", "r493", "r494", "r503", "r521", "r522", "r529", "r532", "r539", "r547", "r605", "r622", "r623", "r624", "r625", "r626", "r627" ], "lang": { "en-us": { "role": { "label": "Maximum [Member]" } } }, "localname": "MaximumMember", "nsuri": "http://fasb.org/srt/2023", "presentation": [ "http://interparfumsinc.com/role/RecentAgreementsDetailsNarrative", "http://interparfumsinc.com/role/Share-basedPaymentsDetailsNarrative" ], "xbrltype": "domainItemType" }, "srt_MinimumMember": { "auth_ref": [ "r240", "r241", "r242", "r243", "r278", "r381", "r410", "r436", "r437", "r489", "r491", "r493", "r494", "r503", "r521", "r522", "r529", "r532", "r539", "r547", "r605", "r622", "r623", "r624", "r625", "r626", "r627" ], "lang": { "en-us": { "role": { "label": "Minimum [Member]" } } }, "localname": "MinimumMember", "nsuri": "http://fasb.org/srt/2023", "presentation": [ "http://interparfumsinc.com/role/RecentAgreementsDetailsNarrative", "http://interparfumsinc.com/role/Share-basedPaymentsDetailsNarrative" ], "xbrltype": "domainItemType" }, "srt_RangeAxis": { "auth_ref": [ "r240", "r241", "r242", "r243", "r271", "r278", "r287", "r288", "r289", "r380", "r381", "r410", "r436", "r437", "r489", "r491", "r493", "r494", "r503", "r521", "r522", "r529", "r532", "r539", "r547", "r550", "r599", "r605", "r623", "r624", "r625", "r626", "r627" ], "lang": { "en-us": { "role": { "label": "Statistical Measurement [Axis]" } } }, "localname": "RangeAxis", "nsuri": "http://fasb.org/srt/2023", "presentation": [ "http://interparfumsinc.com/role/RecentAgreementsDetailsNarrative", "http://interparfumsinc.com/role/Share-basedPaymentsDetailsNarrative" ], "xbrltype": "stringItemType" }, "srt_RangeMember": { "auth_ref": [ "r240", "r241", "r242", "r243", "r271", "r278", "r287", "r288", "r289", "r380", "r381", "r410", "r436", "r437", "r489", "r491", "r493", "r494", "r503", "r521", "r522", "r529", "r532", "r539", "r547", "r550", "r599", "r605", "r623", "r624", "r625", "r626", "r627" ], "localname": "RangeMember", "nsuri": "http://fasb.org/srt/2023", "presentation": [ "http://interparfumsinc.com/role/RecentAgreementsDetailsNarrative", "http://interparfumsinc.com/role/Share-basedPaymentsDetailsNarrative" ], "xbrltype": "domainItemType" }, "srt_SegmentGeographicalDomain": { "auth_ref": [ "r228", "r229", "r429", "r432", "r434", "r490", "r492", "r495", "r504", "r511", "r512", "r513", "r514", "r515", "r516", "r517", "r518", "r519", "r524", "r533", "r550", "r606", "r630" ], "localname": "SegmentGeographicalDomain", "nsuri": "http://fasb.org/srt/2023", "presentation": [ "http://interparfumsinc.com/role/InformationOnCompanysOperationsBySegmentsIsAsFollowsDetails" ], "xbrltype": "domainItemType" }, "srt_StatementGeographicalAxis": { "auth_ref": [ "r228", "r229", "r429", "r432", "r434", "r490", "r492", "r495", "r504", "r509", "r511", "r512", "r513", "r514", "r515", "r516", "r517", "r518", "r519", "r524", "r533", "r550", "r606", "r630" ], "lang": { "en-us": { "role": { "label": "Geographical [Axis]" } } }, "localname": "StatementGeographicalAxis", "nsuri": "http://fasb.org/srt/2023", "presentation": [ "http://interparfumsinc.com/role/InformationOnCompanysOperationsBySegmentsIsAsFollowsDetails" ], "xbrltype": "stringItemType" }, "srt_TitleOfIndividualAxis": { "auth_ref": [ "r597", "r619" ], "lang": { "en-us": { "role": { "label": "Title of Individual [Axis]" } } }, "localname": "TitleOfIndividualAxis", "nsuri": "http://fasb.org/srt/2023", "presentation": [ "http://interparfumsinc.com/role/Share-basedPaymentsDetailsNarrative" ], "xbrltype": "stringItemType" }, "srt_TitleOfIndividualWithRelationshipToEntityDomain": { "auth_ref": [], "localname": "TitleOfIndividualWithRelationshipToEntityDomain", "nsuri": "http://fasb.org/srt/2023", "presentation": [ "http://interparfumsinc.com/role/Share-basedPaymentsDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_AccountingChangesAndErrorCorrectionsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Accounting Changes and Error Corrections [Abstract]" } } }, "localname": "AccountingChangesAndErrorCorrectionsAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "xbrltype": "stringItemType" }, "us-gaap_AccountingPoliciesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Accounting Policies [Abstract]" } } }, "localname": "AccountingPoliciesAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "xbrltype": "stringItemType" }, "us-gaap_AccountsPayableCurrent": { "auth_ref": [ "r23", "r546" ], "calculation": { "http://interparfumsinc.com/role/ConsolidatedBalanceSheets": { "order": 4.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Accounts payable \u2013 trade" } } }, "localname": "AccountsPayableCurrent", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://interparfumsinc.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccountsReceivableNetCurrent": { "auth_ref": [ "r231", "r232" ], "calculation": { "http://interparfumsinc.com/role/ConsolidatedBalanceSheets": { "order": 3.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.", "label": "Accounts receivable, net" } } }, "localname": "AccountsReceivableNetCurrent", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://interparfumsinc.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccruedLiabilitiesCurrent": { "auth_ref": [ "r24" ], "calculation": { "http://interparfumsinc.com/role/ConsolidatedBalanceSheets": { "order": 5.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Accrued expenses" } } }, "localname": "AccruedLiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://interparfumsinc.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax": { "auth_ref": [ "r30", "r31", "r86", "r142", "r395", "r415", "r418" ], "calculation": { "http://interparfumsinc.com/role/ConsolidatedBalanceSheets": { "order": 5.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, after tax, of accumulated increase (decrease) in equity from transaction and other event and circumstance from nonowner source.", "label": "Accumulated other comprehensive loss" } } }, "localname": "AccumulatedOtherComprehensiveIncomeLossNetOfTax", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://interparfumsinc.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccumulatedOtherComprehensiveIncomeMember": { "auth_ref": [ "r1", "r13", "r31", "r319", "r322", "r374", "r411", "r412", "r587", "r588", "r589", "r593", "r594", "r595" ], "lang": { "en-us": { "role": { "documentation": "Accumulated increase (decrease) in equity from transactions and other events and circumstances from non-owner sources, attributable to the parent. Excludes net income (loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners.", "label": "AOCI Attributable to Parent [Member]" } } }, "localname": "AccumulatedOtherComprehensiveIncomeMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://interparfumsinc.com/role/ConsolidatedStatementsOfChangesInEquity" ], "xbrltype": "domainItemType" }, "us-gaap_AcquisitionCosts": { "auth_ref": [ "r113", "r114" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The capitalized costs incurred during the period (excluded from amortization) to purchase, lease or otherwise acquire an unproved property, including costs of lease bonuses and options to purchase or lease properties, the portion of costs applicable to minerals when land including mineral rights is purchased in fee, brokers' fees, recording fees, legal costs, and other costs incurred in acquiring properties.", "label": "Acquisition costs, period cost" } } }, "localname": "AcquisitionCosts", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://interparfumsinc.com/role/RecentAgreementsDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_AdditionalPaidInCapital": { "auth_ref": [ "r78", "r546", "r633" ], "calculation": { "http://interparfumsinc.com/role/ConsolidatedBalanceSheets": { "order": 3.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock.", "label": "Additional paid-in capital" } } }, "localname": "AdditionalPaidInCapital", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://interparfumsinc.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AdditionalPaidInCapitalMember": { "auth_ref": [ "r292", "r293", "r294", "r425", "r593", "r594", "r595", "r614", "r635" ], "lang": { "en-us": { "role": { "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders.", "label": "Additional Paid-in Capital [Member]" } } }, "localname": "AdditionalPaidInCapitalMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://interparfumsinc.com/role/ConsolidatedStatementsOfChangesInEquity" ], "xbrltype": "domainItemType" }, "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Adjustments to reconcile net income to net cash provided by (used in) operating activities:" } } }, "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://interparfumsinc.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_AllocatedShareBasedCompensationExpense": { "auth_ref": [ "r290", "r295" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.", "label": "Share-based payment arrangement, expense" } } }, "localname": "AllocatedShareBasedCompensationExpense", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://interparfumsinc.com/role/Share-basedPaymentsDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount": { "auth_ref": [ "r199" ], "lang": { "en-us": { "role": { "documentation": "Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.", "label": "Antidilutive securities excluded from computation of earnings per share, amount" } } }, "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://interparfumsinc.com/role/NetIncomeAttributableToInterParfumsInc.CommonShareholdersDetailsNarrative" ], "xbrltype": "sharesItemType" }, "us-gaap_Assets": { "auth_ref": [ "r115", "r139", "r170", "r208", "r217", "r222", "r234", "r244", "r245", "r246", "r247", "r248", "r249", "r250", "r251", "r252", "r310", "r314", "r342", "r392", "r457", "r546", "r560", "r601", "r602", "r620" ], "calculation": { "http://interparfumsinc.com/role/ConsolidatedBalanceSheets": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.", "label": "Assets", "negatedLabel": "Total Assets", "totalLabel": "Total assets" } } }, "localname": "Assets", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://interparfumsinc.com/role/ConsolidatedBalanceSheets", "http://interparfumsinc.com/role/InformationOnCompanysOperationsBySegmentsIsAsFollowsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AssetsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "ASSETS" } } }, "localname": "AssetsAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://interparfumsinc.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_AssetsCurrent": { "auth_ref": [ "r136", "r145", "r170", "r234", "r244", "r245", "r246", "r247", "r248", "r249", "r250", "r251", "r252", "r310", "r314", "r342", "r546", "r601", "r602", "r620" ], "calculation": { "http://interparfumsinc.com/role/ConsolidatedBalanceSheets": { "order": 1.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.", "label": "Assets, Current", "totalLabel": "Total current assets" } } }, "localname": "AssetsCurrent", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://interparfumsinc.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AssetsCurrentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Current assets:" } } }, "localname": "AssetsCurrentAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://interparfumsinc.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_AssetsFairValueDisclosure": { "auth_ref": [ "r70" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Fair value portion of probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.", "label": "Total assets" } } }, "localname": "AssetsFairValueDisclosure", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://interparfumsinc.com/role/FollowingTablesPresentOurFinancialAssetsAndLiabilitiesThatAreMeasuredAtFairValueOnRecurringBasisAndAreCategorizedUsingFairValueHierarchy.FairValueHierarchyHasThreeLevelsBasedOnReliabilityOfInputsUseDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AssetsFairValueDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Assets:" } } }, "localname": "AssetsFairValueDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://interparfumsinc.com/role/FollowingTablesPresentOurFinancialAssetsAndLiabilitiesThatAreMeasuredAtFairValueOnRecurringBasisAndAreCategorizedUsingFairValueHierarchy.FairValueHierarchyHasThreeLevelsBasedOnReliabilityOfInputsUseDetails" ], "xbrltype": "stringItemType" }, "us-gaap_BuildingMember": { "auth_ref": [ "r104" ], "lang": { "en-us": { "role": { "documentation": "Facility held for productive use including, but not limited to, office, production, storage and distribution facilities.", "label": "Building [Member]" } } }, "localname": "BuildingMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://interparfumsinc.com/role/RecentAgreementsDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_BusinessAcquisitionAcquireeDomain": { "auth_ref": [ "r307", "r537", "r538" ], "lang": { "en-us": { "role": { "documentation": "Identification of the acquiree in a material business combination (or series of individually immaterial business combinations), which may include the name or other type of identification of the acquiree." } } }, "localname": "BusinessAcquisitionAcquireeDomain", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://interparfumsinc.com/role/RecentAgreementsDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_BusinessAcquisitionAxis": { "auth_ref": [ "r55", "r57", "r307", "r537", "r538" ], "lang": { "en-us": { "role": { "documentation": "Information by business combination or series of individually immaterial business combinations.", "label": "Business Acquisition [Axis]" } } }, "localname": "BusinessAcquisitionAxis", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://interparfumsinc.com/role/RecentAgreementsDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_BusinessAcquisitionDescriptionOfAcquiredEntity": { "auth_ref": [ "r56" ], "lang": { "en-us": { "role": { "documentation": "With respect to a business combination completed during the period, this element provides a description of the business, other than the name, which may include the industry, size, products and other important information.", "label": "Description of recent agreement" } } }, "localname": "BusinessAcquisitionDescriptionOfAcquiredEntity", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://interparfumsinc.com/role/RecentAgreementsDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_BusinessAcquisitionLineItems": { "auth_ref": [ "r307" ], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Business Acquisition [Line Items]" } } }, "localname": "BusinessAcquisitionLineItems", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://interparfumsinc.com/role/RecentAgreementsDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_BusinessCombinationAndAssetAcquisitionAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Business Combination and Asset Acquisition [Abstract]" } } }, "localname": "BusinessCombinationAndAssetAcquisitionAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "xbrltype": "stringItemType" }, "us-gaap_BusinessCombinationDisclosureTextBlock": { "auth_ref": [ "r109", "r308" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for a business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities. The disclosure may include leverage buyout transactions (as applicable).", "label": "Recent Agreements:" } } }, "localname": "BusinessCombinationDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://interparfumsinc.com/role/RecentAgreements" ], "xbrltype": "textBlockItemType" }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": { "auth_ref": [ "r38", "r99", "r167" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents", "periodEndLabel": "Cash and cash equivalents - end of period", "periodStartLabel": "Cash and cash equivalents - beginning of period" } } }, "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://interparfumsinc.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": { "auth_ref": [ "r0", "r99" ], "calculation": { "http://interparfumsinc.com/role/ConsolidatedStatementsOfCashFlows": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect", "totalLabel": "Net increase (decrease) in cash and cash equivalents" } } }, "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://interparfumsinc.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashEquivalentsAtCarryingValue": { "auth_ref": [ "r582", "r629" ], "calculation": { "http://interparfumsinc.com/role/ConsolidatedBalanceSheets": { "order": 1.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.", "label": "Cash and cash equivalents" } } }, "localname": "CashEquivalentsAtCarryingValue", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://interparfumsinc.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashProceedsReceivedAndTaxBenefitFromShareBasedPaymentAwardsTableTextBlock": { "auth_ref": [ "r18" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of cash received from exercise of stock options and similar instruments granted under share-based payment arrangements and tax benefit from exercise of stock options.", "label": "Cash proceeds, tax benefits and intrinsic value related to stock options exercised during the three months ended March 31, 2023 and 2022 were as follows:" } } }, "localname": "CashProceedsReceivedAndTaxBenefitFromShareBasedPaymentAwardsTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://interparfumsinc.com/role/Share-basedPaymentsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_CommonStockDividendsPerShareDeclared": { "auth_ref": [ "r106" ], "lang": { "en-us": { "role": { "documentation": "Aggregate dividends declared during the period for each share of common stock outstanding.", "label": "Dividends declared per share" } } }, "localname": "CommonStockDividendsPerShareDeclared", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://interparfumsinc.com/role/ConsolidatedStatementsOfIncome" ], "xbrltype": "perShareItemType" }, "us-gaap_CommonStockMember": { "auth_ref": [ "r548", "r549", "r550", "r552", "r553", "r554", "r557", "r593", "r594", "r614", "r631", "r635" ], "lang": { "en-us": { "role": { "documentation": "Stock that is subordinate to all other stock of the issuer.", "label": "Common Stock [Member]" } } }, "localname": "CommonStockMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://interparfumsinc.com/role/ConsolidatedStatementsOfChangesInEquity" ], "xbrltype": "domainItemType" }, "us-gaap_CommonStockParOrStatedValuePerShare": { "auth_ref": [ "r77" ], "lang": { "en-us": { "role": { "documentation": "Face amount or stated value per share of common stock.", "label": "Common stock, par or stated value per share" } } }, "localname": "CommonStockParOrStatedValuePerShare", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://interparfumsinc.com/role/ConsolidatedBalanceSheetsParenthetical" ], "xbrltype": "perShareItemType" }, "us-gaap_CommonStockSharesAuthorized": { "auth_ref": [ "r77", "r445" ], "lang": { "en-us": { "role": { "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws.", "label": "Common stock, shares authorized" } } }, "localname": "CommonStockSharesAuthorized", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://interparfumsinc.com/role/ConsolidatedBalanceSheetsParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockSharesOutstanding": { "auth_ref": [ "r14", "r77", "r445", "r463", "r635", "r636" ], "lang": { "en-us": { "role": { "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.", "label": "Common stock, shares, outstanding" } } }, "localname": "CommonStockSharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://interparfumsinc.com/role/ConsolidatedBalanceSheetsParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockValue": { "auth_ref": [ "r77", "r394", "r546" ], "calculation": { "http://interparfumsinc.com/role/ConsolidatedBalanceSheets": { "order": 2.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.", "label": "Common stock, $.001 par; authorized 100,000,000 shares; outstanding 32,012,950 and 31,967,300 shares at March 31, 2023 and December 31, 2022, respectively" } } }, "localname": "CommonStockValue", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://interparfumsinc.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_ComprehensiveIncomeNetOfTax": { "auth_ref": [ "r32", "r151", "r153", "r160", "r388", "r406" ], "calculation": { "http://interparfumsinc.com/role/ConsolidatedStatementsOfComprehensiveIncome": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.", "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Parent", "totalLabel": "Comprehensive income attributable to Inter Parfums, Inc." } } }, "localname": "ComprehensiveIncomeNetOfTax", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://interparfumsinc.com/role/ConsolidatedStatementsOfComprehensiveIncome" ], "xbrltype": "monetaryItemType" }, "us-gaap_ComprehensiveIncomeNetOfTaxAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Comprehensive income:" } } }, "localname": "ComprehensiveIncomeNetOfTaxAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://interparfumsinc.com/role/ConsolidatedStatementsOfComprehensiveIncome" ], "xbrltype": "stringItemType" }, "us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest": { "auth_ref": [ "r8", "r60", "r63", "r151", "r153", "r159", "r387", "r405" ], "calculation": { "http://interparfumsinc.com/role/ConsolidatedStatementsOfComprehensiveIncome": { "order": 2.0, "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income (loss) and other comprehensive income (loss), attributable to noncontrolling interests. Excludes changes in equity resulting from investments by owners and distributions to owners.", "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Noncontrolling Interest", "totalLabel": "Comprehensive income attributable to the noncontrolling interests" } } }, "localname": "ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://interparfumsinc.com/role/ConsolidatedStatementsOfComprehensiveIncome" ], "xbrltype": "monetaryItemType" }, "us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterestAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Comprehensive income attributable to the noncontrolling interests:" } } }, "localname": "ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterestAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://interparfumsinc.com/role/ConsolidatedStatementsOfComprehensiveIncome" ], "xbrltype": "stringItemType" }, "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest": { "auth_ref": [ "r63", "r110", "r151", "r153", "r158", "r386", "r404" ], "calculation": { "http://interparfumsinc.com/role/ConsolidatedStatementsOfComprehensiveIncome": { "order": 1.0, "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income. Excludes changes in equity resulting from investments by owners and distributions to owners.", "label": "Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest", "totalLabel": "Comprehensive income" } } }, "localname": "ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://interparfumsinc.com/role/ConsolidatedStatementsOfComprehensiveIncome" ], "xbrltype": "monetaryItemType" }, "us-gaap_CostOfGoodsAndServicesSold": { "auth_ref": [ "r91", "r382" ], "calculation": { "http://interparfumsinc.com/role/ConsolidatedStatementsOfIncome": { "order": 2.0, "parentTag": "us-gaap_GrossProfit", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities.", "label": "Cost of sales" } } }, "localname": "CostOfGoodsAndServicesSold", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://interparfumsinc.com/role/ConsolidatedStatementsOfIncome" ], "xbrltype": "monetaryItemType" }, "us-gaap_DebtInstrumentFaceAmount": { "auth_ref": [ "r71", "r73", "r253", "r363", "r530", "r531" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Face (par) amount of debt instrument at time of issuance.", "label": "Debt instrument, face amount" } } }, "localname": "DebtInstrumentFaceAmount", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://interparfumsinc.com/role/RecentAgreementsDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_DebtInstrumentInterestRateTerms": { "auth_ref": [ "r26" ], "lang": { "en-us": { "role": { "documentation": "Description of the interest rate as being fixed or variable, and, if variable, identification of the index or rate on which the interest rate is based and the number of points or percentage added to that index or rate to set the rate, and other pertinent information, such as frequency of rate resets.", "label": "Description of debt instrument interest rate terms" } } }, "localname": "DebtInstrumentInterestRateTerms", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://interparfumsinc.com/role/RecentAgreementsDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_DeferredIncomeTaxAssetsNet": { "auth_ref": [ "r296", "r297" ], "calculation": { "http://interparfumsinc.com/role/ConsolidatedBalanceSheets": { "order": 5.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, with jurisdictional netting.", "label": "Deferred tax assets" } } }, "localname": "DeferredIncomeTaxAssetsNet", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://interparfumsinc.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredIncomeTaxExpenseBenefit": { "auth_ref": [ "r10", "r108", "r127", "r305", "r306", "r592" ], "calculation": { "http://interparfumsinc.com/role/ConsolidatedStatementsOfCashFlows": { "order": 7.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.", "label": "Deferred tax provision" } } }, "localname": "DeferredIncomeTaxExpenseBenefit", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://interparfumsinc.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxExpenseFromStockOptionsExercised": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of deferred tax expense from write-off of the deferred tax asset related to deductible stock options at exercise.", "label": "Tax benefits" } } }, "localname": "DeferredTaxExpenseFromStockOptionsExercised", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://interparfumsinc.com/role/CashProceedsTaxBenefitsAndIntrinsicValueRelatedToStockOptionsExercisedDuringThreeMonthsEndedMarch312023And2022WereAsFollowsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DerivativeAssets": { "auth_ref": [ "r146", "r147", "r341", "r427", "r428", "r429", "r430", "r431", "r433", "r434", "r435", "r436", "r437", "r451", "r452", "r496", "r498", "r499", "r500", "r501", "r502", "r526", "r550", "r632" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Fair value, after the effects of master netting arrangements, of a financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes assets not subject to a master netting arrangement and not elected to be offset.", "label": "Interest rate swaps" } } }, "localname": "DerivativeAssets", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://interparfumsinc.com/role/FollowingTablesPresentOurFinancialAssetsAndLiabilitiesThatAreMeasuredAtFairValueOnRecurringBasisAndAreCategorizedUsingFairValueHierarchy.FairValueHierarchyHasThreeLevelsBasedOnReliabilityOfInputsUseDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DerivativeContractTypeDomain": { "auth_ref": [ "r435", "r437", "r450", "r451", "r452", "r453", "r454", "r455", "r456", "r458", "r459", "r460", "r461", "r471", "r472", "r473", "r474", "r477", "r478", "r479", "r480", "r496", "r497", "r499", "r501", "r548", "r550" ], "lang": { "en-us": { "role": { "documentation": "Financial instrument or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset." } } }, "localname": "DerivativeContractTypeDomain", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://interparfumsinc.com/role/DerivativeFinancialInstrumentsDetailsNarrative", "http://interparfumsinc.com/role/Share-basedPaymentsDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_DerivativeFixedInterestRate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Fixed interest rate related to the interest rate derivative.", "label": "Fixed interest rate" } } }, "localname": "DerivativeFixedInterestRate", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://interparfumsinc.com/role/RecentAgreementsDetailsNarrative" ], "xbrltype": "percentItemType" }, "us-gaap_DerivativeInstrumentRiskAxis": { "auth_ref": [ "r64", "r65", "r66", "r67", "r435", "r437", "r450", "r451", "r452", "r453", "r454", "r455", "r456", "r458", "r459", "r460", "r461", "r471", "r472", "r473", "r474", "r477", "r478", "r479", "r480", "r496", "r497", "r499", "r501", "r526", "r548", "r550" ], "lang": { "en-us": { "role": { "documentation": "Information by type of derivative contract.", "label": "Derivative Instrument [Axis]" } } }, "localname": "DerivativeInstrumentRiskAxis", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://interparfumsinc.com/role/DerivativeFinancialInstrumentsDetailsNarrative", "http://interparfumsinc.com/role/Share-basedPaymentsDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Derivative Instruments and Hedging Activities Disclosure [Abstract]" } } }, "localname": "DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "xbrltype": "stringItemType" }, "us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock": { "auth_ref": [ "r112", "r317", "r325" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for derivative instruments and hedging activities including, but not limited to, risk management strategies, non-hedging derivative instruments, assets, liabilities, revenue and expenses, and methodologies and assumptions used in determining the amounts.", "label": "Derivative Financial Instruments:" } } }, "localname": "DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://interparfumsinc.com/role/DerivativeFinancialInstruments" ], "xbrltype": "textBlockItemType" }, "us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable": { "auth_ref": [ "r15", "r64", "r66", "r67", "r68", "r69", "r316" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about the location and amount of derivative instruments and nonderivative instruments designated as hedging instruments reported before netting adjustments, and the amount of gain (loss) on derivative instruments and nonderivative instruments designated and qualified as hedging instruments.", "label": "Derivative Instruments, Gain (Loss) [Table]" } } }, "localname": "DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://interparfumsinc.com/role/DerivativeFinancialInstrumentsDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_DerivativeInstrumentsGainLossLineItems": { "auth_ref": [ "r316" ], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Derivative Instruments, Gain (Loss) [Line Items]" } } }, "localname": "DerivativeInstrumentsGainLossLineItems", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://interparfumsinc.com/role/DerivativeFinancialInstrumentsDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_DerivativeNotionalAmount": { "auth_ref": [ "r612", "r613" ], "lang": { "en-us": { "role": { "documentation": "Nominal or face amount used to calculate payment on derivative.", "label": "Loan amount" } } }, "localname": "DerivativeNotionalAmount", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://interparfumsinc.com/role/DerivativeFinancialInstrumentsDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_DerivativeSwaptionInterestRate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Fixed interest rate that will be received or paid upon exercise of the interest rate swaption contract.", "label": "Derivative swap interest rate" } } }, "localname": "DerivativeSwaptionInterestRate", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://interparfumsinc.com/role/DerivativeFinancialInstrumentsDetailsNarrative" ], "xbrltype": "percentItemType" }, "us-gaap_DerivativeVariableInterestRate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Variable interest rate in effect as of the balance sheet date related to the interest rate derivative.", "label": "Variable interest rate" } } }, "localname": "DerivativeVariableInterestRate", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://interparfumsinc.com/role/RecentAgreementsDetailsNarrative" ], "xbrltype": "percentItemType" }, "us-gaap_DistributionMadeToLimitedPartnerUnitDistribution": { "auth_ref": [ "r106" ], "lang": { "en-us": { "role": { "documentation": "Number of units distributed for payment of a unit distribution to unit-holder of limited partnership (LP).", "label": "Number of share distributed" } } }, "localname": "DistributionMadeToLimitedPartnerUnitDistribution", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://interparfumsinc.com/role/Share-basedPaymentsDetailsNarrative" ], "xbrltype": "sharesItemType" }, "us-gaap_DividendsCash": { "auth_ref": [ "r7", "r106" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of paid and unpaid cash dividends declared for classes of stock, for example, but not limited to, common and preferred.", "label": "Dividends, Cash", "negatedLabel": "Dividends" } } }, "localname": "DividendsCash", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://interparfumsinc.com/role/ConsolidatedStatementsOfChangesInEquity" ], "xbrltype": "monetaryItemType" }, "us-gaap_DividendsPayableCurrent": { "auth_ref": [ "r24" ], "calculation": { "http://interparfumsinc.com/role/ConsolidatedBalanceSheets": { "order": 6.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of dividends declared but unpaid on equity securities issued by the entity and outstanding. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Income taxes payable" } } }, "localname": "DividendsPayableCurrent", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://interparfumsinc.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_EarningsPerShareAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Earnings per share:", "verboseLabel": "Earnings Per Share [Abstract]" } } }, "localname": "EarningsPerShareAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://interparfumsinc.com/role/ConsolidatedStatementsOfIncome" ], "xbrltype": "stringItemType" }, "us-gaap_EarningsPerShareBasic": { "auth_ref": [ "r161", "r181", "r182", "r183", "r184", "r185", "r192", "r194", "r196", "r197", "r198", "r202", "r329", "r330", "r389", "r407", "r527" ], "lang": { "en-us": { "role": { "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.", "label": "Basic", "verboseLabel": "Basic" } } }, "localname": "EarningsPerShareBasic", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://interparfumsinc.com/role/ConsolidatedStatementsOfIncome", "http://interparfumsinc.com/role/ReconciliationBetweenNumeratorsAndDenominatorsOfBasicAndDilutedEpsComputationsIsAsFollowsDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_EarningsPerShareBasicAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Net income attributable to Inter Parfums, Inc. common shareholders:" } } }, "localname": "EarningsPerShareBasicAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://interparfumsinc.com/role/ConsolidatedStatementsOfIncome", "http://interparfumsinc.com/role/ReconciliationBetweenNumeratorsAndDenominatorsOfBasicAndDilutedEpsComputationsIsAsFollowsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_EarningsPerShareDiluted": { "auth_ref": [ "r161", "r181", "r182", "r183", "r184", "r185", "r194", "r196", "r197", "r198", "r202", "r329", "r330", "r389", "r407", "r527" ], "lang": { "en-us": { "role": { "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.", "label": "Diluted", "verboseLabel": "Diluted" } } }, "localname": "EarningsPerShareDiluted", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://interparfumsinc.com/role/ConsolidatedStatementsOfIncome", "http://interparfumsinc.com/role/ReconciliationBetweenNumeratorsAndDenominatorsOfBasicAndDilutedEpsComputationsIsAsFollowsDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_EarningsPerShareTextBlock": { "auth_ref": [ "r191", "r199", "r200", "r201" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for earnings per share.", "label": "Net Income Attributable to Inter Parfums, Inc. Common Shareholders:" } } }, "localname": "EarningsPerShareTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://interparfumsinc.com/role/NetIncomeAttributableToInterParfumsInc.CommonShareholders" ], "xbrltype": "textBlockItemType" }, "us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": { "auth_ref": [ "r353" ], "calculation": { "http://interparfumsinc.com/role/ConsolidatedStatementsOfCashFlows": { "order": 4.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) from effect of exchange rate changes on cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; held in foreign currencies. Excludes amounts for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Effect of exchange rate changes on cash" } } }, "localname": "EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://interparfumsinc.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized": { "auth_ref": [ "r291" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cost not yet recognized for nonvested award under share-based payment arrangement.", "label": "Unrecognized compensation cost" } } }, "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://interparfumsinc.com/role/Share-basedPaymentsDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_EmployeeStockOwnershipPlanESOPCompensationExpense": { "auth_ref": [ "r54" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount of plan compensation cost recognized during the period.", "label": "Recognized as compensation cost" } } }, "localname": "EmployeeStockOwnershipPlanESOPCompensationExpense", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://interparfumsinc.com/role/Share-basedPaymentsDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_EquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Equity:", "verboseLabel": "Equity [Abstract]" } } }, "localname": "EquityAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://interparfumsinc.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_EquityComponentDomain": { "auth_ref": [ "r14", "r132", "r154", "r155", "r156", "r172", "r173", "r174", "r178", "r186", "r188", "r203", "r235", "r238", "r268", "r292", "r293", "r294", "r299", "r300", "r318", "r319", "r320", "r321", "r322", "r324", "r328", "r355", "r356", "r357", "r358", "r359", "r361", "r374", "r411", "r412", "r413", "r425", "r484" ], "lang": { "en-us": { "role": { "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc." } } }, "localname": "EquityComponentDomain", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://interparfumsinc.com/role/ConsolidatedStatementsOfChangesInEquity", "http://interparfumsinc.com/role/Share-basedPaymentsDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_EscrowDeposit": { "auth_ref": [ "r74", "r510" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The designation of funds furnished by a borrower to a lender to assure future payments of the borrower's real estate taxes and insurance obligations with respect to a mortgaged property. Escrow deposits may be made for a variety of other purposes such as earnest money and contingent payments. This element excludes replacement reserves which are an escrow separately provided for within the US GAAP taxonomy.", "label": "Cash held in escrow is included in other assets" } } }, "localname": "EscrowDeposit", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://interparfumsinc.com/role/RecentAgreementsDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_ExtraordinaryAndUnusualItemsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Unusual or Infrequent Items, or Both [Abstract]" } } }, "localname": "ExtraordinaryAndUnusualItemsAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "xbrltype": "stringItemType" }, "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems": { "auth_ref": [ "r335", "r336", "r339" ], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]" } } }, "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://interparfumsinc.com/role/FollowingTablesPresentOurFinancialAssetsAndLiabilitiesThatAreMeasuredAtFairValueOnRecurringBasisAndAreCategorizedUsingFairValueHierarchy.FairValueHierarchyHasThreeLevelsBasedOnReliabilityOfInputsUseDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable": { "auth_ref": [ "r335", "r336", "r339" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about asset and liability measured at fair value on recurring and nonrecurring basis.", "label": "Fair Value, Recurring and Nonrecurring [Table]" } } }, "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://interparfumsinc.com/role/FollowingTablesPresentOurFinancialAssetsAndLiabilitiesThatAreMeasuredAtFairValueOnRecurringBasisAndAreCategorizedUsingFairValueHierarchy.FairValueHierarchyHasThreeLevelsBasedOnReliabilityOfInputsUseDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueByFairValueHierarchyLevelAxis": { "auth_ref": [ "r254", "r272", "r273", "r274", "r275", "r276", "r277", "r336", "r377", "r378", "r379", "r530", "r531", "r534", "r535", "r536" ], "lang": { "en-us": { "role": { "documentation": "Information by level within fair value hierarchy and fair value measured at net asset value per share as practical expedient.", "label": "Fair Value Hierarchy and NAV [Axis]" } } }, "localname": "FairValueByFairValueHierarchyLevelAxis", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://interparfumsinc.com/role/FollowingTablesPresentOurFinancialAssetsAndLiabilitiesThatAreMeasuredAtFairValueOnRecurringBasisAndAreCategorizedUsingFairValueHierarchy.FairValueHierarchyHasThreeLevelsBasedOnReliabilityOfInputsUseDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueByMeasurementFrequencyAxis": { "auth_ref": [ "r335", "r336", "r337", "r338", "r340" ], "lang": { "en-us": { "role": { "documentation": "Information by measurement frequency.", "label": "Measurement Frequency [Axis]" } } }, "localname": "FairValueByMeasurementFrequencyAxis", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://interparfumsinc.com/role/FollowingTablesPresentOurFinancialAssetsAndLiabilitiesThatAreMeasuredAtFairValueOnRecurringBasisAndAreCategorizedUsingFairValueHierarchy.FairValueHierarchyHasThreeLevelsBasedOnReliabilityOfInputsUseDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueDisclosuresAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Fair Value Disclosures [Abstract]" } } }, "localname": "FairValueDisclosuresAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "xbrltype": "stringItemType" }, "us-gaap_FairValueDisclosuresTextBlock": { "auth_ref": [ "r334" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.", "label": "Fair Value Measurement:" } } }, "localname": "FairValueDisclosuresTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://interparfumsinc.com/role/FairValueMeasurement" ], "xbrltype": "textBlockItemType" }, "us-gaap_FairValueInputsLevel1Member": { "auth_ref": [ "r254", "r272", "r277", "r336", "r377", "r534", "r535", "r536" ], "lang": { "en-us": { "role": { "documentation": "Quoted prices in active markets for identical assets or liabilities that the reporting entity can access at the measurement date.", "label": "Fair Value, Inputs, Level 1 [Member]" } } }, "localname": "FairValueInputsLevel1Member", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://interparfumsinc.com/role/FollowingTablesPresentOurFinancialAssetsAndLiabilitiesThatAreMeasuredAtFairValueOnRecurringBasisAndAreCategorizedUsingFairValueHierarchy.FairValueHierarchyHasThreeLevelsBasedOnReliabilityOfInputsUseDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueInputsLevel2Member": { "auth_ref": [ "r254", "r272", "r277", "r336", "r378", "r530", "r531", "r534", "r535", "r536" ], "lang": { "en-us": { "role": { "documentation": "Inputs other than quoted prices included within level 1 that are observable for an asset or liability, either directly or indirectly, including, but not limited to, quoted prices for similar assets or liabilities in active markets, or quoted prices for identical or similar assets or liabilities in inactive markets.", "label": "Fair Value, Inputs, Level 2 [Member]" } } }, "localname": "FairValueInputsLevel2Member", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://interparfumsinc.com/role/FollowingTablesPresentOurFinancialAssetsAndLiabilitiesThatAreMeasuredAtFairValueOnRecurringBasisAndAreCategorizedUsingFairValueHierarchy.FairValueHierarchyHasThreeLevelsBasedOnReliabilityOfInputsUseDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueInputsLevel3Member": { "auth_ref": [ "r254", "r272", "r273", "r274", "r275", "r276", "r277", "r336", "r379", "r530", "r531", "r534", "r535", "r536" ], "lang": { "en-us": { "role": { "documentation": "Unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.", "label": "Fair Value, Inputs, Level 3 [Member]" } } }, "localname": "FairValueInputsLevel3Member", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://interparfumsinc.com/role/FollowingTablesPresentOurFinancialAssetsAndLiabilitiesThatAreMeasuredAtFairValueOnRecurringBasisAndAreCategorizedUsingFairValueHierarchy.FairValueHierarchyHasThreeLevelsBasedOnReliabilityOfInputsUseDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueMeasurementFrequencyDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Measurement frequency." } } }, "localname": "FairValueMeasurementFrequencyDomain", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://interparfumsinc.com/role/FollowingTablesPresentOurFinancialAssetsAndLiabilitiesThatAreMeasuredAtFairValueOnRecurringBasisAndAreCategorizedUsingFairValueHierarchy.FairValueHierarchyHasThreeLevelsBasedOnReliabilityOfInputsUseDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueMeasurementsFairValueHierarchyDomain": { "auth_ref": [ "r254", "r272", "r273", "r274", "r275", "r276", "r277", "r377", "r378", "r379", "r530", "r531", "r534", "r535", "r536" ], "lang": { "en-us": { "role": { "documentation": "Categories used to prioritize the inputs to valuation techniques to measure fair value." } } }, "localname": "FairValueMeasurementsFairValueHierarchyDomain", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://interparfumsinc.com/role/FollowingTablesPresentOurFinancialAssetsAndLiabilitiesThatAreMeasuredAtFairValueOnRecurringBasisAndAreCategorizedUsingFairValueHierarchy.FairValueHierarchyHasThreeLevelsBasedOnReliabilityOfInputsUseDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueMeasurementsRecurringMember": { "auth_ref": [ "r334", "r340" ], "lang": { "en-us": { "role": { "documentation": "Frequent fair value measurement. Includes, but is not limited to, fair value adjustment for impairment of asset, liability or equity, frequently measured at fair value.", "label": "Fair Value, Recurring [Member]" } } }, "localname": "FairValueMeasurementsRecurringMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://interparfumsinc.com/role/FollowingTablesPresentOurFinancialAssetsAndLiabilitiesThatAreMeasuredAtFairValueOnRecurringBasisAndAreCategorizedUsingFairValueHierarchy.FairValueHierarchyHasThreeLevelsBasedOnReliabilityOfInputsUseDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ForeignCurrencyContractsLiabilityFairValueDisclosure": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Fair value portion of liability contracts related to the exchange of different currencies, including, but not limited to, foreign currency options, forward (delivery or nondelivery) contracts, and swaps entered into.", "label": "Forward exchange contracts" } } }, "localname": "ForeignCurrencyContractsLiabilityFairValueDisclosure", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://interparfumsinc.com/role/DerivativeFinancialInstrumentsDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_ForeignCurrencyFairValueHedgeAssetAtFairValue": { "auth_ref": [ "r65" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Fair value as of the balance sheet date of all derivative assets designated as foreign currency fair value hedging instruments.", "label": "Foreign currency forward exchange contracts accounted for using hedge accounting" } } }, "localname": "ForeignCurrencyFairValueHedgeAssetAtFairValue", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://interparfumsinc.com/role/FollowingTablesPresentOurFinancialAssetsAndLiabilitiesThatAreMeasuredAtFairValueOnRecurringBasisAndAreCategorizedUsingFairValueHierarchy.FairValueHierarchyHasThreeLevelsBasedOnReliabilityOfInputsUseDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ForeignCurrencyFairValueHedgeLiabilityAtFairValue": { "auth_ref": [ "r65" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Fair value as of the balance sheet date of all derivative liabilities designated as foreign currency fair value hedging instruments.", "label": "Foreign currency forward exchange contracts not accounted for using hedge accounting" } } }, "localname": "ForeignCurrencyFairValueHedgeLiabilityAtFairValue", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://interparfumsinc.com/role/FollowingTablesPresentOurFinancialAssetsAndLiabilitiesThatAreMeasuredAtFairValueOnRecurringBasisAndAreCategorizedUsingFairValueHierarchy.FairValueHierarchyHasThreeLevelsBasedOnReliabilityOfInputsUseDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ForeignCurrencyTransactionGainLossBeforeTax": { "auth_ref": [ "r346", "r348", "r350", "r352", "r481" ], "calculation": { "http://interparfumsinc.com/role/ConsolidatedStatementsOfIncome": { "order": 2.0, "parentTag": "us-gaap_NonoperatingIncomeExpense", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, before tax, of realized and unrealized gain (loss) from foreign currency transaction.", "label": "Gain (Loss), Foreign Currency Transaction, before Tax", "negatedLabel": "Loss (gain) on foreign currency" } } }, "localname": "ForeignCurrencyTransactionGainLossBeforeTax", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://interparfumsinc.com/role/ConsolidatedStatementsOfIncome" ], "xbrltype": "monetaryItemType" }, "us-gaap_ForeignExchangeContractMember": { "auth_ref": [ "r526", "r534", "r544" ], "lang": { "en-us": { "role": { "documentation": "Derivative instrument whose primary underlying risk is tied to foreign exchange rates.", "label": "Foreign Exchange Contract [Member]" } } }, "localname": "ForeignExchangeContractMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://interparfumsinc.com/role/DerivativeFinancialInstrumentsDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_GrossProfit": { "auth_ref": [ "r90", "r170", "r208", "r216", "r221", "r224", "r234", "r244", "r245", "r246", "r247", "r248", "r249", "r250", "r251", "r252", "r342", "r528", "r601" ], "calculation": { "http://interparfumsinc.com/role/ConsolidatedStatementsOfIncome": { "order": 1.0, "parentTag": "us-gaap_OperatingIncomeLoss", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.", "label": "Gross Profit", "totalLabel": "Gross margin" } } }, "localname": "GrossProfit", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://interparfumsinc.com/role/ConsolidatedStatementsOfIncome" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments": { "auth_ref": [ "r208", "r216", "r221", "r224", "r408", "r528" ], "calculation": { "http://interparfumsinc.com/role/ConsolidatedStatementsOfIncome": { "order": 1.0, "parentTag": "us-gaap_ProfitLoss", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of income (loss) from continuing operations before deduction of income tax expense (benefit) and income (loss) attributable to noncontrolling interest, and addition of income (loss) from equity method investments.", "label": "Income before income taxes" } } }, "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://interparfumsinc.com/role/ConsolidatedStatementsOfIncome" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeLossFromEquityMethodInvestments": { "auth_ref": [ "r10", "r88", "r121", "r212", "r233", "r400" ], "calculation": { "http://interparfumsinc.com/role/ConsolidatedStatementsOfCashFlows": { "order": 5.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of income (loss) for proportionate share of equity method investee's income (loss).", "label": "Income (Loss) from Equity Method Investments", "negatedLabel": "Share of income of equity investment" } } }, "localname": "IncomeLossFromEquityMethodInvestments", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://interparfumsinc.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeStatementAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Income Statement [Abstract]" } } }, "localname": "IncomeStatementAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "xbrltype": "stringItemType" }, "us-gaap_IncomeTaxExpenseBenefit": { "auth_ref": [ "r126", "r130", "r187", "r188", "r213", "r298", "r304", "r409" ], "calculation": { "http://interparfumsinc.com/role/ConsolidatedStatementsOfIncome": { "order": 2.0, "parentTag": "us-gaap_ProfitLoss", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.", "label": "Income taxes" } } }, "localname": "IncomeTaxExpenseBenefit", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://interparfumsinc.com/role/ConsolidatedStatementsOfIncome" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeTaxesPaid": { "auth_ref": [ "r37", "r39" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income.", "label": "Income Taxes Paid", "verboseLabel": "Income taxes" } } }, "localname": "IncomeTaxesPaid", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://interparfumsinc.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeTaxesReceivable": { "auth_ref": [ "r74", "r583" ], "calculation": { "http://interparfumsinc.com/role/ConsolidatedBalanceSheets": { "order": 7.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Carrying amount due within one year of the balance sheet date (or one operating cycle, if longer) from tax authorities as of the balance sheet date representing refunds of overpayments or recoveries based on agreed-upon resolutions of disputes.", "label": "Income taxes receivable" } } }, "localname": "IncomeTaxesReceivable", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://interparfumsinc.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities": { "auth_ref": [ "r9" ], "calculation": { "http://interparfumsinc.com/role/ConsolidatedStatementsOfCashFlows": { "order": 13.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in the amounts payable to vendors for goods and services received and the amount of obligations and expenses incurred but not paid.", "label": "Accounts payable and accrued expenses" } } }, "localname": "IncreaseDecreaseInAccountsPayableAndAccruedLiabilities", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://interparfumsinc.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInAccountsReceivable": { "auth_ref": [ "r9" ], "calculation": { "http://interparfumsinc.com/role/ConsolidatedStatementsOfCashFlows": { "order": 9.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.", "label": "Increase (Decrease) in Accounts Receivable", "negatedLabel": "Accounts receivable" } } }, "localname": "IncreaseDecreaseInAccountsReceivable", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://interparfumsinc.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInAccruedTaxesPayable": { "auth_ref": [ "r590" ], "calculation": { "http://interparfumsinc.com/role/ConsolidatedStatementsOfCashFlows": { "order": 14.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period of all taxes owed but not paid, including income, property and other taxes.", "label": "Income taxes, net" } } }, "localname": "IncreaseDecreaseInAccruedTaxesPayable", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://interparfumsinc.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInInventories": { "auth_ref": [ "r9" ], "calculation": { "http://interparfumsinc.com/role/ConsolidatedStatementsOfCashFlows": { "order": 10.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.", "label": "Increase (Decrease) in Inventories", "negatedLabel": "Inventories" } } }, "localname": "IncreaseDecreaseInInventories", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://interparfumsinc.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Changes in:" } } }, "localname": "IncreaseDecreaseInOperatingCapitalAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://interparfumsinc.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_IncreaseDecreaseInOperatingLeaseLiability": { "auth_ref": [ "r581", "r590" ], "calculation": { "http://interparfumsinc.com/role/ConsolidatedStatementsOfCashFlows": { "order": 12.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in obligation for operating lease.", "label": "Operating lease liabilities" } } }, "localname": "IncreaseDecreaseInOperatingLeaseLiability", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://interparfumsinc.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInOtherOperatingAssets": { "auth_ref": [ "r9" ], "calculation": { "http://interparfumsinc.com/role/ConsolidatedStatementsOfCashFlows": { "order": 11.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in operating assets classified as other.", "label": "Increase (Decrease) in Other Operating Assets", "negatedLabel": "Other assets" } } }, "localname": "IncreaseDecreaseInOtherOperatingAssets", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://interparfumsinc.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IntangibleAssetsNetExcludingGoodwill": { "auth_ref": [ "r45", "r46" ], "calculation": { "http://interparfumsinc.com/role/ConsolidatedBalanceSheets": { "order": 4.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.", "label": "Trademarks, licenses and other intangible assets, net" } } }, "localname": "IntangibleAssetsNetExcludingGoodwill", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://interparfumsinc.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_InterestExpense": { "auth_ref": [ "r72", "r123", "r157", "r211", "r362", "r468", "r558", "r634" ], "calculation": { "http://interparfumsinc.com/role/ConsolidatedStatementsOfIncome": { "order": 1.0, "parentTag": "us-gaap_NonoperatingIncomeExpense", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of the cost of borrowed funds accounted for as interest expense.", "label": "Interest expense" } } }, "localname": "InterestExpense", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://interparfumsinc.com/role/ConsolidatedStatementsOfIncome" ], "xbrltype": "monetaryItemType" }, "us-gaap_InterestPaidNet": { "auth_ref": [ "r162", "r165", "r166" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.", "label": "Interest" } } }, "localname": "InterestPaidNet", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://interparfumsinc.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_InterestRateSwapMember": { "auth_ref": [ "r523", "r555", "r556" ], "lang": { "en-us": { "role": { "documentation": "Forward based contracts in which two parties agree to swap periodic payments that are fixed at the outset of the swap contract with variable payments based on a market interest rate (index rate) over a specified period.", "label": "Interest Rate Swap [Member]" } } }, "localname": "InterestRateSwapMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://interparfumsinc.com/role/DerivativeFinancialInstrumentsDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_InventoryDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Inventory Disclosure [Abstract]" } } }, "localname": "InventoryDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "xbrltype": "stringItemType" }, "us-gaap_InventoryDisclosureTextBlock": { "auth_ref": [ "r239" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for inventory. Includes, but is not limited to, the basis of stating inventory, the method of determining inventory cost, the classes of inventory, and the nature of the cost elements included in inventory.", "label": "Inventories:" } } }, "localname": "InventoryDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://interparfumsinc.com/role/Inventories" ], "xbrltype": "textBlockItemType" }, "us-gaap_InventoryFinishedGoods": { "auth_ref": [ "r584" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before valuation and LIFO reserves of completed merchandise or goods expected to be sold within one year or operating cycle, if longer.", "label": "Finished goods" } } }, "localname": "InventoryFinishedGoods", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://interparfumsinc.com/role/InventoriesConsistOfFollowingDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_InventoryNet": { "auth_ref": [ "r143", "r525", "r546" ], "calculation": { "http://interparfumsinc.com/role/ConsolidatedBalanceSheets": { "order": 4.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.", "label": "Inventories" } } }, "localname": "InventoryNet", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://interparfumsinc.com/role/ConsolidatedBalanceSheets", "http://interparfumsinc.com/role/InventoriesConsistOfFollowingDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_InventoryRawMaterials": { "auth_ref": [ "r585" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before valuation and LIFO reserves of raw materials expected to be sold, or consumed within one year or operating cycle, if longer.", "label": "Raw materials and component parts" } } }, "localname": "InventoryRawMaterials", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://interparfumsinc.com/role/InventoriesConsistOfFollowingDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_InvestmentsFairValueDisclosure": { "auth_ref": [ "r335" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Fair value portion of investment securities, including, but not limited to, marketable securities, derivative financial instruments, and investments accounted for under the equity method.", "label": "Investments, Fair Value Disclosure", "verboseLabel": "Short-term investments" } } }, "localname": "InvestmentsFairValueDisclosure", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://interparfumsinc.com/role/FollowingTablesPresentOurFinancialAssetsAndLiabilitiesThatAreMeasuredAtFairValueOnRecurringBasisAndAreCategorizedUsingFairValueHierarchy.FairValueHierarchyHasThreeLevelsBasedOnReliabilityOfInputsUseDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LandMember": { "auth_ref": [ "r607" ], "lang": { "en-us": { "role": { "documentation": "Part of earth's surface not covered by water.", "label": "Land [Member]" } } }, "localname": "LandMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://interparfumsinc.com/role/RecentAgreementsDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_LeasesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Leases [Abstract]" } } }, "localname": "LeasesAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "xbrltype": "stringItemType" }, "us-gaap_LesseeOperatingLeasesTextBlock": { "auth_ref": [ "r366" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for operating leases of lessee. Includes, but is not limited to, description of operating lease and maturity analysis of operating lease liability.", "label": "Leases:" } } }, "localname": "LesseeOperatingLeasesTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://interparfumsinc.com/role/Leases" ], "xbrltype": "textBlockItemType" }, "us-gaap_LiabilitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Liabilities:" } } }, "localname": "LiabilitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://interparfumsinc.com/role/FollowingTablesPresentOurFinancialAssetsAndLiabilitiesThatAreMeasuredAtFairValueOnRecurringBasisAndAreCategorizedUsingFairValueHierarchy.FairValueHierarchyHasThreeLevelsBasedOnReliabilityOfInputsUseDetails" ], "xbrltype": "stringItemType" }, "us-gaap_LiabilitiesAndStockholdersEquity": { "auth_ref": [ "r82", "r118", "r398", "r546", "r591", "r598", "r616" ], "calculation": { "http://interparfumsinc.com/role/ConsolidatedBalanceSheets": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.", "label": "Liabilities and Equity", "totalLabel": "Total liabilities and equity" } } }, "localname": "LiabilitiesAndStockholdersEquity", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://interparfumsinc.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesAndStockholdersEquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "LIABILITIES AND EQUITY" } } }, "localname": "LiabilitiesAndStockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://interparfumsinc.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_LiabilitiesCurrent": { "auth_ref": [ "r25", "r137", "r170", "r234", "r244", "r245", "r246", "r247", "r248", "r249", "r250", "r251", "r252", "r311", "r314", "r315", "r342", "r546", "r601", "r620", "r621" ], "calculation": { "http://interparfumsinc.com/role/ConsolidatedBalanceSheets": { "order": 1.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.", "label": "Liabilities, Current", "totalLabel": "Total current liabilities" } } }, "localname": "LiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://interparfumsinc.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesCurrentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Current liabilities:" } } }, "localname": "LiabilitiesCurrentAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://interparfumsinc.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_LiabilitiesFairValueDisclosure": { "auth_ref": [ "r70" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Fair value of financial and nonfinancial obligations.", "label": "Total liabilities" } } }, "localname": "LiabilitiesFairValueDisclosure", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://interparfumsinc.com/role/FollowingTablesPresentOurFinancialAssetsAndLiabilitiesThatAreMeasuredAtFairValueOnRecurringBasisAndAreCategorizedUsingFairValueHierarchy.FairValueHierarchyHasThreeLevelsBasedOnReliabilityOfInputsUseDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LineOfCredit": { "auth_ref": [ "r21", "r116", "r628" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The carrying value as of the balance sheet date of the current and noncurrent portions of long-term obligations drawn from a line of credit, which is a bank's commitment to make loans up to a specific amount. Examples of items that might be included in the application of this element may consist of letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to a maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line. Includes short-term obligations that would normally be classified as current liabilities but for which (a) postbalance sheet date issuance of a long term obligation to refinance the short term obligation on a long term basis, or (b) the enterprise has entered into a financing agreement that clearly permits the enterprise to refinance the short-term obligation on a long term basis and the following conditions are met (1) the agreement does not expire within 1 year and is not cancelable by the lender except for violation of an objectively determinable provision, (2) no violation exists at the BS date, and (3) the lender has entered into the financing agreement is expected to be financially capable of honoring the agreement.", "label": "Long-term line of credit" } } }, "localname": "LineOfCredit", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://interparfumsinc.com/role/RecentAgreementsDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_LoansPayableToBankCurrent": { "auth_ref": [ "r75", "r442" ], "calculation": { "http://interparfumsinc.com/role/ConsolidatedBalanceSheets": { "order": 1.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of current portion of long-term loans payable to bank due within one year or the operating cycle if longer.", "label": "Loans payable - banks" } } }, "localname": "LoansPayableToBankCurrent", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://interparfumsinc.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_LongTermDebtCurrent": { "auth_ref": [ "r140" ], "calculation": { "http://interparfumsinc.com/role/ConsolidatedBalanceSheets": { "order": 2.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, after deduction of unamortized premium (discount) and debt issuance cost, of long-term debt classified as current. Excludes lease obligation.", "label": "Current portion of long-term debt" } } }, "localname": "LongTermDebtCurrent", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://interparfumsinc.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_LongTermDebtNoncurrent": { "auth_ref": [ "r141" ], "calculation": { "http://interparfumsinc.com/role/ConsolidatedBalanceSheets": { "order": 2.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, after deduction of unamortized premium (discount) and debt issuance cost, of long-term debt classified as noncurrent. Excludes lease obligation.", "label": "Long\u2013term debt, less current portion" } } }, "localname": "LongTermDebtNoncurrent", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://interparfumsinc.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_LongTermDebtTerm": { "auth_ref": [ "r615" ], "lang": { "en-us": { "role": { "documentation": "Period between issuance and maturity of long-term debt, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.", "label": "Long-term debt, term" } } }, "localname": "LongTermDebtTerm", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://interparfumsinc.com/role/DerivativeFinancialInstrumentsDetailsNarrative", "http://interparfumsinc.com/role/RecentAgreementsDetailsNarrative" ], "xbrltype": "durationItemType" }, "us-gaap_MinorityInterest": { "auth_ref": [ "r29", "r117", "r170", "r234", "r244", "r246", "r247", "r248", "r251", "r252", "r342", "r397", "r447" ], "calculation": { "http://interparfumsinc.com/role/ConsolidatedBalanceSheets": { "order": 2.0, "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of equity (deficit) attributable to noncontrolling interest. Excludes temporary equity.", "label": "Noncontrolling interest" } } }, "localname": "MinorityInterest", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://interparfumsinc.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_MinorityInterestOwnershipPercentageByParent": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The parent entity's interest in net assets of the subsidiary, expressed as a percentage.", "label": "Ownership percentage" } } }, "localname": "MinorityInterestOwnershipPercentageByParent", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://interparfumsinc.com/role/RecentAgreementsDetailsNarrative" ], "xbrltype": "percentItemType" }, "us-gaap_NetCashProvidedByUsedInFinancingActivities": { "auth_ref": [ "r164" ], "calculation": { "http://interparfumsinc.com/role/ConsolidatedStatementsOfCashFlows": { "order": 3.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.", "label": "Net Cash Provided by (Used in) Financing Activities", "totalLabel": "Net cash used in financing activities" } } }, "localname": "NetCashProvidedByUsedInFinancingActivities", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://interparfumsinc.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Cash flows from financing activities:" } } }, "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://interparfumsinc.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_NetCashProvidedByUsedInInvestingActivities": { "auth_ref": [ "r164" ], "calculation": { "http://interparfumsinc.com/role/ConsolidatedStatementsOfCashFlows": { "order": 2.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.", "label": "Net Cash Provided by (Used in) Investing Activities", "totalLabel": "Net cash provided by (used in) investing activities" } } }, "localname": "NetCashProvidedByUsedInInvestingActivities", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://interparfumsinc.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Cash flows from investing activities:" } } }, "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://interparfumsinc.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_NetCashProvidedByUsedInOperatingActivities": { "auth_ref": [ "r99", "r100", "r101" ], "calculation": { "http://interparfumsinc.com/role/ConsolidatedStatementsOfCashFlows": { "order": 1.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0 } }, "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.", "label": "Net Cash Provided by (Used in) Operating Activities", "totalLabel": "Net cash used in operating activities" } } }, "localname": "NetCashProvidedByUsedInOperatingActivities", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://interparfumsinc.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Cash flows from operating activities:" } } }, "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://interparfumsinc.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_NetIncomeLoss": { "auth_ref": [ "r89", "r101", "r122", "r135", "r149", "r152", "r156", "r170", "r177", "r181", "r182", "r183", "r184", "r187", "r188", "r195", "r208", "r216", "r221", "r224", "r234", "r244", "r245", "r246", "r247", "r248", "r249", "r250", "r251", "r252", "r330", "r342", "r403", "r465", "r482", "r483", "r528", "r558", "r601" ], "calculation": { "http://interparfumsinc.com/role/ConsolidatedStatementsOfIncome": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.", "label": "Net income attributable to Inter Parfums, Inc.", "totalLabel": "Net income attributable to Inter Parfums, Inc." } } }, "localname": "NetIncomeLoss", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://interparfumsinc.com/role/ConsolidatedStatementsOfIncome", "http://interparfumsinc.com/role/InformationOnCompanysOperationsBySegmentsIsAsFollowsDetails", "http://interparfumsinc.com/role/ReconciliationBetweenNumeratorsAndDenominatorsOfBasicAndDilutedEpsComputationsIsAsFollowsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetIncomeLossAttributableToNoncontrollingInterest": { "auth_ref": [ "r62", "r111", "r149", "r152", "r187", "r188", "r402", "r589" ], "calculation": { "http://interparfumsinc.com/role/ConsolidatedStatementsOfComprehensiveIncome": { "order": 1.0, "parentTag": "us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest", "weight": 1.0 }, "http://interparfumsinc.com/role/ConsolidatedStatementsOfIncome": { "order": 2.0, "parentTag": "us-gaap_NetIncomeLoss", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of Net Income (Loss) attributable to noncontrolling interest.", "label": "Less:\u00a0\u00a0Net income attributable to the noncontrolling interest", "verboseLabel": "Net income" } } }, "localname": "NetIncomeLossAttributableToNoncontrollingInterest", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://interparfumsinc.com/role/ConsolidatedStatementsOfComprehensiveIncome", "http://interparfumsinc.com/role/ConsolidatedStatementsOfIncome" ], "xbrltype": "monetaryItemType" }, "us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock": { "auth_ref": [ "r128", "r129", "r131", "r134", "r175", "r176", "r179", "r180", "r189", "r190", "r236", "r237", "r301", "r302", "r303", "r323", "r327", "r331", "r332", "r333", "r343", "r344", "r345", "r364", "r365", "r375", "r383", "r384", "r385", "r414", "r415", "r416", "r417", "r418" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for change in accounting principle. Includes, but is not limited to, nature, reason, and method of adopting amendment to accounting standards or other change in accounting principle.", "label": "Recent Accounting Pronouncements:" } } }, "localname": "NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://interparfumsinc.com/role/RecentAccountingPronouncements" ], "xbrltype": "textBlockItemType" }, "us-gaap_NoncontrollingInterestMember": { "auth_ref": [ "r58", "r268", "r593", "r594", "r595", "r635" ], "lang": { "en-us": { "role": { "documentation": "This element represents that portion of equity (net assets) in a subsidiary not attributable, directly or indirectly, to the parent. A noncontrolling interest is sometimes called a minority interest.", "label": "Noncontrolling Interest [Member]" } } }, "localname": "NoncontrollingInterestMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://interparfumsinc.com/role/ConsolidatedStatementsOfChangesInEquity" ], "xbrltype": "domainItemType" }, "us-gaap_NonoperatingIncomeExpense": { "auth_ref": [ "r94" ], "calculation": { "http://interparfumsinc.com/role/ConsolidatedStatementsOfIncome": { "order": 2.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).", "label": "Nonoperating Income (Expense)", "negatedTotalLabel": "Nonoperating Income (Expense)" } } }, "localname": "NonoperatingIncomeExpense", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://interparfumsinc.com/role/ConsolidatedStatementsOfIncome" ], "xbrltype": "monetaryItemType" }, "us-gaap_NonoperatingIncomeExpenseAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Other expenses (income):" } } }, "localname": "NonoperatingIncomeExpenseAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://interparfumsinc.com/role/ConsolidatedStatementsOfIncome" ], "xbrltype": "stringItemType" }, "us-gaap_OperatingIncomeLoss": { "auth_ref": [ "r208", "r216", "r221", "r224", "r528" ], "calculation": { "http://interparfumsinc.com/role/ConsolidatedStatementsOfIncome": { "order": 1.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The net result for the period of deducting operating expenses from operating revenues.", "label": "Operating Income (Loss)", "totalLabel": "Income from operations" } } }, "localname": "OperatingIncomeLoss", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://interparfumsinc.com/role/ConsolidatedStatementsOfIncome" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseCost": { "auth_ref": [ "r370", "r545" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of single lease cost, calculated by allocation of remaining cost of lease over remaining lease term. Includes, but is not limited to, single lease cost, after impairment of right-of-use asset, calculated by amortization of remaining right-of-use asset and accretion of lease liability.", "label": "Noncash additions to operating lease assets" } } }, "localname": "OperatingLeaseCost", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://interparfumsinc.com/role/LeasesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseExpense": { "auth_ref": [ "r618" ], "calculation": { "http://interparfumsinc.com/role/ConsolidatedStatementsOfCashFlows": { "order": 6.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of operating lease expense. Excludes sublease income.", "label": "Noncash lease expense" } } }, "localname": "OperatingLeaseExpense", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://interparfumsinc.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseLiabilityCurrent": { "auth_ref": [ "r368" ], "calculation": { "http://interparfumsinc.com/role/ConsolidatedBalanceSheets": { "order": 3.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.", "label": "Current portion of lease liabilities" } } }, "localname": "OperatingLeaseLiabilityCurrent", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://interparfumsinc.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseLiabilityNoncurrent": { "auth_ref": [ "r368" ], "calculation": { "http://interparfumsinc.com/role/ConsolidatedBalanceSheets": { "order": 3.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.", "label": "Lease liabilities, less current portion" } } }, "localname": "OperatingLeaseLiabilityNoncurrent", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://interparfumsinc.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeasePayments": { "auth_ref": [ "r369", "r371" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.", "label": "Operating Lease, Payments" } } }, "localname": "OperatingLeasePayments", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://interparfumsinc.com/role/LeasesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseRightOfUseAsset": { "auth_ref": [ "r367" ], "calculation": { "http://interparfumsinc.com/role/ConsolidatedBalanceSheets": { "order": 3.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's right to use underlying asset under operating lease.", "label": "Right-of-use assets, net" } } }, "localname": "OperatingLeaseRightOfUseAsset", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://interparfumsinc.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent": { "auth_ref": [ "r373", "r545" ], "lang": { "en-us": { "role": { "documentation": "Weighted average discount rate for operating lease calculated at point in time.", "label": "Operating lease, weighted average discount rate, percent" } } }, "localname": "OperatingLeaseWeightedAverageDiscountRatePercent", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://interparfumsinc.com/role/LeasesDetailsNarrative" ], "xbrltype": "percentItemType" }, "us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1": { "auth_ref": [ "r372", "r545" ], "lang": { "en-us": { "role": { "documentation": "Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.", "label": "Operating lease, weighted average remaining lease term" } } }, "localname": "OperatingLeaseWeightedAverageRemainingLeaseTerm1", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://interparfumsinc.com/role/LeasesDetailsNarrative" ], "xbrltype": "durationItemType" }, "us-gaap_OperatingLeasesRentExpenseNet": { "auth_ref": [ "r124" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Rental expense for the reporting period incurred under operating leases, including minimum and any contingent rent expense, net of related sublease income.", "label": "Operating leases, rent expense, net" } } }, "localname": "OperatingLeasesRentExpenseNet", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://interparfumsinc.com/role/LeasesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherAssetsCurrent": { "auth_ref": [ "r144", "r546" ], "calculation": { "http://interparfumsinc.com/role/ConsolidatedBalanceSheets": { "order": 6.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of current assets classified as other.", "label": "Other current assets" } } }, "localname": "OtherAssetsCurrent", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://interparfumsinc.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherAssetsNoncurrent": { "auth_ref": [ "r138" ], "calculation": { "http://interparfumsinc.com/role/ConsolidatedBalanceSheets": { "order": 6.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of noncurrent assets classified as other.", "label": "Other assets" } } }, "localname": "OtherAssetsNoncurrent", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://interparfumsinc.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPortionAttributableToNoncontrollingInterest": { "auth_ref": [ "r8", "r12", "r110" ], "calculation": { "http://interparfumsinc.com/role/ConsolidatedStatementsOfComprehensiveIncome": { "order": 2.0, "parentTag": "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount after tax and reclassification adjustments, of increase (decrease) in accumulated gain (loss) from derivative instruments designated and qualifying as the effective portion of cash flow hedges and an entity's share of an equity investee's increase (decrease) in deferred hedging gain (loss), attributable to noncontrolling interests.", "label": "Other Comprehensive Income (Loss), Derivatives Qualifying as Hedges, Net of Tax, Portion Attributable to Noncontrolling Interest", "negatedLabel": "Net derivative instrument gain (loss), net of tax", "verboseLabel": "Net derivative instrument gain (loss), net of tax" } } }, "localname": "OtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPortionAttributableToNoncontrollingInterest", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://interparfumsinc.com/role/ConsolidatedStatementsOfChangesInEquity", "http://interparfumsinc.com/role/ConsolidatedStatementsOfComprehensiveIncome" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax": { "auth_ref": [ "r3", "r86", "r347", "r349", "r354" ], "calculation": { "http://interparfumsinc.com/role/ConsolidatedStatementsOfComprehensiveIncome": { "order": 3.0, "parentTag": "us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount after tax, before reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.", "label": "Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Gain (Loss) Arising During Period, Net of Tax", "negatedLabel": "Translation adjustments, net of tax" } } }, "localname": "OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://interparfumsinc.com/role/ConsolidatedStatementsOfComprehensiveIncome" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeForeignCurrencyTranslationGainLossArisingDuringPeriodTax": { "auth_ref": [ "r2", "r4", "r347", "r351", "r360" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of tax expense (benefit), before reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.", "label": "Foreign currency translation adjustment, net of tax" } } }, "localname": "OtherComprehensiveIncomeForeignCurrencyTranslationGainLossArisingDuringPeriodTax", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://interparfumsinc.com/role/ConsolidatedStatementsOfChangesInEquity" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax": { "auth_ref": [ "r2" ], "calculation": { "http://interparfumsinc.com/role/ConsolidatedStatementsOfComprehensiveIncome": { "order": 4.0, "parentTag": "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.", "label": "Translation adjustments, net of tax" } } }, "localname": "OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://interparfumsinc.com/role/ConsolidatedStatementsOfComprehensiveIncome" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Other comprehensive income:" } } }, "localname": "OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://interparfumsinc.com/role/ConsolidatedStatementsOfComprehensiveIncome" ], "xbrltype": "stringItemType" }, "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest": { "auth_ref": [ "r8", "r12", "r110", "r150", "r153" ], "calculation": { "http://interparfumsinc.com/role/ConsolidatedStatementsOfComprehensiveIncome": { "order": 2.0, "parentTag": "us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount after tax of other comprehensive income (loss) attributable to noncontrolling interests.", "label": "Net derivative instrument gain (loss), net of tax" } } }, "localname": "OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://interparfumsinc.com/role/ConsolidatedStatementsOfComprehensiveIncome" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesNetOfTax": { "auth_ref": [ "r6", "r19", "r86", "r148" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount after tax of reclassification adjustment from accumulated other comprehensive income of accumulated gain (loss) realized from derivative instruments designated and qualifying as the effective portion of cash flow hedges and an entity's share of an equity investee's deferred hedging gain (loss).", "label": "Transfer from other comprehensive income into earnings" } } }, "localname": "OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesNetOfTax", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://interparfumsinc.com/role/ConsolidatedStatementsOfChangesInEquity" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherDepreciationAndAmortization": { "auth_ref": [ "r10", "r47", "r92" ], "calculation": { "http://interparfumsinc.com/role/ConsolidatedStatementsOfCashFlows": { "order": 2.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of expense charged against earnings to allocate the cost of tangible and intangible assets over their remaining economic lives, classified as other.", "label": "Depreciation and amortization" } } }, "localname": "OtherDepreciationAndAmortization", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://interparfumsinc.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherNonoperatingIncomeExpense": { "auth_ref": [ "r95" ], "calculation": { "http://interparfumsinc.com/role/ConsolidatedStatementsOfIncome": { "order": 4.0, "parentTag": "us-gaap_NonoperatingIncomeExpense", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of income (expense) related to nonoperating activities, classified as other.", "label": "Other Nonoperating Income (Expense)", "negatedLabel": "Other income" } } }, "localname": "OtherNonoperatingIncomeExpense", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://interparfumsinc.com/role/ConsolidatedStatementsOfIncome" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherReceivablesNetCurrent": { "auth_ref": [], "calculation": { "http://interparfumsinc.com/role/ConsolidatedBalanceSheets": { "order": 5.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, after allowance, of receivables classified as other, due within one year or the operating cycle, if longer.", "label": "Receivables, other" } } }, "localname": "OtherReceivablesNetCurrent", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://interparfumsinc.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsForRepurchaseOfEquity": { "auth_ref": [ "r35", "r421" ], "calculation": { "http://interparfumsinc.com/role/ConsolidatedStatementsOfCashFlows": { "order": 6.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow to reacquire common and preferred stock.", "label": "Payments for Repurchase of Equity", "negatedLabel": "Purchase of treasury stock" } } }, "localname": "PaymentsForRepurchaseOfEquity", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://interparfumsinc.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsOfDividendsCommonStock": { "auth_ref": [ "r35" ], "calculation": { "http://interparfumsinc.com/role/ConsolidatedStatementsOfCashFlows": { "order": 4.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of cash outflow in the form of ordinary dividends to common shareholders of the parent entity.", "label": "Payments of Ordinary Dividends, Common Stock", "negatedLabel": "Dividends paid" } } }, "localname": "PaymentsOfDividendsCommonStock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://interparfumsinc.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsOfDividendsMinorityInterest": { "auth_ref": [ "r35" ], "calculation": { "http://interparfumsinc.com/role/ConsolidatedStatementsOfCashFlows": { "order": 5.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of cash outflow in the form of ordinary dividends provided by the non-wholly owned subsidiary to noncontrolling interests.", "label": "Payments of Ordinary Dividends, Noncontrolling Interest", "negatedLabel": "Dividends paid to noncontrolling interest" } } }, "localname": "PaymentsOfDividendsMinorityInterest", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://interparfumsinc.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsToAcquireIntangibleAssets": { "auth_ref": [ "r98" ], "calculation": { "http://interparfumsinc.com/role/ConsolidatedStatementsOfCashFlows": { "order": 4.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow to acquire asset without physical form usually arising from contractual or other legal rights, excluding goodwill.", "label": "Payments to Acquire Intangible Assets", "negatedLabel": "Payment for intangible assets acquired" } } }, "localname": "PaymentsToAcquireIntangibleAssets", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://interparfumsinc.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsToAcquireInvestments": { "auth_ref": [ "r97" ], "calculation": { "http://interparfumsinc.com/role/ConsolidatedStatementsOfCashFlows": { "order": 1.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow associated with the purchase of all investments (debt, security, other) during the period.", "label": "Payments to Acquire Investments", "negatedLabel": "Purchases of short-term investments" } } }, "localname": "PaymentsToAcquireInvestments", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://interparfumsinc.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsToAcquireProductiveAssets": { "auth_ref": [ "r125", "r609", "r610", "r611" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow for purchases of and capital improvements on property, plant and equipment (capital expenditures), software, and other intangible assets.", "label": "Purchase price, period cost" } } }, "localname": "PaymentsToAcquireProductiveAssets", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://interparfumsinc.com/role/RecentAgreementsDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsToAcquirePropertyPlantAndEquipment": { "auth_ref": [ "r98" ], "calculation": { "http://interparfumsinc.com/role/ConsolidatedStatementsOfCashFlows": { "order": 3.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.", "label": "Payments to Acquire Property, Plant, and Equipment", "negatedLabel": "Purchases of property, equipment and leasehold improvements" } } }, "localname": "PaymentsToAcquirePropertyPlantAndEquipment", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://interparfumsinc.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_PreferredStockParOrStatedValuePerShare": { "auth_ref": [ "r76", "r256" ], "lang": { "en-us": { "role": { "documentation": "Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.", "label": "Preferred stock, par or stated value per share" } } }, "localname": "PreferredStockParOrStatedValuePerShare", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://interparfumsinc.com/role/ConsolidatedBalanceSheetsParenthetical" ], "xbrltype": "perShareItemType" }, "us-gaap_PreferredStockSharesAuthorized": { "auth_ref": [ "r76", "r445" ], "lang": { "en-us": { "role": { "documentation": "The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.", "label": "Preferred stock, shares authorized" } } }, "localname": "PreferredStockSharesAuthorized", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://interparfumsinc.com/role/ConsolidatedBalanceSheetsParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_PreferredStockSharesIssued": { "auth_ref": [ "r76", "r256" ], "lang": { "en-us": { "role": { "documentation": "Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.", "label": "Preferred stock, shares issued" } } }, "localname": "PreferredStockSharesIssued", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://interparfumsinc.com/role/ConsolidatedBalanceSheetsParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_PreferredStockValue": { "auth_ref": [ "r76", "r393", "r546" ], "calculation": { "http://interparfumsinc.com/role/ConsolidatedBalanceSheets": { "order": 1.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.", "label": "Preferred stock, $.001 par; authorized 1,000,000 shares; none issued" } } }, "localname": "PreferredStockValue", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://interparfumsinc.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromIssuanceOfLongTermDebt": { "auth_ref": [ "r34", "r420" ], "calculation": { "http://interparfumsinc.com/role/ConsolidatedStatementsOfCashFlows": { "order": 1.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cash inflow from a debt initially having maturity due after one year or beyond the operating cycle, if longer.", "label": "Proceeds from issuance of long-term debt" } } }, "localname": "ProceedsFromIssuanceOfLongTermDebt", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://interparfumsinc.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromSaleMaturityAndCollectionsOfInvestments": { "auth_ref": [ "r33" ], "calculation": { "http://interparfumsinc.com/role/ConsolidatedStatementsOfCashFlows": { "order": 2.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cash inflow associated with the sale, maturity and collection of all investments such as debt, security and so forth during the period.", "label": "Proceeds from sale of short-term investments" } } }, "localname": "ProceedsFromSaleMaturityAndCollectionsOfInvestments", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://interparfumsinc.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromStockOptionsExercised": { "auth_ref": [ "r5", "r18" ], "calculation": { "http://interparfumsinc.com/role/ConsolidatedStatementsOfCashFlows": { "order": 3.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow from exercise of option under share-based payment arrangement.", "label": "Proceeds from exercise of options", "verboseLabel": "Cash proceeds from stock options exercised" } } }, "localname": "ProceedsFromStockOptionsExercised", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://interparfumsinc.com/role/CashProceedsTaxBenefitsAndIntrinsicValueRelatedToStockOptionsExercisedDuringThreeMonthsEndedMarch312023And2022WereAsFollowsDetails", "http://interparfumsinc.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProfitLoss": { "auth_ref": [ "r135", "r149", "r152", "r163", "r170", "r177", "r187", "r188", "r208", "r216", "r221", "r224", "r234", "r244", "r245", "r246", "r247", "r248", "r249", "r250", "r251", "r252", "r309", "r312", "r313", "r330", "r342", "r390", "r401", "r424", "r465", "r482", "r483", "r528", "r542", "r543", "r559", "r589", "r601" ], "calculation": { "http://interparfumsinc.com/role/ConsolidatedStatementsOfCashFlows": { "order": 1.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 }, "http://interparfumsinc.com/role/ConsolidatedStatementsOfComprehensiveIncome": { "order": 1.0, "parentTag": "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest", "weight": 1.0 }, "http://interparfumsinc.com/role/ConsolidatedStatementsOfIncome": { "order": 1.0, "parentTag": "us-gaap_NetIncomeLoss", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.", "label": "Net income", "totalLabel": "Net income" } } }, "localname": "ProfitLoss", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://interparfumsinc.com/role/ConsolidatedStatementsOfCashFlows", "http://interparfumsinc.com/role/ConsolidatedStatementsOfChangesInEquity", "http://interparfumsinc.com/role/ConsolidatedStatementsOfComprehensiveIncome", "http://interparfumsinc.com/role/ConsolidatedStatementsOfIncome" ], "xbrltype": "monetaryItemType" }, "us-gaap_PropertyPlantAndEquipmentByTypeAxis": { "auth_ref": [ "r11" ], "lang": { "en-us": { "role": { "documentation": "Information by type of long-lived, physical assets used to produce goods and services and not intended for resale.", "label": "Long-Lived Tangible Asset [Axis]" } } }, "localname": "PropertyPlantAndEquipmentByTypeAxis", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://interparfumsinc.com/role/RecentAgreementsDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_PropertyPlantAndEquipmentNet": { "auth_ref": [ "r11", "r391", "r399", "r546" ], "calculation": { "http://interparfumsinc.com/role/ConsolidatedBalanceSheets": { "order": 2.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.", "label": "Property, equipment and leasehold improvements, net" } } }, "localname": "PropertyPlantAndEquipmentNet", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://interparfumsinc.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_PropertyPlantAndEquipmentTypeDomain": { "auth_ref": [ "r104" ], "lang": { "en-us": { "role": { "documentation": "Listing of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale. Examples include land, buildings, machinery and equipment, and other types of furniture and equipment including, but not limited to, office equipment, furniture and fixtures, and computer equipment and software." } } }, "localname": "PropertyPlantAndEquipmentTypeDomain", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://interparfumsinc.com/role/RecentAgreementsDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_PropertyPlantAndEquipmentUsefulLife": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Useful life of long lived, physical assets used in the normal conduct of business and not intended for resale, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Examples include, but not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment.", "label": "Depreciated over a range" } } }, "localname": "PropertyPlantAndEquipmentUsefulLife", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://interparfumsinc.com/role/RecentAgreementsDetailsNarrative" ], "xbrltype": "durationItemType" }, "us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent": { "auth_ref": [ "r20", "r31" ], "calculation": { "http://interparfumsinc.com/role/ConsolidatedStatementsOfComprehensiveIncome": { "order": 3.0, "parentTag": "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount after tax of reclassification adjustments of other comprehensive income (loss) attributable to parent.", "label": "Reclassification from AOCI, Current Period, Net of Tax, Attributable to Parent", "negatedLabel": "Transfer from OCI into earnings" } } }, "localname": "ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://interparfumsinc.com/role/ConsolidatedStatementsOfComprehensiveIncome" ], "xbrltype": "monetaryItemType" }, "us-gaap_RepaymentsOfLongTermDebt": { "auth_ref": [ "r36", "r421" ], "calculation": { "http://interparfumsinc.com/role/ConsolidatedStatementsOfCashFlows": { "order": 2.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow for debt initially having maturity due after one year or beyond the normal operating cycle, if longer.", "label": "Repayments of Long-Term Debt", "negatedLabel": "Repayment of long-term debt" } } }, "localname": "RepaymentsOfLongTermDebt", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://interparfumsinc.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_RetainedEarningsAccumulatedDeficit": { "auth_ref": [ "r79", "r106", "r396", "r414", "r418", "r422", "r446", "r546" ], "calculation": { "http://interparfumsinc.com/role/ConsolidatedBalanceSheets": { "order": 4.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of accumulated undistributed earnings (deficit).", "label": "Retained earnings" } } }, "localname": "RetainedEarningsAccumulatedDeficit", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://interparfumsinc.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_RetainedEarningsMember": { "auth_ref": [ "r132", "r172", "r173", "r174", "r178", "r186", "r188", "r235", "r238", "r292", "r293", "r294", "r299", "r300", "r318", "r320", "r321", "r324", "r328", "r411", "r413", "r425", "r635" ], "lang": { "en-us": { "role": { "documentation": "Accumulated undistributed earnings (deficit).", "label": "Retained Earnings [Member]" } } }, "localname": "RetainedEarningsMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://interparfumsinc.com/role/ConsolidatedStatementsOfChangesInEquity" ], "xbrltype": "domainItemType" }, "us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax": { "auth_ref": [ "r209", "r210", "r215", "r219", "r220", "r226", "r228", "r230", "r269", "r270", "r382" ], "calculation": { "http://interparfumsinc.com/role/ConsolidatedStatementsOfIncome": { "order": 1.0, "parentTag": "us-gaap_GrossProfit", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, including tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value-added and excise.", "label": "Net sales" } } }, "localname": "RevenueFromContractWithCustomerIncludingAssessedTax", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://interparfumsinc.com/role/ConsolidatedStatementsOfIncome", "http://interparfumsinc.com/role/InformationOnCompanysOperationsBySegmentsIsAsFollowsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Revenues from External Customers and Long-Lived Assets [Line Items]" } } }, "localname": "RevenuesFromExternalCustomersAndLongLivedAssetsLineItems", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://interparfumsinc.com/role/InformationOnCompanysOperationsBySegmentsIsAsFollowsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable": { "auth_ref": [ "r55", "r57", "r307" ], "lang": { "en-us": { "role": { "documentation": "Schedule reflecting each material business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities.", "label": "Schedule of Business Acquisitions, by Acquisition [Table]" } } }, "localname": "ScheduleOfBusinessAcquisitionsByAcquisitionTable", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://interparfumsinc.com/role/RecentAgreementsDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock": { "auth_ref": [ "r596" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.", "label": "The reconciliation between the numerators and denominators of the basic and diluted EPS computations is as follows:" } } }, "localname": "ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://interparfumsinc.com/role/NetIncomeAttributableToInterParfumsInc.CommonShareholdersTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock": { "auth_ref": [ "r335", "r336" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of assets and liabilities, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).", "label": "The following tables present our financial assets and liabilities that are measured at fair value on a recurring basis and are categorized using the fair value hierarchy. The fair value hierarchy has three levels based on the reliability of the inputs used to determine fair value." } } }, "localname": "ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://interparfumsinc.com/role/FairValueMeasurementTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfInventoryCurrentTableTextBlock": { "auth_ref": [ "r22", "r83", "r84", "r85" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the carrying amount as of the balance sheet date of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process.", "label": "Inventories consist of the following:" } } }, "localname": "ScheduleOfInventoryCurrentTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://interparfumsinc.com/role/InventoriesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfNonvestedShareActivityTableTextBlock": { "auth_ref": [ "r52" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the changes in outstanding nonvested shares.", "label": "The following table sets forth information with respect to nonvested options for the three months ended March 31, 2023:" } } }, "localname": "ScheduleOfNonvestedShareActivityTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://interparfumsinc.com/role/Share-basedPaymentsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable": { "auth_ref": [ "r43", "r87" ], "lang": { "en-us": { "role": { "documentation": "Schedule of material long-lived assets (excluding financial instruments, customer relationships with financial institutions, mortgage and other servicing rights, deferred policy acquisition costs, and deferred taxes assets) located in identified geographic areas and/or the amount of revenue from external customers attributed to that country from which revenue is material. An entity may also provide subtotals of geographic information about groups of countries.", "label": "Schedule of Revenues from External Customers and Long-Lived Assets [Table]" } } }, "localname": "ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://interparfumsinc.com/role/InformationOnCompanysOperationsBySegmentsIsAsFollowsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock": { "auth_ref": [ "r40", "r41", "r42", "r44" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.", "label": "Information on the Company\u2019s operations by segments is as follows:" } } }, "localname": "ScheduleOfSegmentReportingInformationBySegmentTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://interparfumsinc.com/role/SegmentAndGeographicAreasTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock": { "auth_ref": [ "r16", "r17", "r51" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value.", "label": "The following table summarizes stock option information as of March 31, 2023:" } } }, "localname": "ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://interparfumsinc.com/role/Share-basedPaymentsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfSubsidiaryOrEquityMethodInvesteeTable": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Schedule of subsidiary's sales of previously unissued stock made to investors outside the consolidated group. This includes stock issued in a business combination in exchange for shares of an acquired entity.", "label": "Schedule of Subsidiary or Equity Method Investee [Table]" } } }, "localname": "ScheduleOfSubsidiaryOrEquityMethodInvesteeTable", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://interparfumsinc.com/role/Share-basedPaymentsDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_SegmentReportingAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Segment Reporting [Abstract]" } } }, "localname": "SegmentReportingAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "xbrltype": "stringItemType" }, "us-gaap_SegmentReportingDisclosureTextBlock": { "auth_ref": [ "r204", "r205", "r206", "r207", "r208", "r214", "r218", "r222", "r223", "r224", "r225", "r226", "r227", "r230" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.", "label": "Segment and Geographic Areas:" } } }, "localname": "SegmentReportingDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://interparfumsinc.com/role/SegmentAndGeographicAreas" ], "xbrltype": "textBlockItemType" }, "us-gaap_SellingGeneralAndAdministrativeExpense": { "auth_ref": [ "r93" ], "calculation": { "http://interparfumsinc.com/role/ConsolidatedStatementsOfIncome": { "order": 2.0, "parentTag": "us-gaap_OperatingIncomeLoss", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc.", "label": "Selling, general and administrative expenses" } } }, "localname": "SellingGeneralAndAdministrativeExpense", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://interparfumsinc.com/role/ConsolidatedStatementsOfIncome" ], "xbrltype": "monetaryItemType" }, "us-gaap_ShareBasedCompensation": { "auth_ref": [ "r9" ], "calculation": { "http://interparfumsinc.com/role/ConsolidatedStatementsOfCashFlows": { "order": 4.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of noncash expense for share-based payment arrangement.", "label": "Noncash stock compensation" } } }, "localname": "ShareBasedCompensation", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://interparfumsinc.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1": { "auth_ref": [ "r540" ], "lang": { "en-us": { "role": { "documentation": "Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition.", "label": "Options vesting period" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://interparfumsinc.com/role/Share-basedPaymentsDetailsNarrative" ], "xbrltype": "durationItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized": { "auth_ref": [ "r541" ], "lang": { "en-us": { "role": { "documentation": "Number of shares authorized for issuance under share-based payment arrangement.", "label": "Aggregate shares to offices and managers" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://interparfumsinc.com/role/Share-basedPaymentsDetailsNarrative" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant": { "auth_ref": [ "r50" ], "lang": { "en-us": { "role": { "documentation": "The difference between the maximum number of shares (or other type of equity) authorized for issuance under the plan (including the effects of amendments and adjustments), and the sum of: 1) the number of shares (or other type of equity) already issued upon exercise of options or other equity-based awards under the plan; and 2) shares (or other type of equity) reserved for issuance on granting of outstanding awards, net of cancellations and forfeitures, if applicable.", "label": "Options available for future grants" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://interparfumsinc.com/role/FollowingTableSummarizesStockOptionInformationAsOfMarch312023Details" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber": { "auth_ref": [ "r281" ], "lang": { "en-us": { "role": { "documentation": "The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan.", "label": "Options exercisable" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://interparfumsinc.com/role/FollowingTableSummarizesStockOptionInformationAsOfMarch312023Details" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice": { "auth_ref": [ "r281" ], "lang": { "en-us": { "role": { "documentation": "The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan.", "label": "Weighted average exercise price options exercisable" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://interparfumsinc.com/role/FollowingTableSummarizesStockOptionInformationAsOfMarch312023Details" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue": { "auth_ref": [ "r286" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of accumulated difference between fair value of underlying shares on dates of exercise and exercise price on options exercised (or share units converted) into shares.", "label": "Intrinsic value of stock options exercised" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://interparfumsinc.com/role/CashProceedsTaxBenefitsAndIntrinsicValueRelatedToStockOptionsExercisedDuringThreeMonthsEndedMarch312023And2022WereAsFollowsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod": { "auth_ref": [ "r284" ], "lang": { "en-us": { "role": { "documentation": "The number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures in Period", "negatedLabel": "Options forfeited" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://interparfumsinc.com/role/FollowingTableSummarizesStockOptionInformationAsOfMarch312023Details" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod": { "auth_ref": [ "r608" ], "lang": { "en-us": { "role": { "documentation": "Net number of share options (or share units) granted during the period.", "label": "Options granted" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://interparfumsinc.com/role/Share-basedPaymentsDetailsNarrative" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross": { "auth_ref": [ "r282" ], "lang": { "en-us": { "role": { "documentation": "Gross number of share options (or share units) granted during the period.", "label": "Nonvested options granted" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://interparfumsinc.com/role/FollowingTableSetsForthInformationWithRespectToNonvestedOptionsForThreeMonthsEndedMarch312023Details" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": { "auth_ref": [ "r285" ], "lang": { "en-us": { "role": { "documentation": "The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology.", "label": "Weighted average grant date fair value, nonvested options granted" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://interparfumsinc.com/role/FollowingTableSetsForthInformationWithRespectToNonvestedOptionsForThreeMonthsEndedMarch312023Details" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue": { "auth_ref": [ "r50" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding.", "label": "Aggregate intrinsic value of options outstanding and options outstanding" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://interparfumsinc.com/role/Share-basedPaymentsDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber": { "auth_ref": [ "r279", "r280" ], "lang": { "en-us": { "role": { "documentation": "Number of options outstanding, including both vested and non-vested options.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number", "periodEndLabel": "Options shares under option - end of year", "periodStartLabel": "Options shares under option - beginning of year" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://interparfumsinc.com/role/FollowingTableSummarizesStockOptionInformationAsOfMarch312023Details" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice": { "auth_ref": [ "r279", "r280" ], "lang": { "en-us": { "role": { "documentation": "Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price", "periodEndLabel": "Weighted average exercise price shares under option - end of year", "periodStartLabel": "Weighted average exercise price shares under option - beginning of year" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://interparfumsinc.com/role/FollowingTableSummarizesStockOptionInformationAsOfMarch312023Details" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOtherShareIncreaseDecrease": { "auth_ref": [ "r50" ], "lang": { "en-us": { "role": { "documentation": "Other than shares newly issued, the number of additional shares issued (for example, a stock split) or canceled (for example, to correct a share issuance), during the period under the plan.", "label": "Decreased income" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOtherShareIncreaseDecrease", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://interparfumsinc.com/role/Share-basedPaymentsDetailsNarrative" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice": { "auth_ref": [ "r283" ], "lang": { "en-us": { "role": { "documentation": "Weighted average price at which option holders acquired shares when converting their stock options into shares.", "label": "Weighted average exercise price options exercised" } } }, "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://interparfumsinc.com/role/FollowingTableSummarizesStockOptionInformationAsOfMarch312023Details" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice": { "auth_ref": [ "r284" ], "lang": { "en-us": { "role": { "documentation": "Weighted average price at which grantees could have acquired the underlying shares with respect to stock options that were terminated.", "label": "Weighted average exercise price options forfeited" } } }, "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://interparfumsinc.com/role/FollowingTableSummarizesStockOptionInformationAsOfMarch312023Details" ], "xbrltype": "perShareItemType" }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1": { "auth_ref": [ "r50" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of difference between fair value of the underlying shares reserved for issuance and exercise price of vested portions of options outstanding and currently exercisable.", "label": "Aggregate intrinsic value of options outstanding and options exercisable" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://interparfumsinc.com/role/Share-basedPaymentsDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1": { "auth_ref": [ "r50" ], "lang": { "en-us": { "role": { "documentation": "Weighted average remaining contractual term for vested portions of options outstanding and currently exercisable or convertible, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.", "label": "Weighted average remaining contractual life of options exercisable (in years)" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://interparfumsinc.com/role/Share-basedPaymentsDetailsNarrative" ], "xbrltype": "durationItemType" }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of non-vested options outstanding.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Nonvested, Number of Shares", "periodEndLabel": "Nonvested options end of period", "periodStartLabel": "Nonvested options beginning of period" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://interparfumsinc.com/role/FollowingTableSetsForthInformationWithRespectToNonvestedOptionsForThreeMonthsEndedMarch312023Details" ], "xbrltype": "sharesItemType" }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of non-vested options forfeited.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Nonvested Options Forfeited, Number of Shares", "negatedLabel": "Nonvested options vested or forfeited" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://interparfumsinc.com/role/FollowingTableSetsForthInformationWithRespectToNonvestedOptionsForThreeMonthsEndedMarch312023Details" ], "xbrltype": "sharesItemType" }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Weighted average grant-date fair value of non-vested options forfeited.", "label": "Weighted average grant date fair value, nonvested options vested or forfeited" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://interparfumsinc.com/role/FollowingTableSetsForthInformationWithRespectToNonvestedOptionsForThreeMonthsEndedMarch312023Details" ], "xbrltype": "perShareItemType" }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Weighted average grant-date fair value of non-vested options outstanding.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Option, Nonvested, Weighted Average Exercise Price", "periodEndLabel": "Weighted average grant date fair value, nonvested options end of period", "periodStartLabel": "Weighted average grant date fair value, beginning of year" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://interparfumsinc.com/role/FollowingTableSetsForthInformationWithRespectToNonvestedOptionsForThreeMonthsEndedMarch312023Details" ], "xbrltype": "perShareItemType" }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2": { "auth_ref": [ "r107" ], "lang": { "en-us": { "role": { "documentation": "Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.", "label": "Weighted average remaining contractual life of options outstanding (in years)" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://interparfumsinc.com/role/Share-basedPaymentsDetailsNarrative" ], "xbrltype": "durationItemType" }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1": { "auth_ref": [ "r286" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Fair value of options vested. Excludes equity instruments other than options, for example, but not limited to, share units, stock appreciation rights, restricted stock.", "label": "Fair value of shares vested" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://interparfumsinc.com/role/Share-basedPaymentsDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_ShortTermInvestments": { "auth_ref": [ "r119", "r120", "r586" ], "calculation": { "http://interparfumsinc.com/role/ConsolidatedBalanceSheets": { "order": 2.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of investments including trading securities, available-for-sale securities, held-to-maturity securities, and short-term investments classified as other and current.", "label": "Short-term investments" } } }, "localname": "ShortTermInvestments", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://interparfumsinc.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_SignificantAccountingPoliciesTextBlock": { "auth_ref": [ "r102", "r168" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for all significant accounting policies of the reporting entity.", "label": "Significant Accounting Policies:" } } }, "localname": "SignificantAccountingPoliciesTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://interparfumsinc.com/role/SignificantAccountingPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_StatementEquityComponentsAxis": { "auth_ref": [ "r14", "r28", "r132", "r154", "r155", "r156", "r172", "r173", "r174", "r178", "r186", "r188", "r203", "r235", "r238", "r268", "r292", "r293", "r294", "r299", "r300", "r318", "r319", "r320", "r321", "r322", "r324", "r328", "r355", "r356", "r357", "r358", "r359", "r361", "r374", "r411", "r412", "r413", "r425", "r484" ], "lang": { "en-us": { "role": { "documentation": "Information by component of equity.", "label": "Equity Components [Axis]" } } }, "localname": "StatementEquityComponentsAxis", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://interparfumsinc.com/role/ConsolidatedStatementsOfChangesInEquity", "http://interparfumsinc.com/role/Share-basedPaymentsDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_StatementLineItems": { "auth_ref": [ "r172", "r173", "r174", "r203", "r382", "r419", "r426", "r438", "r439", "r440", "r441", "r443", "r444", "r445", "r448", "r449", "r450", "r451", "r452", "r453", "r454", "r455", "r456", "r458", "r459", "r460", "r461", "r462", "r464", "r466", "r467", "r469", "r470", "r471", "r472", "r473", "r474", "r475", "r476", "r477", "r478", "r479", "r480", "r484", "r551" ], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Statement [Line Items]" } } }, "localname": "StatementLineItems", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://interparfumsinc.com/role/ConsolidatedStatementsOfChangesInEquity" ], "xbrltype": "stringItemType" }, "us-gaap_StatementOfCashFlowsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Statement of Cash Flows [Abstract]" } } }, "localname": "StatementOfCashFlowsAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "xbrltype": "stringItemType" }, "us-gaap_StatementOfFinancialPositionAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Statement of Financial Position [Abstract]" } } }, "localname": "StatementOfFinancialPositionAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "xbrltype": "stringItemType" }, "us-gaap_StatementOfStockholdersEquityAbstract": { "auth_ref": [], "localname": "StatementOfStockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "xbrltype": "stringItemType" }, "us-gaap_StatementTable": { "auth_ref": [ "r172", "r173", "r174", "r203", "r382", "r419", "r426", "r438", "r439", "r440", "r441", "r443", "r444", "r445", "r448", "r449", "r450", "r451", "r452", "r453", "r454", "r455", "r456", "r458", "r459", "r460", "r461", "r462", "r464", "r466", "r467", "r469", "r470", "r471", "r472", "r473", "r474", "r475", "r476", "r477", "r478", "r479", "r480", "r484", "r551" ], "lang": { "en-us": { "role": { "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed.", "label": "Statement [Table]" } } }, "localname": "StatementTable", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://interparfumsinc.com/role/ConsolidatedStatementsOfChangesInEquity" ], "xbrltype": "stringItemType" }, "us-gaap_StockIssuedDuringPeriodSharesNewIssues": { "auth_ref": [ "r14", "r76", "r77", "r106", "r420", "r484", "r505" ], "lang": { "en-us": { "role": { "documentation": "Number of new stock issued during the period.", "label": "Shares issue" } } }, "localname": "StockIssuedDuringPeriodSharesNewIssues", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://interparfumsinc.com/role/RecentAgreementsDetailsNarrative" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised": { "auth_ref": [ "r14", "r76", "r77", "r106", "r283" ], "lang": { "en-us": { "role": { "documentation": "Number of share options (or share units) exercised during the current period.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period", "negatedLabel": "Options exercised" } } }, "localname": "StockIssuedDuringPeriodSharesStockOptionsExercised", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://interparfumsinc.com/role/FollowingTableSummarizesStockOptionInformationAsOfMarch312023Details" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodSharesStockSplits": { "auth_ref": [ "r14", "r76", "r77", "r106" ], "lang": { "en-us": { "role": { "documentation": "Number of shares issued during the period as a result of a stock split.", "label": "Adjusted for stock splits" } } }, "localname": "StockIssuedDuringPeriodSharesStockSplits", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://interparfumsinc.com/role/Share-basedPaymentsDetailsNarrative" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodValueNewIssues": { "auth_ref": [ "r14", "r76", "r77", "r106", "r425", "r484", "r505", "r559" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering.", "label": "Shares value" } } }, "localname": "StockIssuedDuringPeriodValueNewIssues", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://interparfumsinc.com/role/RecentAgreementsDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation": { "auth_ref": [ "r53", "r76", "r77", "r106" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Value, after forfeiture, of shares issued under share-based payment arrangement. Excludes employee stock ownership plan (ESOP).", "label": "Share-based compensation" } } }, "localname": "StockIssuedDuringPeriodValueShareBasedCompensation", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://interparfumsinc.com/role/ConsolidatedStatementsOfChangesInEquity" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised": { "auth_ref": [ "r14", "r28", "r106" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Value of stock issued as a result of the exercise of stock options.", "label": "Shares issued upon exercise of stock options" } } }, "localname": "StockIssuedDuringPeriodValueStockOptionsExercised", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://interparfumsinc.com/role/ConsolidatedStatementsOfChangesInEquity" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockOptionMember": { "auth_ref": [ "r550" ], "lang": { "en-us": { "role": { "documentation": "Contracts conveying rights, but not obligations, to buy or sell a specific quantity of stock at a specified price during a specified period (an American option) or at a specified date (a European option).", "label": "Equity Option [Member]" } } }, "localname": "StockOptionMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://interparfumsinc.com/role/Share-basedPaymentsDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_StockRepurchasedDuringPeriodShares": { "auth_ref": [ "r14", "r76", "r77", "r106", "r421", "r484", "r506" ], "lang": { "en-us": { "role": { "documentation": "Number of shares that have been repurchased during the period and have not been retired and are not held in treasury. Some state laws may govern the circumstances under which an entity may acquire its own stock and prescribe the accounting treatment therefore. This element is used when state law does not recognize treasury stock.", "label": "Shares repurchased" } } }, "localname": "StockRepurchasedDuringPeriodShares", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://interparfumsinc.com/role/Share-basedPaymentsDetailsNarrative" ], "xbrltype": "sharesItemType" }, "us-gaap_StockRepurchasedDuringPeriodValue": { "auth_ref": [ "r14", "r76", "r77", "r106", "r425", "r484", "r506", "r559" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Equity impact of the value of stock that has been repurchased during the period and has not been retired and is not held in treasury. Some state laws may mandate the circumstances under which an entity may acquire its own stock and prescribe the accounting treatment therefore. This element is used when state law does not recognize treasury stock.", "label": "Stock Repurchased During Period, Value", "negatedLabel": "Shares repurchased" } } }, "localname": "StockRepurchasedDuringPeriodValue", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://interparfumsinc.com/role/ConsolidatedStatementsOfChangesInEquity" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockholdersEquity": { "auth_ref": [ "r77", "r80", "r81", "r103", "r447", "r463", "r485", "r486", "r546", "r560", "r591", "r598", "r616", "r635" ], "calculation": { "http://interparfumsinc.com/role/ConsolidatedBalanceSheets": { "order": 1.0, "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest.", "label": "Equity, Attributable to Parent", "totalLabel": "Total Inter Parfums, Inc. shareholders\u2019 equity" } } }, "localname": "StockholdersEquity", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://interparfumsinc.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockholdersEquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Inter Parfums, Inc. shareholders\u2019 equity:" } } }, "localname": "StockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://interparfumsinc.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest": { "auth_ref": [ "r58", "r59", "r61", "r132", "r133", "r155", "r172", "r173", "r174", "r178", "r186", "r235", "r238", "r268", "r292", "r293", "r294", "r299", "r300", "r318", "r319", "r320", "r321", "r322", "r324", "r328", "r355", "r356", "r361", "r374", "r412", "r413", "r423", "r447", "r463", "r485", "r486", "r507", "r559", "r591", "r598", "r616", "r635" ], "calculation": { "http://interparfumsinc.com/role/ConsolidatedBalanceSheets": { "order": 4.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of equity (deficit) attributable to parent and noncontrolling interest. Excludes temporary equity.", "label": "Equity, Including Portion Attributable to Noncontrolling Interest", "periodEndLabel": "Ending Balance", "periodStartLabel": "Beginning Balance", "totalLabel": "Total equity" } } }, "localname": "StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://interparfumsinc.com/role/ConsolidatedBalanceSheets", "http://interparfumsinc.com/role/ConsolidatedStatementsOfChangesInEquity" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockholdersEquityNoteDisclosureTextBlock": { "auth_ref": [ "r105", "r169", "r255", "r257", "r258", "r259", "r260", "r261", "r262", "r263", "r264", "r265", "r266", "r267", "r268", "r326", "r487", "r488", "r508" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for equity.", "label": "Share-Based Payments:" } } }, "localname": "StockholdersEquityNoteDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://interparfumsinc.com/role/Share-basedPayments" ], "xbrltype": "textBlockItemType" }, "us-gaap_SubsidiaryOrEquityMethodInvesteeLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Subsidiary or Equity Method Investee [Line Items]" } } }, "localname": "SubsidiaryOrEquityMethodInvesteeLineItems", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://interparfumsinc.com/role/Share-basedPaymentsDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_SupplementalCashFlowInformationAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Cash paid for:" } } }, "localname": "SupplementalCashFlowInformationAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://interparfumsinc.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_TreasuryStockCommonMember": { "auth_ref": [ "r48" ], "lang": { "en-us": { "role": { "documentation": "Previously issued common shares repurchased by the issuing entity and held in treasury.", "label": "Treasury Stock, Common [Member]" } } }, "localname": "TreasuryStockCommonMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://interparfumsinc.com/role/ConsolidatedStatementsOfChangesInEquity", "http://interparfumsinc.com/role/Share-basedPaymentsDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_TreasuryStockCommonShares": { "auth_ref": [ "r48" ], "lang": { "en-us": { "role": { "documentation": "Number of previously issued common shares repurchased by the issuing entity and held in treasury.", "label": "Treasury stock, shares" } } }, "localname": "TreasuryStockCommonShares", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://interparfumsinc.com/role/ConsolidatedBalanceSheetsParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_TreasuryStockValue": { "auth_ref": [ "r27", "r48", "r49" ], "calculation": { "http://interparfumsinc.com/role/ConsolidatedBalanceSheets": { "order": 6.0, "parentTag": "us-gaap_StockholdersEquity", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount allocated to treasury stock. Treasury stock is common and preferred shares of an entity that were issued, repurchased by the entity, and are held in its treasury.", "label": "Treasury Stock, Value", "negatedLabel": "Treasury stock, at cost, 9,907,865 and 9,864,805 shares at March 31, 2023 and December 31, 2022, respectively" } } }, "localname": "TreasuryStockValue", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://interparfumsinc.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_UnusualOrInfrequentItemsDisclosureTextBlock": { "auth_ref": [ "r96" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for an event or transaction that is unusual in nature or infrequent in occurrence, or both.", "label": "Impact of COVID-19 Pandemic:" } } }, "localname": "UnusualOrInfrequentItemsDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://interparfumsinc.com/role/ImpactOfCovid-19Pandemic" ], "xbrltype": "textBlockItemType" }, "us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment": { "auth_ref": [ "r596" ], "calculation": { "http://interparfumsinc.com/role/ReconciliationBetweenNumeratorsAndDenominatorsOfBasicAndDilutedEpsComputationsIsAsFollowsDetails": { "order": 2.0, "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding", "weight": 1.0 } }, "lang": { "en-us": { "role": { "documentation": "The sum of dilutive potential common shares or units used in the calculation of the diluted per-share or per-unit computation.", "label": "Stock options" } } }, "localname": "WeightedAverageNumberDilutedSharesOutstandingAdjustment", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://interparfumsinc.com/role/ReconciliationBetweenNumeratorsAndDenominatorsOfBasicAndDilutedEpsComputationsIsAsFollowsDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": { "auth_ref": [ "r193", "r198" ], "calculation": { "http://interparfumsinc.com/role/ReconciliationBetweenNumeratorsAndDenominatorsOfBasicAndDilutedEpsComputationsIsAsFollowsDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "lang": { "en-us": { "role": { "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.", "label": "Denominator for diluted earnings per share", "verboseLabel": "Diluted" } } }, "localname": "WeightedAverageNumberOfDilutedSharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://interparfumsinc.com/role/ConsolidatedStatementsOfIncome", "http://interparfumsinc.com/role/ReconciliationBetweenNumeratorsAndDenominatorsOfBasicAndDilutedEpsComputationsIsAsFollowsDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Weighted average number of shares outstanding:", "verboseLabel": "Denominator:" } } }, "localname": "WeightedAverageNumberOfSharesOutstandingAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://interparfumsinc.com/role/ConsolidatedStatementsOfIncome", "http://interparfumsinc.com/role/ReconciliationBetweenNumeratorsAndDenominatorsOfBasicAndDilutedEpsComputationsIsAsFollowsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": { "auth_ref": [ "r192", "r198" ], "calculation": { "http://interparfumsinc.com/role/ReconciliationBetweenNumeratorsAndDenominatorsOfBasicAndDilutedEpsComputationsIsAsFollowsDetails": { "order": 1.0, "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding", "weight": 1.0 } }, "lang": { "en-us": { "role": { "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.", "label": "Weighted average shares", "verboseLabel": "Basic" } } }, "localname": "WeightedAverageNumberOfSharesOutstandingBasic", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://interparfumsinc.com/role/ConsolidatedStatementsOfIncome", "http://interparfumsinc.com/role/ReconciliationBetweenNumeratorsAndDenominatorsOfBasicAndDilutedEpsComputationsIsAsFollowsDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Numerator:" } } }, "localname": "WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://interparfumsinc.com/role/ReconciliationBetweenNumeratorsAndDenominatorsOfBasicAndDilutedEpsComputationsIsAsFollowsDetails" ], "xbrltype": "stringItemType" } }, "unitCount": 7 } }, "std_ref": { "r0": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "230", "Topic": "830", "URI": "https://asc.fasb.org//1943274/2147481877/830-230-45-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r1": { "Name": "Accounting Standards Codification", "Paragraph": "10A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-10A", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r10": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r100": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-25", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r101": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r102": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "235", "URI": "https://asc.fasb.org//235/tableOfContent", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r103": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 4.E)", "Topic": "310", "URI": "https://asc.fasb.org//1943274/2147480418/310-10-S99-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r104": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "360", "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r105": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "505", "URI": "https://asc.fasb.org//505/tableOfContent", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r106": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.3-04)", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147480008/505-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r107": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)(1)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r108": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 6.I.7)", "Topic": "740", "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r109": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "805", "URI": "https://asc.fasb.org//805/tableOfContent", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r11": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "360", "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r110": { "Name": "Accounting Standards Codification", "Paragraph": "19", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "810", "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-19", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r111": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(2)", "Topic": "810", "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-1A", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r112": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "815", "URI": "https://asc.fasb.org//815/tableOfContent", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r113": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-10(c)(3)(ii)(A))", "Topic": "932", "URI": "https://asc.fasb.org//1943274/2147479664/932-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r114": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-10(c)(7)(ii))", "Topic": "932", "URI": "https://asc.fasb.org//1943274/2147479664/932-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r115": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(11))", "Topic": "942", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r116": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(16))", "Topic": "942", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r117": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(22))", "Topic": "942", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r118": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(23))", "Topic": "942", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r119": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(4))", "Topic": "942", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r12": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(3)", "Topic": "810", "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-1A", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r120": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(5))", "Topic": "942", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r121": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(13)(f))", "Topic": "942", "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r122": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(22))", "Topic": "942", "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r123": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04.9)", "Topic": "942", "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r124": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "840", "URI": "https://asc.fasb.org//1943274/2147481501/840-20-50-1", "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef" }, "r125": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-13", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r126": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "740", "URI": "https://asc.fasb.org//1943274/2147482659/740-20-45-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r127": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "740", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-9", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r128": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "20", "Subparagraph": "(d)(1)", "Topic": "310", "URI": "https://asc.fasb.org//1943274/2147481925/310-20-65-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r129": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "20", "Subparagraph": "(d)(2)", "Topic": "310", "URI": "https://asc.fasb.org//1943274/2147481925/310-20-65-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r13": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c),(3)", "Topic": "810", "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-1A", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r130": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(h))", "Topic": "235", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r131": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "250", "URI": "https://asc.fasb.org//250/tableOfContent", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r132": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "105", "URI": "https://asc.fasb.org//1943274/2147479343/105-10-65-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r133": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "105", "URI": "https://asc.fasb.org//1943274/2147479343/105-10-65-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r134": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "105", "URI": "https://asc.fasb.org//1943274/2147479343/105-10-65-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r135": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "205", "URI": "https://asc.fasb.org//1943274/2147483499/205-20-50-7", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r136": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147483467/210-10-45-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r137": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147483467/210-10-45-5", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r138": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(17))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r139": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(18))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r14": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r140": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(20))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r141": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(22))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r142": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30)(a)(4))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r143": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(6))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r144": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(8))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r145": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(9))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r146": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147483466/210-20-50-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r147": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147483444/210-20-55-10", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r148": { "Name": "Accounting Standards Codification", "Paragraph": "17A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-17A", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r149": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-1A", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r15": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r150": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-1A", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r151": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-1A", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r152": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-1B", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r153": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-1B", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r154": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-4", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r155": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-5", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r156": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r157": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(210.5-03(11))", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r158": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(22))", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r159": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(23))", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r16": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r160": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(24))", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r161": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(25))", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r162": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-17", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r163": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r164": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r165": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-25", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r166": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r167": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-8", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r168": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "235", "URI": "https://asc.fasb.org//1943274/2147483426/235-10-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r169": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(e)(1))", "Topic": "235", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r17": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r170": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(g)(1)(ii))", "Topic": "235", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r171": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.12-04(a))", "Topic": "235", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r172": { "Name": "Accounting Standards Codification", "Paragraph": "23", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-23", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r173": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r174": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-5", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r175": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "250", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r176": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(1)", "Topic": "250", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r177": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(2)", "Topic": "250", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r178": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(3)", "Topic": "250", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r179": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(4)", "Topic": "250", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r18": { "Name": "Accounting Standards Codification", "Paragraph": "2A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2A", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r180": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)", "Topic": "250", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r181": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "250", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-11", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r182": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-11", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r183": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r184": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-4", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r185": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "250", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-7", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r186": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-7", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r187": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-8", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r188": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-9", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r189": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 11.M.Q2)", "Topic": "250", "URI": "https://asc.fasb.org//1943274/2147480530/250-10-S99-5", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r19": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "c", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r190": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org//1943274/2147480530/250-10-S99-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r191": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "260", "URI": "https://asc.fasb.org//260/tableOfContent", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r192": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-10", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r193": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-16", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r194": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r195": { "Name": "Accounting Standards Codification", "Paragraph": "60B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "260", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-60B", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r196": { "Name": "Accounting Standards Codification", "Paragraph": "60B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "260", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-60B", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r197": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-7", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r198": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "260", "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r199": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "260", "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r2": { "Name": "Accounting Standards Codification", "Paragraph": "10A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-10A", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r20": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147482739/220-10-55-15", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r200": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r201": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r202": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org//1943274/2147482635/260-10-55-15", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r203": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "272", "URI": "https://asc.fasb.org//1943274/2147483014/272-10-45-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r204": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "280", "URI": "https://asc.fasb.org//280/tableOfContent", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r205": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-15", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r206": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-21", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r207": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-21", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r208": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r209": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r21": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(22))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r210": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r211": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r212": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(g)", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r213": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r214": { "Name": "Accounting Standards Codification", "Paragraph": "26", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-26", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r215": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r216": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r217": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r218": { "Name": "Accounting Standards Codification", "Paragraph": "31", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-31", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r219": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r22": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147483489/210-10-50-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r220": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r221": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r222": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r223": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r224": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r225": { "Name": "Accounting Standards Codification", "Paragraph": "34", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-34", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r226": { "Name": "Accounting Standards Codification", "Paragraph": "40", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-40", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r227": { "Name": "Accounting Standards Codification", "Paragraph": "41", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-41", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r228": { "Name": "Accounting Standards Codification", "Paragraph": "41", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-41", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r229": { "Name": "Accounting Standards Codification", "Paragraph": "41", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-41", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r23": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19(a))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r230": { "Name": "Accounting Standards Codification", "Paragraph": "42", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-42", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r231": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "310", "URI": "https://asc.fasb.org//1943274/2147481990/310-10-45-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r232": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "310", "URI": "https://asc.fasb.org//1943274/2147481990/310-10-45-9", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r233": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "323", "URI": "https://asc.fasb.org//1943274/2147481664/323-10-45-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r234": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "323", "URI": "https://asc.fasb.org//1943274/2147481687/323-10-50-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r235": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "326", "URI": "https://asc.fasb.org//1943274/2147479654/326-10-65-4", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r236": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(e)(1)", "Topic": "326", "URI": "https://asc.fasb.org//1943274/2147479654/326-10-65-4", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r237": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(e)(2)", "Topic": "326", "URI": "https://asc.fasb.org//1943274/2147479654/326-10-65-4", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r238": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(c)(2)", "Topic": "326", "URI": "https://asc.fasb.org//1943274/2147479654/326-10-65-5", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r239": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "330", "URI": "https://asc.fasb.org//330/tableOfContent", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r24": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.20)", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r240": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "450", "URI": "https://asc.fasb.org//1943274/2147483076/450-20-50-4", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r241": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "450", "URI": "https://asc.fasb.org//1943274/2147483076/450-20-50-9", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r242": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "20", "Subparagraph": "(SAB Topic 5.Y.Q2)", "Topic": "450", "URI": "https://asc.fasb.org//1943274/2147480102/450-20-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r243": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "20", "Subparagraph": "(SAB Topic 5.Y.Q4)", "Topic": "450", "URI": "https://asc.fasb.org//1943274/2147480102/450-20-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r244": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(i))", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r245": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r246": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iv))", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r247": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(5))", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r248": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(i))", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r249": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r25": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.21)", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r250": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r251": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iv))", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r252": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(5))", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r253": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r254": { "Name": "Accounting Standards Codification", "Paragraph": "1D", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1D", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r255": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r256": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r257": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r258": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(g)", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r259": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r26": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.22(a)(1))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r260": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(i)", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r261": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-14", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r262": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-14", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r263": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-14", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r264": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-16", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r265": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-18", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r266": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-18", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r267": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-18", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r268": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.3-04)", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147480008/505-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r269": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "606", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-4", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r27": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.29,30)", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r270": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "606", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-5", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r271": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(i)", "Topic": "715", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r272": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(01)", "Topic": "715", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r273": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(02)", "Topic": "715", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r274": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(02)(A)", "Topic": "715", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r275": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(02)(B)", "Topic": "715", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r276": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(02)(C)", "Topic": "715", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r277": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(03)", "Topic": "715", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r278": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(d)", "Topic": "715", "URI": "https://asc.fasb.org//1943274/2147480576/715-80-50-5", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r279": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(i)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r28": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.29-31)", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r280": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(ii)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r281": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iii)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r282": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(01)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r283": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(02)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r284": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(03)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r285": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)(1)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r286": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)(2)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r287": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(ii)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r288": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(iii)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r289": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(iv)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r29": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.31)", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r290": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)(1)(i)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r291": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(i)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r292": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480336/718-10-65-15", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r293": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(f)(1)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480336/718-10-65-15", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r294": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(f)(2)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480336/718-10-65-15", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r295": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 14.F)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147479830/718-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r296": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org//1943274/2147482525/740-10-45-4", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r297": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org//1943274/2147482525/740-10-45-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r298": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-10", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r299": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)(2)", "Topic": "740", "URI": "https://asc.fasb.org//1943274/2147482615/740-10-65-8", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r3": { "Name": "Accounting Standards Codification", "Paragraph": "10A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a-c)", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-10A", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r30": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-14", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r300": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)(3)", "Topic": "740", "URI": "https://asc.fasb.org//1943274/2147482615/740-10-65-8", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r301": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(e)(1)", "Topic": "740", "URI": "https://asc.fasb.org//1943274/2147482615/740-10-65-8", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r302": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(e)(2)", "Topic": "740", "URI": "https://asc.fasb.org//1943274/2147482615/740-10-65-8", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r303": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(e)(3)", "Topic": "740", "URI": "https://asc.fasb.org//1943274/2147482615/740-10-65-8", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r304": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB TOPIC 6.I.7)", "Topic": "740", "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r305": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 6.I.Fact.1)", "Topic": "740", "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r306": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 6.I.Fact.2)", "Topic": "740", "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r307": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "805", "URI": "https://asc.fasb.org//1943274/2147479907/805-20-50-5", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r308": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "805", "URI": "https://asc.fasb.org//1943274/2147479907/805-20-50-5", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r309": { "Name": "Accounting Standards Codification", "Paragraph": "19", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "810", "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-19", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r31": { "Name": "Accounting Standards Codification", "Paragraph": "14A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-14A", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r310": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "810", "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-25", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r311": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "810", "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-25", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r312": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(1)", "Topic": "810", "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-1A", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r313": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)", "Topic": "810", "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-1A", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r314": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bb)", "Topic": "810", "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r315": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "810", "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r316": { "Name": "Accounting Standards Codification", "Paragraph": "4E", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4E", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r317": { "Name": "Accounting Standards Codification", "Paragraph": "5C", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-5C", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r318": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "20", "Subparagraph": "(e)", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r319": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "20", "Subparagraph": "(h)(1)", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r32": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-5", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r320": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "20", "Subparagraph": "(h)(1)(i)", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r321": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "20", "Subparagraph": "(h)(1)(iii)", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r322": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "20", "Subparagraph": "(h)(1)(iv)", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r323": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "20", "Subparagraph": "(i)(1)", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r324": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "20", "Subparagraph": "(i)(3)", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r325": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Subparagraph": "(f)", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480237/815-40-50-5", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r326": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Subparagraph": "(a)", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480237/815-40-50-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r327": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)(1)", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r328": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)(3)", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r329": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)(4)", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r33": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-12", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r330": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r331": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(c)(1)", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r332": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(c)(2)", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r333": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(c)(3)", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r334": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "820", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r335": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "820", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r336": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "820", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r337": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bbb)(1)", "Topic": "820", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r338": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bbb)(2)", "Topic": "820", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r339": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "820", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r34": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-14", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r340": { "Name": "Accounting Standards Codification", "Paragraph": "6A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "820", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-6A", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r341": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "825", "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-10", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r342": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "825", "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-28", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r343": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(e)(1)", "Topic": "825", "URI": "https://asc.fasb.org//1943274/2147482833/825-10-65-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r344": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(e)(2)", "Topic": "825", "URI": "https://asc.fasb.org//1943274/2147482833/825-10-65-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r345": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(e)(3)", "Topic": "825", "URI": "https://asc.fasb.org//1943274/2147482833/825-10-65-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r346": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "830", "URI": "https://asc.fasb.org//1943274/2147481839/830-10-45-17", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r347": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "830", "URI": "https://asc.fasb.org//1943274/2147481839/830-10-45-9", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r348": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "35", "SubTopic": "20", "Topic": "830", "URI": "https://asc.fasb.org//1943274/2147482014/830-20-35-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r349": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "35", "SubTopic": "20", "Topic": "830", "URI": "https://asc.fasb.org//1943274/2147482014/830-20-35-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r35": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-15", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r350": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "830", "URI": "https://asc.fasb.org//1943274/2147481956/830-20-45-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r351": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "830", "URI": "https://asc.fasb.org//1943274/2147481956/830-20-45-5", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r352": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "830", "URI": "https://asc.fasb.org//1943274/2147481926/830-20-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r353": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "230", "Topic": "830", "URI": "https://asc.fasb.org//1943274/2147481877/830-230-45-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r354": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "830", "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-12", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r355": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "830", "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-17", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r356": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "830", "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r357": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(b)", "Topic": "830", "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r358": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(c)", "Topic": "830", "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r359": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(d)", "Topic": "830", "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r36": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-15", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r360": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "830", "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-21", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r361": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "830", "URI": "https://asc.fasb.org//1943274/2147481674/830-30-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r362": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "835", "URI": "https://asc.fasb.org//1943274/2147483013/835-20-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r363": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "835", "URI": "https://asc.fasb.org//1943274/2147482900/835-30-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r364": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(f)(1)", "Topic": "842", "URI": "https://asc.fasb.org//1943274/2147479832/842-10-65-5", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r365": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(f)(3)", "Topic": "842", "URI": "https://asc.fasb.org//1943274/2147479832/842-10-65-5", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r366": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "SubTopic": "20", "Topic": "842", "URI": "https://asc.fasb.org//842-20/tableOfContent", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r367": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "842", "URI": "https://asc.fasb.org//1943274/2147479041/842-20-45-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r368": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "842", "URI": "https://asc.fasb.org//1943274/2147479041/842-20-45-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r369": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "842", "URI": "https://asc.fasb.org//1943274/2147479041/842-20-45-5", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r37": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-25", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r370": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "842", "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-4", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r371": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(g)(1)", "Topic": "842", "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-4", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r372": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(g)(3)", "Topic": "842", "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-4", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r373": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(g)(4)", "Topic": "842", "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-4", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r374": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(a)(3)(iii)(03)", "Topic": "848", "URI": "https://asc.fasb.org//1943274/2147483550/848-10-65-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r375": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "848", "URI": "https://asc.fasb.org//1943274/2147483550/848-10-65-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r376": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "852", "URI": "https://asc.fasb.org//1943274/2147481435/852-10-45-14", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r377": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(bb)(1)", "Topic": "860", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r378": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(bb)(2)", "Topic": "860", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r379": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(bb)(3)", "Topic": "860", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r38": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-4", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r380": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(1)", "Topic": "860", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r381": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "910", "URI": "https://asc.fasb.org//1943274/2147482546/910-10-50-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r382": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 11.L)", "Topic": "924", "URI": "https://asc.fasb.org//1943274/2147479941/924-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r383": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "20", "Subparagraph": "(f)(1)", "Topic": "926", "URI": "https://asc.fasb.org//1943274/2147483194/926-20-65-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r384": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "20", "Subparagraph": "(f)(2)", "Topic": "926", "URI": "https://asc.fasb.org//1943274/2147483194/926-20-65-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r385": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "20", "Subparagraph": "(f)(3)", "Topic": "926", "URI": "https://asc.fasb.org//1943274/2147483194/926-20-65-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r386": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(24))", "Topic": "942", "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r387": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(25))", "Topic": "942", "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r388": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(26))", "Topic": "942", "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r389": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(27))", "Topic": "942", "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r39": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r390": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "235", "Subparagraph": "(SX 210.9-05(b)(2))", "Topic": "942", "URI": "https://asc.fasb.org//1943274/2147479557/942-235-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r391": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "360", "Topic": "942", "URI": "https://asc.fasb.org//1943274/2147480842/942-360-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r392": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(12))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r393": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(21))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r394": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(22))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r395": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(23)(a)(3))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r396": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r397": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(24))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r398": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(25))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r399": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(8))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r4": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-12", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r40": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r400": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(10))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r401": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(16))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r402": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(17))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r403": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(18))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r404": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(20))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r405": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(21))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r406": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(22))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r407": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(23))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r408": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(8))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r409": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(9))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r41": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-25", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r410": { "Name": "Accounting Standards Codification", "Paragraph": "7A", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Subparagraph": "(d)", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147480081/944-40-50-7A", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r411": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r412": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)(1)", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r413": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)(2)", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r414": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(g)(2)(i)", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r415": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(g)(2)(ii)", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r416": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(g)(2)(iii)", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r417": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(g)(2)(iv)", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r418": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(h)(2)", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r419": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.6-03(d))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r42": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r420": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.6-03(i)(1))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r421": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.6-03(i)(2))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r422": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480990/946-20-50-11", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r423": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "205", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480767/946-205-45-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r424": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "205", "Subparagraph": "(a)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480767/946-205-45-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r425": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "205", "Subparagraph": "(a)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480767/946-205-45-4", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r426": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "210", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480555/946-210-45-4", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r427": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "210", "Subparagraph": "(a)(1)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r428": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "210", "Subparagraph": "(b)(1)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r429": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "210", "Subparagraph": "(b)(2)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r43": { "Name": "Accounting Standards Codification", "Paragraph": "41", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-41", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r430": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "210", "Subparagraph": "(c)(2)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r431": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "210", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-12", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r432": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "210", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r433": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "210", "Subparagraph": "(a)(1)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r434": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "210", "Subparagraph": "(a)(2)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r435": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "210", "Subparagraph": "(a)(4)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r436": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "210", "Subparagraph": "(e)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r437": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "210", "Subparagraph": "(f)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r438": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(1))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r439": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(12)(b)(1))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r44": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "350", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r440": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(12)(b)(2))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r441": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(12)(b)(3))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r442": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(13)(a)(1))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r443": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(13)(a)(2))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r444": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(13)(a)(3))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r445": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(16)(a))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r446": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(17))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r447": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(19))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r448": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(2)(a))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r449": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(2)(b))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r45": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "350", "URI": "https://asc.fasb.org//1943274/2147482686/350-30-45-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r450": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(3)(a))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r451": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(3)(b))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r452": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(3)(c))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r453": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(6)(b))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r454": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(6)(c))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r455": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(6)(d))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r456": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(6)(e))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r457": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(8))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r458": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(9)(b))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r459": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(9)(c))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r46": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "((a)(1),(b))", "Topic": "350", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r460": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(9)(d))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r461": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(9)(e))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r462": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-05(2))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r463": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-05(4))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r464": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "220", "Subparagraph": "(b)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483581/946-220-45-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r465": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "45", "SubTopic": "220", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483581/946-220-45-7", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r466": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07(1))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r467": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07(2)(a))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r468": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07(3))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r469": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07(7)(a)(1))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r47": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "360", "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r470": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07(7)(a)(2))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r471": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07(7)(a)(3))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r472": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07(7)(a)(5))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r473": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07(7)(a)(6))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r474": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07(7)(a)(7))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r475": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07(7)(c)(1))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r476": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07(7)(c)(2))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r477": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07(7)(c)(3))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r478": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07(7)(c)(5))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r479": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07(7)(c)(6))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r48": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481549/505-30-45-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r480": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07(7)(c)(7))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r481": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07(7))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r482": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07(9))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r483": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-09(1)(d))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r484": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-09(4)(b))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r485": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-09(6))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r486": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-09(7))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r487": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147481062/946-235-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r488": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(d)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147481062/946-235-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r489": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12(Column A)(Footnote 2))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r49": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481520/505-30-50-4", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r490": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12(Column C)(Footnote 5))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r491": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12A(Column A)(Footnote 2))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r492": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12A(Column C)(Footnote 4))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r493": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 4)(a))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r494": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 4)(b))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r495": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12B(Column C)(Footnote 2))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r496": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-13(Column A)(Footnote 3))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r497": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-13(Column G)(Footnote 8))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r498": { "Name": "Accounting Standards Codification", "Paragraph": "5A", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-13A(Column E))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5A", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r499": { "Name": "Accounting Standards Codification", "Paragraph": "5B", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-13B(Column E)(Footnote 4))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5B", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r5": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-14", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r50": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r500": { "Name": "Accounting Standards Codification", "Paragraph": "5B", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-13B(Column E))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5B", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r501": { "Name": "Accounting Standards Codification", "Paragraph": "5C", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-13C(Column H)(Footnote 7))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5C", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r502": { "Name": "Accounting Standards Codification", "Paragraph": "5C", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-13C(Column H))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5C", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r503": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-14(Column A)(Footnote 2))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r504": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-14(Column F)(Footnote 7))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r505": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "505", "Subparagraph": "(a)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r506": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "505", "Subparagraph": "(c)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r507": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "505", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r508": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "505", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r509": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "310", "Subparagraph": "(SX 210.12-29(Footnote 4))", "Topic": "948", "URI": "https://asc.fasb.org//1943274/2147479851/948-310-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r51": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r510": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "440", "Subparagraph": "(d)", "Topic": "954", "URI": "https://asc.fasb.org//1943274/2147480327/954-440-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r511": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column B))", "Topic": "970", "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r512": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column C))", "Topic": "970", "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r513": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column D))", "Topic": "970", "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r514": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column E))", "Topic": "970", "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r515": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column F))", "Topic": "970", "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r516": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column G))", "Topic": "970", "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r517": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column H))", "Topic": "970", "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r518": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column I))", "Topic": "970", "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r519": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Footnote 2))", "Topic": "970", "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r52": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r520": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Footnote 4))", "Topic": "970", "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r521": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "310", "Subparagraph": "(c)", "Topic": "976", "URI": "https://asc.fasb.org//1943274/2147482856/976-310-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r522": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "310", "Subparagraph": "(b)", "Topic": "978", "URI": "https://asc.fasb.org//1943274/2147482707/978-310-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r523": { "Name": "Accounting Standards Codification", "Paragraph": "4D", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(1)", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4D", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r524": { "Name": "Accounting Standards Codification", "Paragraph": "13H", "Publisher": "FASB", "Section": "55", "SubTopic": "40", "Subparagraph": "(b)", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147480046/944-40-55-13H", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r525": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147483467/210-10-45-1", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r526": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147483444/210-20-55-22", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r527": { "Name": "Accounting Standards Codification", "Paragraph": "52", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org//1943274/2147482635/260-10-55-52", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r528": { "Name": "Accounting Standards Codification", "Paragraph": "31", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-31", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r529": { "Name": "Accounting Standards Codification", "Paragraph": "12A", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "310", "URI": "https://asc.fasb.org//1943274/2147481933/310-10-55-12A", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r53": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)(1)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r530": { "Name": "Accounting Standards Codification", "Paragraph": "69B", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481568/470-20-55-69B", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r531": { "Name": "Accounting Standards Codification", "Paragraph": "69C", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481568/470-20-55-69C", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r532": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r533": { "Name": "Accounting Standards Codification", "Paragraph": "91", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "606", "URI": "https://asc.fasb.org//1943274/2147479777/606-10-55-91", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r534": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(ii)", "Topic": "715", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r535": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(01)", "Topic": "715", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r536": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "715", "URI": "https://asc.fasb.org//1943274/2147480482/715-20-55-17", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r537": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(a)", "Topic": "715", "URI": "https://asc.fasb.org//1943274/2147480576/715-80-50-11", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r538": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(a)", "Topic": "715", "URI": "https://asc.fasb.org//1943274/2147480576/715-80-50-6", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r539": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "55", "SubTopic": "80", "Topic": "715", "URI": "https://asc.fasb.org//1943274/2147480547/715-80-55-8", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r54": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Subparagraph": "(c)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480489/718-40-50-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r540": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(1)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r541": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(3)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r542": { "Name": "Accounting Standards Codification", "Paragraph": "4J", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "810", "URI": "https://asc.fasb.org//1943274/2147481175/810-10-55-4J", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r543": { "Name": "Accounting Standards Codification", "Paragraph": "4K", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "810", "URI": "https://asc.fasb.org//1943274/2147481175/810-10-55-4K", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r544": { "Name": "Accounting Standards Codification", "Paragraph": "4D", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(2)", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4D", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r545": { "Name": "Accounting Standards Codification", "Paragraph": "53", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "842", "URI": "https://asc.fasb.org//1943274/2147479589/842-20-55-53", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r546": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "852", "URI": "https://asc.fasb.org//1943274/2147481372/852-10-55-10", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r547": { "Name": "Accounting Standards Codification", "Paragraph": "29F", "Publisher": "FASB", "Section": "55", "SubTopic": "40", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147480046/944-40-55-29F", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r548": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "210", "Subparagraph": "(b)(1)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-1", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r549": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "210", "Subparagraph": "(a)(1)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r55": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "805", "URI": "https://asc.fasb.org//1943274/2147479328/805-10-50-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r550": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "55", "SubTopic": "210", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480493/946-210-55-1", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r551": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "310", "Subparagraph": "(d)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480833/946-310-45-1", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r552": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12(Column A)(Footnote 2)(i))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r553": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12A(Column A)(Footnote 2))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-2", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r554": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 1)(a))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r555": { "Name": "Accounting Standards Codification", "Paragraph": "5C", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-13C(Column A)(Footnote 1))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5C", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r556": { "Name": "Accounting Standards Codification", "Paragraph": "5C", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-13C(Column B)(Footnote 1))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5C", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r557": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-14(Column A)(Footnote 2))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r558": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "55", "SubTopic": "830", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480167/946-830-55-10", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r559": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "55", "SubTopic": "830", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480167/946-830-55-11", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r56": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "805", "URI": "https://asc.fasb.org//1943274/2147479328/805-10-50-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r560": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "55", "SubTopic": "830", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480167/946-830-55-12", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r561": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r562": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r563": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-2", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r564": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-23", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r565": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "d1-1", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r566": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "g", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r567": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12, 13, 15d", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r568": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "13e", "Subsection": "4c", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r569": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14d", "Subsection": "2b", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r57": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "805", "URI": "https://asc.fasb.org//1943274/2147479328/805-10-50-3", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r570": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "15", "Subsection": "d", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r571": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14a", "Subsection": "12", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r572": { "Name": "Form 10-K", "Number": "249", "Publisher": "SEC", "Section": "310", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r573": { "Name": "Form 10-Q", "Number": "240", "Publisher": "SEC", "Section": "308", "Subsection": "a", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r574": { "Name": "Form 20-F", "Number": "249", "Publisher": "SEC", "Section": "220", "Subsection": "f", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r575": { "Name": "Form 40-F", "Number": "249", "Publisher": "SEC", "Section": "240", "Subsection": "f", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r576": { "Name": "Forms 10-K, 10-Q, 20-F", "Number": "240", "Publisher": "SEC", "Section": "13", "Subsection": "a-1", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r577": { "Name": "Regulation S-T", "Number": "232", "Publisher": "SEC", "Section": "405", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r578": { "Name": "Securities Act", "Number": "230", "Publisher": "SEC", "Section": "405", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r579": { "Name": "Securities Act", "Number": "230", "Publisher": "SEC", "Section": "425", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r58": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "810", "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-15", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r580": { "Name": "Securities Act", "Number": "7A", "Publisher": "SEC", "Section": "B", "Subsection": "2", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r581": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(g)(1)", "Topic": "842", "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-4", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r582": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(1))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r583": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(3)(a)(4))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r584": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(6)(a)(1))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r585": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(6)(a)(4))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r586": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(8))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r587": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-4", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r588": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-5", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r589": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-6", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r59": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "810", "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-16", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r590": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r591": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(g)(1)(ii))", "Topic": "235", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r592": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(h)(1)(Note 1))", "Topic": "235", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r593": { "Name": "Accounting Standards Codification", "Paragraph": "23", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-23", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r594": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-24", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r595": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-5", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r596": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "260", "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-1", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r597": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "310", "URI": "https://asc.fasb.org//1943274/2147481990/310-10-45-13", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r598": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "323", "URI": "https://asc.fasb.org//1943274/2147481687/323-10-50-3", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r599": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(c)", "Topic": "410", "URI": "https://asc.fasb.org//1943274/2147481931/410-30-50-10", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r6": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-15", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r60": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "810", "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-21", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r600": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(i))", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r601": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(ii))", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r602": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iii))", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r603": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iv))", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r604": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iv))", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r605": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r606": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "606", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-5", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r607": { "Name": "Accounting Standards Codification", "Paragraph": "91", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "606", "URI": "https://asc.fasb.org//1943274/2147479777/606-10-55-91", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r608": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(01)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r609": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "25", "SubTopic": "50", "Topic": "805", "URI": "https://asc.fasb.org//1943274/2147480060/805-50-25-1", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r61": { "Name": "Accounting Standards Codification", "Paragraph": "4I", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "810", "URI": "https://asc.fasb.org//1943274/2147481175/810-10-55-4I", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r610": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "30", "SubTopic": "50", "Topic": "805", "URI": "https://asc.fasb.org//1943274/2147480027/805-50-30-1", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r611": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "30", "SubTopic": "50", "Topic": "805", "URI": "https://asc.fasb.org//1943274/2147480027/805-50-30-2", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r612": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-1A", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r613": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-1B", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r614": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)(3)", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r615": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bbb)(2)", "Topic": "820", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r616": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "825", "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-28", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r617": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "30", "Topic": "830", "URI": "https://asc.fasb.org//1943274/2147479424/830-30-S99-1", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r618": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "842", "URI": "https://asc.fasb.org//1943274/2147479041/842-20-45-4", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r619": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "850", "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-2", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r62": { "Name": "Accounting Standards Codification", "Paragraph": "4J", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "810", "URI": "https://asc.fasb.org//1943274/2147481175/810-10-55-4J", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r620": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "852", "URI": "https://asc.fasb.org//1943274/2147481404/852-10-50-7", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r621": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "852", "URI": "https://asc.fasb.org//1943274/2147481404/852-10-50-7", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r622": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(1)", "Topic": "860", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r623": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(2)", "Topic": "860", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r624": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(3)", "Topic": "860", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r625": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(1)", "Topic": "860", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r626": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(2)", "Topic": "860", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r627": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(3)", "Topic": "860", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r628": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(16)(a)(2))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r629": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(2))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r63": { "Name": "Accounting Standards Codification", "Paragraph": "4K", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "810", "URI": "https://asc.fasb.org//1943274/2147481175/810-10-55-4K", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r630": { "Name": "Accounting Standards Codification", "Paragraph": "2B", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147479432/944-30-50-2B", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r631": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "205", "Subparagraph": "(a)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480767/946-205-45-4", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r632": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "210", "Subparagraph": "(a)(3)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r633": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(18))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r634": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "220", "Subparagraph": "(i)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483581/946-220-45-3", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r635": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-09(4)(b))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r636": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-09(7))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r637": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12(Column A)(Footnote 2)(ii))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r638": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12A(Column A)(Footnote 2))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-2", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r639": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 1)(b))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r64": { "Name": "Accounting Standards Codification", "Paragraph": "4A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4A", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r640": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-14(Column A)(Footnote 2))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r65": { "Name": "Accounting Standards Codification", "Paragraph": "4B", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4B", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r66": { "Name": "Accounting Standards Codification", "Paragraph": "4C", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4C", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r67": { "Name": "Accounting Standards Codification", "Paragraph": "4D", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4D", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r68": { "Name": "Accounting Standards Codification", "Paragraph": "182", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480401/815-10-55-182", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r69": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "25", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480238/815-25-50-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r7": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "405", "Topic": "942", "URI": "https://asc.fasb.org//1943274/2147481071/942-405-45-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r70": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "820", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r71": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "835", "URI": "https://asc.fasb.org//1943274/2147482925/835-30-45-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r72": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "835", "URI": "https://asc.fasb.org//1943274/2147482925/835-30-45-3", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r73": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "55", "SubTopic": "30", "Topic": "835", "URI": "https://asc.fasb.org//1943274/2147482949/835-30-55-8", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r74": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03.10)", "Topic": "942", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r75": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(19))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r76": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(28))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r77": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(29))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r78": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30)(a)(1))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r79": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30)(a)(3))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r8": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "810", "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-20", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r80": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r81": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(31))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r82": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(32))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r83": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(6)(a))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r84": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(6)(b))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r85": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(6)(c))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r86": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-11", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r87": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(1))", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r88": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(12))", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r89": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(20))", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r9": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r90": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.1,2)", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r91": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.2(a),(d))", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r92": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.3)", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r93": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.4)", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r94": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.7)", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r95": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.9)", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r96": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "SubTopic": "20", "Topic": "220", "URI": "https://asc.fasb.org//220-20/tableOfContent", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r97": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-13", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r98": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-13", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r99": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-24", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" } }, "version": "2.2" } ZIP 54 0001753926-23-000594-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001753926-23-000594-xbrl.zip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end